category,datetime,headline,id,image,related,source,summary,url
company,2022-09-24 06:49:00,3 Medical Stocks Displaying Remarkable Relative Strength In 2022,116234351,https://images.pexels.com/photos/2383010/pexels-photo-2383010.jpeg?auto=compress&cs=tinysrgb&h=750&w=1260,AZN,TalkMarkets,3 medical stocks that displayed a substantial amount of relative strength year-to-date.,https://finnhub.io/api/news?id=5a5b8f9effec2f3b65eb2f13e494edb5f2be4dae9f85203a1eb64f10fe750aa1
company,2022-09-23 09:41:29,Ionis Pharmaceuticals Nosedives After AstraZeneca Drops High Cholesterol Drug Test,116215057,https://s.yimg.com/uu/api/res/1.2/JphEJ9EpEfrLXIR_ADszLg--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/616695ca8d8e75585248b67d063c72a1,AZN,Yahoo,Ionis stock tumbled Friday after partner AstraZeneca decided against sending their high cholesterol treatment into Phase 3 testing.,https://finnhub.io/api/news?id=fd82395bae129903210a057db12ff5ae7f671f19374c4f9b38a088cb49daf17b
company,2022-09-23 14:26:06,Ionis' (IONS) Hypercholesterolemia Drug Not to Enter Phase III,116225386,https://s.yimg.com/uu/api/res/1.2/c23rHSrGLTeyi6ecjtGakg--~B/aD0zNDY7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/88c5b382e5e9e4ea852e01bfc1435a7b,AZN,Yahoo,"Ionis (IONS) posts data from the phase IIb SOLANO study on ION449 for treating hypercholesterolemia. Though the study met the primary endpoint, ION449 will not advance into phase III development.",https://finnhub.io/api/news?id=907698df6d97076aa4aa7d30bdf59e31f64f2093621398dfe20e4c24e42f5900
company,2022-09-23 14:12:00,"ADRs End Lower, Alibaba and AstraZeneca Trade Actively",116242570,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,By Denny Jacob International stocks trading in New York closed lower on Friday. The S&P/BNY Mellon index of American depositary receipts dropped 3.4% to...,https://finnhub.io/api/news?id=3080191b492c739b7d27004e78c41f6fe1aa35313da83375c0141882205c1d85
company,2022-09-23 12:39:00,AstraZeneca PLC ADR underperforms Friday when compared to competitors,116223171,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR shed 3.07% to $54.58 Friday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite...",https://finnhub.io/api/news?id=838cb2d18669a677975a030087c766cc407cc5b4e51f5be1d018c3f275697946
company,2022-09-23 10:02:02,"Pharma Stock Roundup: EU Nod to AZN & RHHBY Drugs, FDA Updates for LLY & MRK",116219642,https://s.yimg.com/uu/api/res/1.2/VTpWEp9iphTX3xsYcMogbg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/ca9d72216d7bb42fc496430c3df29b41,AZN,Yahoo,"Roche's (RHHBY) eye drug, Vabysmo and AstraZeneca's (AZN) asthma drug Tezspire get approval in Europe. The FDA approves expanded use of Lilly's (LLY) cancer drug, Retevmo.",https://finnhub.io/api/news?id=ca5fbb3c03fadd2922292c4596a0757ef4d592fae798d048060193872da445e3
company,2022-09-23 09:12:01,AstraZeneca Pulls Plug On Ionis Pharma-Partnered Cholesterol Med,116225387,https://s.yimg.com/uu/api/res/1.2/Dv6AP_ySmVgN23LYluXzzA--~B/aD00MDA7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Benzinga/b2797ff8e382c0c7cc66b62c8d437dcb,AZN,Yahoo,"Ionis Pharmaceuticals Inc (NASDAQ: IONS) announced topline data from the Phase 2b SOLANO study of ION449 (AZD8233) for hypercholesterolemia (high cholesterol levels). Ionis said that although the candidate met the primary endpoint, its partners at AstraZeneca Plc (NASDAQ: AZN) have decided not to move it into Phase III studies because the ""results did not achieve pre-specified efficacy criteria."" The trial showed that 60mg of ION449 (AZD8233) administered monthly achieved a statistically signifi",https://finnhub.io/api/news?id=482f7b2a5e9ff8702824551806a12508e90c3e2c6be9a481bb71be0f5d5e957c
company,2022-09-23 06:45:38,"VGK: Deutsche Bank Sees Brutal EU Economic Contraction In 2023, Yet It May Still Be Overly Optimistic",116214591,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1367897388/image_1367897388.jpg?io=getty-c-w750,AZN,SeekingAlpha,Deutsche Bank expects EU economy to contract 2.2%. Read more to see why EU as a whole will underperform and VGK ETF's significant headwinds.,https://finnhub.io/api/news?id=1d3dcd0bc3aa41b1409bd329957105d8f67b22d5ef6ed9e3ab776bdb9dc2ab8a
company,2022-09-23 01:23:00,AstraZeneca's Ultomiris approved in Europe in gMG treatment,116219339,https://thefly.com/images/meta/hotstocks.jpg,AZN,Thefly.com,"The company states: ""... AZN",https://finnhub.io/api/news?id=0df59aa44062322313a3663a6eb244b546f1deb6acdcae83062b35fdabdbb524
company,2022-09-23 00:12:00,Ionis Pharmaceuticals announces AstraZeneca decision to not advance ION449 trial,116219340,https://thefly.com/images/meta/hotstocks.jpg,AZN,Thefly.com,"Ionis Pharmaceuticals (IO... IONS, AZN",https://finnhub.io/api/news?id=0d1b16a4235e78b9efdb9ba05f34a406923f291acec1ea9e24d4c8a78a4e5463
company,2022-09-22 23:19:00,TOP NEWS: AstraZeneca's Ultomiris approved in EU for myasthenia gravis,116219341,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=3b3a93989a78c66feb536e17947c839e41511640f305b1928818c0dea72e49c0
company,2022-09-22 22:43:00,LONDON BRIEFING: Smiths annual revenue rises; Made.com up for sale,116216508,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=3a0af6c3f2be8e4a436a5a6bf200b26ac03b6060c1a6544191f6366606fa3d85
company,2022-09-22 22:13:00,AstraZeneca Gets EU Approval for Ultomiris Drug,116223172,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,By Sabela Ojea AstraZeneca PLC said Friday that its Ultomiris drug has been approved in the European Union for the treatment of adults with the rare disease...,https://finnhub.io/api/news?id=647e0a9693ef6c8b97e565ce4d33c3e6f0a59b6014ea6d2a23e60aab4b668dbc
company,2022-09-28 14:52:00,Apellis Pharmaceuticals: Trying To Develop A Blockbuster Franchise,116314116,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/964042716/image_964042716.jpg?io=getty-c-w750,AZN,SeekingAlpha,"APLS' flagship product was rolled out last year, is pursuing other indications, and could eventually achieve blockbuster status. Read more on the stock here.",https://finnhub.io/api/news?id=a259c44386a86556ec84c8f8eab3116cb3eac27612c06a59633555a59a93cb21
company,2022-09-28 11:40:03,AZN vs. LLY: Which Stock Is the Better Value Option?,116309166,https://s.yimg.com/uu/api/res/1.2/bHsRpCKrGzzbaGHEolBtWw--~B/aD02MTg7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/023168c7ea091c342492be3899b280af,AZN,Yahoo,AZN vs. LLY: Which Stock Is the Better Value Option?,https://finnhub.io/api/news?id=0eddd68d2daa68642953b6e43309d3ff407a0601707151440a9303385ca92bf9
company,2022-09-28 09:06:20,PhaseBio Might Have To Return Global Rights To Its Lead Program,116306362,https://s.yimg.com/uu/api/res/1.2/6yhMIDEtuUBRRzLm721eRQ--~B/aD00MDA7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Benzinga/cf007d0a46fa511b5995913969670855,AZN,Yahoo,"PhaseBio Pharmaceuticals Inc (NASDAQ: PHAS) received a notice that its partner SFJ Pharmaceuticals Group elected to transfer bentracimab rights to SFJ as PhaseBio failed to remedy its Going Concern Condition. Formerly known as PB2452, bentracimab reverses the effects of AstraZeneca Plc's (NASDAQ: AZN) blood thinner Brilinta (ticagrelor) In January 2020, PhaseBio announced a financing and co-development partnership with SFJ Pharmaceuticals. PhaseBio retains exclusive worldwide commercial rights.",https://finnhub.io/api/news?id=6b3e04bb728de1537c02864828925648c94a317647a17776c3b98e1d98102469
company,2022-09-28 07:15:00,Cantor Fitzgerald healthcare analysts to hold KOL luncheon panel,116308315,https://thefly.com/images/meta/converenceevents.jpg,AZN,Thefly.com,"In conjunction with Canto... AZN, AMGN, MRTX, GILD, IMAB, NVS, SURF, PFE, ALXO, RHHBY, MRK",https://finnhub.io/api/news?id=1926d0e59864f56ab4cb7342c8c43478564671697ad81ed28a5aeef8646795e6
company,2022-09-28 07:00:18,"Covid vaccination linked to slight increase in menstrual cycle, NIH study confirms",116305920,https://image.cnbcfm.com/api/v1/image/107096030-1659098293923-gettyimages-1238021664-MASSACHUSETTS_VACCINES.jpeg?v=1664377218&w=1920&h=1080,AZN,CNBC,"A change in menstrual cycle length of eight days or less is considered within the normal range of variation, according to NIH.",https://finnhub.io/api/news?id=1b596a8670dfecb23c5abd1ce19f4fa8d0f01b4f81d725ffe852f5fd3f98f6c9
company,2022-09-28 01:22:00,7 Large-Cap Stocks With Sustained Dividend Growth Potential,116306451,https://investorplace.com/wp-content/uploads/2022/05/dividends_1600_kid.jpg,AZN,InvestorPlace,Large-cap stocks with dividend growth potential have robust cash flows and are likely to increase their dividends in the coming years.,https://finnhub.io/api/news?id=d0fc0634d42dd33b5c5321dbf712a3382c38a896924f696fdfc81260946c6fd0
company,2022-09-27 08:57:44,"Japan Approves AstraZeneca's Two Treatments For Asthma, Rare Form Of Cancer",116287523,https://s.yimg.com/uu/api/res/1.2/019Z7fIDHjjS0X2ctYCkFg--~B/aD00MDA7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Benzinga/51a2cc23a6cbfb23a80640fd054e7696,AZN,Yahoo,Japan's health agency has approved AstraZeneca Plc's (NASDAQ: AZN) Koselugo (selumetinib) for pediatric patients with plexiform neurofibromas (PNs) in neurofibromatosis type 1 (NF1) with clinical symptoms and which cannot be entirely removed by surgery without the risk of substantial morbidity. The approval is based on positive results from the SPRINT Stratum 1 Phase 2 trial that showed Koselugo reduced the size of inoperable tumors in children. The SPRINT Stratum 1 Phase 2 trial showed Koselugo,https://finnhub.io/api/news?id=3f47d3de3a725d54a53e8d5c7ad17dc7658a461932c8d186429eeddd12617233
company,2022-09-27 06:00:07,7 Vaccine Stocks to Sell ASAP Now That the ‘Pandemic’s Over’,116354682,https://s.yimg.com/uu/api/res/1.2/yAduqX6WbzPOI2m41YYgwg--~B/aD00MDA7dz03Mjg7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/investorplace_417/6771c817cd2954ad4c84683ca446dc0d,AZN,Yahoo,"As people acclimatize to the new normal, it’s time to look at some vaccine stocks to sell. Instead of relying primarily on vaccines and antiviral drugs, the government let people manage infections. Once infected with the less fatal strain, Omicron, people would isolate themselves for a few days and then return to work. By shifting away from its reliance on drug companies, investors must recognize there are vaccine stocks that it’s time to sell. The government cut orders for vaccines and antivira",https://finnhub.io/api/news?id=131bf33592a55a329c7bf5ef6e2da889c9550dfc8bae6027a694a9f352bcb9dd
company,2022-09-27 05:21:00,Adding $100 to These 7 Stocks Would Be a Genius Move Right Now,116274111,https://s.yimg.com/ny/api/res/1.2/C1JfAMPQ5MX0T9q7kCu1EA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD05MDA-/https://media.zenfs.com/en/motleyfool.com/56218cdff703949627aaf08d9b25e7c4,AZN,Yahoo,You don't need a mountain of cash to build wealth on Wall Street -- especially with deals like these.,https://finnhub.io/api/news?id=fa0c2aa16ca9eaa306b84ef725a736739a08ad09d766fb0543d0ea0372e21810
company,2022-09-27 03:01:49,Wall Street Breakfast: Dollar Vs. Stocks,116275581,https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png,AZN,SeekingAlpha,"Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify. Dollar vs. Stocks The U.S.",https://finnhub.io/api/news?id=c2cf63d6bc9cc770fa012680b40c2ff1c3d166e22bf0ca6cbb9e032deccc9ff3
company,2022-09-27 01:11:00,AstraZeneca's Koselugo approved in Japand for pediatric plexiform neurofibromas,116306453,https://thefly.com/images/meta/hotstocks.jpg,AZN,Thefly.com,"The company states: ""... AZN",https://finnhub.io/api/news?id=148162155a5009a63cd5f7a54e801a0fcb755d0477ff2fea12cedce945ac1ed4
company,2022-09-27 01:09:00,AstraZeneca's Tezspire approved in Japan for severe asthma treatment,116306454,https://thefly.com/images/meta/hotstocks.jpg,AZN,Thefly.com,"The company states: ""... AZN",https://finnhub.io/api/news?id=0ae75bf63c6e97c3482f457e06e307e22a4e769238dcb6b30b17052e954ccd3d
company,2022-09-27 01:08:00,7 Vaccine Stocks to Sell ASAP Now That the 'Pandemic's Over',116306455,https://investorplace.com/wp-content/uploads/2021/04/vaccine-passport-2.jpg,AZN,InvestorPlace,"Investors have seven widely-followed vaccine stocks to sell now, after the world decided the pandemic is over.",https://finnhub.io/api/news?id=2af780bf958979d59b5f108e0e9f81e16137a9646b0bb84a8a7257403c3dae43
company,2022-09-27 00:25:00,TOP NEWS: AstraZeneca's Tezspire and Koselugo approved in Japan,116306456,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=935906b592496262eeb8ed49f3c40cc6c41e4c5701451e430eb0d9627a8a0f4d
company,2022-09-26 11:17:03,AstraZeneca's (AZN) Ultomiris Gets EC Nod for New Indication,116261578,https://s.yimg.com/uu/api/res/1.2/LQ_ww2eZjlMvbiXmaf.EDA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9d995582658bf49e50317a8120603e3e,AZN,Yahoo,AstraZeneca's (AZN) Ultomiris becomes the first and only long-acting C5 inhibitor to be approved for gMG in Europe.,https://finnhub.io/api/news?id=64a36acd2a247ae06bffdc9ba8274b8f73af4437488be1562d4101dc445fe3f6
company,2022-09-26 09:03:32,10 Best Diabetes Stocks To Buy Now,116254991,,AZN,Yahoo,"In this article, we discuss the 10 best diabetes stocks to buy now. If you want to read about some more diabetes stocks, go directly to 5 Best Diabetes Stocks To Buy Now. The diabetes market has grown in the past few years as organizations and individuals in the private and public domains make significant […]",https://finnhub.io/api/news?id=e0150b0de4d4057006bdbe033fda7edc059af04fedb5ddd14bbe7b32070bbb23
company,2022-09-25 23:55:00,TOP NEWS: GSK names Burberry's Julie Brown as new CFO from May,116261316,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=b5edc63d52a3d8057f59e287fc1475769c88ea399ca64a0ba15501091490aec1
company,2022-09-25 22:47:00,LONDON BRIEFING: Unilever CEO to step down; RPS backs new takeover bid,116258770,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=bb819677cc694b31a6f657e7d48f0505f0ec1e82f659e352224692b123ab1898
company,2022-09-25 22:18:00,GSK Appoints Julie Brown as New CFO,116348652,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,"By Ian Walker GSK PLC said Monday that it has appointed Julie Brown as its new chief financial officer, replacing Iain Mackay, from May 2023. The...",https://finnhub.io/api/news?id=3721db422c5193f41f62a045ed14411d84a68f18eb654fe2907ebfe2b284f61f
company,2022-10-02 01:00:00,Investors shouldn't have to choose between 'growth' and 'safety' – this stock offers both,116376747,https://s.yimg.com/ny/api/res/1.2/S9kElCvV5yyBPbvFh0UaLw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD03NTE-/https://media.zenfs.com/en/the_telegraph_818/d39931e005c45108f650612dd60a2cb0,AZN,Yahoo,Investing in shares is a tough task at the best of times. The stock market’s continual ebb and flow between joy and despair means that investors can frequently find themselves on the wrong side of consensus views for extended periods.,https://finnhub.io/api/news?id=f8c1d134b8101c28eb2c066e9fc7c57b7221a0ae287e20898b1460002f55c92a
company,2022-09-30 06:50:10,5 Dividend Growth Stocks to Beat Market Volatility,116354681,https://s.yimg.com/uu/api/res/1.2/G05k0xkDQ621Nj5X9U6u9Q--~B/aD02NzU7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/5ef2abadfacf56ce9dded85e1dd08191,AZN,Yahoo,"Coca-Cola (KO), General Dynamics (GD), AstraZeneca (AZN), Boise Cascade (BCC), and Insperity (NSP) that offer dividend growth could be compelling picks amid market volatility.",https://finnhub.io/api/news?id=4737d7ee628ca59579f97ca391e412f5eeffc05f81ffbdc00f25366f2c6a7c5d
company,2022-09-29 03:07:00,GLOBAL BROKER RATINGS: Nordisk and GSK raised; BofA cuts Apple,116334219,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=6ab10417d5e11c28924b99a71e48fe6ec1749d34e7abcd822868fccb5a496ff3
company,2022-09-29 00:36:00,LONDON BROKER RATINGS: GSK raised to 'outperform'; RBC cuts THG,116335129,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=e667a5584e314031003c1fd98a6d2ae9d5d63e9ffa38dcd81a58fc31609568bf
company,2022-10-06 11:00:00,HONEYWELL BEGINS PRODUCTION OF NEAR-ZERO GLOBAL-WARMING-POTENTIAL MEDICAL PROPELLANT,116513003,https://s.yimg.com/uu/api/res/1.2/.dl5luSXFuTYY0C_9wRzxw--~B/aD04Mzt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/prnewswire.com/52f35805bebf4ce9fb06210799d2abf0,AZN,Yahoo,"Honeywell (Nasdaq: HON) today announced the opening of a plant in Baton Rouge, La., that is the company's first large-scale manufacturing site for Solstice® Air (HFO-1234ze(E) cGMP), a near-zero global-warming-potential (GWP) medical propellant for use in respiratory inhalers.",https://finnhub.io/api/news?id=38590ba56fa7787834173b13b8f6f6bb4a57217afc7df5b2d11580dbf5afaefe
company,2022-10-06 10:59:07,Top 20 Drug Companies in the World in 2022,116513014,https://s.yimg.com/uu/api/res/1.2/1.x_TmbebC4DnO9AYZ8ypw--~B/aD00NzQ7dz03Njg7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/d13bc0eacb984711f97f75d4d5fa774a,AZN,Yahoo,"In this article, we will be taking a look at the top 20 drug companies in the world in 2022. To skip our detailed analysis, you can go directly to see the top 5 drug companies in the world in 2022. While major pharmaceutical companies have always been derided for considering profits over the well-being […]",https://finnhub.io/api/news?id=c81b8dbe469c244a136597169eba47b170d040fd5916d13b17395fee01a31e6f
company,2022-10-06 07:34:00,AZN November 25th Options Begin Trading,116507277,,AZN,Stock Options Channel,"Staff article entitled AZN November 25th Options Begin Trading, about stock options, from Stock Options Channel.",https://finnhub.io/api/news?id=8bd9ce1b4c40c40b2df1560c8e421b13f3bca65ac6edfb6c8cf7740c618b9f47
company,2022-10-06 07:32:18,FTSE 100 to pay £81.5bn to investors in dividend bonanza,116502559,https://s.yimg.com/ny/api/res/1.2/nXyNS4QJNeRhzuQYLu04_w--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD03NTU-/https://s.yimg.com/os/creatr-uploaded-images/2020-12/cb9828c0-45c6-11eb-bbfd-a40c91a86109,AZN,Yahoo,FTSE 100 set for record cash returns to investors but dividend forecasts stall.,https://finnhub.io/api/news?id=c29b9cc11f8c6d21db1fd078f65587efb365540d1ad2d328726329829bc22bbe
company,2022-10-06 00:31:41,GSK: Some Upside Likely,116495607,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1282176744/image_1282176744.jpg?io=getty-c-w750,AZN,SeekingAlpha,"GSK's price might have underwhelmed recently, but it's picking up now. Read more to know why GSK stock looks like a buy to me.",https://finnhub.io/api/news?id=602169e29a354562d5f333c7a92e3e9fb5f479a8fcf1c896ba4feec13739e918
company,2022-10-05 09:12:16,10 Healthcare Stocks to Watch in Light of Biden’s ‘60 Minutes’ Interview,116465273,https://s.yimg.com/uu/api/res/1.2/BwZ6ltH8fATW46ejWybaHg--~B/aD01MDA7dz03NTA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/3370590db737e59fb2f15f745fd120ab,AZN,Yahoo,"In this article, we will be taking a look at the 10 healthcare stocks to watch in light of Biden’s 60 Minutes interview. To skip our detailed analysis of these stocks and Biden’s insights, you can go directly to see the 5 Healthcare Stocks to Watch in Light of Biden’s 60 Minutes Interview. On September […]",https://finnhub.io/api/news?id=0c3da75beb95b55568689a6ca72f34cc2980b2c77574db7ff2831af9f30d197f
company,2022-10-05 08:20:00,Biotech Alert: Searches spiking for these stocks today,116474401,https://image.thefly.com/catalog/201812/img_174.jpg,AZN,Thefly.com,"Stay ahead of biotech stocks seeing a surge in interest from retail and financial professional investors with this exclusive recap from The Fly LOGC, CALA, MYOV, ACOR, CDXC, AZN",https://finnhub.io/api/news?id=4dd8ccf25faf66114a95660a96ddcb13a93034222cd807c44389696c77b23811
company,2022-10-05 06:00:00,FOCUS-Fresenius taps pre-dialysis kidney care as drugs promise treatment change,116461723,https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png,AZN,Yahoo,"The world’s largest dialysis company is seeking out kidney disease patients long before they need the most acute form of care as it plans for growth of new drugs that attack the condition’s causes early on.  For decades, Germany's Fresenius Medical Care (FMC) has been the biggest player in the $50 billion U.S. market providing dialysis and related machines that help filter out blood toxins for people whose kidneys have failed to function.  The company’s 17.6 billion euros ($17.6 billion) in annual revenue has been sustained for decades by high rates of obesity and diabetes, which contribute to kidney damage.",https://finnhub.io/api/news?id=7df619006a4fb5c8dc0f0394919b7d4c283fe7bb84d77ff76a3eed078b0d2e99
company,2022-10-04 01:49:00,FDA approves Roche breast cancer detection test eligible for ENHERTU,116429347,https://thefly.com/images/meta/hotstocks.jpg,AZN,Thefly.com,"Roche (RHHBY) ""annou... RHHBY, AZN, DSNKY",https://finnhub.io/api/news?id=f0fa2c7c781432c486c63a09d08c12e10c512028e99caf26cd639becd3393af4
company,2022-10-03 18:15:10,Astrazeneca (AZN) Gains But Lags Market: What You Should Know,116409331,https://s.yimg.com/uu/api/res/1.2/I67vygGrP1BjgOjVx.apeA--~B/aD03Mjg7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/b9775f315e7b6c4ada6e36d0048a929a,AZN,Yahoo,"Astrazeneca (AZN) closed at $55.55 in the latest trading session, marking a +1.29% move from the prior day.",https://finnhub.io/api/news?id=88ba9fce21e01c50a778b313b7eb6fb91919eb4799232a0d2f7b05e0f600c3ed
company,2022-10-03 14:37:44,AstraZeneca acquires local startup at 660% premium,116409332,https://s.yimg.com/uu/api/res/1.2/YpeMcTx7EAePrHwKe0gWYA--~B/aD0xNzY4O3c9MTE3OTthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/bizjournals.com/2cf4cd2a6fbff16a7f669726d1bc2437,AZN,Yahoo,"AstraZeneca Rare Disease, the local division formed when the British pharma giant acquired Alexion Pharmaceuticals Inc. last year, has scooped up a struggling local biotech at a significant premium.  AstraZeneca plc (Nasdaq: AZN) is buying LogicBio Therapeutics Inc. (Nasdaq: LOGC) for $2.07 per share, a 660% premium that values the total acquisition at $68 million.  Lexington-based LogicBio has been struggling since February, when the U.S. Food and Drug Administration ordered a halt to an early-stage trial testing a drug in pediatric patients with methylmalonic acidemia, a disorder in which the body cannot break down certain proteins and fats.",https://finnhub.io/api/news?id=880a77d84007270a70ee6e57d32d76c37439efeadbf259a5dd17ce7461c6549d
company,2022-10-03 13:59:00,"ADRs End Higher, ABB and AstraZeneca Trade Actively",116591541,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,By Denny Jacob International stocks trading in New York closed higher Monday. The S&P/BNY Mellon index of American depositary receipts edged up 2.6% to...,https://finnhub.io/api/news?id=cb35d951b6dd31480f7646428d107154c4da8c0a8eb270cc6daa8c9e99678988
company,2022-10-03 09:56:05,LogicBio's stock skyrockets after buyout bid for a 667% premium,116409333,https://s.yimg.com/uu/api/res/1.2/S8SCotpO9m2XQyQUIGU5dw--~B/aD02MzA7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/marketwatch.com/96d076434b2a015a3010bd2787b8c856,AZN,Yahoo,"Shares of LogicBio Therapeutics Inc. skyrocketed more than seven-fold (up 643%) in morning trading, to bounce off the previous session's record low, after the genetic medicine company announced an agreement to be acquired by AstraZeneca PLC's Alexion, AstraZeneca Rare Disease in a deal that values LogicBio at about $68.23 million. The stock had closed Friday at a record low of 27 cents, representing a market capitalization for LogicBio of about $8.9 million. Under terms of the buyout deal, Alexi",https://finnhub.io/api/news?id=380d0dc990bcb79e69668aaf0082dff0307a9c38814e6e0b44d89813312e8331
company,2022-10-03 07:21:52,Why Are LogicBio Therapeutics Shares Skyrocketing Today?,116409335,https://s.yimg.com/uu/api/res/1.2/BZRCrFalTrLGt4q7VU5SIQ--~B/aD00MDA7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Benzinga/bc0d9bab42bc482b4fbb47bc01474da2,AZN,Yahoo,"AstraZeneca Plc's (NASDAQ: AZN) subsidiary, Alexion, has agreed to acquire LogicBio Therapeutics Inc (NASDAQ: LOGC) for $2.07 per share. Both boards have unanimously approved the transaction. Alexion plans to close the deal in four to six weeks, subject to the tender of at least a majority of the outstanding shares of LogicBio common stock. It plans to retain LogicBio employees at their current location. Also Read: LogicBio Therapeutics Shares Skyrocket As FDA Lifts Clinical Hold On Its Pediatri",https://finnhub.io/api/news?id=ac4293917d8646b5d632517ccb939060d2332343966c7589db5e9ef805b40fcb
company,2022-10-03 07:15:00,"Alexion, AstraZeneca Rare Disease to Acquire LogicBio® Therapeutics to Accelerate Growth in Genomic Medicine",116409336,https://s.yimg.com/uu/api/res/1.2/phVqOTuNMtcJcb5UnZnkRQ--~B/aD0xNTk7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/67b05b4a9c5efa51a7be417ab9bd851a,AZN,Yahoo,"WILMINGTON, Del., October 03, 2022--Alexion, AstraZeneca Rare Disease, today announced that it has entered a definitive agreement to acquire Lexington, Mass.-based LogicBio® Therapeutics, Inc. (NASDAQ: LOGC), a pioneering genomic medicine company. The proposed acquisition aims to rapidly accelerate Alexion’s growth in genomic medicines through LogicBio’s unique technology, experienced rare disease R&D team, and expertise in pre-clinical development.",https://finnhub.io/api/news?id=c7db7f93a3ece8297329e3d07cdf58314726428d5806da03dc81120569c6841e
company,2022-10-03 06:51:00,LogicBio Therapeutics Shares Soar on Takeover by AstraZeneca >LOGC,116591542,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,By Colin Kellaher Shares of LogicBio Therapeutics Inc. skyrocketed Monday after the genetic-medicine company agreed to be acquired by Anglo-Swedish pharma...,https://finnhub.io/api/news?id=0201dcb3a54d63ee982cbbbe6b635a6a37150bb71a12aead20d8e49b587ddb19
company,2022-10-03 05:36:00,Why Is LogicBio (LOGC) Stock Up 600% Today?,116430551,https://investorplace.com/wp-content/uploads/2019/08/azn-stock-3.jpg,AZN,InvestorPlace,LogicBio (LOGC) stock is seeing massive gains on Monday following news that AstraZeneca (AZN) subsidiary Alexion is acquiring the company.,https://finnhub.io/api/news?id=861c17784a5c82aec641b1efeb4b7387fcd19a1a83469a9e6a0235e00c869b85
company,2022-10-03 04:30:08,"Zacks.com featured highlights include Coca-Cola, General Dynamics, AstraZeneca, Boise Cascade and Insperity",116409338,https://s.yimg.com/uu/api/res/1.2/5qKaX7h6rX3X7AdNi5sLsA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/620c947649b5dd3d93ee6e3e17bfae15,AZN,Yahoo,"Coca-Cola, General Dynamics, AstraZeneca, Boise Cascade and Insperity have been highlighted in this Screen of The Week article.",https://finnhub.io/api/news?id=7b8b876f603b1317782b7ba35ba3b907fe846179ca8c4971751bf5f678030ca8
company,2022-10-03 03:57:00,Fly Intel: Pre-market Movers,116400279,https://image.thefly.com/catalog/202004/img_793.jpg,AZN,Thefly.com,"Myovant Sciences soars following acquisition proposal from Sumitovant Biopharma LOGC, MYOV, VSAT, BOX, WFC, APRN, CS, TSLA, DOCU, AZN",https://finnhub.io/api/news?id=1cf4de69bdac8ab5317ec4facf6ad84d48a1ba592d4686dd71b4f2366b58a4db
company,2022-10-03 03:27:00,AstraZeneca to Buy LogicBio Therapeutics for $68 Million >LOGC,116591544,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,By Colin Kellaher LogicBio Therapeutics Inc. on Monday said it agreed to be acquired by AstraZeneca PLC for about $68 million in a deal supporting the...,https://finnhub.io/api/news?id=2a04a2a27e02c9448b4d6484a981c6634c534bc32a66eb758f5d0b7a7f5fa45e
company,2022-10-03 03:22:00,,116432434,,AZN,TipRanks,,https://finnhub.io/api/news?id=b4817a7385484584b49f77b817af8aad3fbf701f5c7bd45c3454bd00bc75ae70
company,2022-10-03 02:35:00,"Alexion, AstraZeneca Rare Disease to acquire LogicBio for $2.07 per share",116432437,https://thefly.com/images/meta/hotstocks.jpg,AZN,Thefly.com,"Alexion (ALXN), AstraZene... ALXN, AZN, LOGC",https://finnhub.io/api/news?id=44102d37e0709a74f89c63a9edbc01011b4fb84074813a4d31149a9b52667c30
company,2022-10-03 02:02:00,"Alexion, AstraZeneca Rare Disease to acquire LogicBio Therapeutics for $2.07 p/s",116432438,https://thefly.com/images/meta/hotstocks.jpg,AZN,Thefly.com,"LogicBio Therapeutics (LO... LOGC, AZN",https://finnhub.io/api/news?id=4bc4dedaa521603823c6a87ae9cd3f62d9fd938e922999e9a3fd5dfd5a482983
company,2022-10-03 00:36:00,Large Cap Biopharmaceuticals: Core Holdings For Your Portfolio ,116429088,https://cdn.pixabay.com/photo/2018/07/15/10/44/dna-3539309_960_720.jpg,AZN,TalkMarkets,Now that some clarity is apparent for drug pricing legislation you should have a few large-cap biopharmaceutical stocks in your portfolio.,https://finnhub.io/api/news?id=e586d7b067baa4caedf4f0bf0873b3145abd9657570bee9335d39e0401f9311e
company,2022-10-10 19:01:53,Nasal version of Oxford/AstraZeneca Covid vaccine fails in trial,116582931,https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png,AZN,Yahoo,"A nasal version of the Oxford/AstraZeneca Covid-19 vaccine has failed in an early-stage trial, dealing a blow to hopes for a more effective way to prevent transmission of the virus.  Oxford university said on Tuesday a nasal formulation of the vaccine elicited mucosal antibody responses in a “minority of participants” and systemic immune responses were weaker compared with intramuscular vaccination.  The setback highlights the complexity of designing a nasal formulation against coronavirus, which spreads through tiny particles in the air.",https://finnhub.io/api/news?id=f28ff91b86e2ed09da67c4770816606d57eecd2336049e1115cb11503b7ae4dc
company,2022-10-10 19:01:00,AstraZeneca's COVID vaccine suffers a setback in nasal spray trial,116582819,https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png,AZN,Yahoo,"Attempts by Oxford University researchers and AstraZeneca Plc  to create a nasal-spray version of their jointly developed COVID-19 shot suffered a setback on Tuesday as initial testing on humans did not yield the desired protection.  An antibody response in the respiratory mucous membranes was seen in only a minority of participants in the trial, which was in the first of usually three phases of clinical testing, the University of Oxford said in a statement on Tuesday.  Also, the immune response measured in the blood was weaker than that from a shot-in-the-arm vaccination.",https://finnhub.io/api/news?id=374a5e0c2c886e3c2c006f0b5f47629995e17afb80f10f13d345acd01f34e28a
company,2022-10-10 10:52:02,"Apellis' (APLS) Empaveli Aids Growth, Stiff Competition a Woe",116579254,https://s.yimg.com/uu/api/res/1.2/LQ_ww2eZjlMvbiXmaf.EDA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9d995582658bf49e50317a8120603e3e,AZN,Yahoo,"Apellis' (APLS) lead drug, Empaveli, is approved for treating paroxysmal nocturnal hemoglobinuria. The drug's label expansion studies hold promise. Stiff competition remains an overhang.",https://finnhub.io/api/news?id=893c5f78ded6e3e846f3c9b4c9cef2b041ec889954008ad81b72211893bfb243
company,2022-10-10 06:57:38,Strong Dollar Means Buy Abroad - Assessing Foreign Assets,116572640,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/483658563/image_483658563.jpg?io=getty-c-w750,AZN,SeekingAlpha,"Investors are flocking to USD, and most foreign currencies are now weak. Click here to know about the ways that a strong USD influences foreign assets.",https://finnhub.io/api/news?id=ad131762e58825905289704128bb76b5fef2685cb0c883fdeeac52eb07443edc
company,2022-10-09 07:00:00,"Have $2,000? 2 Market Crash-Ready Stocks to Buy",116572215,https://s.yimg.com/ny/api/res/1.2/sTOFdpmGyOVRINyHsjDMwA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/496e4189e452d73b67ea0965b2244308,AZN,Yahoo,"Specifically, there are a pair of pharmaceutical companies whose roster of in-demand medicines makes their prospects better than most in the face of market turbulence of any kind, so let's analyze each and see why they could be a smart pickup for some downside protection.  Pfizer (NYSE: PFE) is a company that needs no introduction, especially not after its rapid development and commercialization of Comirnaty, its coronavirus vaccine.  Furthermore, Pfizer has a veritable cornucopia of other medicines that people rely on, too.",https://finnhub.io/api/news?id=811e99cc0a192c8422dc2292a297ff93af167ffef599cb637b8dcc6608c55d8d
company,2022-10-07 15:12:52,Here’s Why AstraZeneca PLC (AZN) Benefited in the Second Quarter,116532710,https://s.yimg.com/uu/api/res/1.2/5pauLosoN1w4T3nTn6aJWQ--~B/aD01MTI7dz03Njg7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/d7b54ab6c172424f8eb29273c1277201,AZN,Yahoo,"Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Growth & Income Fund” second quarter 2022 investor letter. A copy of the same can be downloaded here. Since 2015, for the first time, the market witnessed two consecutive quarterly losses. During the second quarter, the S&P 500 Index continued its decline, trading at -16.1%. […]",https://finnhub.io/api/news?id=4d176c65650efca26ca7e1a0405e1448fecb7d5cafb11d092a32da8d39a170ff
company,2022-10-07 14:54:54,Omicron BA.4.6 subvariant makes up nearly 14% of COVID variants in U.S. - CDC,116529020,https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png,AZN,Yahoo,"The U.S. Centers for Disease Control and Prevention (CDC) on Friday estimated that by Oct. 8 nearly 14% of the circulating coronavirus variants in the United States were of the BA.4.6 subvariant of Omicron.  The subvariant has been slowly increasing in prevalence across the U.S., even as the BA.5 subvariant of Omicron remains the dominant strain with 79.2% of the cases.  The BA.4.6 subvariant has been found to be better at evading COVID-19 antibody therapies, with the U.S. Food and Drug Administration in early October warning healthcare providers that AstraZeneca's Evusheld had the risk of being ineffective against some variants it cannot neutralize.",https://finnhub.io/api/news?id=ed1e83519391fc96df8b489f46dd73bf0de7b132b75a919dce53a07458bd9b08
company,2022-10-07 01:40:00,Home - The Fly,116529446,https://thefly.com/images/meta/metatags.jpg,AZN,Thefly.com,The Fly is a leading digital publisher of real-time financial news. The Fly team scours all sources of company news and delivers short-form stories consisting of only market moving content.,https://finnhub.io/api/news?id=1fe3021417d6a97e744728e7d1a827aeb21c455bf19f55d9c3122a590bc19c82
company,2022-10-14 12:39:00,"AstraZeneca PLC ADR falls Friday, still outperforms market",116709964,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR shed 1.01% to $54.97 Friday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite...",https://finnhub.io/api/news?id=de99c6d90290fbfb8cfbf7cb04fe597fafa1a16df39199a3697bc9ceb811021f
company,2022-10-14 10:15:00,2 Top Biotech Stocks to Buy Right Now,116649034,https://s.yimg.com/ny/api/res/1.2/YDq.jYO_uo4xxrT488b4Ng--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/7230e0dab5d375315f86f598e25758e1,AZN,Yahoo,Healthcare is a reliable sector of the economy for those looking to create wealth over the long haul.,https://finnhub.io/api/news?id=f218a3bc4a1f81acefd396358e89c02d10a029791d51103f44eafda20215c79f
company,2022-10-13 18:00:10,Astrazeneca (AZN) Gains But Lags Market: What You Should Know,116628689,https://s.yimg.com/uu/api/res/1.2/e0VWXB5.wUFiKGuJPPpLzg--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/a7cdcede0bb5a646be035f4a7e678781,AZN,Yahoo,"In the latest trading session, Astrazeneca (AZN) closed at $55.53, marking a +0.84% move from the previous day.",https://finnhub.io/api/news?id=b84c0b0ed44054dd663281f4aeb789a091e40f96545cb39e7a2fe382c78e98f9
company,2022-10-13 12:38:00,"AstraZeneca PLC ADR rises Thursday, still underperforms market",116709965,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR inched 0.84% higher to $55.53 Thursday, on what proved to be an all-around great trading session for the stock market, with the...",https://finnhub.io/api/news?id=bab89505519189c01d9542f1db925fa45bc059d30680472c46c127e9b1ce3e2c
company,2022-10-13 10:30:00,3 Incredibly Cheap Blue Chip Stocks to Buy Right Now,116621535,https://s.yimg.com/ny/api/res/1.2/g6hWR8ssg.Kx4A4I16TxIg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD01NDk-/https://media.zenfs.com/en/motleyfool.com/5aaf145ce6c9b1d21632a13400679150,AZN,Yahoo,"Bear markets are never fun.  Good news often fails to land with investors, blue chip stocks rarely prove to be rock-solid safe havens, and important sources of passive income, such as dividends, can dry up as companies rethink their capital allocation strategies.  History has shown, however, that bear markets are some of the best times to buy equities and hold them for long periods.",https://finnhub.io/api/news?id=4544183f8b2261919b7b583709ab8103665f3f5f8649de6c2e7ce2e96c19116e
company,2022-10-12 18:15:10,Astrazeneca (AZN) Dips More Than Broader Markets: What You Should Know,116619190,https://s.yimg.com/uu/api/res/1.2/nxwFIPS2ImeTQYZMYlnAgg--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/1a018a29aef5adbf5b4319f32058e209,AZN,Yahoo,"In the latest trading session, Astrazeneca (AZN) closed at $55.07, marking a -0.42% move from the previous day.",https://finnhub.io/api/news?id=b046aeee0194a13641ffc74197a39375f80104ad0e5710e7e2185daff5ee6227
company,2022-10-12 12:39:00,AstraZeneca PLC ADR outperforms competitors despite losses on the day,116709966,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR slumped 0.42% to $55.07 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=29829925683513f4c70ace12d44ab3d53abfb517b7a8c16ada89a3d21b9c9595
company,2022-10-12 09:31:32,10 Best Cancer Stocks to Buy Now,116608550,https://s.yimg.com/uu/api/res/1.2/tt5ZPXm5C8joAWdYSrUXQw--~B/aD01MTI7dz03Njg7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/f684954d16386fc36b032963179d458b,AZN,Yahoo,"In this article, we discuss the 10 best cancer stocks. To skip the detailed analysis of the oncology market, go directly to 5 Best Cancer Stocks to Buy Now. Due to the COVID-19 pandemic, the oncology segment of the market saw a slight impact. The screening and oncology care services saw a decline in priority […]",https://finnhub.io/api/news?id=ffabc9a8afe7a5543a8835112d542b8c88c02d6365356b5be0a5dafcfa9524d2
company,2022-10-12 09:15:00,2 No-Brainer Stocks to Buy Right Now for Less Than $100,116607017,https://s.yimg.com/ny/api/res/1.2/mvO3v9Z2olbtLqBmo.I1BA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/dae62f925f45ae158b925f82e5a9eaab,AZN,Yahoo,Here are two excellent companies to consider: AstraZeneca (NASDAQ: AZN) and Roku (NASDAQ: ROKU).  U.K.-based AstraZeneca has a rich and diversified lineup of drugs.  The company's best-selling therapeutic area is oncology.,https://finnhub.io/api/news?id=7666dd362e5d2bbb1200443e900630f12e64e8c64b0a98a34cf8efb54ccb1196
company,2022-10-12 08:01:00,U.K. stocks drop for sixth day,116709967,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,"U.K. stocks fell Wednesday, as the FTSE 100 Index finished down 0.86% at 6,826.15. Of the FTSE 100 constituents, clothing retail company JD Sports Fashion...",https://finnhub.io/api/news?id=c626d112cbc35c8cd7bf9aad5d5cdaf8a8797dde64e3c9dc4da6a485f23c4bc3
company,2022-10-12 08:00:00,LONDON MARKET CLOSE: Stocks down as BoE confirms end to bond-buying,116609636,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=8971f41cbc760577634a3003b439974eeafd7675c497977ea8220193fbdc8ae6
company,2022-10-12 07:00:00,Alexion aims to advance NMOSD treatment landscape with exceptional ULTOMIRIS® (ravulizumab-cwvz) efficacy data at ECTRIMS 2022,116612901,https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png,AZN,Yahoo,"WILMINGTON, Del., October 12, 2022--Alexion, AstraZeneca Rare Disease, will present new data showing significant advances for the treatment of anti-aquaporin-4 (AQP4) antibody-positive (Ab+) neuromyelitis optica spectrum disorder (NMOSD) at the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) Congress, October 26 to 28, 2022.",https://finnhub.io/api/news?id=0ca868a638b80a3ce0bc9ee3f872501219af6658de6fb4c85f99c8703fb5a8b4
company,2022-10-12 02:08:00,"Alexion, AstraZeneca Rare Disease to present new Ultomiris data",116611750,https://thefly.com/images/meta/hotstocks.jpg,AZN,Thefly.com,"Alexion (ALXN), AstraZene... ALXN, AZN",https://finnhub.io/api/news?id=d2a933b9147b3bb737a5313740567a6ffe32873b0658b6ee67330786c8c0bca5
company,2022-10-12 01:47:00,AstraZeneca to show 'exceptional' data on neuromyelitis drug Ultomiris,116611752,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=57215fa8cb496f85e32fbd976c242fcfaf5b939e019719611912faa0c3fb45ff
company,2022-10-12 01:15:00,AstraZeneca's  Alexion to present new data on advancement in treating NMOSD,116611753,https://thefly.com/images/meta/hotstocks.jpg,AZN,Thefly.com,"The company states: ""... AZN",https://finnhub.io/api/news?id=497e2fc908fa1a7010ebb1946bd80e03410353d4490881782da830a8374f0094
company,2022-10-11 22:23:00,Illumina collaborates with AstraZeneca on AI-focused research,116611755,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=d43a1ba628917a35ff9d4d18ad70999c2ffeeae0e05443718a25b0342202f5c5
company,2022-10-11 12:18:47,Illumina Inks AI Pact With AstraZeneca To Accelerate Drug Target Discovery,116596337,https://s.yimg.com/uu/api/res/1.2/EYh58YC4T47.B7teNzsMsQ--~B/aD00MDA7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Benzinga/c91333929e4155e828b6e1e263d15e6e,AZN,Yahoo,"Illumina Inc (NASDAQ: ILMN) entered a strategic research collaboration with AstraZeneca plc (NASDAQ: AZN) on drug target discovery. Financial and other details of the partnership were not disclosed. Under the terms of the agreement, the firms will join forces on artificial intelligence-based genome interpretation and genomic analysis and evaluate whether a combined framework can increase the yield of and confidence in target discovery. AstraZeneca's Center for Genomics Research will use the comb",https://finnhub.io/api/news?id=9eac5da8663538dde47f32dfdfba66b0caf78889b96b619d70031a8809d06fbd
company,2022-10-11 08:19:54,GSK to Hire Top AstraZeneca Dealmaker After Agreement Reached,116593567,https://s.yimg.com/ny/api/res/1.2/bA7aS_HwWMviz9TP4hdNNA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/bloomberg_markets_842/45ae393a871cefc89598dd7c9c4d9b6c,AZN,Yahoo,"(Bloomberg) -- GSK Plc is free to hire a top dealmaker from AstraZeneca Plc after reaching an agreement with its rival, which had sued to block the sharing of sensitive information.Most Read from BloombergHere’s How Weird Things Are Getting in the Housing MarketThis Is What 7% Mortgages Will Do to the Housing MarketIt’s Official: The Fed’s in the RedThe Most Powerful Buyers in Treasuries Are All Bailing at OnceScreening Procedure Fails to Prevent Colon Cancer Deaths in Large StudyChris Sheldon w",https://finnhub.io/api/news?id=1e6ef8e6d071a6a51336730976a48bc3b90b6e9e96d8a16c55eb0692acc7409a
company,2022-10-11 07:59:35,Oxford/AstraZeneca COVID vaccine nasal spray fails in trial,116596339,https://s.yimg.com/ny/api/res/1.2/jD26i0vJH7uM9MdHNEAIhQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04NjY-/https://media.zenfs.com/en/fortune_175/ee5ec63ea38bbb383475de0bb4ec1fc7,AZN,Yahoo,The nasal version of the Oxford/AstraZeneca COVID vaccine failed to elicit an antibody response in an early trial and the company is shelving its development,https://finnhub.io/api/news?id=726a58cfcab4d4872fe3e014faf5e8a7475937d3352769f7a30b1c6591a16d8e
company,2022-10-11 07:50:36,AstraZeneca-Oxford University Partnered Nasal COVID-19 Vaccine Flunks Human Trial,116596340,https://s.yimg.com/uu/api/res/1.2/5riNCS.fLi4tEViOhSQdZw--~B/aD00MDA7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Benzinga/808f8444f956e09f09ede6d4c88b8e37,AZN,Yahoo,"AstraZeneca Plc (NASDAQ: AZN) and Oxford University scientists said that the initial testing of its nasal COVID-19 vaccine did not yield the desired protection. The AstraZeneca-funded phase 1 trial tested the efficacy of the Oxford vaccine when delivered through a simple device that sprays droplets up the nose. In a statement, the University of Oxford said that an antibody response in the respiratory mucous membranes was seen in only a minority of participants in the trial. While the trial raise",https://finnhub.io/api/news?id=88c4a414f155700a8448204498b5e192928c24ab6ba2111a46b03b01a27ccbc1
company,2022-10-11 07:00:00,"AstraZeneca Looks to Cancer, RSV Drugs for Growth as Covid-Vaccine Demand Wanes",116582930,https://s.yimg.com/ny/api/res/1.2/769MYC9pLmn3VY1kn.Tj7A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02MDA-/https://media.zenfs.com/en/wsj.com/4f0f34a27711bc0fbd9ef17810087e67,AZN,Yahoo,The British drugmaker is reducing production of its Covid-19 vaccine and betting on new therapies for other conditions.,https://finnhub.io/api/news?id=dbd1588b92d98d2ba16ab5c4c5048e80a0596d995d021c250895842bcd8785dd
company,2022-10-11 04:17:00,Illumina launches strategic research collaboration with AstraZeneca,116589466,https://thefly.com/images/meta/hotstocks.jpg,AZN,Thefly.com,"Illumina (ILMN) announced... ILMN, AZN",https://finnhub.io/api/news?id=9e84ed06400b940a5837dd91c6c7be565110e7c64509c7bf0605b5d87a2313a1
company,2022-10-11 02:48:00,"AstraZeneca price target lowered to 11,800 GBp from 12,000 GBp at Guggenheim",116590424,https://thefly.com/images/meta/streetresearch_recommendations.jpg,AZN,Thefly.com,Guggenheim analyst Seamus... AZN,https://finnhub.io/api/news?id=c037f9e631095f6bf2b06386248923a6cf3be3a187f1fcfdb5a9e3c59214aa01
company,2022-10-10 21:25:00,AstraZeneca call volume above normal and directionally bullish,116590425,https://thefly.com/images/meta/options.jpg,AZN,Thefly.com,Bullish option flow detec... AZN,https://finnhub.io/api/news?id=7905dfd089daec18cc9b2adb955257a1636a6d55b6d4aac05f45ddd133398e3a
company,2022-10-18 14:43:00,"ADRs End Mostly Stronger; AstraZeneca, atai Life Sciences Trade Actively",116708167,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,By Denny Jacob International stocks trading in New York closed mostly higher Tuesday. The S&P/BNY Mellon index of American depositary receipts edged up 0.3%...,https://finnhub.io/api/news?id=dbb89296b4d9ff51643919bf767a5feaf9ae8770e1e0886d78aa6ed3ea8b9d04
company,2022-10-18 12:39:00,"AstraZeneca PLC ADR falls Tuesday, underperforms market",116709962,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR sank 0.37% to $55.97 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=c564c1cb9742f0306d8566725297ae3255f4ca324f93e6370864ae8ef2454f7a
company,2022-10-18 11:29:40,Should You Invest in AstraZeneca PLC (AZN)?,116708367,https://s.yimg.com/uu/api/res/1.2/tt5ZPXm5C8joAWdYSrUXQw--~B/aD01MTI7dz03Njg7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/f684954d16386fc36b032963179d458b,AZN,Yahoo,"Baron Funds, an investment management company, released its “Baron Health Care Fund” third quarter 2022 investor letter. A copy of the same can be downloaded here. In the third quarter, the fund declined 6.01% compared to a 4.72% decline for the Russell 3000 Health Care Index. The fund’s underperformance in the quarter was attributed to poor […]",https://finnhub.io/api/news?id=32634ae64869a66edc8e8f7830d137b2c47eb2c1059a65c3099dee5d0f8b3575
company,2022-10-18 07:30:00,Ikena Oncology Provides Research & Development Update on IK-930 Program Targeting the Hippo Pathway,116697345,https://s.yimg.com/uu/api/res/1.2/mi4qvvclWUEEVHGA6s94tw--~B/aD0xMjA7dz0yMTQ7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/8e30a68cac108b927e582bc6707bfad2,AZN,Yahoo,"Clinical collaboration with AstraZeneca announced for the evaluation of osimertinib in combination with IK-930 for patients with EGFR-mutant lung cancers Company shares further detail on the differentiators of IK-930, a TEAD-paralog selective inhibitor BOSTON, Oct. 18, 2022 (GLOBE NEWSWIRE) -- Ikena Oncology, Inc. (Nasdaq: IKNA, “Ikena”), a targeted oncology company forging new territory in patient-directed cancer treatment, today provided a research & development update on the Company’s lead ta",https://finnhub.io/api/news?id=f5186095d002589c3b791da03f0a392d8db83d3013624016d1ad2ca0fc555c79
company,2022-10-18 05:04:00,What Is Going on With AVEO Pharmaceuticals (AVEO) Stock Today?,116717300,https://investorplace.com/wp-content/uploads/2021/08/srne_doctor_oncology_1600.jpg,AZN,InvestorPlace,AVEO stock jumped on the news that LG Chem will pay $15/share for Aveo Oncology and make it the centerpiece of a new oncology division.,https://finnhub.io/api/news?id=700cddcdef105474f4c4b0944108bcf7dfc9b0001c7460b15c5b5caa76f49497
company,2022-10-18 04:32:00,7 Stocks to Buy When There's Blood in the Streets,116720929,https://investorplace.com/wp-content/uploads/2022/06/dont-panic-1600.png,AZN,InvestorPlace,"For investors looking for high-quality stocks to buy when there is blood in the streets, there happen to be plenty of companies to pick.",https://finnhub.io/api/news?id=dae1fbc097d2953d2c4c33cb47a2ef8aab35f042d2fa87ee94f0188bc731e314
company,2022-10-18 02:33:00,"iKena Oncology provides research, development update on IK-930 program",116726933,https://thefly.com/images/meta/hotstocks.jpg,AZN,Thefly.com,"Ikena Oncology (IKNA) pro... IKNA, AZN",https://finnhub.io/api/news?id=5b084e3aacf11dea376ed1acc101aa1140fa584f8d46d3162fdc535ed3439471
company,2022-10-17 12:38:00,"AstraZeneca PLC ADR rises Monday, still underperforms market",116709963,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR advanced 2.20% to $56.18 Monday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=d5e24c93328a4f59ac7c41d5b0a997f1ccc538acb2b485ca92c74d84a34ebd09
company,2022-10-17 11:09:17,"Moderna CEO talks competition with J&J, Novavax, AstraZeneca",116691314,https://s.yimg.com/ny/api/res/1.2/xWGU6rMoI4E4F4WwU5P8Xw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzQ-/https://s.yimg.com/os/creatr-uploaded-images/2022-10/93803060-4e2d-11ed-be9d-d0b6acad752f,AZN,Yahoo,Moderna CEO Stephane Bancel on competing with traditional players in the drug and vaccine space.,https://finnhub.io/api/news?id=9977566eb40ebdbcdd45caafeff9396cac5a5045e0ba06fc45d739d3dc9cae98
company,2022-10-17 10:29:04,10 Best FTSE Dividend Stocks To Buy Now,116688393,https://s.yimg.com/uu/api/res/1.2/.zlFdOgIal41b4Dpc4kZCg--~B/aD01MDA7dz03NTA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/8b188cbde663decbf2cf6049a11f9e0c,AZN,Yahoo,"In this article, we discuss 10 best FTSE dividend stocks to buy now. If you want to see more stocks in this selection, check out 5 Best FTSE Dividend Stocks To Buy Now. The Office for National Statistics reported that the U.K. economy contracted by 0.3% in August, potentially initiating a long recession that can […]",https://finnhub.io/api/news?id=32cfbc286dad5aed6518590ae9684b6cae01c02f5e7455cc56c6e75e8459d231
company,2022-10-17 07:17:07,Cytokinetics: Surprise Adcomm For Omecamtiv Causing Concern,116683096,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1359132050/image_1359132050.jpg?io=getty-c-w750,AZN,SeekingAlpha,The FDA announced a surprise advisory committee meeting for Cytokinetics' omecamtiv. Read why I have grave doubts whether omecamtiv will be approved easily.,https://finnhub.io/api/news?id=bf29937cc1ab86917c6c4ee1ef4b9b62c0195bc78ee389fed888648fe9afc450
company,2022-10-17 05:35:00,Is This Monster Stock on the Verge of a Home Run?,116691450,,AZN,Yahoo,Ultomiris was just approved in the European Union to treat patients with generalized myasthenia gravis.,https://finnhub.io/api/news?id=11d92180dca59548004b464c4cb9c197f50dddcc1c6d43e5bcfafc41ff718d6b
company,2022-10-21 13:10:05,"Top Stock Reports for AstraZeneca, Caterpillar & Crown Castle",116779953,https://s.yimg.com/uu/api/res/1.2/0RKNrtcqi89Y7aBnUDarHQ--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/01e9b0067cb7888e6c19de3b070d63db,AZN,Yahoo,"Today's Research Daily features new research reports on 16 major stocks, including AstraZeneca PLC (AZN), Caterpillar Inc. (CAT) and Crown Castle Inc. (CCI).",https://finnhub.io/api/news?id=8e02298a4a44cd36a6718d1c4e9979a4d6bfecdeff2f15435117ef02fa0f5c3f
company,2022-10-21 12:39:00,"AstraZeneca PLC ADR rises Friday, still underperforms market",116790047,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR advanced 1.14% to $54.97 Friday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=1a9446d370c8788ac2f3c01e6462e8b4bf5be82f39e80c8ab177541ec1c11234
company,2022-10-21 09:37:00,3 Alzheimer's Therapy Stocks to Invest in,116773580,,AZN,Yahoo,"Alzheimer's therapies are big news lately.  The disease is the leading cause of dementia and memory loss.  The Alzheimer's Association estimates that 6.5 million Americans 65 and older are living with Alzheimer's dementia (AD) and by 2050, the number of people 65 and older with AD is projected to reach 12.7 million.",https://finnhub.io/api/news?id=22e17af989872971d569e7167cf96af0e37ba214117901c59ae8be40241b0c7e
company,2022-10-20 18:00:10,Astrazeneca (AZN) Stock Moves -0.29%: What You Should Know,116755316,https://s.yimg.com/uu/api/res/1.2/ZVGBNd2_.kAicju5mLde7g--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/71afbbc0512eb3c471136d93f39079c9,AZN,Yahoo,"Astrazeneca (AZN) closed the most recent trading day at $54.35, moving -0.29% from the previous trading session.",https://finnhub.io/api/news?id=7a21da65f23ca6e433ac5533d2d6fffd523bea97cca0b9bd41769036156ddfdb
company,2022-10-20 12:39:00,"AstraZeneca PLC ADR falls Thursday, still outperforms market",116776541,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR slumped 0.29% to $54.35 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=3d409c54fdc844e7a9fd1c9e409a1012772332c949d33706276afe3183050550
company,2022-10-20 09:00:00,AstraZeneca Announces Winners of Fourth Annual Cancer Community Awards,116743668,https://s.yimg.com/uu/api/res/1.2/fatLvfe.0piC8fSLyXhGjw--~B/aD0xNTk7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/aa4cb1e26e0f6ba41c8daae3f74fced1,AZN,Yahoo,"WILMINGTON, Del., October 20, 2022--AstraZeneca, in partnership with Scientific American Custom Media, today announced the winners of the fourth annual Cancer Community Awards (C2 Awards). A part of the AstraZeneca YOUR Cancer program, the C2 Awards celebrate and recognize inspiring work that exemplifies the full promise of community partnerships in advancing equitable access to quality cancer care.",https://finnhub.io/api/news?id=ea6c64c7b981f6bd7a07d7e4a51392d93f96959ca6178b5f9f7f4da908301315
company,2022-10-20 01:09:00,"Drugmakers look to limit Medicare's power to negotiate drug prices, WSJ reports",116744725,https://thefly.com/images/meta/periodicals.jpg,AZN,Thefly.com,"Under the Inflation Reduc... BMY, JNJ, LLY, MRK, PFE, SNY, AZN, GSK, RHHBY, NVS",https://finnhub.io/api/news?id=b4be8192056a3b3521c17351db1e4d9743a2eccbd5bfcc66a4c9dd32c93c914c
company,2022-10-20 00:06:00,TOP NEWS: AstraZeneca says Evusheld shows promise on Covid variants,116747735,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=fa76fb61949894206d13d38b7461fc38ccbe0cbc23b35cddb0492652fef1398d
company,2022-10-19 12:39:00,AstraZeneca PLC ADR underperforms Wednesday when compared to competitors,116724780,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR shed 2.61% to $54.51 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=0e87c70bde96749862a23410bff71209e5ff8bdf40e465f6580c4b2a7fa0aa3b
company,2022-10-19 03:38:00,GLOBAL BROKER RATINGS: Deutsche Bank and JPMorgan upgrade Netflix,116716963,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=3a2e4511c950a38dbd3ba5cc0d23fca091f337deb8ff4916a5a41f5a9777e089
company,2022-10-19 00:43:00,LONDON BROKER RATINGS: HSBC lifts Marston's; Barclays cuts Flutter,116716263,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=e32a16c2eb907760576a4d733a259cb86bb5f9d67af5268ce2af3508583759e1
company,2022-10-18 21:29:28,7 Stocks to Buy When There’s Blood in the Streets,116782691,https://s.yimg.com/uu/api/res/1.2/8duy.lzEar_sfiiROB09yQ--~B/aD00MDA7dz03Mjg7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/investorplace_417/e35cedb39e26264889e1bb86de0037be,AZN,Yahoo,"In general, the last quarter of the year is good for equity markets. However, it’s too early to assume that the markets are automatically headed higher. From the perspective of most investors, Q4 is set up to provide both opportunities and challenges. The upside is that the best time to look for stocks to buy is when there is blood in the streets. The bad news is that stocks may continue to struggle, given the current macro backdrop. So, what’s the reason for concern? Well, inflation remains hig",https://finnhub.io/api/news?id=0900123f9d9a235bbd69aef348df57ecbeb064b653c9a9c76db301cc8d165c8e
company,2022-10-18 21:13:00,AstraZeneca price target lowered to 118 GBp from 120 GBp at Berenberg,116726929,https://thefly.com/images/meta/streetresearch_recommendations.jpg,AZN,Thefly.com,Berenberg analyst Luisa H... AZN,https://finnhub.io/api/news?id=bdf5b45f92e43e8b0a07f8ae3af33db988eebfc1962073bd46579c38502e4cc7
company,2022-10-26 07:53:14,AstraZeneca Touts Positive Data From Two Experimental Drugs In Breast Cancer Settings,116843682,https://s.yimg.com/uu/api/res/1.2/lGhM4He1sW5jh__I0F0s9A--~B/aD00MDA7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Benzinga/276254f30e57ce9ea77283c5f5f6bed5,AZN,Yahoo,"AstraZeneca Plc (NASDAQ: AZN) shared positive topline data from the CAPItello-291 Phase 3 trial of capivasertib in combination with Faslodex (fulvestrant) in hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-low or negative locally advanced or metastatic breast cancer patients, following recurrence or progression on or after endocrine therapy. The capivasertib + Faslodex combo demonstrated a statistically significant and clinically meaningful improvement in progress",https://finnhub.io/api/news?id=feeb51953bc8c583a4750d6befef134aeba26d4654c2dcfcb915a3f6ede3fb63
company,2022-10-26 07:05:00,Camizestrant Significantly Improved Progression-free Survival Vs. FASLODEX® (fulvestrant) in SERENA-2 Phase II Trial in Advanced ER-positive Breast Cancer,116843683,https://s.yimg.com/uu/api/res/1.2/YNDR.CK3_pOEX7R.bOkwXg--~B/aD0xNTk7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/46847a890a1918cf61b7a430580ce1f5,AZN,Yahoo,"WILMINGTON, Del., October 26, 2022--Positive high-level results from the SERENA-2 Phase II trial showed that AstraZeneca’s next-generation oral selective estrogen receptor degrader (ngSERD) camizestrant met the primary endpoint of demonstrating a statistically significant and clinically meaningful progression-free survival (PFS) benefit at both 75mg and 150mg dose levels versus FASLODEX® (fulvestrant) 500mg in post-menopausal patients with estrogen receptor (ER)-positive locally advanced or meta",https://finnhub.io/api/news?id=5ca2d327595d78cce0c3f3a21201a57f64ffb78c78b92575b35bb4d48afac466
company,2022-10-26 07:00:00,Capivasertib plus FASLODEX® (fulvestrant) significantly improved progression-free survival vs. FASLODEX in CAPItello-291 Phase III trial in advanced HR-positive breast cancer,116843684,https://s.yimg.com/uu/api/res/1.2/IatfBP3O1YY4B9zL3O9AmQ--~B/aD0xNTk7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/e50b3e4a06cbb648fd951ed96ab3766a,AZN,Yahoo,"WILMINGTON, Del., October 26, 2022--Positive high-level results from the CAPItello-291 Phase III trial showed that AstraZeneca’s capivasertib in combination with FASLODEX® (fulvestrant) demonstrated a statistically significant and clinically meaningful improvement in progression-free survival (PFS) versus placebo plus FASLODEX in patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-low or negative locally advanced or metastatic breast cancer, following re",https://finnhub.io/api/news?id=e43b01cb5e48b3c12433dd4bd6b02bcb3d558a81fe72b29e05784b21aac8ce28
company,2022-10-26 02:51:00,AstraZeneca says advanced trial of breast-cancer drug Capivasertib meets primary endpoints,116833809,https://s.yimg.com/ny/api/res/1.2/qx.UCawxByxSkw6TAW6dAg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02MDA-/https://media.zenfs.com/en/marketwatch.com/6dfd9d6b639106d9605f54c471362eca,AZN,Yahoo,The Anglo-Swedish pharma giant said the trial met both primary endpoints of improving progression-free survival in the overall patient population and in a prespecified biomarker subgroup of patients whose tumors had qualifying alterations.,https://finnhub.io/api/news?id=1541b65086f46f4d6636e8a4728a8b2b0c94f3aae8df9f235a751df66d1e58f2
company,2022-10-26 01:21:00,AstraZeneca phase 3 study shows Capivasertib+Faslodex improves breast cancer PFS,116850378,https://thefly.com/images/meta/hotstocks.jpg,AZN,Thefly.com,"The company states: ""... AZN",https://finnhub.io/api/news?id=38eb762f5e4ea0247ee32268a8da98f424a7298c501b65b4b02eca91f29a6fd1
company,2022-10-26 00:36:00,TOP NEWS: AstraZeneca hails survival rates of breast cancer drugs,116850379,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=5b657ff4b4cfea6e9d4ab7e32175abc69cf168cc5496519b8bc1d36cd42d4aef
company,2022-10-25 23:49:00,"LONDON MARKET OPEN: Sterling climbs above USD1.15, euro above parity",116846806,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=02af16201093ff190ce046174d55b486ea0f3a7dc6c6ff597aae7034c34a636f
company,2022-10-25 14:13:00,"ADRs End Mostly Higher, AstraZeneca and atai Life Sciences Trade Actively",116878868,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,By Denny Jacob International stocks trading in New York closed mostly higher on Tuesday. The S&P/BNY Mellon index of American depositary receipts edged up...,https://finnhub.io/api/news?id=5e53d915642957eb200d2fdb313eca6bb71b18d75f02343e779eab2b1a492065
company,2022-10-25 12:39:00,"AstraZeneca PLC ADR rises Tuesday, still underperforms market",116878869,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR rallied 1.30% to $55.90 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=1eb1cc14bda20dfa5f5124d5517f635166354c50dcb2f6a72de325654f0e37b5
company,2022-10-25 11:15:15,12 Best Value Dividend Stocks To Buy,116818469,https://s.yimg.com/uu/api/res/1.2/cZQ.FGuAjlrFngapbpgXjQ--~B/aD0zMDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/e1c2eea9c78ea98f586c72b3b7cc6347,AZN,Yahoo,"In this article, we will take a look at 12 best value dividend stocks to buy. If you want to see more of the best value dividend stocks to buy, go directly to 5 Best Value Dividend Stocks To Buy. Inflation remains a headwind for the markets in 2022. In terms of inflation, the annual […]",https://finnhub.io/api/news?id=ee027a7d4d8764638024da1f98323bb80c3d87d5eb0b07ddcf3c8eacd8189d00
company,2022-10-25 06:09:10,AstraZeneca's Fasenra Flunks Late-Stage Trial In Patients With Esophagus Inflammation,116821350,https://s.yimg.com/uu/api/res/1.2/m0NAax.80N2gQEDzDsQhjA--~B/aD00MDA7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Benzinga/0f4535775a1c9e3a3dcdf82b09f0bf33,AZN,Yahoo,"AstraZeneca Plc (NASDAQ: AZN) has reported topline data from the MESSINA Phase 3 trial Fasenra (benralizumab) in Eosinophilic esophagitis (EoE) patients aged 12 years or older. Eosinophilic esophagitis (EoE) is characterized by the abnormal presence of eosinophils, a type of white blood cell, in the inner lining of the esophagus. Patients experience difficulty swallowing (dysphagia), pain, food getting stuck, and anxiety. The data showed that Fasenra (benralizumab) did not meet one of the two du",https://finnhub.io/api/news?id=6fc09fc8d20fd63439627f28f276256414e7652afe1e95490356cc9a69147f86
company,2022-10-24 23:24:00,TOP NEWS: AstraZeneca's Fasenra fails to meet trial's primary endpoint,116822659,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=53eb5b864c87d14d30b82dd536fea7a0d0794a6c552e2baa02405c2b904dcbe4
company,2022-10-24 22:17:00,AstraZeneca's Fasenra Treatment Passed One of Two Endpoints in Trial,116878870,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,By Joe Hoppe AstraZeneca PLC said Tuesday that a Phase 3 trial of its Fasenra treatment for eosinophilic esophagitis passed one dual-primary endpoint but...,https://finnhub.io/api/news?id=bf659b989554e241ce79d7fd9b71bc364ddf6305373fcd7acd7a245da8234fc6
company,2022-10-24 09:40:01,"The Zacks Analyst Blog Highlights AstraZeneca, Caterpillar, Crown Castle, Nasdaq and American Water Works",116803559,https://s.yimg.com/uu/api/res/1.2/rj9rvD0uUgpZgYYbvMEcMw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/dfbf477ce67e2ca9b1c9e4b00f36cf66,AZN,Yahoo,"AstraZeneca, Caterpillar, Crown Castle, Nasdaq and American Water Works are part of the Zacks top Analyst Blog.",https://finnhub.io/api/news?id=fc3a16775bfb06f00dffcf23689ccc1fce4ba83826c1f5db8fcf69bbf4e87756
company,2022-10-24 07:47:11,Merck (MRK) to Report Q3 Earnings: What's in the Cards?,116802357,https://s.yimg.com/uu/api/res/1.2/sWuU5JHrorQjYnKhObHttQ--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/1b28b8f55ab25205feceb1a2771a2b3a,AZN,Yahoo,"Investor focus is likely to be on the sales of Merck's (MRK) blockbuster oncology medicine, Keytruda, and COVID-19 antiviral pill, molnupiravir when the company reports Q3 earnings.",https://finnhub.io/api/news?id=980972b951aff2bb1b1d51e6e4a9c224168af1156827d8e6ab059cdd1a19ce7d
company,2022-10-24 07:12:00,IMJUDO® (tremelimumab) in Combination With IMFINZI® (durvalumab) Approved in the US for Patients With Unresectable Liver Cancer,116802358,https://s.yimg.com/uu/api/res/1.2/iSdEqG9EC2hYCrHvBnq.QA--~B/aD0xNTk7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/b0d84ecc7d38780cd4d8ac857605fc07,AZN,Yahoo,"WILMINGTON, Del., October 24, 2022--AstraZeneca’s IMJUDO® (tremelimumab) in combination with IMFINZI® (durvalumab) has been approved in the US for the treatment of adult patients with unresectable hepatocellular carcinoma (HCC), the most common type of liver cancer. The novel dose and schedule of the combination, which includes a single dose of the anti-CTLA-4 antibody IMJUDO 300mg added to the anti-PD-L1 antibody IMFINZI 1500mg followed by IMFINZI every four weeks, is called the STRIDE regimen",https://finnhub.io/api/news?id=b195a67e40a6f20a72975ea5ee6a69d1b7b9ab9e60a4bf3cb02ff286a49bb60d
company,2022-10-24 06:21:47,AstraZeneca's Imfinzi Combo Scores FDA Approval For Liver Cancer,116806066,https://s.yimg.com/uu/api/res/1.2/_UIxPr.TUgG3FNNAGaSqYQ--~B/aD00MDA7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Benzinga/85fbc30f40080e6149d495fafe40f675,AZN,Yahoo,"The FDA has approved AstraZeneca Plc's (NASDAQ: AZN) Imjudo (tremelimumab) in combination with Imfinzi (durvalumab) for unresectable hepatocellular carcinoma (HCC), the most common type of liver cancer. The novel dose and schedule of the combination includes a single dose of the anti-CTLA-4 antibody Imjudo 300mg added to the anti-PD-L1 antibody Imfinzi 1500mg, followed by Imfinzi every four weeks, dubbed the STRIDE regimen. The approval was based on positive results from the HIMALAYA Phase 3 tri",https://finnhub.io/api/news?id=0c7a27b4c7a544d57a45e77fbf71560c057a0529dca122be0924a2b6db44d4f2
company,2022-10-24 01:04:00,AstraZeneca's Imjudo+Imfinzi approved in U.S. for unresectable liver cancer,116805017,https://thefly.com/images/meta/hotstocks.jpg,AZN,Thefly.com,"The company states: ""... AZN",https://finnhub.io/api/news?id=c06c1a62ac4863fb7b70f3c06933b024fa4b666751fe2985277cf016a9121efa
company,2022-10-23 23:23:00,AstraZeneca treatment gets FDA approval for US liver cancer patients,116805018,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=3ae002fe2bc7fa89724fca893d53dabf8345930114d2b455ce222916f12f945a
company,2022-10-30 10:35:39,AstraZeneca: Acquisitions And Some Thoughts About Biotech Investing,116863100,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1236338088/image_1236338088.jpg?io=getty-c-w750,AZN,SeekingAlpha,"Big pharma investment is about the long term, and AstraZeneca has that focus. Read more on how investors should look for emerging companies that fit with big pharma or partner interests.",https://finnhub.io/api/news?id=bc6b2449f5e25a64e017ac638ec49ee3881a25422cc1f39d27fc266ed7885672
company,2022-10-29 04:19:34,AstraZeneca PLC's (LON:AZN) Intrinsic Value Is Potentially 99% Above Its Share Price,116900942,https://media.zenfs.com/en/simply_wall_st__316/bba95900ab96866c17a285be850152bf,AZN,Yahoo,In this article we are going to estimate the intrinsic value of AstraZeneca PLC ( LON:AZN ) by taking the forecast...,https://finnhub.io/api/news?id=6e1b744fa23c388dabd0c0a7e78ac528c648f0fde1e1c6f1642f40fe45d6f449
company,2022-10-28 12:39:00,"AstraZeneca PLC ADR rises Friday, still underperforms market",116878864,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR rallied 1.91% to $58.71 Friday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=ff5cd6551cf249b7f1895bae51f3a6e0b27c8092ecdd34c952c7b8389edffe0f
company,2022-10-28 12:09:04,"Pharma Stock Roundup: NVS, MRK Report Q3 Earnings JNJ's Tecvayli Gets FDA Nod",116865410,https://media.zenfs.com/en/zacks.com/44fc6e96ff9dff6be2f033510781bcfa,AZN,Yahoo,"Novartis (NVS) and Merck (MRK) announce Q3 results. FDA approves J&J's (JNJ) multiple myeloma candidate, Tecvayli.",https://finnhub.io/api/news?id=96eeba1d440ebf152e6aafa6183d640d9719ae21203b15cde021f60660aca2bc
company,2022-10-28 09:33:00,Why Invitae Stock Was So Healthy This Week,116900944,https://s.yimg.com/ny/api/res/1.2/4q6rBjOaEOeE.j.CwoCmOg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDE-/https://media.zenfs.com/en/motleyfool.com/cb230b2af74d47401b7b46f5c2711762,AZN,Yahoo,"Even though the genetics testing specialist didn't divulge the financial details of a new partnership, investors nevertheless were happpy about the news.",https://finnhub.io/api/news?id=b4b6e0a1543982e5477e5abbf2a4fce43e89e884e98667b408dafc636d883faf
company,2022-10-28 08:01:00,U.K. stocks break two-day climbing streak,116878865,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,"U.K. stocks finished lower Friday, with the FTSE 100 Index decreasing 0.37% at 7,047.67. Of the FTSE 100 constituents, banking company NatWest Group PLC saw...",https://finnhub.io/api/news?id=810524e7edbe63f2ea7482b3c283fedbc418929aa475d97e68eef10314c31f87
company,2022-10-28 05:21:00,3 Perfect Stocks Retirees Can Buy Hand Over Fist Right Now,116869589,https://s.yimg.com/ny/api/res/1.2/S6ckvxAFWUmC.VPAVf882A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD03MjM-/https://media.zenfs.com/en/motleyfool.com/43c974ba64c5980fc6bdf9753caa2411,AZN,Yahoo,"For many investors, 2021 was ideal.  The benchmark S&P 500 endured no more than a 5% correction for the entirety of the year, and the major stock indexes finished higher by a double-digit percentage.  All three major U.S. stock indexes have plunged into a bear market, with volatility hitting levels not seen since 2009.",https://finnhub.io/api/news?id=c704d4faccf1a7ee8ef204e10db8951063bf6c081aeb6da465ea4c889c037851
company,2022-10-27 14:56:47,11 Best UK Stocks To Buy Now,116852120,https://media.zenfs.com/en/insidermonkey.com/98c0c7d011f7e68747c68035233f9ade,AZN,Yahoo,"In this article, we discuss 11 best UK stocks to buy now. If you want to see more stocks in this selection, click 5 Best UK Stocks To Buy Now. On October 22, Moody’s downgraded the United Kingdom’s economic outlook from “stable” to “negative”, citing political instability and skyrocketing inflation. However, Moody’s credit rating for […]",https://finnhub.io/api/news?id=f4afd9297e0e4483f529981e921f837ea673b82386010a9d051e40974f3f5611
company,2022-10-27 12:39:00,"AstraZeneca PLC ADR falls Thursday, still outperforms market",116878866,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR slipped 0.60% to $57.61 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...",https://finnhub.io/api/news?id=30095926f827856441aebc79722e1da7ace55e2fc8bba109d36c78c8dc007942
company,2022-10-27 10:44:28,"AstraZeneca's Ultomiris Showed Zero Relapses In Patients With Chronic Disorder Of Brain, Spinal Cord",116900948,https://media.zenfs.com/en/Benzinga/5bc9a82bf685d0696dee38b174d6a32d,AZN,Yahoo,"AstraZeneca Plc (NASDAQ: AZN) posted detailed results from the Phase 3 CHAMPION-NMOSD trial of Ultomiris (ravulizumab) For neuromyelitis optica spectrum disorder (NMOSD). NMOSD is an autoimmune disease that affects the central nervous system (CNS), including the spine and optic nerves. The data showed that Ultomiris significantly reduced relapse risk in adults with anti-aquaporin-4 (AQP4) antibody-positive (Ab+) NMOSD, compared to the external placebo arm from the pivotal Soliris PREVENT clinica",https://finnhub.io/api/news?id=2db4313871f11bc09683df38dc330fea00c216a0b03c7b0ae222c17f2f658281
company,2022-10-27 07:30:00,Invitae Announces Partnership for Real-World Data Sharing to Inform Rare Cancer Research,116900950,https://media.zenfs.com/en/prnewswire.com/4bd44a6659089f1ac6d2dd1c37f06ba1,AZN,Yahoo,"Invitae (NYSE: NVTA), a leading medical genetics company, today announced a partnership with AstraZeneca (LSE/STO/Nasdaq: AZN) to use Invitae's Ciitizen natural history data in a retrospective and prospective study of patients diagnosed with cholangiocarcinoma, a rare bile duct cancer. This partnership will enable sharing of high-quality, patient-consented data from the patient community of the Cholangiocarcinoma Foundation (CCF), a leading patient advocacy group whose mission is to find a cure",https://finnhub.io/api/news?id=c632c05ce68d3ae2ff1cae0c0b9ee871077d7a01b5763c6725ba39613c4188c4
company,2022-10-27 07:00:00,ULTOMIRIS® (ravulizumab-cwvz) showed zero relapses in adults with neuromyelitis optica spectrum disorder (NMOSD) with median treatment duration of 73 weeks,116900952,https://media.zenfs.com/en/business-wire.com/f30d321205f5adff36e5c201badc3764,AZN,Yahoo,"WILMINGTON, Del., October 27, 2022--Detailed positive results from the Phase III CHAMPION-NMOSD trial showed that ULTOMIRIS® (ravulizumab-cwvz) significantly reduced relapse risk in adults with anti-aquaporin-4 (AQP4) antibody-positive (Ab+) neuromyelitis optica spectrum disorder (NMOSD), compared to the external placebo arm from the pivotal SOLIRIS® PREVENT clinical trial. Data were presented today at the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) Congress.",https://finnhub.io/api/news?id=2adf2b714615af204c45f15593d9b80897d0e1ffbe1f227b42e994c446f8fe41
company,2022-10-27 04:00:01,"Omicron subvariants are resistant to key antibody treatments, putting people with weak immune systems at risk of Covid ",116848125,https://image.cnbcfm.com/api/v1/image/106998529-1641587130211-icu2.jpg?v=1666872001&w=1920&h=1080,AZN,CNBC,President Biden cautioned that the immunocompromised are at heightened risk this winter and should talk to their physician about precautions.,https://finnhub.io/api/news?id=c8380c1e56de7a2a66120eff532e5de7a3b896cd29458fed852ac4fee73a7277
company,2022-10-27 02:36:00,Invitae announces collaboration with AstraZeneca,116849458,https://thefly.com/images/meta/hotstocks.jpg,AZN,Thefly.com,"Invitae (NVTA) announced ... NVTA, AZN",https://finnhub.io/api/news?id=52794ca2ee6a70e2f79d8c7fc1de85dfe337b6c0ef830a70a861fac11927a3b2
company,2022-10-27 01:58:00,AstraZeneca's Ultomiris treatment gets good results from Phase 3 trial,116850372,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=c0502f3d70beddaf83e71567c718dfd5f17a741ae5670a651a77031bf4794386
company,2022-10-27 01:15:00,AstraZeneca's Ultomiris showed zero relapses in adults with NMOSD,116850373,https://thefly.com/images/meta/hotstocks.jpg,AZN,Thefly.com,"The company states: ""... AZN",https://finnhub.io/api/news?id=116872ae8a1bed7b63377633705ac89c3591fba3798cf7cb6f7d6b897834a131
company,2022-10-26 21:11:00,Study confirms AstraZeneca jab's higher risk of very rare clot,116849797,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=f16fe9e848aa39edbae0b3dc031e16cdaad568f598f50c5ae8c47b02f7a79792
company,2022-10-26 20:48:00,GLOBAL BRIEFING: Meta quarterly revenue drops; Xi wants US cooperation,116846855,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=f9656d5a610344bc44d1cc8c3b9859551c25b5646992eb7b614a19fab93f6d73
company,2022-11-03 12:39:00,"AstraZeneca PLC ADR rises Thursday, outperforms market",116975950,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR inched 0.39% higher to $59.93 Thursday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=c8e4d9fba477e652e63cacfc72d154bf2fe8cf2d65f6a564fd0bc3ef0f0fd2dc
company,2022-11-02 18:00:10,Astrazeneca (AZN) Stock Moves -0.25%: What You Should Know,116929628,https://media.zenfs.com/en/zacks.com/0c6f98f4bf655bec3b199bc1a71b8b85,AZN,Yahoo,"In the latest trading session, Astrazeneca (AZN) closed at $59.70, marking a -0.25% move from the previous day.",https://finnhub.io/api/news?id=ca7eb0e4f6c016002cdf0f6907a95ca721f4bfa5f5b9285c7aa8f7e16c475aca
company,2022-11-02 12:39:00,"AstraZeneca PLC ADR falls Wednesday, still outperforms market",116923821,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR slid 0.25% to $59.70 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=a2f65054dc9d00b9f2733268501e19edfd67dbb2058ed4dba96fef2fe078e554
company,2022-11-02 09:01:00,U.K. stocks break two-day winning streak,116922774,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,"U.K. stocks decreased Wednesday, as the FTSE 100 Index finished down 0.58% at 7,144.14. Among FTSE 100 constituents, tobacco company British American Tobacco...",https://finnhub.io/api/news?id=afe0001fca44768ca7f29dab4001d25ffdda88dce9fc478ce0650b3f733dc930
company,2022-11-01 23:00:00,ClearBridge Global Growth Strategy Q3 2022 Portfolio Manager Commentary,116899178,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/529696395/image_529696395.jpg?io=getty-c-w750,AZN,SeekingAlpha,"During the third quarter of 2022, the ClearBridge Global Growth Strategy outperformed its MSCI ACWI benchmark. Click here to read the full fund letter.",https://finnhub.io/api/news?id=b3f86334eb3192d7edbe20773799a5895a79ce5c99cb0e3ffef6ac08e2613be5
company,2022-11-01 14:56:00,"ADRs End Higher, Alibaba and AstraZeneca Trade Actively",116890854,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,By Denny Jacob International stocks trading in New York closed higher on Tuesday. The S&P/BNY Mellon index of American depositary receipts edged up 0.9% to...,https://finnhub.io/api/news?id=8cb6e828866f1a3b78ba890c489b07e2eed542769f81c50c97b8d758a0329766
company,2022-11-01 12:39:00,"AstraZeneca PLC ADR rises Tuesday, outperforms market",116898523,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR rose 1.77% to $59.85 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite...",https://finnhub.io/api/news?id=2ac18ed4c43f065fd48bf1431716da71ea818657161fda462124ac08f03d1ebf
company,2022-11-01 12:26:53,Roche Needs Some Wins,116887384,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1386962514/image_1386962514.jpg?io=getty-c-w750,AZN,SeekingAlpha,"Roche has enjoyed strong reputation, but it can sometimes outrun or outlast underlying facts. Read why I'm getting more concerned that that may be the case here.",https://finnhub.io/api/news?id=a59adad86b6a0f69ea11706db1c2317f44bb3c8a4f3ff08d418b8f21941ebac4
company,2022-11-01 10:37:00,Hospitalizations on the rise in New York City as new COVID strains spread rapidly,116900939,https://s.yimg.com/ny/api/res/1.2/tB1Vr5l17fiPPBdfKZo0wA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02MDA-/https://media.zenfs.com/en/marketwatch.com/a68a5e68f0dc4c902e8b7e6f3218a6b1,AZN,Yahoo,"Hospitalizations are rising again in New York City with the spread of new COVID-19 subvariants that are better at evading immunity, along with flu and respiratory syncytial virus, or RSV.",https://finnhub.io/api/news?id=4f31698542fe77959deb3864662ad7a49fc164e88df633952323f3e2c3f8ecf0
company,2022-11-01 08:49:29,European Regulator Grants Complete Approval To AstraZeneca's COVID-19 Vaccine,116900940,https://media.zenfs.com/en/Benzinga/7562a1ee4e60197ec445dafbf2ff93a1,AZN,Yahoo,"The European Medicines Agency (EMA) has granted full Marketing Authorisation to AstraZeneca Plc's (NASDAQ: AZN) COVID-19 vaccine, Vaxzevria (ChAdOx1-S [Recombinant]). Vaxzevria was initially granted a conditional Marketing Authorisation due to the urgency of the COVID-19 pandemic. As there continues to be sufficient evidence of safety and efficacy confirming the benefits of Vaxzevria, the EMA has now granted full approval. The approval covers the use of Vaxzevria in both a primary vaccination se",https://finnhub.io/api/news?id=8402c5e2b33572fa8461f825258f57fb003c2efbc2ffa0bcf76cbf18cac3b523
company,2022-11-01 05:02:55,JPMorgan Chase hires OrbiMed Advisors executive for new life sciences venture capital unit,116884898,https://s.wsj.net/public/resources/MWimages/MW-GP644_MicroS_ZG_20180906154215.jpg,AZN,MarketWatch,JPMorgan Chase & Co. undefined said Tuesday its J.P. Morgan Asset Management unit is launching a new private capital team aimed at investments in life...,https://finnhub.io/api/news?id=cff7544004f7a11e9679d0bcf88859442ab3cea4d7ca998d122863d7651c5052
company,2022-11-01 02:35:00,TOP NEWS: AstraZeneca's Vaxzevria wins full market authorisation in EU,116884712,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=4cc9a979e12cc0fe627b8eb0ec57a535dc9ccbde024d9b10c03b30e4e791279c
company,2022-10-31 23:56:00,LONDON BRIEFING: FTSE 100 to open higher; BP swings to profit,116883355,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=b613263590360442b21779c420a0047a53e518513d297cf25f0d5e8171e6e8d2
company,2022-10-31 23:19:42,Biotech And XBI: The Bottom Is In,116877517,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/168634446/image_168634446.jpg?io=getty-c-w750,AZN,SeekingAlpha,XBI is a widely diversified ETF comprised of myriad small and midcap biotech stocks. Read how I've built up a large position in the ETF since mid-June.,https://finnhub.io/api/news?id=83789becc8e24683fe2c150723a5441a93b4fd828d5a9ca89d3791e1b897e39b
company,2022-10-31 23:11:00,AstraZeneca's Vaxzevria Gets Full Marketing Authorization in EU for Prevention of Covid-19,116878863,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,By Kyle Morris AstraZeneca PLC said Tuesday that its Covid-19 vaccine Vaxzevria has been granted full marketing authorization in the European Union. The...,https://finnhub.io/api/news?id=68ba27a6bc272f1730eec3968c875956b6f7a4f894f1b1df89095211835c85ef
company,2022-10-31 18:05:00,ClearBridge Value Equity Strategy Q3 2022 Portfolio Manager Commentary,116874175,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1277592662/image_1277592662.jpg?io=getty-c-w750,AZN,SeekingAlpha,The ClearBridge Value Equity Strategy outperformed its Russell 1000 Value Index during the third quarter 2022. Click here to read the full fund letter.,https://finnhub.io/api/news?id=898940cf85fd8010c1b078beddad4858480d06affef381c50180764ff3749e4d
company,2022-10-31 12:48:04,Amgen (AMGN) to Report Q3 Earnings: What's in the Cards?,116900941,https://media.zenfs.com/en/zacks.com/65410c79c0b8184da264ed17fda575ce,AZN,Yahoo,"Volume growth from Amgen's (AMGN) key drugs like Prolia, Xgeva, Repatha and others is expected to have been partially offset by biosimilar/generic competition for mature drugs.",https://finnhub.io/api/news?id=da2f46ec31738e556a2eed54adc7b93f82d2a0702fda83ec945ebf514e6a8dfe
company,2022-10-31 05:01:00,Top 5 3rd Quarter Trades of ST - GuruFocus.com,116870702,https://static.gurufocus.com/images/logo_global.png,AZN,GuruFocus,GuruFocus Article or News written by insider and the topic is about: ,https://finnhub.io/api/news?id=3a5e69731724064c44c576c1f54c71b5eb2256e845ecccc545c11434c825c7bc
company,2022-10-31 04:05:00,"AstraZeneca to present new cardiovascular, renal drug data in US",116884715,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=b8f56738f4b219154a7a2c9bb1357a843e08617df3bf8fc85a0c7f027ae83d04
company,2022-10-31 01:12:00,AstraZeneca to present over 60 abstracts at ASN and AHA events this week,116884716,https://thefly.com/images/meta/hotstocks.jpg,AZN,Thefly.com,"The company states: ""... AZN",https://finnhub.io/api/news?id=d6418094ac2628a7579d5afc27a9129511f35bfa1fae8b8f2fe1292ef5527088
company,2022-11-07 13:06:38,Most Promising Pharmaceutical Company During A Recession,116989900,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1250576655/image_1250576655.jpg?io=getty-c-w750,AZN,SeekingAlpha,"AstraZeneca's revenue was $10,771 million in the 2nd quarter of 2022, showing a 31% increase from the previous year. Click here to read more.",https://finnhub.io/api/news?id=9fff4bd9a66225b121d4a65e0d358a25e6b81198c82291dcf86a077f4b03bcaa
company,2022-11-07 11:38:00,"AstraZeneca PLC ADR rises Monday, still underperforms market",117036439,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR inched 0.18% higher to $61.10 Monday, on what proved to be an all-around positive trading session for the stock market, with the...",https://finnhub.io/api/news?id=45628ad184bee527143a9a646b71f881744c203fc56e29a837baf134505cc9fb
company,2022-11-07 10:06:03,AstraZeneca (AZN) to Report Q3 Earnings: What's in the Cards?,116986830,https://media.zenfs.com/en/zacks.com/44fc6e96ff9dff6be2f033510781bcfa,AZN,Yahoo,"Higher sales of AstraZeneca's (AZN) key medicines, Lynparza, Tagrisso and Imfinzi and Farxiga are expected to have driven sales, partially offset by lower sales of legacy drugs.",https://finnhub.io/api/news?id=bee0f66996763cea2c1bf81f8329159eb9261cb9bf95e0173254c4212632a706
company,2022-11-07 09:59:00,AstraZeneca notes positive phase III analysis for heart failure drug,117001043,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=b47a6cca8883a936011d0326c74bf3da28deb73e0c9ca09b01a126d7ab89b705
company,2022-11-07 05:54:00,"UK earnings, trading statements calendar - next 7 days",116987240,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=935f6c91e35272168a0c81d7078a67a357de68403b57cc327307786921103194
company,2022-11-07 00:15:00,AstraZeneca presents data on Farxiga and importance of earlier screening for CKD,117001045,https://thefly.com/images/meta/hotstocks.jpg,AZN,Thefly.com,"The company states: ""... AZN",https://finnhub.io/api/news?id=7560bc8024fdda6a390b6adf1b9bb5a9af8c5f67c198f4fd15d78da2ea4ec6b2
company,2022-11-04 16:19:08,12 Best Non-REIT Dividend Stocks To Buy,116958360,https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png,AZN,Yahoo,"In this article, we discuss 12 best non-REIT dividend stocks to buy. If you want to see more stocks in this selection, go see 5 Best Non-REIT Dividend Stocks To Buy. A well-proven way to fight inflation is to look for investments that have categorically outperformed during times of high inflation. Dividends have contributed nearly […]",https://finnhub.io/api/news?id=60f2c0c7c87ea0da75139ce91d228fc756eb81d59e050eb746156902bc3f1c42
company,2022-11-04 14:46:00,"ADRs End Higher, Alibaba and AstraZeneca Trade Actively",116972147,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,By Denny Jacob International stocks trading in New York closed higher Friday. The S&P/BNY Mellon index of American depositary receipts rose 3.7% to 128.80....,https://finnhub.io/api/news?id=6282e91ce7fcb1de118eb83fdd19cab14e4053505c7886a9b694c814419d6d17
company,2022-11-04 12:39:00,"AstraZeneca PLC ADR rises Friday, outperforms market",116975947,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR rallied 1.77% to $60.99 Friday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=33826a4e3ec92582bc27887833343dac619b2398300f74b8c2a5b3380f1ea469
company,2022-11-04 10:35:02,"Amgen (AMGN) Beats on Q3 Earnings & Sales, Tweaks 2022 View",116957972,https://media.zenfs.com/en/zacks.com/88c5b382e5e9e4ea852e01bfc1435a7b,AZN,Yahoo,Amgen (AMGN) beats Q3 estimates for earnings and sales. It tightens previously issued revenue and adjusted earnings guidance ranges.,https://finnhub.io/api/news?id=07b129c6d286567b739cfb849da41a25fb96600b2c9163443d27b5e2c6ec216f
company,2022-11-04 10:30:00,"Lilly, Boehringer say Jardiance slows kidney disease progression in trial",116954480,https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png,AZN,Yahoo,"Boehringer Ingelheim and Eli Lilly said their diabetes drug Jardiance was shown to slow the progression of chronic kidney disease (CKD), as they seek to catch up with market segment leader AstraZeneca.  In a statement on Friday, the two partners said Jardiance cut the risk of kidney disease progression and cardiovascular death by 28%, citing results from a late-stage trial which included people with and without diabetes.",https://finnhub.io/api/news?id=61a15bc2369513bf45e3823065c962e9f112fbd86ebd23fd1a3c6fbb79ab580c
company,2022-11-04 07:51:00,Europe OK's 1st one-dose drug to protect babies against RSV,117001046,,AZN,"Associated Press, The",Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=81f6acff38bca87d439ec93b4885074e22f2813049ed33d187970913a90df7ca
company,2022-11-04 07:40:00,Global company events calendar - next 7 days,116952553,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=f41dede8badc038576ed30e68363d3fafaf4e06e91c466219f1a6f449b6ab175
company,2022-11-04 07:37:57,Europe Approves AstraZeneca-Sanofi Partnered Antibody To Prevent RSV Infection In Infants,116953141,https://media.zenfs.com/en/Benzinga/01edee7863c01e5bff85cb124a9c6383,AZN,Yahoo,"The European Commission has approved AstraZeneca plc (NASDAQ: AZN) and Sanofi SA’s (NASDAQ: SNY) Beyfortus (nirsevimab) long-acting antibody to prevent respiratory syncytial virus (RSV) lower respiratory tract disease in newborns and infants during their first RSV season. Beyfortus is the first and only single-dose RSV passive immunization for the broad infant population, including those born healthy, at term or preterm, or with specific health conditions. In the pivotal MELODY efficacy trial, B",https://finnhub.io/api/news?id=f13f0d986c209d6217effd442544e453dd577b2d1a7b129b2baa184f5b15765c
company,2022-11-04 04:30:00,"EMEA Earnings to Watch: Ryanair, Bayer, AstraZeneca, Richemont",116952684,https://s.yimg.com/ny/api/res/1.2/GzKYpAAbrk36lEoKbFhCqw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD03NzA-/https://media.zenfs.com/en/bloomberg_markets_842/36dc764b72b27caecbbdabe4cc297e07,AZN,Yahoo,"(Bloomberg) -- A glance at the Stoxx Europe 600 Index’s performance at the sector level gives an indication of the winners and losers of the third-quarter earnings cycle, with travel and leisure stocks streaking ahead, and food, beverage and tobacco bringing up the rear, the only group in the red. Next week will be a test for both as the current reporting season nears a close.Most Read from BloombergTwitter Sued for Mass Layoffs by Musk Without Enough NoticeMusk Plans to Eliminate Half of Twitte",https://finnhub.io/api/news?id=3c100e922dd8e38f683040d7bba1e001465cba413653510ec11205ea7cb747b5
company,2022-11-04 04:25:00,Cowen biotech/pharma analysts hold an analyst/industry conference call,116999286,https://thefly.com/images/meta/converenceevents.jpg,AZN,Thefly.com,"Biotech Analysts Werber &... AZN, ALXN, ARGX",https://finnhub.io/api/news?id=23230a2aec2b29d699f45d0df47cbc55d9de56c28e58a732ef56c34583e599bb
company,2022-11-04 03:00:00,"Sanofi, Astra win EU approval for prevention of infant RSV",116953142,https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png,AZN,Yahoo,"The European Commission on Friday approved Sanofi and AstraZeneca's Beyfortus for the prevention of a common and highly contagious type of respiratory infections in infants.  The long-acting therapy, also known as nirsevimab, was given EU marketing authorisation for the prevention of disease from infections caused by the respiratory syncytial virus (RSV), Sanofi said in a statement.",https://finnhub.io/api/news?id=bf64ef3c500c53924159925595738ee0a8b2e0f5d82b611c0a9c4c0ac96a962a
company,2022-11-04 01:01:00,LONDON MARKET OPEN: FTSE 100 boosted by miners as commodities rise,116989428,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=e10e94680e6d3fd025b82d72345d65b1ff4f2c8217cb617a8b8f63029e7afe36
company,2022-11-04 00:08:00,TOP NEWS: AstraZeneca's Beyfortus wins EU approval for RSV in newborns,116994720,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=dd767e94d639edf9c8936ccece15858bbc0733fa87f4da1f7d1886492d7f299c
company,2022-11-03 23:49:00,LONDON BRIEFING: Stocks called higher; US job growth expected to slow,116954889,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=8594515d406bb5b74c4d163ed9451aa48b0441573f299ee454ba56d42936052d
company,2022-11-03 23:22:00,AstraZeneca's Nirsevimab Approved in the EU,116975949,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,"By Anthony O. Goriainoff AstraZeneca PLC said Friday that nirsevimab, a treatment for the prevention of respiratory syncytial virus, a...",https://finnhub.io/api/news?id=340ad3a923bdd734564203ca8acc47f7f1502927f7fb1842080a0329e5cd29ce
company,2022-11-03 23:21:30,Will AstraZeneca PLC (AZN) Deliver Promising Return?,116958366,https://media.zenfs.com/en/insidermonkey.com/a3355b66f8b9be42d814254460df8013,AZN,Yahoo,"Baron Funds, an investment management company, released its “Baron International Growth Fund” third quarter 2022 investor letter. A copy of the same can be downloaded here. In the third quarter, the fund declined 11.51% (Institutional Shares), compared to a 9.91% decline for its principal benchmark, the MSCI ACWI ex USA Index. Due to global weakness in […]",https://finnhub.io/api/news?id=9b4e89a8390fb4d707c64482de236da72afccc544de4289659d8fb73ae72da8a
company,2022-11-11 11:38:00,AstraZeneca PLC ADR underperforms Friday when compared to competitors,117126686,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR slid 3.56% to $62.77 Friday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=03f489b3eaa98302c1596af22d1fcc924b14cd35b28628a0197ab510f6b01115
company,2022-11-11 10:20:03,Viatris (VTRS) Wins in Court Against AstraZeneca's Symbicort,117114039,https://media.zenfs.com/en/zacks.com/4df374875d521774a962c44b602b92b5,AZN,Yahoo,Viatris (VTRS) and its partner win a court decision that invalidates branded drug Symbicort's patent and opens the door for them to launch their generic version of the drug.,https://finnhub.io/api/news?id=f83fc5794612df966910da1d7e1ecfe78b3d27df2590d56526e93e644a27e63a
company,2022-11-11 09:33:02,"Pharma Stock Roundup: Q3 Earnings of BAYRY, AZN, EU Nod for AZN, SNY RSV Vaccine",117112831,https://media.zenfs.com/en/zacks.com/f91db6bb14dedc17d5edb20f29c41da3,AZN,Yahoo,"Bayer (BAYRY) and AstraZeneca (AZN) announce third-quarter results. AstraZeneca and Sanofi's (SNY) RSV vaccine, nirsevimab gets approval in Europe.",https://finnhub.io/api/news?id=cbf68b37ca215ac4ba7e628c1e6cf949901a4af440b60e968dd71d36cc99b3ef
company,2022-11-11 07:38:31,FDA Approves AstraZeneca's Imfinzi/Imjudo Chemo Combo For Late Stage Lung Cancer,117112832,https://media.zenfs.com/en/Benzinga/6dd28049b2f77224f7a6ccb1dbff3948,AZN,Yahoo,The FDA has approved AstraZeneca plc’s (NASDAQ: AZN) Imfinzi (durvalumab) in combination with Imjudo (tremelimumab) plus platinum-based chemotherapy for Stage IV (metastatic) non-small cell lung cancer (NSCLC). The approval was based on the results from the POSEIDON Phase 3 trial. Patients treated with a limited course of five cycles of the anti-CTLA-4 antibody Imjudo added to Imfinzi plus four cycles of platinum-based chemotherapy experienced a 23% reduction in the risk of death versus a range,https://finnhub.io/api/news?id=6038ef0317bcbdcf3afd6949b04440ae5c448377b8311dcf44cedf9600aa77d1
company,2022-11-11 07:38:00,IMFINZI and IMJUDO with chemotherapy approved in the US for patients with metastatic non-small cell lung cancer,117109353,https://media.zenfs.com/en/business-wire.com/85b3a4700a1bf251cddf9a33d9077f6f,AZN,Yahoo,"WILMINGTON, Del., November 11, 2022--AstraZeneca’s IMFINZI® (durvalumab) in combination with IMJUDO® (tremelimumab) plus platinum-based chemotherapy has been approved in the US for the treatment of adult patients with Stage IV (metastatic) non-small cell lung cancer (NSCLC).",https://finnhub.io/api/news?id=73b26222f99feb7a90ba4274e3877366cfc74db48aeee89bcb069c8fc6441ac9
company,2022-11-11 07:01:00,U.K. stocks weaken Friday,117125814,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,"U.K. stocks finished lower Friday, with the FTSE 100 Index falling 0.78% at 7,318.04. Among FTSE 100 constituents, defense equipment/products company BAE...",https://finnhub.io/api/news?id=9fb224cdb2d4b9c4476fe323f60f17ea8fe865302fa1eccdc3bdea6b3a6f4061
company,2022-11-11 07:01:00,LONDON MARKET CLOSE: FTSE 100 lags behind peers in risk-on mood,117114643,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=2062a4011c7c6831532c337afe1549985b4068aa27ce4763c3139adb615cdfb8
company,2022-11-11 05:35:00,AstraZeneca put volume heavy and directionally bearish,117117319,https://thefly.com/images/meta/options.jpg,AZN,Thefly.com,Bearish flow noted in Ast... AZN,https://finnhub.io/api/news?id=36d03954fd48225d39cac1fd3255e5e34ab69546f9478e19c5996431643d20c8
company,2022-11-11 01:46:00,"Analysts Offer Insights on Healthcare Companies: AstraZeneca (AZN), Ayr Wellness (OtherAYRWF) and Privia Health Group (PRVA)",117113729,,AZN,TipRanks,Analysts have been eager to weigh in on the Healthcare sector with new ratings on AstraZeneca (<a...,https://finnhub.io/api/news?id=57dad2cb4dcbfbe052138b018a204836798f234a0d196aecba938e7e2e746c80
company,2022-11-11 00:52:00,FDA Approves AstraZeneca’s (NASDAQ:AZN) Lung Cancer Combination Treatment,117117323,https://blog.tipranks.com/wp-content/uploads/2022/01/azn-1-750x406.jpg,AZN,TipRanks,"U.K.-based drugmaker AstraZeneca’s (NASDAQ:AZN) metastatic non-small cell lung cancer treatment, which is a combination of Imjudo and Imfinzi along with platinum-ba...",https://finnhub.io/api/news?id=23a5d12e5b24cb44e5a3e6ae83e0ef3a364501a45a7cc41ee3e90f50c5827bd4
company,2022-11-11 00:30:00,AstraZeneca announces availability of Alexion rare disease therapy in China,117117324,https://thefly.com/images/meta/hotstocks.jpg,AZN,Thefly.com,"The company states: ""... AZN",https://finnhub.io/api/news?id=6ef5e10ea9c099d4d87d5edfab3d1648c05c8ce9115cda652aa1f6a9d58efef2
company,2022-11-11 00:28:00,AstraZeneca's Imfinzi and Imjudo approved in U.S. for NSCLC patients,117117325,https://thefly.com/images/meta/hotstocks.jpg,AZN,Thefly.com,"The company states: ""... AZN",https://finnhub.io/api/news?id=daa46e0264719f133afc75560cb8d3aeaf95ebf527791ec2ed14450692d0b333
company,2022-11-10 23:12:00,TOP NEWS: AstraZeneca wins US FDA approval for lung cancer drugs,117117326,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=3fe494eeb2d73f188c0b114283a9483b0dadff5cd54fe1caf50fab34e1223309
company,2022-11-10 21:30:43,AstraZeneca PLC (AZN) Q3 2022 Earnings Call Transcript,117102161,,AZN,Yahoo,"Before I hand it over to AstraZeneca, I'd like to read the safe harbor statement.  Participants on this call may make forward-looking statements with respect to the operations and financial performance of AstraZeneca.  Although we believe our expectations are based on reasonable assumptions, by their very nature, forward-looking statements involve risks and uncertainties and may be influenced by factors that could cause actual results to differ materially from those expressed or implied by these forward-looking statements.",https://finnhub.io/api/news?id=d01655c0dec08a4cba0e1db418338feea5d1e46ef9c7ab18e9fb4effb93ddaed
company,2022-11-10 21:20:00,AstraZeneca's Combined Imfinzi-Imjud Lung Cancer Treatment Gets Approval for Use in US,117126688,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,By Michael Susin AstraZeneca PLC said Friday that U.S.'s Food and Drug Administration has approved the use of its combined treatment Imfinzi with Imjud for...,https://finnhub.io/api/news?id=6dc94ddbd96311eed821eeac67b626b4eecd2abebd193d448f4a21c3cd37a582
company,2022-11-10 18:30:42,Why AstraZeneca Stock Shot Higher Today,117087523,,AZN,Yahoo,The company trounced analyst profitability estimates for its latest quarter and raised its guidance.,https://finnhub.io/api/news?id=cf9d3c756e712b65ba568638597c5c74577c27d7af1005a46e6454f6045ce84b
company,2022-11-10 11:54:36,AstraZeneca Makes A Break For A Buy Point On Massive Third-Quarter Growth,117076383,https://media.zenfs.com/en/ibd.com/b54f5096e15160ed5819a31865b3b407,AZN,Yahoo,"AstraZeneca leaned on cancer drugs in the third-quarter, leading to double-digit sales growth, a strong beat and a jump for AZN stock.",https://finnhub.io/api/news?id=3f236e17f205a80fe5501d38bde3f007a9642dae030e986791f007634d5eb945
company,2022-11-10 11:38:00,"AstraZeneca PLC ADR rises Thursday, still underperforms market",117126689,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR advanced 6.62% to $65.09 Thursday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=9f7b23136dcb9e74fd0db156c9fc611a0d1dd7755fd2c36746d31ea565100886
company,2022-11-10 11:23:00,AstraZeneca EVUSHELD Named on TIME’s List of the Best Inventions of 2022,117076384,https://media.zenfs.com/en/business-wire.com/f146a20a7430fa7f37e438a73718a169,AZN,Yahoo,"WILMINGTON, Del., November 10, 2022--Today, TIME named AstraZeneca’s EVUSHELD (tixagevimab co-packaged with cilgavimab) on their 2022 list of Best Inventions. Their selection of EVUSHELD reflects its impact as the first and only long-acting monoclonal antibody to receive emergency use authorization in the US for the prevention of COVID-19 in immunocompromised people.",https://finnhub.io/api/news?id=5a9cf2edbd070e9dd5279b1505cdfbca2bc924ab22181afb17f09205941062a8
company,2022-11-10 10:20:03,"AstraZeneca's (AZN) Q3 Earnings Beat, EPS Growth View Up",117073471,https://media.zenfs.com/en/zacks.com/ca9d72216d7bb42fc496430c3df29b41,AZN,Yahoo,"AstraZeneca (AZN) beats third-quarter estimates for earnings while sales come in line. AZN raises its 2022 earnings growth guidance, keeping its sales forecast unchanged.",https://finnhub.io/api/news?id=f7420c2cc736c96054421517f043db4ac271c739dcd381aa0d04821e4719317c
company,2022-11-10 08:53:43,"Troubled FTX Faces SEC Probe And 'Urgently Needs' $8B To Avoid Bankruptcy, NIO Posts Wider Q3 Loss, AstraZeneca Ditches US Application Submission For COVID-19 Shot: Top Stories Thursday, Nov. 11",117073552,https://media.zenfs.com/en/Benzinga/b3f3cc7557a10264cccba91625a61b7a,AZN,Yahoo,"Bloomberg FTX 'Urgently Needs' $8B To Avoid Bankruptcy, Bankman-Fried Reportedly Tells Investors FTX (FTT/USD) CEO Sam Bankman-Fried reportedly told investors on Wednesday that he urgently needs $8 billion in emergency funding to cover withdrawal requests and avert bankruptcy. In a call with investors, Bankman-Fried said he hoped to raise as much as $3 billion to $4 billion in equity and some debt. FTX Stares At More Trouble As Justice Department Reportedly Joins SEC Probe Into Liquidity Crisis",https://finnhub.io/api/news?id=b70c21b5157bc4d369004fb9d16056d97c2fa0c43eb31b3187cce979163b4710
company,2022-11-10 08:30:00,Worried About a Recession? Park Your Money In These 2 High-Yielding Dividend Stocks,117068381,https://s.yimg.com/ny/api/res/1.2/nV6oghKdB_wFTpCH_8FQuA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/d97aedf5d23203658a6cbbfc942dd337,AZN,Yahoo,"Two stocks that risk-averse investors should consider today are AstraZeneca (NASDAQ: AZN) and Coca-Cola (NYSE: KO).  AstraZeneca is a top healthcare company with solid financials, a bright future, and a terrific dividend.  Sales rose 43% year over year to $22.2 billion as AstraZeneca benefited from growth in multiple segments as well as the acquisition of rare disease company Alexion Pharmaceuticals, which it completed last year.",https://finnhub.io/api/news?id=19859fee321092c7e6471a6fb8c42af78bc9262d734690933082210813405310
company,2022-11-10 08:28:51,"Stocks making the biggest moves midday: Six Flags, Rivian, Bumble, Coinbase, Dutch Bros and more",117075413,https://image.cnbcfm.com/api/v1/image/106942550-1631744578989BROS-CB-Photo-210915-CC-PRESS-2.jpg?v=1668104931&w=1920&h=1080,AZN,CNBC,These are the stocks posting the largest moves in midday trading. ,https://finnhub.io/api/news?id=c224b56514dcd9624e4eb3881cc9892849406346edcdb6bcb049f0688423a6e4
company,2022-11-10 08:26:34,"AstraZeneca: Q322 Earnings Boost Share Price, Narrowing The Long-Term Upside Opportunity",117072407,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1250576655/image_1250576655.jpg?io=getty-c-w750,AZN,SeekingAlpha,AZN reported Q322 results today. Revenues grew 37% year-on-year and from a core reporting perspective at least the Pharma looks very profitable. Read more here.,https://finnhub.io/api/news?id=e3531bde013fc1dd9cd2794c873a4f0d21749a44fb13c966041cbdadd51ced58
company,2022-11-10 08:22:07,"AstraZeneca Ditches US Application Submission For COVID-19 Shot, Q3 Edges Analyst Expectations On Oncology Strength",117076389,https://media.zenfs.com/en/Benzinga/ea01015da21dac09e6ad4d38d2d96faf,AZN,Yahoo,"AstraZeneca Plc (NASDAQ: AZN) has reported Q3 core EPS of $1.67, up 55% Y/Y (+70 constant currency), beating the consensus of $0.72. The company clocked Q3 sales of $10.98 billion, +11% (+19% CC), beating the consensus of $10.91 billion. Sales of AstraZeneca's key cancer medicines — Tagrisso and Imfinzi — helped the company's revenue beat, with sales of its broader oncology portfolio rising 24%. Tagrisso generated nearly $1.4 billion, and Imfinzi brought in $737 million in the quarter. Related:",https://finnhub.io/api/news?id=ae47300fc1609b298e5aa0cf0719171ff722e3e53c1ba47de97e8b5602d04a77
company,2022-11-10 06:04:16,"AstraZeneca CFO on Profit Guidance, Expansion, Vaccine Demand",117087531,https://s.yimg.com/ny/api/res/1.2/Ef.GF02nUpTJlsIDkUWtHw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzU-/https://media.zenfs.com/en/bloomberg_markets_video_2/9fc2ea7a1b261f321c831ea0972c3668,AZN,Yahoo,"Astrazeneca's Chief Financial Officer Aradhana Sarin discusses the UK drugmaker's earnings for this quarter. Profit surged to $1.67 per share in the third quarter, beating the $1.52 analysts had estimated. The company benefited from sales of cancer drugs as diagnoses progressively return to pre-pandemic levels.",https://finnhub.io/api/news?id=6cf25541127f244880f95a4df6b3b329866354e3d6a8564aaf67a8141bb63c0e
company,2022-11-10 06:03:00,What You Missed On Wall Street This Morning,117069600,https://image.thefly.com/catalog/201904/img_457.jpg,AZN,Thefly.com,"Five top five lists with the news and calls moving stocks, powered by The Fly. ATVI, RBLX, TJX, PANW, CTMX, RIVN, MQ, SIX, RNG, NIO, AMZN, MSFT, AZN, ZM, TSLA, BTC, BITCOIN, $BTC, RPAY, RDFN, MGNI, APPS, TGTX, EGIO, VCSA, CANO, VERU, YETI, BYND, DSP, RL, DGII",https://finnhub.io/api/news?id=0c8b4b7a91b3537b65d07afe51a65bd41886de8e88ef30f86239eb8ae12d5948
company,2022-11-10 05:35:00,AstraZeneca Drops Plan to Sell Covid-19 Vaccine in U.S.,117060186,https://media.zenfs.com/en/wsj.com/da4eb5271972c254cf299a82797eae34,AZN,Yahoo,"AstraZeneca  PLC said it had dropped plans to submit its Covid-19 vaccine to the Food and Drug Administration for approval, ending a long-running ambition to eventually sell the shot in the U.S. despite initial setbacks.  The Cambridge, England-based pharmaceutical company said Thursday that there would likely be a lack of demand in the U.S., where it said primary vaccination needs had been met.  It would continue to focus its efforts on ensuring the availability of the vaccine, called Vaxzevria, elsewhere, including seeking its approval as a booster shot, the company said.",https://finnhub.io/api/news?id=16a5ae00e0649149def1b948ea1163f5c58aaf9744f7a962d02c3962c1c8c118
company,2022-11-10 05:10:44,FTSE 100: AstraZeneca raises profit guidance amid strong demand,117060187,https://s.yimg.com/ny/api/res/1.2/N4L_icA0cNXuYFudhYszIw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD03NTc-/https://s.yimg.com/os/creatr-uploaded-images/2022-11/1e1db0c0-60db-11ed-aebd-559b559d163a,AZN,Yahoo,AstraZeneca returns to profit on higher drugs revenue.,https://finnhub.io/api/news?id=54ce905d49b9f5ee141d131c3a2255af89a2388789aa092067b3cadb3c5b7765
company,2022-11-10 05:05:23,UPDATE 3-European stocks scale 11-week high after soft U.S. inflation data,117076392,https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png,AZN,Yahoo,"European shares clocked an 11-week closing high on Thursday as a slower-than-expected rise in U.S. consumer prices strengthened hopes of less aggressive interest rate hikes from the Federal Reserve going ahead.  The pan-European STOXX 600 jumped 2.8%, notching its biggest percentage gain in five weeks.  A U.S. Labor Department report showed consumer prices rose less than expected in October, pushing the annual increase below 8% for the first time in eight months.",https://finnhub.io/api/news?id=ce8c99d2c45aaabc7a671a0d9a3aed18b89652235162cb478ff6a28f8d71e15a
company,2022-11-10 05:05:00,AstraZeneca Raises 2022 Guidance After Swing to 3Q Profit -- Earnings Review,117126691,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,By Cecilia Butini AstraZeneca PLC reported third-quarter earnings on Thursday. Here is what we watched. SALES: Sales at the Anglo-Swedish pharma major rose...,https://finnhub.io/api/news?id=0fc24864a20461cdf975793c6f4caeb69441e12f8cb19a7af76da6c87e3c5fe1
company,2022-11-10 03:12:00,Fly Intel: Pre-market Movers,117066903,https://image.thefly.com/catalog/202004/img_793.jpg,AZN,Thefly.com,"Yeti surges following Q3 results SIX, USFD, YETI, NIO, AZN, RNG, ZIP, BDX, WE, TTGT, BMBL, VERU, MO",https://finnhub.io/api/news?id=a8da6498adbf72266cd197a9a3e61481e33a4c918bd4e1a5ace5c5c7bff67274
company,2022-11-10 03:07:32,"AstraZeneca Lifts Profit Guidance on Cancer, Diabetes Drugs",117076393,https://s.yimg.com/ny/api/res/1.2/BKcYUZEbbL6oFoD8R148ig--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/bloomberg_markets_842/f9ad77068fe8068de38582dcd36f480d,AZN,Yahoo,"(Bloomberg) -- AstraZeneca Plc raised its profit guidance for this year, saying drugs like Farxiga for diabetes and Tagrisso for cancer are fueling demand.Most Read from BloombergMusk’s First Email to Twitter Staff Ends Remote WorkSam Bankman-Fried’s $16 Billion Fortune Is Eviscerated in DaysUS Inflation Slows More Than Forecast, Gives Fed Downshift RoomFTX Warns of Bankruptcy Without Rescue for $8 Billion ShortfallMeta to Cut 11,000 Jobs; Zuckerberg Says ‘I Got This Wrong’Core earnings per shar",https://finnhub.io/api/news?id=f4b37b2123b011900bc348065addfde1154a551f281ef1ef4f74b24081521bed
company,2022-11-10 02:51:15,AstraZeneca drops submission to US regulators for Covid-19 vaccine approval,117076394,https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png,AZN,Yahoo,"AstraZeneca has abandoned its submission for US regulatory approval for the Covid-19 vaccine it developed with Oxford university, almost two years after it was initially approved in the UK and Europe.  Pascal Soriot, AstraZeneca’s chief executive, said the company had decided to focus its regulatory team’s efforts on areas with larger unmet medical need, pointing to 19 regulatory approvals since the last earnings call.",https://finnhub.io/api/news?id=ffc75965ff1c1015eb97d0212b29d76a67689b650247ddf73b6ee896f58ac15c
company,2022-11-10 02:47:00,AstraZeneca lifts guidance after forecast-beating profit and sales,117055878,https://s.yimg.com/ny/api/res/1.2/FuFd12Q8Y2nXwhfU8pLPhw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02MDA-/https://media.zenfs.com/en/marketwatch.com/e9ce13150d5fc6a64381ff9752349881,AZN,Yahoo,"After tax, profit was $1.64 billion compared with a loss of $1.65 billion the year prior. Analysts had expected the company to post a net profit of $629 million.",https://finnhub.io/api/news?id=a44f53091147d7e34cc68f64d52292ef118ba8147e9a4cd3eac3cf5a0fee6433
company,2022-11-10 02:43:15,"Stocks making the biggest moves premarket: Tapestry, WeWork, Rivian and others",117075414,https://image.cnbcfm.com/api/v1/image/107149115-1668017811807-gettyimages-1244639173-US_STOCKS.jpeg?v=1668084195&w=1920&h=1080,AZN,CNBC,These are the stocks posting the largest moves before the bell.,https://finnhub.io/api/news?id=922bff10fdc9d1f35c04c9f0a9b16eb9e4f1526a2f887030916242f2aedc8b51
company,2022-11-10 02:38:00,Viatris wins court decision invalidating AstraZeneca's Symbicort patent,117071310,https://thefly.com/images/meta/hotstocks.jpg,AZN,Thefly.com,"Viatris (VTRS), a global ... VTRS, AZN",https://finnhub.io/api/news?id=19f228ac6da787885e722cf432751493dfdcc84fe14c0fcba7794aef40088cd4
company,2022-11-10 02:12:16,AstraZeneca lifts 2022 earnings outlook as cancer drugs boost results,117076397,https://media.zenfs.com/en/reuters-finance.com/b0f94ea00b7d654e9d0ce57102857d21,AZN,Yahoo,"(Reuters) -AstraZeneca raised its full-year earnings outlook on Thursday after strong sales of its key cancer drugs helped it beat quarterly profit and revenue forecasts, driving its shares to a 2-1/2 month high.  The Anglo-Swedish company said it managed to grow its business in China despite protracted COVID lockdowns and was no longer pursuing U.S. approval for its COVID-19 vaccine.  AstraZeneca is seen as a bellwether for the pharmaceutical sector in China, which accounted for about 16% of the company's total revenue last year.",https://finnhub.io/api/news?id=6546672a48ead2cf69e1bc9bcd5340e2cd567d5988942e2490a38222932780f2
company,2022-11-10 02:11:00,"AstraZeneca (NASDAQ:AZN) Stock Rises on Upbeat Q3 Results, Guidance Lift",117071311,https://blog.tipranks.com/wp-content/uploads/2022/11/shutterstock_1866527854-750x406.jpg,AZN,TipRanks,"Shares of the pharma giant AstraZeneca (NASDAQ:AZN) advanced in Thursday’s early trading hours on better-than-expected third-quarter results, fueled by cancer drugs...",https://finnhub.io/api/news?id=abfa3b0b6bd62471b7115be8f2cd15ce1ec5e47fbc1ba3d0f947e0f0517c108a
company,2022-11-10 02:04:43,AstraZeneca PLC 2022 Q3 - Results - Earnings Call Presentation,117059910,https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png,AZN,SeekingAlpha,The following slide deck was published by AstraZeneca PLC in conjunction with their 2022 Q3 earnings call.,https://finnhub.io/api/news?id=7fb07530f4144d76531e91308cf688dbb7cd471c59e64a4b8e0f969bf54f448b
company,2022-11-10 00:48:00,TOP NEWS: AstraZeneca swings to third-quarter profit and ups guidance,117071312,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=61bd10396f7561a5ff58ba74bb3b5a268258e9738c4711e7a4a735596a417037
company,2022-11-10 00:07:00,"AstraZeneca drops plans to submit COVID-19 vaccine to U.S. FDA, WSJ reports",117071314,https://thefly.com/images/meta/periodicals.jpg,AZN,Thefly.com,AstraZeneca said it has d... AZN,https://finnhub.io/api/news?id=9fd87e6075cb00b3bac91e051272b5b39a4ac596d3e73cab7e2a0f2b82db6619
company,2022-11-10 00:03:00,Astrazeneca: Q3 Earnings Snapshot,117071316,,AZN,"Associated Press, The",Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=9a7231c8792bfd623f9fdfd9f9ce6bbde37a77589dc73e2297e18390d0c91452
company,2022-11-10 00:02:00,"AstraZeneca reports Q3 core EPS $1.67, YTD core EPS $5.28",117071317,https://thefly.com/images/meta/earnings.jpg,AZN,Thefly.com,YTD Total Revenue increas... AZN,https://finnhub.io/api/news?id=cf9710db277bcc41c1a5579b5b7c1b7740e62ceb364a475e5f9721ff91e81a9f
company,2022-11-09 23:54:00,"Dow scores 1,200-point gain as stocks log biggest one-day advance since 2020 on signs inflation is softening",117125672,https://images.mktw.net/im-663684/social,AZN,MarketWatch,"U.S. stocks finished sharply higher on Thursday, logging their biggest single-session rally in more than two years as the Dow soared more than 1,200 points...",https://finnhub.io/api/news?id=5ec1da4eda099c3d3282244afdc162975177ecdcb10fc65b523dfa2dc80ddd50
company,2022-11-09 23:03:00,What You Missed On Wall Street On Thursday,117080815,https://image.thefly.com/catalog/201810/img_66.png,AZN,Thefly.com,"Five top five lists with the news and calls moving stocks, powered by The Fly. RIVN, MQ, SIX, RNG, NIO, ATVI, RBLX, TJX, PANW, CTMX, AMZN, COIN, AZN, TSLA, IBEX, RPAY, RDFN, MGNI, APPS, TGTX, EGIO, VCSA, CANO, VERU, YETI, BYND, DSP, RL, DGII",https://finnhub.io/api/news?id=4541572b087b831cf971c608ba95f1e2ae36c10509118e9af5b5f3d619a3f9ae
company,2022-11-09 22:53:00,LONDON MARKET OPEN: Centrica helps FTSE 100 outperform ahead of US CPI,117071319,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=918f46c15c8911c213c6d1303ad77ec5052322311e39169e648cd29bb9e8c6a2
company,2022-11-09 22:35:00,FDA approves tremelimumab combo for metastatic non-small cell lung cancer,117117328,https://thefly.com/images/meta/hotstocks.jpg,AZN,Thefly.com,"On November 10, the Food ... AZN",https://finnhub.io/api/news?id=a4170a001773497ac27a7089395d41254e4faf86d30bfbe38ef775cce9d99c84
company,2022-11-09 22:30:34,AstraZeneca raises 2022 earnings outlook after Q3 results beat estimates,117060195,https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png,AZN,Yahoo,By Scott Kanowsky,https://finnhub.io/api/news?id=c561de51ca11383cf7d77f05d29ab2ad3302c6deec33e4818f7f093b828e08a1
company,2022-11-09 22:08:00,"AstraZeneca Lifts 2022 Guidance After Swing to 3Q Profit, Higher Sales -- Update",117126692,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,By Cecilia Butini AstraZeneca PLC on Thursday lifted its guidance for the full year after reporting a swing to net profit and higher sales for the third...,https://finnhub.io/api/news?id=491b8d508b708d4b9bc08e5276c188ee205160f59dc25c4944f9aba0c64e77dc
company,2022-11-09 21:58:00,LONDON BRIEFING: AstraZeneca and Haleon lift annual guidance,117071321,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=abbfbf659577c7beab842c5907d8770ff3dae8731f4f3f3d8344e21eec4e2b00
company,2022-11-09 20:57:00,LONDON MARKET EARLY CALL: FTSE 100 called lower ahead of US inflation,117071322,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=78ea5d79ed985a3619d02cebe3c94544d816410695331839607f759d8b103e71
company,2022-11-09 20:37:00,"GET READY: AstraZeneca, National Grid and WH Smith at 0700 BST",117066378,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=708df66a25540aad6899e01d87790c7b4ceacd51fcc430cb456343ed2b5aa7f1
company,2022-11-09 20:24:00,AZN Crosses Above Key Moving Average Level,117117329,,AZN,Market News Video,"In trading on Thursday, shares of AstraZeneca plc (AZN) crossed above their 200 day moving average of $62.56, changing hands as high as $65.92 per share - AstraZeneca plc shares are currently trading up about 5.4% on the day. - AZN.",https://finnhub.io/api/news?id=6abb17a2bf0dc35d9d74477df8023f4c60b6764b99d37ac64efb1368fc2ef336
company,2022-11-09 19:30:00,"GLOBAL BRIEFING: Biden hails ""strong"" midterm election in US",117066379,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=c18aac472324bdbe028fab27df359b23c2fc0da3231ed3e46e1055d0bf605cf3
company,2022-11-09 17:35:10,AstraZeneca Q3 Preview: Can Shares Stay Strong?,117042506,https://media.zenfs.com/en/zacks.com/ef77d5a5eb4e72e4dd31ccfaf4ca4ccd,AZN,Yahoo,"AZN shares have been a bright spot in an otherwise dim market in 2022, up nearly 8% and widely outperforming the general market.",https://finnhub.io/api/news?id=c0f8de9e959aa792888adcfee5a86bae3214739dc53fb8e31b9370bae624c91e
company,2022-11-09 17:32:38,Tracking Ken Fisher's Fisher Asset Management Portfolio - Q3 2022 Update,117045633,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/186805810/image_186805810.jpg?io=getty-c-w750,AZN,SeekingAlpha,Fisherâs 13F portfolio value decreased from ~$141B to ~$133B in Q3 2022. Read more to see Fisher Asset Management's holdings and trades for Q3 2022.,https://finnhub.io/api/news?id=db3e8abca049e1e440bf74f475213126220c44706f3d2f40ee6be20d49db4e44
company,2022-11-09 11:38:00,AstraZeneca PLC ADR outperforms market despite losses on the day,117126694,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR slipped 0.46% to $61.05 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=156597a0ab90b5f062bb259332b141f2c102b5b3046b8326fe6f046e5601fbf0
company,2022-11-09 11:04:47,"FDA Adcomm Backs AstraZeneca's 2-In-1 Asthma Inhaler, Only For Adults Being Less Sure For Adolescents, Kids",117031321,https://media.zenfs.com/en/Benzinga/52375b2a0d16aeb412633f15f45a0496,AZN,Yahoo,"The FDA's Pulmonary-Allergy Drugs Advisory Committee has voted 16 to 1 that the data support a favorable benefit-risk assessment for AstraZeneca Plc's (NASDAQ: AZN) PT027 (albuterol/budesonide) for asthma in people aged 18 years and older. In adolescents aged 12 to 17 years, the Committee voted 9 to 8, and for children aged 4 to 11 years, the Committee voted 16 to 1 that the data do not support a favorable benefit-risk assessment for PT027 for asthma. The FDA is slated to decide in the first hal",https://finnhub.io/api/news?id=0e642b8172b76ce7c56bd37f7b1a1d61286ec58f2b609b3e562256aab2804d4d
company,2022-11-09 10:48:08,Is AstraZeneca PLC (AZN) a Solid Long-Term Investment?,117031322,https://media.zenfs.com/en/insidermonkey.com/03a6e5ed068a6575327e23896182338c,AZN,Yahoo,"ClearBridge Investments, an investment management company, released its “ClearBridge Value Equity Strategy” third quarter 2022 investor letter. A copy of the same can be downloaded here. The strategy outperformed its benchmark, the Russell 1000 Value Index, in the third quarter. Sector allocation effects and overall stock selection contributed positively to the strategy’s relative performance in the […]",https://finnhub.io/api/news?id=8f192a7cedfd43c3da6db9ec1f4467bab28b44ba3618b6adb1ce6b3c600ea56e
company,2022-11-09 08:36:01,Why AstraZeneca (AZN) Might Surprise This Earnings Season,117031324,https://media.zenfs.com/en/zacks.com/ef77d5a5eb4e72e4dd31ccfaf4ca4ccd,AZN,Yahoo,AstraZeneca (AZN) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.,https://finnhub.io/api/news?id=209000df9fdc3fff767360cbe77c748ebfa4f58c6671d7de769de94efa1519ec
company,2022-11-09 07:37:46,Clovis Oncology stock slides 75% after biotech warns it will run out of cash by January of 2023,117036433,https://s.wsj.net/public/resources/MWimages/MW-GP644_MicroS_ZG_20180906154215.jpg,AZN,MarketWatch,"Clovis Oncology Inc. shares undefined plunged 75% Wednesday, after the Colorado-based biotech said it will not have sufficient liquidity to maintain...",https://finnhub.io/api/news?id=7dac00ef0baf27ab6a806a357d1d8eb0f3f72d3acb58e2a3dd5053890365d6ba
company,2022-11-09 07:05:00,LONDON MARKET CLOSE: European stocks tread water amid US midterms,117030820,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=19b5555341fca982ba2c8c11b30dd089aacaea7ea286bc8c238178c54eb4fa2a
company,2022-11-09 07:00:00,PT027 Recommended by FDA Advisory Committee as New Rescue Treatment for Asthma,117031325,https://media.zenfs.com/en/business-wire.com/5a25d79f7435b7a44fae01fb53f9545c,AZN,Yahoo,"WILMINGTON, Del., November 09, 2022--The Food and Drug Administration’s (FDA) Pulmonary-Allergy Drugs Advisory Committee (PADAC) has voted 16 to 1 that the data support a favorable benefit risk assessment for the use of PT027 (albuterol/budesonide) for the treatment of asthma in people aged 18 years and older. In adolescents aged 12 to 17 years, the Committee voted 9 to 8 that the data do not support a favorable benefit risk assessment for the use of PT027 for the treatment of asthma. In childre",https://finnhub.io/api/news?id=fe61c30b909c711b93d85d463422f099a4336356c5933e9f10b24922d8957788
company,2022-11-09 05:55:00,"UK earnings, trading statements calendar - next 7 days",117023797,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=0719a58526ec06db2adca04ef15f6ab88ab901dd66dd1767f51e52562510c054
company,2022-11-09 02:24:00,AstraZeneca Expected to Report Higher 3Q Earnings With Key Drugs in Focus -- Earnings Preview,117036435,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,By Cecilia Butini AstraZeneca PLC is scheduled to report results for the third quarter on Nov. 10. Here's what you need to know: SALES: Sales at the...,https://finnhub.io/api/news?id=7336fe02f77d93eff3930d5b53cbf48da1986c5a90be0bb785a93871bf298693
company,2022-11-08 23:53:00,AstraZeneca celebrates asthma treatment recommendation by US FDA,117035443,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=fef223950ea452026f6b394001c830b2b52bc8fefa46b9f57da2443d74de0184
company,2022-11-08 12:48:21,Options Action: A bet against AstraZeneca,117001268,https://image.cnbcfm.com/api/v1/image/107148362-16679475913ED3-FM-C-block-110822.jpg?v=1667947701&w=1920&h=1080,AZN,CNBC,"Optimize Advisors' Mike Khouw looks at what's going on in the biotech space, including a bet against AstraZeneca ahead of earnings. With CNBC's Melissa Lee and the Fast Money traders, Carter Worth, Dan Nathan, Guy Adami and Jeff Mills.",https://finnhub.io/api/news?id=357353c00eec3887b8bcf96f1d0a73401b4d367a823eeb6fa00b407478a76028
company,2022-11-08 11:38:00,"AstraZeneca PLC ADR rises Tuesday, still underperforms market",117036436,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR inched 0.38% higher to $61.33 Tuesday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=b6e33161548def65793037daff48c358da0c4aff7fc2e4ec547d4b6f9069b733
company,2022-11-08 09:00:02,Why Investors Need to Take Advantage of These 2 Medical Stocks Now,117005618,https://media.zenfs.com/en/zacks.com/62d8c8e05376a18ba1420a1733ffdda4,AZN,Yahoo,Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.,https://finnhub.io/api/news?id=ae89d86cd781bc873afdd8da6669ec6d282123776c67648fa7b12c4e27474578
company,2022-11-08 03:25:00,FDA Pulmonary-Allergy Drugs Advisory Committee to hold a virtual meeting,117001036,https://thefly.com/images/meta/converenceevents.jpg,AZN,Thefly.com,The Committee discusses A... AZN,https://finnhub.io/api/news?id=3955a676ad6bece85da5ff28089032d5bac9d1ddaf4053800d547c8ba041897f
company,2022-11-08 03:00:00,IN BRIEF: Beximco Pharmaceuticals revenue up thanks to domestic sales,116999957,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=c20a9f92524de3bf43da5b27805defdff6777b8d344cac0e9370737dcf1beb60
company,2022-11-07 19:34:00,GLOBAL BRIEFING: Trump teases 2024 run ahead of US midterms,116994702,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=9b195dcb5be9cebfec7ed30f056240eb0db7da835e02bc32a8ede2f84e3a7959
company,2022-11-15 12:19:05,Ionis (IONS) Inks Deal to Develop Precision Genetic Medicines,117164387,https://media.zenfs.com/en/zacks.com/a1d7049b0977a02a21fd2aa02b46f307,AZN,Yahoo,"Ionis (IONS) inks collaboration deal with the gene editing company, Metagenomi, to expand the former's capabilities in delivering precision genetic medicines.",https://finnhub.io/api/news?id=e77a85642aef07a7253e3dc308df6ea3ab43c1ed73d5d46954a2527bf4a920a7
company,2022-11-15 11:38:00,"AstraZeneca PLC ADR rises Tuesday, still underperforms market",117246363,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR inched 0.06% higher to $63.95 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the...",https://finnhub.io/api/news?id=b8dc2eed0dee5caaa51561e18d7a05387f5b535118e9d167e32e6d155c7e6b5c
company,2022-11-15 10:09:03,AstraZeneca's (AZN) 3 Cancer Drugs Get CHMP Nod for Expanded Use,117164388,https://media.zenfs.com/en/zacks.com/ca9d72216d7bb42fc496430c3df29b41,AZN,Yahoo,"The CHMP recommends expanded use of AstraZeneca's (AZN) three key cancer drugs, Lynparza, Enhertu and Imfinzi.",https://finnhub.io/api/news?id=9f54da2ee360f142f34a2ef890c2ce57100d9e1686471fd9a0c6e7001a82d2ba
company,2022-11-15 05:01:00,"BRIDGER MANAGEMENT, LLC Buys 1 - GuruFocus.com",117159530,https://static.gurufocus.com/images/logo_global.png,AZN,GuruFocus,GuruFocus Article or News written by insider and the topic is about: ,https://finnhub.io/api/news?id=a50ff34808d9046f85e5dcf0d468633ee37ca2b33e2f9deeee41d83f23f3d33a
company,2022-11-15 03:01:00,Top 5 3rd Quarter Trades of Ca - GuruFocus.com,117161456,https://static.gurufocus.com/images/logo_global.png,AZN,GuruFocus,GuruFocus Article or News written by insider and the topic is about: ,https://finnhub.io/api/news?id=da082be35eebe5b864d228102b210877ea0026190515d75afe8e8475d39b3e0a
company,2022-11-15 02:49:00,GLOBAL BROKER RATINGS: Liberum initiates ConvaTec with 'buy',117159761,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=a9ca9a8fa8637c3c31c25632898358d48cae63c0fe4cc7f470294b3122885b13
company,2022-11-15 01:01:00,BECKER CAPITAL MANAGEMENT INC  - GuruFocus.com,117171888,https://static.gurufocus.com/images/logo_global.png,AZN,GuruFocus,GuruFocus Article or News written by insider and the topic is about: ,https://finnhub.io/api/news?id=7904b26a41ed02a2000745d01e4b7aa971aa3f2d0feef143c64cea7608309715
company,2022-11-14 23:58:00,LONDON BROKER RATINGS: Jefferies cuts Aston Martin to 'underperform',117159327,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=375c3020cb4ac69456cb3efe9412d2b53682027f7a1eee502651a28524402bb3
company,2022-11-14 14:10:07,AstraZeneca's (AZN) Imfinzi/Imjudo Combo Gets Another FDA Nod,117150799,https://media.zenfs.com/en/zacks.com/ef77d5a5eb4e72e4dd31ccfaf4ca4ccd,AZN,Yahoo,AstraZeneca (AZN) gets its second FDA approval for the Imfinzi+Imjudo combo in non-small cell lung cancer (NSCLC) indication.,https://finnhub.io/api/news?id=7b1cbf20b0c8a002a27491583ccf4281020548cbffccfe2bce1fe18a15d565e1
company,2022-11-14 11:11:01,Tango Therapeutics: Behind The Recent Momentum,117147274,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1368429013/image_1368429013.jpg?io=getty-c-w750,AZN,SeekingAlpha,"Shares of early clinical-stage biotech Tango Therapeutics, Inc. (TNGX) are down ~50% since going public in August 2021 â primarily victimized by a lack of catalysts and a tough market.",https://finnhub.io/api/news?id=8e5ec39fd7e2b600273692d674f128b18cff2be03fd32e01d591e59098aca31c
company,2022-11-14 08:15:22,European Medicines Agency's Advisory Committee Backs Approval Of AstraZeneca's Three Cancer Drugs,117143796,https://media.zenfs.com/en/Benzinga/be31bfa4d353ab6127881d71562288ff,AZN,Yahoo,The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has recommended approving AstraZeneca Plc (NASDAQ: AZN) - Merck & Co Inc (NYSE: MRK) partnered Lynparza (olaparib) in combination with abiraterone and prednisone or prednisolone for prostate cancer setting. The opinion covers metastatic castration-resistant prostate cancer (mCRPC) patients for whom chemotherapy is not clinically indicated. The CHMP also backed the approval of AstraZeneca’s Imfinzi (durvalu,https://finnhub.io/api/news?id=42e4e432e96846779eb6945f36d9e8d257bc3acf5fd545d38ac682c43bf25382
company,2022-11-14 02:06:00,GLOBAL BROKER RATINGS: HSBC cuts Azimut to 'hold' from 'buy',117143958,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=e72be0e852c985f23372c445191d029f356e309dc5e5532d6ad96695461337db
company,2022-11-14 01:33:00,"Analysts Are Bullish on These Healthcare Stocks: AstraZeneca (AZN), Halozyme (HALO)",117144104,,AZN,TipRanks,There&#8217;s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on AstraZeneca (<span class='tr-stock-ticker' style='color:blue; f...,https://finnhub.io/api/news?id=317c899f7056f50c5197e1ac934e50fea5b615a0a06e798055124f38a75fd148
company,2022-11-14 00:38:00,AstraZeneca Lynparza+biraterone recommended for E.U. approval in mCRPC,117145287,https://thefly.com/images/meta/hotstocks.jpg,AZN,Thefly.com,"The company states: ""... AZN, MRK",https://finnhub.io/api/news?id=6edff8cd0780e1e9da5cf5bf8fe4a472f1823646ae46b444096a1381467803d0
company,2022-11-13 23:38:00,TOP NEWS: AstraZeneca receives three recommendations for EU approval,117145288,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=9e1c905a31c01d6d935b5b76cb250ae2a83c68af6394a1a0c578f8c0db8719c9
company,2022-11-13 23:25:00,LONDON BROKER RATINGS: Credit Suisse cuts Ferrexpo to 'neutral',117143960,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=1e83d4ac9dae8f3e484ef38592afbdb6537e13245c9d1f43d2ed24769169788f
company,2022-11-13 22:58:00,LONDON MARKET OPEN: Informa lifts FTSE 100; pound above USD1.18,117145038,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=3ee3770f6fb4088483dca83fb8485153345507695722284f96198848fb44086e
company,2022-11-13 21:22:00,AstraZeneca Says Enhertu Recommended for EU Approval for Gastric Cancer,117245745,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,By Kyle Morris AstraZeneca PLC said Monday that Enhertu has been recommended for approval in the European Union for patients with gastric cancer. The...,https://finnhub.io/api/news?id=a3adfff54b0bd5fe35b9058b988bb8cdce47a64bf4709adb5eeec796d0ed3bcc
company,2022-11-13 21:19:00,AstraZeneca's Imfinzi Plus Chemotherapy Recommended for Market Authorization in EU,117246365,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,By Joe Hoppe AstraZeneca PLC said Monday that its Imfinzi product has been recommended for marketing authorization in the European Union for treating adults...,https://finnhub.io/api/news?id=9c6f828590002637e1f71596ff393558ac1d029c3e3e8143fd29222a87990669
company,2022-11-13 21:14:00,AstraZeneca: Lynparza Combo Recommended in EU for Prostate Cancer,117246366,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,By Kyle Morris AstraZeneca PLC said Monday that a Lynparza combination has been recommended for marketing authorization in the European Union for the...,https://finnhub.io/api/news?id=3347083a2fd056f017b20668e15b5cef36f918303a97e64cdb87309805f93e2b
company,2022-11-13 21:00:00,ENHERTU® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Advanced Gastric Cancer,117145291,,AZN,Business Wire,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=61e2f08edb96e701c89c74971dc9273d7a529e473588f398fde3d13c40fe51cd
company,2022-11-12 14:57:55,15 Most Valuable NASDAQ Companies in the World,117132396,https://media.zenfs.com/en/insidermonkey.com/d279f357cb7ade87d189354aa129af07,AZN,Yahoo,"In this article, we will take a look at the 15 most valuable NASDAQ companies in the world. If you want to see more of the most valuable NASDAQ companies in the world, go directly to 5 Most Valuable NASDAQ Companies in the World. When most people hear NASDAQ, they think of technology given that […]",https://finnhub.io/api/news?id=867c4803ff75c3653968cbaa14de26a45847a3e392ede115bf866e0bc1606ab0
company,2022-11-12 02:08:22,AstraZeneca Third Quarter 2022 Earnings: Beats Expectations,117125140,,AZN,Yahoo,AstraZeneca ( LON:AZN ) Third Quarter 2022 Results Key Financial Results Revenue: US$11.0b (up 11% from 3Q 2021). Net...,https://finnhub.io/api/news?id=5c259ccd0209db26656fb29b6aa1e2d4f0f090bc8185136181ae86adcb228d71
company,2022-11-19 10:57:50,Billionaire Steve Cohen’s Top 10 Dividend Stocks,117213889,https://media.zenfs.com/en/insidermonkey.com/c46d0c6af568ad500b756b7abc38d54e,AZN,Yahoo,"In this article, we will take a look at billionaire Steve Cohen’s top dividend stocks. If you want to see more of billionaire Steve Cohen’s top dividend stocks, go directly to Billionaire Steve Cohen’s Top 5 Dividend Stocks. Billionaire Steve Cohen is the founder of Point72 Asset Management which as of the end of September […]",https://finnhub.io/api/news?id=a388af89f25d018232e7745cb7505a758089a1295f869e8d52f1def6799deee7
company,2022-11-18 11:38:00,"AstraZeneca PLC ADR rises Friday, outperforms market",117246360,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR advanced 1.58% to $65.07 Friday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=b99d9301d0d9a3b397a3953e10386af4140295be4f380ad90e89f85efd30d86e
company,2022-11-18 09:37:00,2 Stocks to Buy Whether or Not a Recession Is Coming,117196295,https://s.yimg.com/ny/api/res/1.2/ZbGlOm1nFyURWsrQb_r7QQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/162b7def0f835eb473943a50e528cac1,AZN,Yahoo,"Let's look at two pharma giants that could help investors navigate the next recession and beyond: Bristol Myers Squibb (NYSE: BMY) and AstraZeneca (NASDAQ: AZN).  Bristol Myers' top-line growth seems unimpressive right now.  During the third quarter, the company's revenue declined by 3% year over year (YoY) to $11.2 billion.",https://finnhub.io/api/news?id=1b736b8f12e1d969215bae54de14f47f63c8cf8e9010bf2dd9eb0acb5cab7e09
company,2022-11-18 07:50:12,"Pharma Stock Roundup: RHHBY's Alzheimer's Study Failure, EU Nod for SNY's Enjaymo",117196296,https://media.zenfs.com/en/zacks.com/a1d7049b0977a02a21fd2aa02b46f307,AZN,Yahoo,"Roche's (RHHBY) late-stage Alzheimer's disease study on key pipeline candidate, gantenerumab fails. Sanofi's (SNY) Enjaymo to treat a rare form of anemia gets approval in Europe.",https://finnhub.io/api/news?id=17dac5cfd09801966cf208d771f3b69b9724f1704323b7888206391319aab9ce
company,2022-11-17 11:38:00,AstraZeneca PLC ADR outperforms competitors on strong trading day,117246361,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR inched 0.41% higher to $64.06 Thursday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=ee3a24998cabd9ee85a50ea8e9c6451aa13c2e7d8ce800ad5274de15bd42c79e
company,2022-11-17 11:21:04,Merck (MRK) Outpaces Industry YTD: What's in Store for 2023?,117186980,https://media.zenfs.com/en/zacks.com/9883d206905e7516b2353476e213e60c,AZN,Yahoo,Strong sales of key products like Keytruda and Gardasil and positive pipeline/regulatory developments keep Merck's (MRK) stock afloat in 2023.,https://finnhub.io/api/news?id=5f4ab3d262e94395044aa901ab4cf6a598b3bcd860b9d8d3daa151ac9a3f9b86
company,2022-11-17 09:54:02,Key Factors Driving Amgen's (AMGN) Outperformance This Year,117186981,https://media.zenfs.com/en/zacks.com/9d995582658bf49e50317a8120603e3e,AZN,Yahoo,"Amgen's (AMGN) key drugs like Prolia, Repatha and Otezla are driving sales. Amgen is also rapidly advancing its robust pipeline of early and late-stage assets.",https://finnhub.io/api/news?id=79e2e7b724953bb2c7b72580806d9693d7d8ee17bd9f817cf755b8796497afdb
company,2022-11-16 11:38:00,AstraZeneca PLC ADR outperforms competitors despite losses on the day,117246362,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR dropped 0.23% to $63.80 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=6fea5c9b38e50ce75d9daf254ee501aa0e9f498cf21bd67acf1705bf0cc20a77
company,2022-11-16 09:57:22,Investor AB: Not Cheap Enough,117174058,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1358050858/image_1358050858.jpg?io=getty-c-w750,AZN,SeekingAlpha,Investor AB is a Swedish holding company that invests both in listed and unlisted European companies.,https://finnhub.io/api/news?id=d6b5bf449d553c067063fb3757e1c37536d77ebbf6c54574ba697313a5832057
company,2022-11-16 08:23:00,"Alexion, AstraZeneca Rare Disease, Completes Acquisition of LogicBio® Therapeutics",117177927,https://media.zenfs.com/en/business-wire.com/36a47e42f9bfb2eeabdf7481bb0b5da5,AZN,Yahoo,"WILMINGTON, Del., November 16, 2022--Alexion, AstraZeneca Rare Disease, today announced the completion of its acquisition of LogicBio® Therapeutics, Inc. (NASDAQ: LOGC), a pioneering genomic medicine company.",https://finnhub.io/api/news?id=dcc85fcf9785fdd3a8deb7f0869077731575c93ac824fdbe4fc509227aa402a5
company,2022-11-16 01:05:00,Compugen to receive $7.5M milestone payment from AstraZeneca,117173398,https://thefly.com/images/meta/hotstocks.jpg,AZN,Thefly.com,"Compugen (CGEN) expects t... CGEN, AZN",https://finnhub.io/api/news?id=dec24f67d876a52a60f6ad5365cd37f034ccdc112a0e9c89a2ace2cdb9f355f8
company,2022-11-23 11:38:00,"AstraZeneca PLC ADR rises Wednesday, still underperforms market",117296776,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR inched 0.18% higher to $66.12 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the...",https://finnhub.io/api/news?id=058378deefdb012e57d4e5f7b90ef99efd9ca8965ceb9d4d0fc65c5111164002
company,2022-11-23 09:36:54,15 Biggest European Pharmaceutical Companies,117264578,https://media.zenfs.com/en/insidermonkey.com/99eb1b005fb207dc5a1af7700d305596,AZN,Yahoo,"In this piece, we will take a look at the 15 biggest European pharmaceutical companies. For more companies, head on over to 5 Biggest European Pharmaceutical Companies. Alongside the United States, Europe has some of the most advanced industries and economies in the world. While the Americans are rightly credited with having pioneered the modern […]",https://finnhub.io/api/news?id=8c62b1d93ef7b47ed1f52158f30f9322cde77626e04dc7df519de34ebbb61b20
company,2022-11-22 14:36:18,Alexion's new U.S. head is looking for 'the next generation of medicines to unpack',117256196,https://s.yimg.com/ny/api/res/1.2/2J4E1IQHafOcAcRnGGy7Ng--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD0xODAw/https://media.zenfs.com/en/bizjournals.com/9b60683757b88c89ea94754cece48428,AZN,Yahoo,"A little more than a year since its acquisition by AstraZeneca plc, Alexion Pharmaceuticals Inc. is operating in ""the best of both worlds"" as the official rare disease unit of the U.K. pharma giant.",https://finnhub.io/api/news?id=545768819d582b377e8dbe854fe54b250cfb9283f354502e4134763b068f1e8b
company,2022-11-22 11:38:00,"AstraZeneca PLC ADR rises Tuesday, still underperforms market",117296777,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR inched 0.87% higher to $66.00 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the...",https://finnhub.io/api/news?id=34050215709c684feca3779558fa9ec66f7702b1f17c2d7e842f0467ef2e1307
company,2022-11-22 09:08:38,"Regeneron: Stock Priced Too High To Buy, But Keep One Eye On This Pharma",117254475,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1409383663/image_1409383663.jpg?io=getty-c-w750,AZN,SeekingAlpha,Regeneron Pharmaceuticals is hoping to establish itself as a major oncology player. See why I no longer see REGN stock price upside in the near term.,https://finnhub.io/api/news?id=b8c46582b0d89b08aace9733554a204afafd5345f8cbb557d8a9442edca1de7a
company,2022-11-22 07:05:00,AstraZeneca Aims to Redefine Breast Cancer Care With New Data Across the Treatment Spectrum At SABCS 2022,117250092,https://media.zenfs.com/en/business-wire.com/b9a2c0e49b8569d31993b93d2aa3c67b,AZN,Yahoo,"WILMINGTON, Del., November 22, 2022--AstraZeneca will present new data advancing its ambition to redefine care at the 2022 San Antonio Breast Cancer Symposium (SABCS), December 6-10, 2022.",https://finnhub.io/api/news?id=ce3b4672fde81258501578658ba668bee340fdad0e4157334d54af9144d0e363
company,2022-11-22 06:00:00,Merck Vs. AbbVie: Which Is Better Buy As The Patent Cliffs Approach?,117252030,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1370358685/image_1370358685.jpg?io=getty-c-w750,AZN,SeekingAlpha,I will be comparing AbbVie and Merck to see which is better positioned for its patent cliff. Read to know why I like AbbVie more than Merck.,https://finnhub.io/api/news?id=04e4d88a73e24c5c4b5927b5538baf447a9b3ff977e6fbca00ee9c33cb80c3a9
company,2022-11-21 19:30:13,Here’s Why AstraZeneca PLC (AZN) Declined in the Third Quarter,117244307,https://media.zenfs.com/en/insidermonkey.com/134a4c0e84241a15f81448116eee04f0,AZN,Yahoo,"Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Growth & Income Fund” third quarter 2022 investor letter. A copy of the same can be downloaded here. In the third quarter, the fund delivered negative returns. The market continued its decline in the third quarter and the S&P 500 Index fell -4.9%. In addition, […]",https://finnhub.io/api/news?id=4b300bed2bd37855d982f7b760a3abfdb723903a46a8ca3e939177a9b61dea97
company,2022-11-21 11:38:00,AstraZeneca PLC ADR outperforms market on strong trading day,117246359,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR inched 0.55% higher to $65.43 Monday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=519a004a217dc0cd83f49531c8fb1fe50a908dea299d90b010afa46f6117cac1
company,2022-11-27 17:27:45,11 Best Diabetes Stocks To Buy Now,117305478,https://media.zenfs.com/en/insidermonkey.com/19beccb56da372276573d70787ab8a6c,AZN,Yahoo,"In this article, we discuss 11 best diabetes stocks to buy now. If you want to see more stocks in this selection, check out 5 Best Diabetes Stocks To Buy Now. The global diabetes market is segmented based on the type, drug class, and devices used to treat the condition. Based on the type, the […]",https://finnhub.io/api/news?id=563d342075988c311813bc2c697a477a1bf6af19a4ebfe965ff0e3a357c2b12a
company,2022-11-25 15:20:29,10 Best Biotech Stocks To Buy According To Hedge Funds,117288555,,AZN,Yahoo,"In this article, we discuss 10 best biotech stocks to buy according to hedge funds. If you want to see more stocks in this selection, check out 5 Best Biotech Stocks To Buy According To Hedge Funds. In 2023, digitalization will increase in the biotech industry as the possibility of online and remote assessment, diagnosis, […]",https://finnhub.io/api/news?id=eabaf09bec0bc4b4691bd61a7ff53c1bf174675cf5d05d5765df91b5a368fe5e
company,2022-11-25 12:34:05,Clovis (CLVS) Stock Down 50% in the Past 6 Months: Here's Why,117288393,,AZN,Yahoo,Clovis Oncology (CLVS) tanks in the past six months following the possibility of a bankruptcy filing in the near term.,https://finnhub.io/api/news?id=0477656451df6ea7608770f8662717aa665d9db0083ec10125df2766b9bc6fed
company,2022-11-24 21:00:00,"AstraZeneca Thailand Wins Two ACES Awards 2022: ""Industry Champions of the Year"" and ""Community Initiative""",117282188,https://media.zenfs.com/en/prnewswire.com/a66183735d80e0dbc5e838d15c0f2fe4,AZN,Yahoo,"AstraZeneca (Thailand) Co., Ltd., was recently honoured with two accolades in the categories of Industry Champions of the Year and Community Initiative at the Asia Corporate Excellence & Sustainability Awards 2022 (ACES Awards 2022).",https://finnhub.io/api/news?id=b1b29812ef42c2f22928e9c71bd6f3d9f7960557d5bbd89f647f1be851c31123
company,2022-11-24 09:40:02,Astrazeneca (AZN) is a Top-Ranked Value Stock: Should You Buy?,117276719,https://media.zenfs.com/en/zacks.com/ac90b3d74679f6d01a122aa033d8a9a4,AZN,Yahoo,"Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.",https://finnhub.io/api/news?id=cbbc2db261f2774d6b381eecffa16e55f7cbd46a6b48492cb9aec26d35edf022
company,2022-12-01 11:40:00,AstraZeneca PLC ADR outperforms competitors on strong trading day,117408971,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR inched 0.54% higher to $68.34 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the...",https://finnhub.io/api/news?id=287a01d6dd3a97f72423c8dd09752c62f1534b3f8c7977562e2898c2784d3eed
company,2022-12-01 05:10:00,2 Stocks That Could Surprise Investors in 2023,117357270,https://s.yimg.com/ny/api/res/1.2/44RjVc45aTl6De_zUxBmuw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD05NTY-/https://media.zenfs.com/en/motleyfool.com/1928af818e2aca05fcf4539060c3780d,AZN,Yahoo,"The healthcare industry can make for a safe place to invest regardless of the macroeconomic conditions.  A couple of healthcare stocks that are diversified and that could be good buys heading into the new year are AstraZeneca (NASDAQ: AZN) and PetMed Express (NASDAQ: PETS).  AstraZeneca's business performed well in 2022, but its stock isn't doing as well as perhaps it should be.",https://finnhub.io/api/news?id=dccfaec4402c5ef9ff04e777ef0a8aeb68fad60421597714b12ce3b7541b63d5
company,2022-11-30 16:49:40,Why Shares of Compugen Rose 16.5% on Wednesday,117350190,,AZN,Yahoo,"Shares of Compugen (NASDAQ: CGEN), a clinical-stage biotech company that specializes in immunology therapies to treat cancer, saw its shares rise 16.5% on Wednesday.  The stock closed on Tuesday at $1.03, then opened on Wednesday at $1.01, before jumping to $1.23 in the late afternoon and closing at $1.20.  The stock has been volatile, with a 52-week low of $0.51 and a 52-week high of $4.88.",https://finnhub.io/api/news?id=31b881cf534e0fe03498dbd895c6344b1006768fbeb404c1897f7a8be761afbb
company,2022-11-30 12:54:47,Mirati Therapeutics: Is There A Big Pharma Buyout In Play And What's The Price Tag?,117350726,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/483287873/image_483287873.jpg?io=getty-c-w750,AZN,SeekingAlpha,Mirati Therapeutics will find out in December if the FDA will approve its lead drug candidate Adagrasib in NSCLC. Read why the company also is part of acquisition speculation.,https://finnhub.io/api/news?id=21065decc13c0cf2f36d93627d133ef3e7293dc9f5b1cbab1dc97feeae2174cc
company,2022-11-30 08:34:01,AstraZeneca (AZN) Boosts Cell Therapies With Neogene Deal,117344397,https://media.zenfs.com/en/zacks.com/00ec4a55c0f0d99f7e816f5da7894e0c,AZN,Yahoo,The acquisition of Neogene is set to give AstraZeneca (AZN) access to the latter's next-generation T-cell receptor therapies.,https://finnhub.io/api/news?id=19168681506e1a5435f3165c3904fa541b51cfc9c18b8316a49907a8186e9021
company,2022-11-30 07:00:00,AstraZeneca Showcases Strength of Hematology Portfolio and Pipeline Across Multiple Hard-to-Treat Conditions at ASH 2022,117344398,https://media.zenfs.com/en/business-wire.com/893bd7e7b84f74dbe82623dc30e52d09,AZN,Yahoo,"WILMINGTON, Del., November 30, 2022--AstraZeneca will present 47 abstracts showcasing new data from across its hematology portfolio and clinical pipeline, demonstrating its commitment to redefining care for hard-to-treat blood diseases at the 64th American Society of Hematology (ASH) Annual Meeting and Exposition, December 10 to 13, 2022.",https://finnhub.io/api/news?id=cee01b6040c66b8c0754d277945237e9551e887d9d5e895e0eda19ea3f358618
company,2022-11-29 11:40:00,AstraZeneca PLC ADR outperforms market despite losses on the day,117408972,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR dropped 0.20% to $66.08 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...",https://finnhub.io/api/news?id=e86af4ce639b0a697fbeeb920a352d7b5d49b7746ea4e9b3d68023c1af46d1ac
company,2022-11-29 09:30:19,ADC Therapeutics: Running Through A Stretch Of Bad Luck,117329433,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1358868801/image_1358868801.jpg?io=getty-c-w750,AZN,SeekingAlpha,ADC Therapeutics faced the brunt of the FDA's new policy against rampant accelerated approvals. See why ADCT stock remains something of a risky bet.,https://finnhub.io/api/news?id=085001133dec65385c403e2354a7719b66853346b1716f1fc0cfe95d4144f042
company,2022-11-29 02:34:28,UPDATE 2-AstraZeneca boosts cancer portfolio with $320 mln Neogene deal,117321506,https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png,AZN,Yahoo,"AstraZeneca will acquire biotechnology company Neogene Therapeutics for up to $320 million, the London-listed drugmaker said on Tuesday, seeking to build its pipeline of cell-based cancer treatments.  Though AstraZeneca's oncology portfolio accounted for more than a third of the company's revenue last year, it does not have an approved cell-based cancer therapy and is behind rivals such as Novartis and Gilead.  ""Neogene's leading (T-cell receptor) discovery capabilities and extensive manufacturing experience complement the cell therapy capability we have built over the last three years,"" said Susan Galbraith, AstraZeneca's executive vice president of oncology research.",https://finnhub.io/api/news?id=1b57371714529187fc56e5e76bbe090da52c6d5b09a16ff4e4e28cb331fcf881
company,2022-11-29 00:12:07,AstraZeneca acquires biotech Neogene for $320M in bid to expand cancer treatments,117326574,https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png,AZN,Yahoo,By Scott Kanowsky,https://finnhub.io/api/news?id=2eec0bccbdfc37f300ece06a8b9bbdf235650dc3c0c6004cbd5f9fc5f96c7720
company,2022-11-28 21:23:00,AstraZeneca to Buy Neogene Therapeutics for $320 Mln,117408973,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,By Ian Walker AstraZeneca PLC said Tuesday that it is buying biotechnology company Neogene Therapeutics Inc. for up to $320 million. The pharmaceutical giant...,https://finnhub.io/api/news?id=a40f4e97a637c08b741c4a81374d46de0f9f33ecb47688a4dd67f6f843fcf0e2
company,2022-11-28 20:02:13,"BOE: Global Exposure, Call Writing Strategy, ~7.6% Distribution Yield",117320555,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1356381571/image_1356381571.jpg?io=getty-c-w750,AZN,SeekingAlpha,BlackRock Enhanced Global Dividend Trust's discount is attractive and leads to an enticing distribution yield. See the factors that make BOE CEF a Buy.,https://finnhub.io/api/news?id=2050a1289f92f96b5543e7c38fa82359bf93b82d5ddc4eaf02846b44cdddeced
company,2022-11-28 11:40:00,"AstraZeneca PLC ADR rises Monday, outperforms market",117318059,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR inched 0.06% higher to $66.21 Monday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=aae8ada05e0c843ac052e9b558187c889345d03176037a4ad94f57224b4e3050
company,2022-11-28 10:54:31,AstraZeneca acquires rights to potential COPD treatment in deal valued at up to $402M,117313767,,AZN,Yahoo,The global licensing deal also includes exclusive rights for other undisclosed inflammatory and respiratory diseases.,https://finnhub.io/api/news?id=e15568185076766b017ae8bdb8e5e583ba581114ec3f0a9c816bb6de1567f4ac
company,2022-11-28 08:25:40,AstraZeneca Bets On UK Listed Firm For Lung Diseases,117313768,https://media.zenfs.com/en/Benzinga/ecac711ab0ce5f91b6dfede211a57938,AZN,Yahoo,"Drug Discovery company C4X Discovery Holdings plc has signed an exclusive worldwide licensing agreement with AstraZeneca plc (NASDAQ: AZN) worth up to $402 million for its NRF2 Activator program. C4X Discovery is listed on the London Stock exchange, and the deal is the third significant deal with a major pharmaceutical company. AstraZeneca will develop and commercialize an oral therapy for inflammatory and respiratory diseases with a lead focus on chronic obstructive pulmonary disease (COPD). Re",https://finnhub.io/api/news?id=4239b0332f175c12604af932b32422cce68fe84a1e49121296b9fc82f22359be
company,2022-11-28 02:00:00,C4X Discovery Holdings plc: C4XD signs exclusive global licence worth up to $402 million¹ with AstraZeneca  for the development and commercialisation of NRF2 Activator programme,117308059,https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png,AZN,Yahoo,"C4XD is eligible to receive upfront and pre-clinical payments of $16 million, plus development and commercial milestones, and tiered mid-single digit royalties Agreement further substantiates C4XD's scientific expertise and strategy through a third significant deal with a major pharmaceutical company MANCHESTER, United Kingdom, Nov. 28, 2022 (GLOBE NEWSWIRE) -- C4X Discovery Holdings plc (AIM: C4XD), a pioneering Drug Discovery company, has signed an exclusive worldwide licensing agreement with",https://finnhub.io/api/news?id=63433b62733692ddaede47a04eed85a69c5ee2a69b3b0a15d9ce40c412480e58
company,2022-11-27 21:34:00,C4X Discovery Signs Licensing Deal with AstraZeneca Worth up to $402 Mln,117318060,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,By Joe Hoppe C4X Discovery Holdings PLC said Monday that it has signed a worldwide licensing deal with AstraZeneca PLC worth up to $402 million for the...,https://finnhub.io/api/news?id=9839f363d6de83341dfea640f1f89bfe2c4ca95e76c6599f3e50e6a3e0c77ca4
company,2022-12-05 11:41:00,AstraZeneca PLC ADR outperforms competitors despite losses on the day,117408968,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR dropped 0.07% to $68.42 Monday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=9d7477147a6ab7924f070c1c0426e08b705180f850b42519160bc12031a546c0
company,2022-12-05 11:22:47,10 Best Foreign Stocks to Buy Now,117403104,https://media.zenfs.com/en/insidermonkey.com/a6f27e253abf10eeafb1cb1a425baac0,AZN,Yahoo,"In this article, we will take a look at 10 best foreign stocks to buy now. If you want to see more best foreign stocks to buy, go directly to 5 Best Foreign Stocks to Buy Now. Although it has the largest economy in the world, the United States doesn’t have a monopoly on good companies. […]",https://finnhub.io/api/news?id=ab13bc128d878ba62def070402838003c2e9cfd37a9f365d6d52f1696ac9c48e
company,2022-12-05 02:15:43,Ocugen: Still Struggling,117401107,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1392708770/image_1392708770.jpg?io=getty-c-w750,AZN,SeekingAlpha,"Ocugen introduces its mucosal COVID vaccine, but can it compete with the mRNA vaccine technology of Moderna and BioNTech/Pfizer? Read more here.",https://finnhub.io/api/news?id=bab12b8b1a44522cd1d80cf3fb2d28800b783843086b98f1126bb32dc88020fa
company,2022-12-04 23:12:50,"Arvinas: Promising Science, Poor Data",117400306,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1394125060/image_1394125060.jpg?io=getty-c-w750,AZN,SeekingAlpha,Arvinas produced underwhelming data for the second time. Read more to see why I sold out my position in ARVN stock recently.,https://finnhub.io/api/news?id=560b846949b7cfeade1385ad7c195be82d8a0ef23bc2881e6ca9249d6f15c966
company,2022-12-02 11:41:00,AstraZeneca PLC ADR underperforms Friday when compared to competitors despite daily gains,117408969,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR inched 0.19% higher to $68.47 Friday, on what proved to be an all-around mixed trading session for the stock market, with the Dow...",https://finnhub.io/api/news?id=b405421600c3c2c90ed995d0cddfc74fab80babdab70375fa01ce58d6363d13b
company,2022-12-02 07:55:12,"Pharma Stock Roundup: PFE & AZN Ink New M&A Deals, LLY Meets Alzheimer's Study Goal",117375117,https://media.zenfs.com/en/zacks.com/a1d7049b0977a02a21fd2aa02b46f307,AZN,Yahoo,Pfizer (PFE) and Roivant Sciences (ROIV) form a new Roivant subsidiary to develop an inflammatory disease drug. AstraZeneca (AZN) to boost cell therapies portfolio with private company buyout.,https://finnhub.io/api/news?id=d597afcef4f40a17a6f045ba59ce9ad1b5b7176f1470ea67368c97fe4470e752
company,2022-12-02 04:13:00,Vaxxinity Covid-19 Booster Candidate Matches Rivals At Trial,117408710,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,"By Dean Seal Vaxxinity Inc. said Friday that UB-612, its Covid-19 booster candidate, achieved at trial similar results to Pfizer Inc.'s Covid-19 vaccine and...",https://finnhub.io/api/news?id=2574289424a7f0722b233b3e0defcac23107dcd895eace0bf69069395d39cf78
company,2022-12-09 15:15:51,"UPDATE 1-Patient selection for AstraZeneca, Daiichi breast cancer drug needs improvement, experts say",117457926,https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png,AZN,Yahoo,"The rush to use AstraZeneca and Daiichi-Sankyo's drug Enhertu to treat certain types of breast cancer has far outpaced doctors' ability to determine with certainty which patients might benefit, experts said this week at a meeting of breast cancer doctors.  Enhertu, which won U.S. approval in late 2019, is used in patients with advanced breast, gastric and lung cancers whose tumor cells carry a protein called HER2.  Early this year, researchers found that Enhertu could also benefit certain breast cancer patients whose HER2 levels were previously thought to be too low for the drug to have a meaningful effect.",https://finnhub.io/api/news?id=91e232fab7fd4d30cc3a43ba3f64fd2cf749aef1dd9915b8a9b06b8b870a0028
company,2022-12-09 12:22:00,"ADRs End Lower; AstraZeneca, British American Tobacco Trade Actively",117507359,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,By Denny Jacob International stocks trading in New York closed lower on Friday. The S&P/BNY Mellon index of American depositary receipts ticked down 0.3% to...,https://finnhub.io/api/news?id=ea4d3928eb45cd7f4be0709c71c241325ac67879b9665bc5c480355925be08d6
company,2022-12-09 11:38:00,"AstraZeneca PLC ADR rises Friday, outperforms market",117507360,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR inched 0.55% higher to $69.55 Friday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=9b7b8c1d9c2453cfb30a0a11bd4979d9bb67c7fbe1dcf1f61cf8a27300d8567c
company,2022-12-09 11:21:04,Alnylam (ALNY) Seeks to Expand Onpattro Label in Cardiomyopathy,117455842,https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0,AZN,Yahoo,Alnylam (ALNY) initiates label expansion filing with FDA for Onpattro to treat cardiomyopathy in patients suffering from ATTR-amyloidosis. The drug is already approved to treat polyneuropathy in such patients.,https://finnhub.io/api/news?id=237b38b20301f40faecdf34fef10657a81beadb1e42bbe3a2f716db2bc158bae
company,2022-12-09 07:01:00,"AstraZeneca rises Friday, outperforms market",117507361,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"AstraZeneca PLC shares inched up 0.34% to £113.54 Friday, on what proved to be an all-around positive trading session for the stock market, with the FTSE 100...",https://finnhub.io/api/news?id=910c1db61adaa20ec7acb893eb6b0ccb6966e07cd874a0ce0996ed114f3d0172
company,2022-12-09 07:00:00,"Patient selection for AstraZeneca, Daiichi breast cancer drug needs improvement, experts say",117451687,https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png,AZN,Yahoo,"The rush to use AstraZeneca and Daiichi-Sankyo's drug Enhertu to treat certain types of breast cancer has far outpaced doctors' ability to determine with certainty which patients might benefit, experts said this week at a meeting of breast cancer doctors.  Enhertu, which won U.S. approval in late 2019, is used in patients with advanced breast, gastric and lung cancers whose tumor cells carry a protein called HER2.  Early this year, researchers found that Enhertu could also benefit certain breast cancer patients whose HER2 levels were previously thought to be too low for the drug to have a meaningful effect.",https://finnhub.io/api/news?id=2406dd139272650dbf80936e9972764bcc39ddb244bd21d4d53990b2f6ba2b98
company,2022-12-09 06:14:19,AstraZeneca Highlights First Results From Datopotamab Study In Pretreated Breast Cancer Patients,117452764,https://media.zenfs.com/en/Benzinga/2e9d789d3a3e7044b9f22d98354dd544,AZN,Yahoo,"AstraZeneca Plc (NASDAQ: AZN) reported initial data from the TROPION-PanTumor01 Phase 1 trial of datopotamab deruxtecan (Dato-DXd). The data showed encouraging and durable efficacy in patients with heavily pretreated hormone receptor (HR)-positive, HER2-low, or HER2-negative (IHC 0) unresectable or metastatic breast cancer. Safety results were consistent with previous trials of datopotamab deruxtecan. Also see: AstraZeneca Highlights Detailed Data From Two Breast Cancer Trials. In this cohort of",https://finnhub.io/api/news?id=2ea735624b7da67c16a46e87a15e55f3b55d9351386dda751d5b23fab2425cf9
company,2022-12-08 13:41:10,AstraZeneca Highlights Detailed Data From Two Breast Cancer Trials,117445042,https://media.zenfs.com/en/Benzinga/61b75e56ef9e745406a2f7dfac9c1b95,AZN,Yahoo,AstraZeneca Plc (NASDAQ: AZN) announced detailed results from the SERENA-2 Phase 2 trial of camizestrant in pretreated post-menopausal patients with estrogen receptor (ER)-positive locally advanced or metastatic breast cancer. The data showed that camizestrant demonstrated a statistically significant and clinically meaningful improvement in progression-free survival (PFS) at 75mg and 150mg dose levels versus Faslodex (fulvestrant) 500mg in patients previously treated with endocrine therapy. In t,https://finnhub.io/api/news?id=1da3aa2a690b88232979ac6d18ca4604facbfd52947621a42c510528158221a0
company,2022-12-08 11:40:00,"AstraZeneca PLC ADR rises Thursday, still underperforms market",117507362,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR inched 0.46% higher to $69.17 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the...",https://finnhub.io/api/news?id=3d7a7bdfb9af139a98e0bb60d8efe51c755c9a53261cfcc3a358504f03e64aff
company,2022-12-08 09:42:25,Lexicon Continues To Drift Ahead Of An Expected FDA Approval And A High-Risk Commercialization Effort,117443868,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1359314170/image_1359314170.jpg?io=getty-c-w750,AZN,SeekingAlpha,"Lexicon shares have drifted lower since the summer, with little news of consequence to sway investor opinions. Read the outlook here.",https://finnhub.io/api/news?id=3a17041d2ac24e1b2b64dfa6e897443f0547e3efb1983915bfdd2c58d3e9450e
company,2022-12-08 08:35:00,"Camizestrant Significantly Delayed Disease Progression in Advanced ER-Positive Breast Cancer, Adding at Least 3.5 Months Benefit Versus FASLODEX® (fulvestrant)",117441535,https://media.zenfs.com/en/business-wire.com/85dd84154ca77d6491298b13bd78fd13,AZN,Yahoo,"WILMINGTON, Del., December 08, 2022--Detailed results from the SERENA-2 Phase II trial showed AstraZeneca’s next-generation oral selective estrogen receptor degrader (ngSERD) camizestrant demonstrated a statistically significant and clinically meaningful improvement in progression-free survival (PFS) at both 75mg and 150mg dose levels versus FASLODEX® (fulvestrant) 500mg in post-menopausal patients with estrogen receptor (ER)-positive locally advanced or metastatic breast cancer, previously trea",https://finnhub.io/api/news?id=31d8738d85cbce4c96536615a480c1e46f25e4d1c8adbe7e92b460dfd9c23972
company,2022-12-08 08:30:00,Capivasertib Plus FASLODEX® (fulvestrant) Reduced the Risk of Disease Progression or Death by 40% Versus FASLODEX in Advanced HR-Positive Breast Cancer,117441536,https://media.zenfs.com/en/business-wire.com/f74d578c723c9e0d2a73193cbe0573e2,AZN,Yahoo,"WILMINGTON, Del., December 08, 2022--Detailed results from the CAPItello-291 Phase III trial showed AstraZeneca’s capivasertib in combination with FASLODEX® (fulvestrant) demonstrated a statistically significant and clinically meaningful improvement in progression-free survival (PFS) versus placebo plus FASLODEX in patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-low or negative, locally advanced or metastatic breast cancer, following recurrence or pr",https://finnhub.io/api/news?id=727f2d50b329d3a7313d39e7a593d9a66b602fe70ed81e4ea2d8e02ba83153e2
company,2022-12-08 00:36:52,IOO: We're Thinking A Soft Landing,117440583,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1257405518/image_1257405518.jpg?io=getty-c-w750,AZN,SeekingAlpha,iShares Global 100 ETF is mostly just a value weighted US portfolio. Click here to read more about the fund.,https://finnhub.io/api/news?id=1d815b77727a100fcbd4cac0a4ae1140faf2373608895f7c58dd3ed357e9e619
company,2022-12-07 12:01:58,AstraZeneca's Enhertu Cuts Risk Of Death By 36% VsTrastuzumab In Metastatic Breast Cancer,117435281,https://media.zenfs.com/en/Benzinga/4d617d310ab74501b82cdcce641c5ea0,AZN,Yahoo,"AstraZeneca Plc (NASDAQ: AZN) shared updated data from the DESTINY-Breast03 Phase 3 trial evaluating Enhertu versus trastuzumab emtansine (T-DM1) in previously treated patients with HER2-positive unresectable and/or metastatic breast cancer. Enhertu demonstrated a statistically significant and clinically meaningful improvement in overall survival (OS) compared to T-DM1. In the key secondary endpoint analysis of overall survival for DESTINY-Breast03, Enhertu demonstrated a 36% reduction in risk o",https://finnhub.io/api/news?id=cdbf67380742366a82f87680847908bb78cff3a2ab1a73b41f3f946efffc08a0
company,2022-12-07 11:40:00,AstraZeneca PLC ADR underperforms Wednesday when compared to competitors despite daily gains,117507363,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR inched 0.42% higher to $68.85 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the Dow...",https://finnhub.io/api/news?id=915c075017c11065ba38b51dd43d6b0f6331692ef85f279d1f31af1f099b172a
company,2022-12-07 08:30:00,"ENHERTU® (fam-trastuzumab deruxtecan-nxki) Achieved Statistically Significant Overall Survival, Reducing the Risk of Death by 36% Vs. Trastuzumab Emtansine (T-DM1) in Patients With HER2-positive Metastatic Breast cancer in DESTINY-Breast03",117429014,https://media.zenfs.com/en/business-wire.com/577d874e79750db244ae2ff683c0252e,AZN,Yahoo,"WILMINGTON, Del., December 07, 2022--Updated results from the DESTINY-Breast03 Phase III trial showed that ENHERTU® (fam-trastuzumab deruxtecan-nxki) demonstrated a statistically significant and clinically meaningful improvement in overall survival (OS) compared to trastuzumab emtansine (T-DM1) in patients with HER2-positive unresectable and/or metastatic breast cancer previously treated with trastuzumab and a taxane. These results and primary results from the DESTINY-Breast02 Phase III trial wi",https://finnhub.io/api/news?id=ad9377d582e7de62c18ad9703c3d13c9a313476c9146a0bc56709e9ce1bb8512
company,2022-12-13 15:19:39,"AstraZeneca Stock Hits New Relative Strength Highs, Reaches Buy Zone",117502547,,AZN,Yahoo,AstraZeneca is breaking out on the strength of its relative strength highs and as profits continue to grow.,https://finnhub.io/api/news?id=9f0e1ab5f0c60bf403b9bb5749e722b61967b18924a4f70abfff7d23ce8a5b0e
company,2022-12-13 11:38:00,"AstraZeneca PLC ADR rises Tuesday, still underperforms market",117507353,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR inched 0.43% higher to $69.58 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the...",https://finnhub.io/api/news?id=5b9d1ca52da49a382677fe37bd3c7ea9a22130aa85b9144118fe34936afce10b
company,2022-12-13 10:02:00,AstraZeneca Awards $4M to Nonprofit Organizations to Advance Health Equity,117498031,https://media.zenfs.com/en/business-wire.com/944da7e404fb168741a7ff957e7efd86,AZN,Yahoo,"WILMINGTON, Del., December 13, 2022--AstraZeneca is proud to announce $4 million in financial contributions to 52 nonprofit organizations through its second-annual Accelerate Change Together (ACT) on Health Equity: Community Solutions Challenge and National Strategic Collaborations. Building on the learnings and impact from its inaugural year, the 2022 contributions will support community-based, regional and national nonprofit programs working to advance health equity and enhance STEM (Science,",https://finnhub.io/api/news?id=c3fa7b56e08c52963388a82af7573d6e90f021213436df21375d0fb5dc67146c
company,2022-12-13 07:01:00,"AstraZeneca falls Tuesday, underperforms market",117507354,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"AstraZeneca PLC shares inched down 0.21% to £113.26 Tuesday, on what proved to be an all-around great trading session for the stock market, with the FTSE 100...",https://finnhub.io/api/news?id=dc065bbf9284156fcdcda953425d9573207c7a095e7cdc4c747c60be57776e89
company,2022-12-12 11:39:00,AstraZeneca PLC ADR underperforms Monday when compared to competitors,117507356,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR dropped 0.39% to $69.28 Monday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=1e03705c8ed420e6d0bb2dcdc271fc9607e0f1bc1ebba5af4bd8d2e418aee660
company,2022-12-12 07:01:00,"AstraZeneca falls Monday, still outperforms market",117507357,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"Shares of AstraZeneca PLC inched down 0.04% to £113.50 Monday, on what proved to be an all-around dismal trading session for the stock market, with the FTSE...",https://finnhub.io/api/news?id=da76034dab95e195dfe42bca826bf0d4b07dac95f07f3780a30b833ddedef09b
company,2022-12-12 06:22:35,Pfizer: The Best Long-Term Investment Setup Since 2009,117483239,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1344323367/image_1344323367.jpg?io=getty-c-w750,AZN,SeekingAlpha,Pfizer has a history of performing well during recessions and bear markets on Wall Street. COVID-19 sales may remain high. Read more on PFE stock here.,https://finnhub.io/api/news?id=0e74d2cf86a7d6ee6bf5b3f5638c57c73af098e1f08b0737c71762970272a841
company,2022-12-10 21:35:56,Eli Lilly: What To Do When The Market Doesn't Care About Valuation,117473162,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1344251576/image_1344251576.jpg?io=getty-c-w750,AZN,SeekingAlpha,Eli Lilly is one of the best performing pharmaceutical stocks in 2022. Click here to see why LLY stock is overvalued according to me.,https://finnhub.io/api/news?id=72ea78494524af8e59579b4893e04fbdea8ce774d30d56966b79d5a447654ce2
company,2022-12-10 06:20:00,"Netflix, Workday, Costco, Caterpillar and more: These stocks are Cowen's favorites for 2023",117477502,https://images.mktw.net/im-595785/social,AZN,MarketWatch,"Across the market, Cowen & Co. analysts see undervalued stocks.",https://finnhub.io/api/news?id=a9aff5503cfcfc573f24297e236f73fbf3a36219914488ec50562ef1c98dd706
company,2022-12-16 11:38:04,"FDA Delays Decision on AstraZeneca (AZN), Merck's Lynparza sNDA",117543073,https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0,AZN,Yahoo,The FDA extends the review period of AstraZeneca (AZN)/Merck's filing seeking label expansion for Lynparza's indication in prostate cancer. The FDA intends to use this time to review the submission.,https://finnhub.io/api/news?id=d4a027cdfc750b62443774d1cae7884bb694c82b112aae11608c5a79c7ec5dbb
company,2022-12-16 11:38:00,AstraZeneca PLC ADR underperforms Friday when compared to competitors,117559708,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR slipped 2.58% to $67.94 Friday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=d360a5ab920230ec8d38c8ed5dcaf0084b53f8a69c33b90ecc77e6ff6d7ee4d8
company,2022-12-16 07:01:00,"AstraZeneca falls Friday, underperforms market",117559709,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"Shares of AstraZeneca PLC slid 1.80% to £111.56 Friday, on what proved to be an all-around poor trading session for the stock market, with the FTSE 100 Index...",https://finnhub.io/api/news?id=2da68f6f1381a9f4feb9c926ebd0babdd6fc1f6d87c229dfd164693b9132a8df
company,2022-12-16 06:27:00,"Prenetics Acquires ACT Genomics, Creating a Leader in Comprehensive Cancer Genetics and Precision Oncology",117535838,https://s.yimg.com/ny/api/res/1.2/37KlocxTyp_YQDR_MgV8hw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD0yMTU-/https://media.zenfs.com/en/globenewswire.com/29e60d9889720e55d9d1ef0d3ac31f62,AZN,Yahoo,"Acquisition to bring germline and somatic testing, cell-free DNA-based (liquid biopsy), and tissue-genomic profiling onto a single platformCancer genomics testing is now standard practice for cancer care and has shown to be highly successful such as Foundation One (acquired by Roche), Grail (acquired by Illumina), Exact Sciences, Guardant Health and moreExpects ACT to contribute US$25-30 million in revenues in 2023Positions Prenetics solidly within the US$80+ billion global precision oncology ma",https://finnhub.io/api/news?id=412a833874a343311dc19ccc637b7393e57eaceda438658c0862e1b8b43190a8
company,2022-12-16 05:57:00,"AstraZeneca`s cancer, heart drugs gets EMA panel nod for expanded use in EU",117759601,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=e4b5607a21a1f25b306939da52398ec7bcdc6f03fd4a67603887603db8d57029
company,2022-12-16 04:00:00,Guardant Health (GH) Stock Sinks on Disappointing Blood Test Results,117652575,,AZN,InvestorPlace,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=2f33d12dd618381b18b33b678df5e62fd5d4ab1f8bee46650a899bb5585248e2
company,2022-12-16 01:06:00,"AstraZeneca`s Imjudo combo gets EMA panel nod to treat liver, lung cancers in EU",117759606,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=3f594b0a27f7cc20cceb076ddfb1c1340c89047c35440e8a1294e1e21fcf1ec7
company,2022-12-16 00:27:00,"HealthBeacon appoints new interim CFO, permanent CFO process ongoing",117734862,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=852add8fc4cabf8dbe5b2bec45892a402ec0c11b2f90950f46de6a08225aeb1e
company,2022-12-15 22:06:00,Primecap Odyssey Funds` 2022 Annual Shareholder Letter,117650830,,AZN,GuruFocus,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=577f1fe945f914f28916dddc99b1b1d27e7a30ea5dabaedbf280c877e6355de2
company,2022-12-15 11:38:00,AstraZeneca PLC ADR outperforms market despite losses on the day,117559710,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR slumped 0.99% to $69.74 Thursday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=c6c30f3b64367af8a77b08ac739ddff96797877d7059221fd68a67f50e962ef5
company,2022-12-15 10:58:54,FibroGen: Growth Prospects Are Not Worth Current Valuations,117526824,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1368429047/image_1368429047.jpg?io=getty-c-w750,AZN,SeekingAlpha,"Amid strong headwinds, FibroGen has achieved a high market valuation. Click here to read my analysis on why I think investors should avoid FGEN stock.",https://finnhub.io/api/news?id=65dd664284b39ae47a7b5ad227eb08ae943d421ff00d0e013e5d79fae2238466
company,2022-12-15 09:15:42,U.S. Commerce removes Wuxi Biologics from unverified list,117532956,https://media.zenfs.com/en/reuters-finance.com/463a25ef49246160db3db857d20cbfce,AZN,Yahoo,"The Commerce Department also removed nine Russian entities from the unverified list and addded them to the entity list because the United States has been unable to conduct site visits.  Companies are added to the unverified list if the United States cannot complete on-site visits to determine if they can be trusted to receive sensitive U.S. technology exports, inspections which in China require approval from the commerce ministry.",https://finnhub.io/api/news?id=15f746b468b3925920c2dcfc88dbb1504ad0abf22e21cb46dc089f4ab6df790a
company,2022-12-15 08:42:01,Implied Volatility Surging for AstraZeneca (AZN) Stock Options,117532957,https://media.zenfs.com/en/zacks.com/ef77d5a5eb4e72e4dd31ccfaf4ca4ccd,AZN,Yahoo,Investors need to pay close attention to AstraZeneca (AZN) stock based on the movements in the options market lately.,https://finnhub.io/api/news?id=38a951bbc3c0f2d04cc3195ec0ec25aa059e38cbab905f4e559987685c692907
company,2022-12-15 07:01:00,"AstraZeneca falls Thursday, still outperforms market",117559711,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"Shares of AstraZeneca PLC inched down 0.35% to £113.60 Thursday, on what proved to be an all-around grim trading session for the stock market, with the FTSE...",https://finnhub.io/api/news?id=447c17c500d4deab9ec80d26edb026617ac59ab491075ee39e81376d6d3ebe3c
company,2022-12-15 06:10:40,"FDA Extends Review Period For AstraZeneca-Merck Partnered Cancer Drug, Lynparza",117524954,https://media.zenfs.com/en/Benzinga/153b7701e41f378fed7433d5bb2b2444,AZN,Yahoo,The FDA will extend the Prescription Drug User Fee Act (PDUFA) date for AstraZeneca Plc (NASDAQ: AZN) and Merck & Co Inc's (NYSE: MRK) supplemental marketing application for Lynparza (olaparib) by three months. The application seeks approval for Lynparza in combination with abiraterone & prednisone or prednisolone for metastatic castration-resistant prostate cancer (mCRPC). Related: AstraZeneca-Merck's Lynparza Treatment Shows Long-Term Survival In Ovarian Cancer. The supplemental application is,https://finnhub.io/api/news?id=1972f473226455ecaf7f1650d2fb693de8a1f0ceb2c9a43e93ae69114bbc083e
company,2022-12-15 05:00:10,"Zacks Industry Outlook Highlights Johnson & Johnson, Novo Nordisk, Merck and AstraZeneca",117528897,https://media.zenfs.com/en/zacks.com/ef77d5a5eb4e72e4dd31ccfaf4ca4ccd,AZN,Yahoo,"Johnson & Johnson, Novo Nordisk, Merck and AstraZeneca have been highlighted in this Industry Outlook article.",https://finnhub.io/api/news?id=7d596ad0f7296e98a8f51307174f555126f3d50c3be913776453148c28720f25
company,2022-12-15 02:13:00,C4X Holdings loss widens; outlook strong amid AstraZeneca partnership,117759614,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=d22aa2bac7541f10d1a2e49a42cadb745a95512cca5649fdc4fc4d3e610880a5
company,2022-12-15 02:01:00,"Merck, AstraZeneca Receive FDA Extension on Lynparza New Drug Application Date",117559712,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,By Denny Jacob Drugmaker Merck &amp; Co. and pharmaceutical company AstraZeneca PLC on Thursday said the Food and Drug Administration will extend the date...,https://finnhub.io/api/news?id=2fde96e4024bc34d9ed5cb2e739c98e7362458c959a78fa5d5cc5cdbed2af401
company,2022-12-15 01:46:00,GLOBAL BROKER RATINGS: Investec raises Phoenix Group to 'buy',117628651,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=62964a1134fe7ff599635149d246fbc364d737fd200deb6b2c7893038df44a2c
company,2022-12-15 00:47:00,"Merck, AstraZeneca: FDA to extend PDUFA date for sNDA for LYNPARZA combo",117759617,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=a04fc92e15b395b2eb77da74ba9873e281f938647e6f028edcd194cd48c8b567
company,2022-12-14 22:37:00,AstraZeneca and Merck receive US FDA extension for Lynparza review,117759621,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=d83e7e7e0d32830525f2973827d9f54f1321f93988639d0deb5017f000d1ca6c
company,2022-12-14 22:36:00,FDA extends review of AstraZeneca/Merck`s Lynparza`s expanded use in prostate cancer,117759622,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=438f9ad8d262b7b8977a7f91e5f9b14d5ac2d69f074b9c2ef9bc1064b84d1c15
company,2022-12-14 21:49:00,"LONDON BRIEFING: Lower open ahead of BoE, ECB; Currys swings to loss",117759627,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=7e7fb5f970d541d7390d56b40a87203970fb51dd2da7bfd8d4168dd1b387d2a6
company,2022-12-14 20:30:00,"AstraZeneca price target raised to 13,000 GBp from 12,000 GBp at Deutsche Bank",117759629,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=3c3a825774b7c5cc78f4a7aeb095cb862006677ad1773dd585056fa80f290a04
company,2022-12-14 11:38:00,AstraZeneca PLC ADR underperforms Wednesday when compared to competitors despite daily gains,117559713,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR advanced 1.24% to $70.44 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=ae0076284c150ba1d7e1c6a0f23b374c948154ebbc7c6d9e4df47249677335d2
company,2022-12-14 09:40:02,Astrazeneca (AZN) is a Top-Ranked Value Stock: Should You Buy?,117520070,https://media.zenfs.com/en/zacks.com/8442d24e11d454aa89061259a9714d43,AZN,Yahoo,"Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.",https://finnhub.io/api/news?id=67d3a56b516c4dac9b315edbc7b3bb76b2f78a10a8ec514cb70f5135e5415d80
company,2022-12-14 08:34:01,4 Large Drug Stocks to Watch in a Booming Industry,117514879,https://media.zenfs.com/en/zacks.com/ca9d72216d7bb42fc496430c3df29b41,AZN,Yahoo,"Drug/biotech companies are likely to see significant advances in innovation in 2023. In the Large-Cap Pharmaceuticals industry, Johnson & Johnson (JNJ), Novo Nordisk (NVO), Merck (MRK) and AstraZeneca (AZN) are worth retaining in your portfolio.",https://finnhub.io/api/news?id=25e2ab7c4d004d60e1cec93a934473f7efa732e57386ca14cf74536e6c6ab71b
company,2022-12-14 07:01:00,"AstraZeneca rises Wednesday, outperforms market",117559714,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"AstraZeneca PLC shares inched up 0.65% to £114.00 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the FTSE 100...",https://finnhub.io/api/news?id=5bc645547da6183ddee12760ee32ca1428e7020a0e913e1b9ede6df31c7353cb
company,2022-12-21 13:07:00,"ADRs End Higher, AstraZeneca and Carnival Trade Actively",117697195,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,By Denny Jacob International stocks trading in New York closed higher on Wednesday. The S&P/BNY Mellon index of American depositary receipts ticked up 1.5%...,https://finnhub.io/api/news?id=01e508561b0952e55421970363c097616b329185742a05e5abb447ac4319a0e8
company,2022-12-21 11:38:00,"AstraZeneca PLC ADR rises Wednesday, still underperforms market",117743217,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR inched 0.27% higher to $67.90 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the...",https://finnhub.io/api/news?id=1462ac42c80790091a853d93a74893257e06f19af947936efc6bdb64712fa4f6
company,2022-12-21 08:26:01,AstraZeneca (AZN) Gets EU Nod to Expanded Use of 2 Cancer Drugs,117604393,https://media.zenfs.com/en/zacks.com/ef77d5a5eb4e72e4dd31ccfaf4ca4ccd,AZN,Yahoo,The European Commission approves AstraZeneca's (AZN) two key cancer drugs Lynparza and Imfinzi for expanded use.,https://finnhub.io/api/news?id=db3490944eb8d37035f0764a131cca7f3887c972eacdaccf3e6a839701b828d8
company,2022-12-21 08:17:38,"Europe Approves AstraZeneca's Two Combo Therapies For Prostate, Bile Duct Cancer Settings",117601938,https://media.zenfs.com/en/Benzinga/e9384c425a5ffc22b676a7b336472790,AZN,Yahoo,"The European Commission has approved AstraZeneca Plc (NASDAQ: AZN) and Merck & Co Inc's (NYSE: MRK) Lynparza (olaparib) plus abiraterone and prednisone or prednisolone for metastatic castration-resistant prostate cancer (mCRPC) for patients for whom chemotherapy is not clinically indicated. The approval was based on results from the PROpel Phase III trial. In the trial, Lynparza combo therapy reduced the risk of disease progression or death by 34% versus abiraterone and prednisone or prednisolon",https://finnhub.io/api/news?id=4c6c5fa0217e73ff5ad0f025f2d3e9de5b3c15f0c46c31962a36fa56f01cf9fa
company,2022-12-21 07:01:00,"AstraZeneca rises Wednesday, still underperforms market",117743220,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"AstraZeneca PLC shares advanced 1.06% to £112.44 Wednesday, on what proved to be an all-around great trading session for the stock market, with the FTSE 100...",https://finnhub.io/api/news?id=5780dfa143774d4c9aedbe9f7a60d5a02ba98a06d616b016b9b5c3e5b2355f61
company,2022-12-21 06:03:32,Madrigal: Next Steps After 'Wow' Data In NASH,117600556,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1352674281/image_1352674281.jpg?io=getty-c-w750,AZN,SeekingAlpha,"On Monday, Madrigal Pharmaceuticals announced a best-case dataset from its phase 3 trial in NASH. Click here to read why I think his opens up a Huge market for MDGL.",https://finnhub.io/api/news?id=8dc6d4b12215639df0bb85512ae1a47feb692a3c2e29ab800356197db3c3e8b9
company,2022-12-21 05:08:00,Madrigal: Next Steps After `Wow` Data In NASH,117663116,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=0d0f38a4ffeb80582feccceb018858e324eea88bcd6a3a9f6b36e47893dc67be
company,2022-12-21 00:49:00,AstraZeneca`s Lynparza approved in E.U. as first line treatment in mCRPC,117759555,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=f9484b664db427c8df6b5a245f2e2a86a524d25d695a87e188a29943f9342e02
company,2022-12-21 00:49:00,"Merck, AstraZeneca: LYNPARZA/abiraterone and prednisone combo approved in EU",117759554,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=c469c63ea0cb89cff0c45980c9e5599a2bac45fee234486d8d60b2d9b3aa756b
company,2022-12-21 00:43:00,AstraZeneca`s Imfinzi+chemotherapy approved in E.U. in BTC patients,117759557,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=8a23a6353b1aa960f558629b990ac4ad5754fbb9a7194bd6c9d3f771e0dff966
company,2022-12-20 23:16:00,AstraZeneca wins two new approvals in EU for cancer drugs,117759559,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=f5aecd350dc17d38f1f1cd7c3d74b256fd513336d160849c6fbd7dd8460d34cc
company,2022-12-20 23:00:00,LONDON MARKET OPEN: European markets make gains in early trade,117642294,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=38818a05ad6cc463762591591afea796946cb41214ef15d518c210bc4971e2a1
company,2022-12-20 22:55:00,AstraZeneca Imfinzi combo for biliary tract cancer gets approval in EU,117759562,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=2848dbff4b22738e6fbfc1ea207990c6485a0c024befaaa2c46ac7e3ec2a0511
company,2022-12-20 22:33:00,"AstraZeneca, Merck`s Lynparza gets approval in EU for expanded use in prostate cancer",117759566,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=f061a14f94b3f1b98bf13cc095aa997cdd98afc3ae31e3981679f14096457b0c
company,2022-12-20 21:55:00,LONDON BRIEFING: UK public sector borrowing shoots up in November,117637857,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=cfca46595d0aac0f757f4ace5acee536f3ae441286a6254f13b78f996438bbc3
company,2022-12-20 11:38:00,"AstraZeneca PLC ADR rises Tuesday, outperforms market",117743223,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR inched 0.37% higher to $67.72 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the...",https://finnhub.io/api/news?id=c61a98976fdcd50ca87854f2cacc58939f125f53bb29a34c64066627d563f1b0
company,2022-12-20 09:30:00,Could AstraZeneca's Asthma Drug Candidate Generate Billions?,117589005,,AZN,Yahoo,AstraZeneca's new asthma rescue treatment could soon be approved in the United States for adults.,https://finnhub.io/api/news?id=58b5872a2b3b7262164117e9de2c6b686653b6af52efcfe7aa4b15188583e92f
company,2022-12-20 08:56:01,AstraZeneca (AZN) Gets EU Nod & CHMP Opinions for Some Drugs,117586451,https://media.zenfs.com/en/zacks.com/9d995582658bf49e50317a8120603e3e,AZN,Yahoo,"The CHMP recommends approvals for expanded use of AstraZeneca's (AZN) Enhertu in breast cancer, Imfinzi plus Imjudo in lung and liver cancers and Forxiga in heart failure.",https://finnhub.io/api/news?id=4d10731b6c8311b7ea6b286e79a3aa4ac329a2032cfd255a93e3be6ba1719fc4
company,2022-12-20 07:01:00,"AstraZeneca rises Tuesday, outperforms market",117743225,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"AstraZeneca PLC shares inched up 0.16% to £111.26 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the FTSE...",https://finnhub.io/api/news?id=0a24210baff49ee8379bdaab75b39fa3414cdf9eb93b5e86491487e7bb543238
company,2022-12-20 04:00:53,FTSE 100 lower as Bank of Japan's surprise move sparks fear,117582587,https://s.yimg.com/ny/api/res/1.2/ivPP.dwFrvaTrvxIfUAMlg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04Nzg-/https://s.yimg.com/os/creatr-uploaded-images/2022-12/9f82f4f0-8042-11ed-bfff-ff354b115c5a,AZN,Yahoo,Bank of Japan unexpectedly tweaks its ultra loose monetary policy.,https://finnhub.io/api/news?id=992960ac03340212da983cf79a6fcdc9eaf68252e50d12e4d15b6084a967ac81
company,2022-12-20 03:57:00,"AstraZeneca, G42 Healthcare enter strategic partnership agreement",117759569,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=5ba8d0f0546679bb5c85d7949211c113390bda21c6038a78fc12aec91d42e485
company,2022-12-19 18:15:11,Astrazeneca (AZN) Stock Moves -0.69%: What You Should Know,117578920,https://media.zenfs.com/en/zacks.com/432476d296d64c50172213c0415587c9,AZN,Yahoo,"Astrazeneca (AZN) closed the most recent trading day at $67.47, moving -0.69% from the previous trading session.",https://finnhub.io/api/news?id=176f7916c8a116462aaaba18beaf3b48e6d271db413c88dbdf459c15013c9be3
company,2022-12-19 13:08:00,"ADRs End Mixed; AstraZeneca, atai Life Sciences Trade Actively",117743227,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,By Denny Jacob International stocks trading in New York closed mixed on Monday. The S&P/BNY Mellon index of American depositary receipts ticked down 0.1% to...,https://finnhub.io/api/news?id=eddc7acf43cdee90521ae91aa9f62bc2fc28dd8d4281a787a1a165fb86f9ece5
company,2022-12-19 11:38:00,"AstraZeneca PLC ADR falls Monday, still outperforms market",117743231,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR shed 0.69% to $67.47 Monday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=6744dd212cc57dce9746c1b0222c1e01f043c63ee16bfb75fa11d7166341f518
company,2022-12-19 08:27:53,"AstraZeneca - Daiichi Sankyo's Enhertu Wins European Approval For Gastric Cancer, CHMP Backs Other Cancer Drugs",117573240,https://media.zenfs.com/en/Benzinga/321b3f1e37cc6751ec7d9f289af02e82,AZN,Yahoo,"The European Commission has approved AstraZeneca Plc (NASDAQ: AZN) - Daiichi Sankyo’s (OTC: DSKYF) (OTC: DSNKY) Enhertu (trastuzumab deruxtecan) for advanced HER2-positive gastric or gastroesophageal junction (GEJ) adenocarcinoma. The approval covers patients who have received a prior trastuzumab-based regimen. Concurrently, the Committee for Medicinal Products (CHMP) for Human Use (CHMP) of the European Medicines Agency has backed the approval for Enhertu for unresectable or metastatic HER2-low",https://finnhub.io/api/news?id=52dc65d088cd139702bb9462b1faf2703d96e8e8de8ed667ba11bbe9c81809f9
company,2022-12-19 07:01:00,"AstraZeneca falls Monday, underperforms market",117743233,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"AstraZeneca PLC shares inched down 0.43% to £111.08 Monday, on what proved to be an all-around positive trading session for the stock market, with the FTSE...",https://finnhub.io/api/news?id=3af0c27c76fe1bb4af2ade7bd48e13be2eb6dc8546339250a37c89baf4b1185c
company,2022-12-19 05:48:07,AstraZeneca Drug Imfinzi Fails As Monotherapy In Metastatic Lung Cancer Setting,117572427,https://media.zenfs.com/en/Benzinga/1804525bb52f8d997adcacc3f46aa51c,AZN,Yahoo,AstraZeneca Plc (NASDAQ: AZN) announced topline data from the PEARL Phase 3 trial of Imfinzi (durvalumab) monotherapy versus platinum-based chemotherapy (investigator's choice) as a 1st-line treatment in patients with Stage IV (metastatic) non-small cell lung cancer (NSCLC). The study did not achieve statistical significance for the primary endpoints of improving overall survival (OS) versus platinum-based chemotherapy as a monotherapy treatment for metastatic NSCLC whose tumor cells express hig,https://finnhub.io/api/news?id=89bad04dfd364e7c133c7fded0061dae7352e0c78d2077eaa75de509c66cba6c
company,2022-12-19 03:27:00,AstraZeneca’s Forxiga gets EU approval recommendation for symptomatic chronic heart failure,117572428,,AZN,Yahoo,The recommendation covers heart failure with reduced ejection fraction--a measure of the amount of blood the heart's left ventricle pumps with each heartbeat.,https://finnhub.io/api/news?id=6fc5163d981c7e0238a8f0377c9dbc34de27b47c2df431f595e7fcc74b4e8ba0
company,2022-12-19 02:54:00,AstraZeneca’s Imfinzi plus Imjudo recommended for approval in the EU,117572429,,AZN,Yahoo,"The Anglo-Swedish pharma giant said the Committee for Medicinal Products for Human Use of the European Medicines Agency based its opinion on results from the Himalaya Phase 3 trial, and results from the Poseidon Phase 3 trial.",https://finnhub.io/api/news?id=88192d7c66efba9e5f8d04376bbd21cad63fde316e1dde175393229c2c98d54a
company,2022-12-19 01:39:00,AstraZeneca says PEARL trial didn`t achieve statistical significance on endpoint,117759573,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=5ff97fe9a06cd675180377e182169a3aa8e45402852960d5b377af4fdb872081
company,2022-12-19 01:37:00,AstraZeneca says Imfinzi plus Imjudo recommended for approval in EU by CHMP,117759574,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=a01d73f728cba93ae2200ed1960c85228064a8d27266234156eb22a03c8cddec
company,2022-12-19 01:29:00,AstraZeneca reports Enhertu approved in EU for previously treated gastric cancer,117759577,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=b3dd089a67052c1c38c4cf2f8d504c4b018686099753d24684304fccd96b8322
company,2022-12-19 01:27:00,AstraZeneca reports Forxiga recommended for extend indication in EU by CHMP,117759579,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=5d379b8da6d5aa13dcdc5ebd2e02bf75b407b87792622a917932b7668bf95e47
company,2022-12-19 00:56:42,AstraZeneca slips after Imfinzi falls short in cancer trial,117572430,https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png,AZN,Yahoo,By Geoffrey Smith,https://finnhub.io/api/news?id=573411f4966e747219aa73d212217c8a1d810870f41e9f87a4619a12c4433cd0
company,2022-12-18 23:46:00,TOP NEWS: AstraZeneca receives host of EU approvals or recommendations,117759580,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=9f8e6d65f8912f8b0ec948b6c4ad114b9f2fe917c72cdba5cc12186177d18a82
company,2022-12-18 23:18:00,"AstraZeneca, Daiichi Sankyo announce Enhertu recommended for approval in the EU",117759582,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=64ec8304a8d737b9f8fddadca191afbc5c803b6a361099e9df6f1c3d1346f86d
company,2022-12-18 22:55:00,LONDON MARKET OPEN: Stocks higher as China begins shaky reopening,117641575,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=6eaa7f0aab4eb02e43c6eb654adcccfcb4ff0b92e2aa05ecf004c0d683a39788
company,2022-12-18 21:52:00,"LONDON BRIEFING: Stocks called up, but prospect of Santa rally fades",117759587,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=2e517aed8a6fc2e70bbab99ffa025f1442ae3385bfc5dee77d26619098b657e2
company,2022-12-18 21:50:00,AstraZeneca`s Enhertu wins EU approval for advanced gastric cancer,117759589,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=047a1278971026137770dffa94b006a502c24e8546f2cd499c554982f3e37280
company,2022-12-18 21:30:00,AstraZeneca`s Forxiga gets EU approval recommendation for symptomatic chronic heart failure,117759591,,AZN,MarketWatch,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=624c012456ebdaa98570a0bd415ae88e54488e93e873540878d9993221f1fbf2
company,2022-12-18 21:00:00,ENHERTU® Recommended for Approval in the EU by CHMP for Patients with HER2 Low Metastatic Breast Cancer,117759594,,AZN,Business Wire,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=af1c44b360c40653abaf6cebe366983671c62f4f1938fc96a1582f04b0cb5bf1
company,2022-12-18 21:00:00,ENHERTU® Approved in the EU for Patients with Previously Treated HER2 Positive Advanced Gastric Cancer,117759592,,AZN,Business Wire,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=2e334624a25083db96e7ff1ab663513636bb4fcb990803625ae381d8730fd258
company,2022-12-18 20:58:00,AstraZeneca`s Imfinzi plus Imjudo recommended for approval in the EU,117759596,,AZN,MarketWatch,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=7b401616dc362e76062ec92c529ea1a32e110eb1431094f930c82c7f4f41fcf5
company,2022-12-18 05:45:00,AstraZeneca (AZN) Gets a Buy from SVB Securities,117759597,,AZN,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=985d51d79b7f85bc479283b14cc95607e7bd23c9bf6ee3e13aa4a4456bbe79c6
company,2022-12-18 00:00:17,IBBQ: Healthcare Dashboard For December,117565452,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1310024666/image_1310024666.jpg?io=getty-c-w750,AZN,SeekingAlpha,The pharmaceuticals/biotechnology subsector has good value and quality scores. Click here to read more about IBBQ ETF.,https://finnhub.io/api/news?id=e5bf97def27912b4a2d83c6964251e037ef37a2457f0e776d37832fcc5e3cfcb
company,2022-12-24 04:00:00,"HQH: 50 Big-Yield Healthcare Stocks, These 3 Worth Considering",117670966,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1426076413/image_1426076413.jpg?io=getty-c-w750,AZN,SeekingAlpha,"We share data on over 50 big-yield healthcare investments, including individual stocks, REITs, closed-end funds (CEFs) and bonds. Learn about our 3 top picks here.",https://finnhub.io/api/news?id=90a31bbb4df25c0d58e1bf3fc1dcb54df8cc83ab76b41dcd03bb1ebb3a4dd5ef
company,2022-12-23 11:38:00,"AstraZeneca PLC ADR falls Friday, underperforms market",117743205,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR sank 0.15% to $67.98 Friday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite...",https://finnhub.io/api/news?id=ab31161d4d3644d5a32f89e921ab8cd3eed1c8c2c87a2393bbd5ccc47d10fd79
company,2022-12-23 09:18:02,"The Zacks Analyst Blog Highlights Novo Nordisk, AstraZeneca, Accenture, Chubb and Roper Technologies",117626757,https://media.zenfs.com/en/zacks.com/556a57099e556bffce2597caf4795440,AZN,Yahoo,"Novo Nordisk, AstraZeneca, Accenture, Chubb and Roper Technologies are part of the Zacks top Analyst Blog.",https://finnhub.io/api/news?id=b74e2c6401d019d7d80e1ad8f99c7a5b337d83119f21c6010f1b9a558d590a88
company,2022-12-23 00:27:30,VEU: An Ex-U.S. Fully Diversified Passive ETF With A Low But Decent Yield,117624060,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1220627489/image_1220627489.jpg?io=getty-c-w750,AZN,SeekingAlpha,VEU is a good option for investors seeking geographical and sectoral diversification. Read why the fund has a higher chance of successfully generating strong returns in the long run.,https://finnhub.io/api/news?id=3304d092de8558bc2084d31e9a1235fa7767d0406ef0ee517cba1ebfb1c866e1
company,2022-12-22 14:31:07,"Top Research Reports for Novo Nordisk, AstraZeneca & Accenture",117619942,https://media.zenfs.com/en/zacks.com/4acc462c890120da9a1551f4cfd337cb,AZN,Yahoo,"Today's Research Daily features new research reports on 16 major stocks, including Novo Nordisk A/S (NVO), AstraZeneca PLC (AZN) and Accenture plc (ACN).",https://finnhub.io/api/news?id=2b143a46009c71250b27d764442ac5e23eade9883773a6ae9732b15a323c245a
company,2022-12-22 11:38:00,"AstraZeneca PLC ADR rises Thursday, outperforms market",117743208,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR inched 0.27% higher to $68.08 Thursday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=446880ecaf7eafd2658de0741ae6ed47ddf6a439566972399b40a65013f593f8
company,2022-12-22 09:45:02,Astrazeneca (AZN) is a Top-Ranked Growth Stock: Should You Buy?,117617881,https://media.zenfs.com/en/zacks.com/62d8c8e05376a18ba1420a1733ffdda4,AZN,Yahoo,"Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.",https://finnhub.io/api/news?id=a9e4c7a20ecea2f071f41d34fa15a7dfa5ef2fc92e9969e1220f229ed1fd7004
company,2022-12-22 08:30:00,The Top Healthcare Stocks to Buy With $100,117615329,,AZN,Yahoo,"AstraZeneca (NASDAQ: AZN) and Bristol Myers Squibb (NYSE: BMY) are two pharmaceutical stocks that investors can buy with less than a $100 bill.  AstraZeneca's $219 billion market capitalization makes it the eighth-largest pharmaceutical company in the world and the third-biggest international-based drugmaker.  Perhaps unsurprisingly, the $44.6 billion in revenue that analysts expect the company to generate in 2022 is well-diversified.",https://finnhub.io/api/news?id=502ad536f99b8f94c21bfd5e3a15dde4116727f2e00381bd3cc04db961f02fda
company,2022-12-22 07:01:00,"AstraZeneca rises Thursday, outperforms market",117743211,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"AstraZeneca PLC shares inched up 0.55% to £113.06 Thursday, on what proved to be an all-around grim trading session for the stock market, with the FTSE 100...",https://finnhub.io/api/news?id=a0d5452885c6d9e58ad91e9c49349636da7f1961d45ab7aec87ab55c8786d8f0
company,2022-12-22 06:21:00,Analysts` Opinions Are Mixed on These Healthcare Stocks: AstraZeneca (AZN) and ContraFect (CFRX),117759548,,AZN,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=3ea42f08364835b5399191749636bae482aefc2dd8d245e13cd64aa039b01513
company,2022-12-29 11:38:00,"AstraZeneca PLC ADR rises Thursday, still underperforms market",117969810,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR inched 0.80% higher to $68.10 Thursday, on what proved to be an all-around positive trading session for the stock market, with the...",https://finnhub.io/api/news?id=71e21be268907e565e54a5fb5f2bd35a3e40fd1a9eba042b9d254c464e11a560
company,2022-12-29 10:07:03,AstraZeneca's (AZN) Imfinzi+Imjudo Gets Japan Nod for 2 Cancers,117863216,https://media.zenfs.com/en/zacks.com/ef77d5a5eb4e72e4dd31ccfaf4ca4ccd,AZN,Yahoo,The Japanese Ministry of Health approves AstraZeneca's (AZN) Imfinzi plus Imjudo for treating advanced liver cancer and lung cancer.,https://finnhub.io/api/news?id=a8bd3e433cdc07babe66c4d14410a1001238f0456c1376b3663d5d7876c3bb21
company,2022-12-29 09:38:31,AstraZeneca PLC (NASDAQ:AZN) Q3 2022 Earnings Call Transcript,117863217,https://media.zenfs.com/en/insidermonkey.com/03a6e5ed068a6575327e23896182338c,AZN,Yahoo,"AstraZeneca PLC (NASDAQ:AZN) Q3 2022 Earnings Call Transcript November 10, 2022 AstraZeneca PLC beats earnings expectations. Reported EPS is $0.84, expectations were $0.72. Operator: Good morning to those joining from the U.K. and the U.S., good afternoon to those in Central Europe, and good evening to those listening in Asia. Welcome, ladies and gentlemen, to […]",https://finnhub.io/api/news?id=712b839e679e42e7070e9e669b112abc71ae5b5b655a98a86dc7cae702161f9c
company,2022-12-29 07:01:00,"AstraZeneca rises Thursday, outperforms market",117969811,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"AstraZeneca PLC shares inched up 0.87% to £113.48 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the FTSE...",https://finnhub.io/api/news?id=5c1b2547e4843e853dbe2fcf9780e15122fca968d3dbd06507737d5a29f54d12
company,2022-12-29 05:47:00,February 2023 Options Now Available For AstraZeneca (AZN),117950420,,AZN,Stock Options Channel,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=d5503cd8602290cd4ee55d7d899fd9f1fce2898fc4f4982803dd330a7a87c643
company,2022-12-29 03:00:00,"Novartis: Competitors Take Note, Iptacopan Is Coming",117850777,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1340913479/image_1340913479.jpg?io=getty-c-w750,AZN,SeekingAlpha,Novartis recently reported positive results from two phase 3 trials of iptacopan in PNH patients. Read why iptacopan should become a decent growth product for NVS stock.,https://finnhub.io/api/news?id=d8c47541c3ccfd5f8910f16c3ddbc62874340de28e57809b66d3b08b592c33e2
company,2022-12-28 12:46:15,AstraZeneca: Our 2023 Growth Pick,117829870,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/57611036/image_57611036.jpg?io=getty-c-w750,AZN,SeekingAlpha,AstraZeneca's stock price performance is almost flat since our buy rating target released in May. Click here to read our latest analysis of AZN stock.,https://finnhub.io/api/news?id=d3fbe520b6a8118e9624d24047594f57323d040f533ce5f6ab3f7974ef54bdbe
company,2022-12-28 11:38:00,AstraZeneca PLC ADR outperforms market despite losses on the day,117840958,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR dropped 0.54% to $67.56 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=11f6d206b63e5a50a6b3c52ee0e5f32c18a51023528b7e189840abc64c54ab6b
company,2022-12-28 11:37:00,"ADRs End Mostly Lower, AstraZeneca and ABB Trade Actively",117840921,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,By Denny Jacob International stocks trading in New York closed mostly lower on Wednesday. The S&P/BNY Mellon index of American depositary receipts ticked...,https://finnhub.io/api/news?id=7c413058d3cd80df7fde771433063f9a2488549d95282e52ec22f9747afb9676
company,2022-12-28 07:01:00,"AstraZeneca rises Wednesday, still underperforms market",117840960,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"AstraZeneca PLC shares inched up 0.11% to £112.50 Wednesday, on what proved to be an all-around great trading session for the stock market, with the FTSE 100...",https://finnhub.io/api/news?id=9f610ee345cdd29c39d0308b734f24e0ba372cbe84ded4a231ffa25f8d653144
company,2022-12-28 02:15:00,LONDON MARKET MIDDAY: FTSE 100 rises with positive 2022 in sight,117821452,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=f84d74d21677d2d1d4ba4c2265d01dbb968eec03f36316039e2f11bcfe8cc130
company,2022-12-27 23:52:00,AstraZeneca announces Calquence approved in Japan to treat CLL,117950431,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=25306d497b7cc6340042580f77008f95d781e7ee705cd2b1bda6e27841db580b
company,2022-12-27 23:50:00,"AstraZeneca announces Imfinzi, Imjudo approved in Japan to treat three cancers",117950433,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=638dfc9f31466f2ba641d8a31f2f1acf30117317ad9dae0a5c25f351b13c0c6e
company,2022-12-27 23:03:00,Japan approves AstraZeneca`s blood cancer drug Calquence,117950436,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=7fe1def6f6b1f7080c87042fc44ef0345e488f3fe20d7edc9341d59babeb6f0b
company,2022-12-27 22:44:00,"AstraZeneca`s Imjudo/Imfinzi combo gets approval in Japan for liver, lung cancers",117950438,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=11faaf3642a00dd055cc016124c106c2ac836d07be5d5daa7f47021ad6cbcb52
company,2022-12-27 21:51:00,TOP NEWS: AstraZeneca wins approvals for cancer treatments in Japan,117950441,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=d1ac90653138ead515f89c187785dc1aa3421958db6293c09a160a084446a82a
company,2022-12-27 21:40:00,LONDON BRIEFING: UK strikes continue; AstraZeneca wins Japan approvals,117882887,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=34613c15ff293e6a416c512bfad9efbce73fda6d75d27bd6cba3daa03c0f83f7
company,2022-12-27 11:38:00,"AstraZeneca PLC ADR falls Tuesday, still outperforms market",117840961,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR shed 0.07% to $67.93 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...",https://finnhub.io/api/news?id=ec2986ad67b95291790b12420e094b7ac5a519e18637a4a04281f642099d72de
company,2022-12-27 06:10:03,AstraZeneca PLC (LON:AZN) is a favorite amongst institutional investors who own 88%,117812734,https://media.zenfs.com/en/simply_wall_st__316/bba95900ab96866c17a285be850152bf,AZN,Yahoo,A look at the shareholders of AstraZeneca PLC ( LON:AZN ) can tell us which group is most powerful. We can see that...,https://finnhub.io/api/news?id=27a7196b325c5da66814a715be54b93ac7e43843648cfb5e236503d7483944ac
company,2022-12-26 22:05:00,Novavax COVID-19 shot lags in effectiveness in first study of its kind,117879790,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=867f79cd38faab491f10ba9d043e6399ad0dc88642351342b9c526e2695980ff
company,2022-12-26 05:06:00,"Got $1,000? 5 Sensational Stocks to Buy to Start 2023 With a Bang",117799963,https://s.yimg.com/ny/api/res/1.2/itykH8dixlHt25wwG3lk9g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/473ffa4acf1a87ccd329992b9e546e80,AZN,Yahoo,"The ageless Dow Jones Industrial Average, broad-based S&P 500, and growth-dependent Nasdaq Composite, have tumbled as much as 22%, 28%, and 38%, respectively, from their all-time highs.  For those of you keeping score at home, it means all three indexes are, or were at one point, in a bear market.  Since every bear market throughout history has eventually been recouped (and then some) by a bull market rally, the 2022 bear market represents the ideal time for long-term investors to pounce.",https://finnhub.io/api/news?id=b36826f04b88c4a1df04c815cb4c8e0b5b1de16082cf49d649ce18302229f9af
company,2022-12-31 17:52:13,Jim Simons Stock Portfolio: 10 Biggest Healthcare Stocks,118034914,https://media.zenfs.com/en/insidermonkey.com/00d514a054884081553dae19073f6d33,AZN,Yahoo,"In this article we take a look at Jim Simons Stock Portfolio: 10 Biggest Healthcare Stocks. Click to skip ahead and see Jim Simons Stock Portfolio: 5 Biggest Healthcare Stocks. Gilead Sciences, Inc. (NASDAQ:GILD), Novo Nordisk A/S (NYSE:NVO), and Molina Healthcare, Inc. (NYSE:MOH) are three of the healthcare companies that Jim Simons’ quant fund has identified as […]",https://finnhub.io/api/news?id=f9b4731747f162f815cfd5f58bfa8b1a1e52c06f56cf786ae4c10e0f771715ca
company,2022-12-31 04:04:00,"Align, Invitae among healthcare stocks SA contributors correctly said to avoid in 2022",118003555,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=305d8e68249d0682eb7a2b11a42778465fa3805aee93466db1910037186b72c4
company,2022-12-30 15:37:07,Exclusive-Drugmakers to raise prices on at least 350 drugs in U.S. in January,117940475,https://media.zenfs.com/en/reuters.com/eaeb44890fbb9148262aed46a66bff64,AZN,Yahoo,"Drugmakers including Pfizer Inc, GlaxoSmithKline PLC, Bristol Myers Squibb, AstraZeneca PLC and Sanofi SA plan to raise prices in the United States on more than 350 unique drugs in early January, according to data analyzed by healthcare research firm 3 Axis Advisors.  The increases are expected to come as the pharmaceutical industry prepares for the Biden Administration's Inflation Reduction Act (IRA), which allows the government's Medicare health program to negotiate prices directly for some drugs starting in 2026.",https://finnhub.io/api/news?id=632964f0086bae2b157165059b1f278d26878f7d0f022c9b2167d8ee7a4ca0d3
company,2022-12-30 11:38:00,"AstraZeneca PLC ADR falls Friday, underperforms market",117969809,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR slid 0.44% to $67.80 Friday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite...",https://finnhub.io/api/news?id=6b33444811b77132b421e10a0f1e1ec706cde0ec78196da5aa29438d04acc5f6
company,2022-12-30 08:31:01,"Pharma Stock Roundup: FDA Gives Nod to RHHBY's Lunsumio, Accepts PFE Vaccine BLA",117920421,https://media.zenfs.com/en/zacks.com/ca9d72216d7bb42fc496430c3df29b41,AZN,Yahoo,FDA approves Roche's (RHHBY) Lunsumio for follicular lymphoma and accepts Pfizer's (PFE) BLA for the pentavalent meningococcal vaccine candidate.,https://finnhub.io/api/news?id=4269feee62d30a411c743c0f835f2f55672b0bed695c7567b180570b6846ca3e
company,2022-12-30 06:17:00,Diabetes rates in children set to skyrocket by 2060 - study,117923042,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=1001eced706cb94b1232185c4e9dd9af7f7e1dfa7e3cfecb050e36bf3de53fda
company,2022-12-29 23:00:06,GSK on hunt for attractive biotechs ‘hiding in plain sight’,117898482,https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png,AZN,Yahoo,"GSK’s chief commercial officer is looking to acquire or partner with biotechs “hiding in plain sight”, as the UK drugmaker focuses on replenishing its drug pipeline.  Luke Miels said the company was hoping to avoid “getting into a bidding war” by identifying under-appreciated targets worth $1bn-$2.5bn, such as its acquisition of Sierra Oncology earlier this year.  Earlier this month, Amgen bought Horizon Therapeutics for $28bn.",https://finnhub.io/api/news?id=bd427c9c9c19f43fa4bdcdc6f16d5b827f967366ab63c2ade0429d92cf4974fe
company,2023-01-06 12:32:00,A Highly Contagious Covid-19 Variant Is Spreading in the U.S. What to Know.,118165992,https://s.yimg.com/ny/api/res/1.2/3hjUZ5zhuG6MUWAWiSW7.A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02MDA-/https://media.zenfs.com/en/Barrons.com/57917bcb250ad9a49eb4a1b1c32abb9a,AZN,Yahoo,"XBB.1.5 now accounts for the vast majority of Covid-19 cases in northeastern U.S., where hospitalizations are climbing.",https://finnhub.io/api/news?id=32852f5944df7b5a930205525708405fa07bc569fc6e98601a28ccb7d6b0d8cf
company,2023-01-06 12:00:00,"As the U.S. Gets Older, Some ETFs Bet on Aging in Place",118165993,https://s.yimg.com/ny/api/res/1.2/sFXjEqL.TX_7xw2rztcl4A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02MDA-/https://media.zenfs.com/en/wsj.com/bd1df38d8fccf82e2ce92ea91876e88f,AZN,Yahoo,A number of thematic funds are focused on companies that help seniors who want to stay in their homes as long as possible.,https://finnhub.io/api/news?id=fb78472e5538b58e8fac65fdb8d96d2c6aea6f7381ee5bb84761f64095170508
company,2023-01-06 09:53:00,"1 Stock Defying the Downturn to Buy, and 1 to Avoid",118165994,https://s.yimg.com/ny/api/res/1.2/X8.fBderj2qvmDLE9Ve2Kg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/eb8841f777d44669863c8c7517e8f5d2,AZN,Yahoo,"AstraZeneca is a U.K.-based pharmaceutical company with a long list of products, many of which are hugely successful and generate well over $1 billion in annual sales.  The company's oncology lineup is particularly impressive, with products such as Tagrisso, Imfinzi, Lynparza, and Calquence, all of which are blockbusters.  AstraZeneca's oncology drugs made up about 35% of the company's revenue in the third quarter.",https://finnhub.io/api/news?id=88c4e5267a6cbe9bb6b6cfc947d21cf5a0f69e179d7a3a51c3794a589c081304
company,2023-01-06 05:11:03,AstraZeneca And Daiichi Sankyo's Zauberkugel (Magic Bullet),118162148,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/139978748/image_139978748.jpg?io=getty-c-w750,AZN,SeekingAlpha,"AstraZeneca, Daiichi Sankyo to market HER-2 cancer domain targeting therapy Enhertu. See why I consider accumulating DSKYF stock for Enhertu momentum play.",https://finnhub.io/api/news?id=8ccd333990eb55a6645377839ea5da15a0573b04871785958b410c34387f6013
company,2023-01-06 04:15:00,AstraZeneca And Daiichi Sankyo`s Zauberkugel (Magic Bullet),118166241,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=52ad5d4190beddf4a70045bb1e522f36e27ee99f50d8aaf628d45d9630354de5
company,2023-01-06 02:08:00,IN BRIEF: Zoom appoints AstraZeneca Chief Information Officer to board,118175589,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=538728df4eeadb9e4bc648e00ce99fb19310189493198be9aa7f27522ed8e9c3
company,2023-01-06 00:00:17,A pharma partnership that brought a breakthrough in breast cancer,118158423,https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png,AZN,Yahoo,Daiichi Sankyo and AstraZeneca’s Enhertu could double time patients can live without their condition progressing,https://finnhub.io/api/news?id=988e1b2cf179a9fd953f3e1c3b7f4f48a55342e7195394d7d26df7a117280a90
company,2023-01-05 23:22:00,LONDON BROKER RATINGS: Credit Suisse cuts Next to 'underperform',118165707,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=c308401ec280da12f24721945bedd4744b2a22edbf36b98fd7dc5afaf78aea98
company,2023-01-05 22:51:00,"AstraZeneca`s COVID drug Evusheld unlikely to neutralize newest variant, FDA says",118192346,,AZN,MarketWatch,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=1830d63eccf2995b2b16425a9c90d397737f88c88e775b75b6128103ef15d2fd
company,2023-01-05 22:40:00,"AstraZeneca PLC ADR rises Friday, still underperforms market",118192347,,AZN,MarketWatch,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=2c8a1dfa8e0086fbe212bf73b458737c3eff6e140e3ff3c339a8a8a68cfda7fe
company,2023-01-05 13:16:23,"AstraZeneca's Current Valuation Not Reflective Of Its Strong Fundamentals, Analyst Says",118149953,https://media.zenfs.com/en/Benzinga/f0e63e9039fc55d17d8e7bc1336c64d1,AZN,Yahoo,"BMO Capital Markets initiated coverage on AstraZeneca Plc (NASDAQ: AZN) with an Outperform rating and a price target of $82. The analyst writes that AstraZeneca's growth and margin expansion are undervalued relative to peers as the company continues to migrate to higher-margin programs. AZN trades at a discount to peers through 2026E with top-and-bottom-line growth 2023-2026 of ~6% and ~14%, respectively, based on consensus, and ~7% and ~13% based on BMO estimates. Also see: AstraZeneca Bets On",https://finnhub.io/api/news?id=00aa181aebd3b1f2cc7160567df83fc8cc9f984ea7b52e41fa19351327975d62
company,2023-01-05 09:30:00,Tempus Announces Prospective Study for Biomarker Discovery in Small Cell Lung Cancer,118142225,https://media.zenfs.com/en/business-wire.com/caee61368a317cee94f7c73d90c390dd,AZN,Yahoo,"CHICAGO, January 05, 2023--Tempus, a leader in artificial intelligence and precision medicine, today announced a prospective study (NCT05257551), in collaboration with AstraZeneca (LSE/STO/Nasdaq: AZN), that aims to identify biomarkers of response in patients with small cell lung cancer (SCLC). The study, titled Sculptor, is co-sponsored by Tempus and AstraZeneca’s Personalize SCLC Initiative and is currently open for enrollment.",https://finnhub.io/api/news?id=3333371a57e879c93fbe0b1da1b76fdd5c1c3b7f3b25ed619919eddbb73f433e
company,2023-01-05 05:54:00,AstraZeneca initiated as a buy at BMO as pharma is udvervalued compared to peers,118192349,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=69efca30e8b6c23e5ca07831859d4bdfdad1ac26e9fff89adc0fd4236282665c
company,2023-01-05 04:10:00,"Street Wrap: Today`s Top 15 Upgrades, Downgrades, Initiations",118165717,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=aebb18d329c7120a655999b7cacf7024f2fa018581ea66ff47d44d92b9ddf8da
company,2023-01-05 02:47:00,Sanofi says FDA accepts BLA for nirsevimab,118192353,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=ab560bd7a72d0c7b8d1d39867a9866a7719ca44bb8da76da7f98ed116d818f4b
company,2023-01-05 02:09:00,GLOBAL BROKER RATINGS: Bernstein raises Schneider to 'outperform',118162820,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=911bdd44d95938c01f65a09167521ea2abd6c5a84cbe96c168377d6afedc9cd4
company,2023-01-05 01:18:00,AstraZeneca`s BLA for nirsevimab in RSV prevention accepted by FDA for review,118192356,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=818df8ed4bf9be2df0bd81bf66994e123c42f2cc75ef8be7e7214ee92f8d6086
company,2023-01-04 23:48:00,AstraZeneca initiated with an Outperform at BMO Capital,118192358,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=ed26a30b6738a50b775cf4d362a02ba83cff3826e2dd9f97a1c8f5d95a71a7d8
company,2023-01-04 23:20:00,LONDON BROKER RATINGS: Bank of America cuts Pearson to 'underperform',118165177,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=e953e0798aee8759b345d4f322d13f601e165a2c570dc324806736f62b449bec
company,2023-01-04 22:40:00,"AstraZeneca PLC ADR rises Thursday, outperforms market",118192361,,AZN,MarketWatch,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=2968bc170542605213d3b64e568661feb728a373145ac9df0218ba837e8367c5
company,2023-01-04 21:47:00,TOP NEWS: AstraZeneca's and Sanofi's nirsevimab approved for US review,118192362,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=affb8996497fe6b97919d0ca5b6d0522b31fadc844ecf6222e0820c53e3da1f4
company,2023-01-04 20:00:00,Genomic Vision Announces Successful Beta Testing of FiberSmart®,118192366,,AZN,Business Wire,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=81fd53b01ffbfaf45490f87b27e4199085ca0918d21165b3be54711d4a8a1f4e
company,2023-01-04 14:03:00,AstraZeneca Stock Scores Relative Strength Rating Upgrade,118119314,,AZN,Yahoo,"AstraZeneca ADR shows improving price performance, earning an upgrade to its IBD Relative Strength Rating.",https://finnhub.io/api/news?id=26fdd969db521e53f769f2fe00983e1c205be97ada5a7f82f4c04f62e9ba9150
company,2023-01-04 11:38:00,"AstraZeneca PLC ADR rises Wednesday, still underperforms market",118130614,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR inched 0.25% higher to $69.50 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the...",https://finnhub.io/api/news?id=c42c556f0c06697078640966c8a2adc66d054a16fd46b6feba9aac1e41e5cab9
company,2023-01-04 07:01:00,"AstraZeneca rises Wednesday, outperforms market",118130616,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"AstraZeneca PLC shares inched up 0.59% to £116.02 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the FTSE...",https://finnhub.io/api/news?id=a39730bfc0b41e53da16421cc12e1d326813bdcebce53287b8afb0f68c0fc343
company,2023-01-04 03:20:00,EMA validates change to Daiichi Sankyo`s application for lung cancer drug Enhertu,118115457,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=27f7fc7c22b9414210f407378c843d8aac2df6645e519ab126f98798d80e8736
company,2023-01-04 02:46:59,"Stocks making the biggest moves premarket: General Electric, Salesforce, Alibaba and more",118120647,https://image.cnbcfm.com/api/v1/image/106976793-1637162351005-gettyimages-1341336170-ge21ii.jpeg?v=1672836419&w=1920&h=1080,AZN,CNBC,These are the stocks posting the largest moves in early morning trading. ,https://finnhub.io/api/news?id=c5ccc8b833edb629435ab43a4d3eb929cf587d12dfd76ad0c2b729ec9a79b703
company,2023-01-04 01:13:00,"Kymera Therapeutics appoints Chiniara as CLO, Corporate Secretary",118115458,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=9e0f7eba3232f815bfe4f600b0faaa0574a8e9edd516b78a3fde3bd6d5224203
company,2023-01-03 22:00:00,On This Day: Pelosi is 1st woman elected speaker of the House,118115460,,AZN,United Press International,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=1a97e2889890d3e0c1f28003c77189cb47633b3e93b5ea16a8b56c38e4a82a85
company,2023-01-03 21:00:00,ENHERTU® Type II Variation Application Validated by EMA for the Treatment of HER2 Mutant Metastatic Non-Small Cell Lung Cancer,118115462,,AZN,Business Wire,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=c65a7da04b938f97672e1a92179b6f06db45dc9618fd5fa8503cf47cd0878a97
company,2023-01-03 13:06:08,IBD 50 Stocks To Watch: Pharmaceutical Leader AstraZeneca Retakes Latest Buy Point,118104371,,AZN,Yahoo,"Among the top stocks to watch, pharmaceutical leader AstraZeneca is retaking its latest buy point despite Tuesday's stock market weakness.",https://finnhub.io/api/news?id=82f06b15687bc8bc71e1bf8575774e15dad48d83ad1541c40dd5f2bbddabc0e1
company,2023-01-03 11:38:00,AstraZeneca PLC ADR outperforms market on strong trading day,118130618,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR rose 2.26% to $69.33 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite...",https://finnhub.io/api/news?id=bdc11d193e7940c8113bd48f070c658c2e0e82a3f5c58ce44c868acc0e75a74e
company,2023-01-03 10:45:00,3 Top Healthcare Stocks Defying the Bear Market,118097897,https://s.yimg.com/ny/api/res/1.2/THvopnPmjIISpn6dOipmsA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzU-/https://media.zenfs.com/en/motleyfool.com/4be8c61e32f69e8d2a82469a7ab26fe5,AZN,Yahoo,Let's take a closer look at these three healthcare stocks defying the current bear market.  Shares for TransMedics Group rose 222% in 2022.  The price jump was due in part to the company's financial performance and partly to its extended moat as the only organ transplant system approved by the Food and Drug Administration (FDA) to transport multiple organs.,https://finnhub.io/api/news?id=effa3724fe108c34589b2129feba5539ccd9eb186f8abf888d4ae98def6ee4bb
company,2023-01-03 09:16:02,DocuSign and Ford Motor have been highlighted as Zacks Bull and Bear of the Day,118097931,https://media.zenfs.com/en/zacks.com/27bef8a907b838c4e127bebe3eef9a2d,AZN,Yahoo,DocuSign and Ford Motor have been highlighted as Zacks Bull and Bear of the Day.,https://finnhub.io/api/news?id=ed364b617b6873b7c2d9c8ee4996be09bfff846899283ac9d9dac2617ab34fe8
company,2023-01-03 07:01:00,"AstraZeneca rises Tuesday, outperforms market",118130619,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"Shares of AstraZeneca PLC advanced 2.82% to £115.34 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the FTSE...",https://finnhub.io/api/news?id=557deae0e4cb4a7c31da81041c9b9afcea529835386f042ec5fa25e785759904
company,2023-01-03 06:41:38,Valneva Touts Additional Positive Heterologous Booster Data From COVID-19 Vaccine Study,118102540,https://media.zenfs.com/en/Benzinga/a683e8568d24d350501ab52db69ba15c,AZN,Yahoo,"Valneva SE (NASDAQ: VALN) reported further heterologous booster data from an exploratory, small clinical study for its inactivated COVID-19 vaccine, VLA2001. The data show that a booster dose of VLA2001 was well tolerated in previously vaccinated participants with either Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) or Moderna Inc (NASDAQ: MRNA) shots. The data confirm the favorable safety profile of VLA2001 seen across all studies, including in homologous or heterologous booster setting",https://finnhub.io/api/news?id=1e9070122f719c52adaeb34858a51ca2daedb0ff2e5a9b679b9c31abcef4aaa8
company,2023-01-03 03:55:13,4D Molecular Therapeutics: Another Gene Therapy Player With A Differentiated Profile,118096049,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1407359737/image_1407359737.jpg?io=getty-c-w750,AZN,SeekingAlpha,FDMT is an undercovered gene therapy developer. It claims certain competitive differences for its vector delivery platform. Read more on FDMT stock here.,https://finnhub.io/api/news?id=69a4c20dc7292f2246a14eb25a28c196ea41006af64d4445946e991e142a4fe2
company,2023-01-02 23:24:00,LONDON BROKER RATINGS: Citigroup cuts Wizz Air; Redburn likes CRH,118096667,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=8c910d688f27cea296eb4747de91729a777fa75cddfcbe2b1b2725c8c4895e1d
company,2023-01-02 21:17:00,"AstraZeneca price target raised to 13,500 GBp from 12,500 GBp at JPMorgan",118104180,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=275468fa79f80b227cba841ee7f68162b53610de98127fb647d1b72aca686f88
company,2023-01-10 18:30:11,10 Most Fined Pharmaceutical Companies in the World,118196063,https://media.zenfs.com/en/insidermonkey.com/d13bc0eacb984711f97f75d4d5fa774a,AZN,Yahoo,"In this article, we will be taking a look at the 10 most fined pharmaceutical companies in the world. To skip our detailed analysis, you can go directly to see the 5 Most Fined Pharmaceutical Companies in the World. Pharmaceutical companies have often been derided by conspiracy theorists who coined the term “Big Pharma”. The […]",https://finnhub.io/api/news?id=a1db9de29526617459a174e5ee5e2ce024edf0ff2f00e34fe3cc8ba31c68caf0
company,2023-01-10 16:39:47,Stock Market Holds Gains; Chip Stock Breaks Out,118200719,https://media.zenfs.com/en/ibd.com/9764d79088c6ea1dfe8d43efe7800110,AZN,Yahoo,The stock market held afternoon gains as a server and storage stock flashed a sell signal. Air pollution control stock broke out of a base.,https://finnhub.io/api/news?id=62590a05d1b2950c89b577d6b18a5cf35845085c0d9478f5fd13e57f74bcac81
company,2023-01-10 16:06:38,AstraZeneca Stock Nabs Brief Breakout After $1.8 Billion CinCor Buyout,118200720,https://media.zenfs.com/en/ibd.com/63dd14d68de0bfa687b1eb8d2e58b9cc,AZN,Yahoo,"AstraZeneca stock briefly broke out on Tuesday, a day after announcing its $1.8 billion plan to acquire CinCor.",https://finnhub.io/api/news?id=7097c846e1f1075719c14007d1e59bed0338a57aa34e1d2366533bd893315916
company,2023-01-10 08:29:01,AstraZeneca (AZN) Set to Acquire CinCor Pharma for $1.3B,118197303,https://media.zenfs.com/en/zacks.com/f91db6bb14dedc17d5edb20f29c41da3,AZN,Yahoo,AstraZeneca's (AZN) CinCor Pharma buyout is going to add blood pressure drug baxdrostat to its cardiorenal pipeline.,https://finnhub.io/api/news?id=fdb2fdbf615476666da9c05f78bb325695101e87e3a57fa8f67332330ac9671a
company,2023-01-09 18:15:11,Astrazeneca (AZN) Gains As Market Dips: What You Should Know,118200722,https://media.zenfs.com/en/zacks.com/3cb5117fc22f5e37890d1860dcd61f9f,AZN,Yahoo,"Astrazeneca (AZN) closed the most recent trading day at $70.90, moving +0.14% from the previous trading session.",https://finnhub.io/api/news?id=94edeb44a2c6c3fdc0f677f1e2ce9b7e5f6d35caf61377ff21cf8b42a4c336c7
company,2023-01-09 16:05:44,AstraZeneca To Acquire Blood-Pressure Drugmaker In $1.8 Billion Deal,118200723,https://media.zenfs.com/en/ibd.com/b54f5096e15160ed5819a31865b3b407,AZN,Yahoo,"AstraZeneca said it has agreed to buy CinCor Pharma, maker of clinical-stage blood pressure drug baxdrostat, in a deal valued at $1.8 billion.",https://finnhub.io/api/news?id=6454068345078b3b648ab7109588e63ef5d2d3921eeb86d9a556aaf6a870cc90
company,2023-01-09 15:00:01,JPMorgan Health Conference Kicks Off With Predictable Flurry of (Small) Deals,118200724,https://media.zenfs.com/en/wsj.com/5a1902233c88bbfaa2f551e2508cb061,AZN,Yahoo,"The annual JPMorgan Healthcare Conference in San Francisco, which kicked off today, is often a magnet for deal announcements. This year was no exception, though they were all of the smaller variety — mostly European drug companies paying big premiums to fill their pipelines. Among them, AstraZeneca PLC’s announcement that it would purchase CinCor Pharma Inc. for [as much as $1.8 billion](https://www.wsj.com/livecoverage/stock-market-news-today-01-09-2023/card/astrazeneca-to-buy-u-s-drugmaker-cin",https://finnhub.io/api/news?id=a6eebab8d508e7db2148e6b7af3312a0c38eb5690cbd93c09c9e3787952cfb58
company,2023-01-09 12:13:13,AstraZeneca/CinCor: deal may herald start of biotech buying spree,118200725,https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png,AZN,Yahoo,"AstraZeneca’s $1.8bn cash acquisition of CinCor should provide a bit of a pick-me-up for biotech investors.  If this finding were to be confirmed in a larger phase 3 trial, baxdrostat would have a huge addressable market.  It is paying $1.3bn upfront, or roughly $800mn excluding the cash on CinCor’s balance sheet.",https://finnhub.io/api/news?id=319208e48e837fa9bb23c971898e6fc3681aac7f7d91957bf263fb55ce013790
company,2023-01-09 11:36:54,Ipsen to buy liver disease drugmaker for $952M,118196258,https://s.yimg.com/ny/api/res/1.2/hgQ9lJHBXRut5qNd9jjCWA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD0xODAw/https://media.zenfs.com/en/bizjournals.com/c95a47ecd86cf453261c49070d9fd0c2,AZN,Yahoo,"Ipsen is set to acquire Albireo Pharma Inc., the rare liver disease-focused biopharma spun out of AstraZeneca in 2008, for about $952 million.",https://finnhub.io/api/news?id=ad04a31a8eef1e339c87edc3b46397f1d0f1231e22ce3087c6b9288312cb8499
company,2023-01-09 10:31:03,Signet Jewelers and America's Car-Mart have been highlighted as Zacks Bull and Bear of the Day,118196057,https://media.zenfs.com/en/zacks.com/41bb4c4e30b7bd2ec195f59918e94713,AZN,Yahoo,Signet Jewelers and America's Car-Mart have been highlighted as Zacks Bull and Bear of the Day.,https://finnhub.io/api/news?id=37e54198c6dae508530fc40bf827bc99eb4d82c259e73d55e5a0834b51aa6860
company,2023-01-09 10:20:59,AstraZeneca reaches deal to buy CinCor Pharma for up to $1.8B,118200728,https://s.yimg.com/ny/api/res/1.2/fRrPpTCE4HWMsZB5wSKDAg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/bizjournals.com/65ea27f1f7e97d33366637fdbc6c8183,AZN,Yahoo,"AstraZeneca entered into a definitive agreement Monday to acquire CinCor Pharma Inc. for up to $1.8 billion.  CinCor (NASDAQ: CINC), based in Waltham, Massachusetts, is developing new treatments for hypertension and chronic kidney disease.  The deal, which still requires shareholder and regulatory approval, is expected to be completed during the first quarter of this year.",https://finnhub.io/api/news?id=08912e9dd787ce0279e990d0bf421b9c518e392ceace47dcd55d9637b374f331
company,2023-01-09 09:37:51,AstraZeneca to Buy CinCor Pharma for Up to $1.8 Billion,118200729,https://media.zenfs.com/en/bloomberg_markets_842/3bb24af6e6b0693de9e305a37da16ab7,AZN,Yahoo,"(Bloomberg) -- AstraZeneca Plc agreed to buy US biotech CinCor Pharma Inc. for as much as $1.8 billion to gain a promising new treatment for hypertension and kidney disease.Most Read from BloombergUS Safety Agency to Consider Ban on Gas Stoves Amid Health FearsGoldman to Cut About 3,200 Jobs This Week After Cost ReviewCommodity Ship Heads for Inspection After Suez Canal MishapStocks Give Up Rally Above Key Mark After Fedspeak: Markets WrapRental Housing Is Suddenly Headed Toward a Hard LandingTh",https://finnhub.io/api/news?id=d2d19348d5a684e9bf7384fa744860a588a14c0e01ba3e2ba15bb55796cf8d78
company,2023-01-09 08:48:00,CinCor Pharma Stock Surges on AstraZeneca Deal to Buy It,118200730,https://s.yimg.com/ny/api/res/1.2/ZlvvfmQvg0MNx1yuWHmrow--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02MDA-/https://media.zenfs.com/en/Barrons.com/69a2cbebd282a008cfd1593ded9cde25,AZN,Yahoo,"AstraZeneca said the deal, expected to close in the first quarter of 2023, will bolster its cardiorenal pipeline",https://finnhub.io/api/news?id=29ac2140c8161dd6c636bffbb8af4b307aabe8168a4f42a9d288338d12b1a8d6
company,2023-01-09 08:28:07,"Midday movers: Lululemon Athletica, CinCor Pharma, Exact Sciences and more",118200731,https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png,AZN,Yahoo,By Liz Moyer,https://finnhub.io/api/news?id=abe9164168439cd9f3fba0f37aadc549c888233e6611f8ada5c8a7d8b625dbc0
company,2023-01-09 08:13:17,AstraZeneca To Acquire CinCor Pharma To Strengthen Cardiorenal Pipeline,118200732,https://media.zenfs.com/en/Benzinga/404fb2171700a6b1fdc69d62aefbed89,AZN,Yahoo,"AstraZeneca Plc (NASDAQ: AZN) has agreed to acquire to CinCor Pharma Inc (NASDAQ: CINC) for $26.00 per share in cash plus a contingent value right of $10.00 per share in cash payable upon a specified regulatory submission of a baxdrostat product. Marc de Garidel, Chief Executive Officer at CinCor, said: ""We are excited about the proposed acquisition of CinCor Pharma by AstraZeneca as we believe it offers the prospect of accelerating the development timeline and expanding the breadth of benefits",https://finnhub.io/api/news?id=b8fe5fa1b19610b271f8a15caf3dd4aa6ba6fc767d33d072f13476b9d871df81
company,2023-01-09 06:58:00,European drugmakers including AstraZeneca pony up for U.S.-listed biopharmas,118200733,https://s.yimg.com/ny/api/res/1.2/hRLlMrvsimDuj0WDmLnZEw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02MDA-/https://media.zenfs.com/en/marketwatch.com/a8df2f966c6423b9c638761384f7e1b3,AZN,Yahoo,European drugmakers announced a trio of deals around a billion dollars each to buy U.S.-listed biopharmas at hefty premiums,https://finnhub.io/api/news?id=051433834dfaea8d4acf54c6c122c6e73fddc9a9b0cec1b79b1d5b884b5ebcce
company,2023-01-09 06:47:00,"Fed Wants Weaker Markets, Investors Want a Bargain. Brace for Earnings Season.",118200734,https://s.yimg.com/ny/api/res/1.2/.yEunfyPqVR25pswW5DuSg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02MDA-/https://media.zenfs.com/en/Barrons.com/40569534c74f2dfa04be19edeb26dea3,AZN,Yahoo,"Wall Street lowers fourth-quarter earnings expectations, AstraZeneca to buy CinCor Pharma in $1.8 billion deal, new Covid-19 strain is the most contagious yet, and other news to start your day.",https://finnhub.io/api/news?id=fd52e2a63f6e5c5b0371d5bdd2db6d5ecba4cf925b548b52ba1ddd0c21363c3f
company,2023-01-14 07:50:00,3 Growth Stocks Poised for Huge Gains in 2023,118263236,https://s.yimg.com/ny/api/res/1.2/VckJd3ulEoZhnHD6hd8sVA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD05MDA-/https://media.zenfs.com/en/motleyfool.com/bf72ba45a89b4aec91f19f8474949d07,AZN,Yahoo,"Pharmaceutical companies Bayer (OTC: BAYR.Y), Eli Lilly (NYSE: LLY), and AstraZeneca (NASDAQ: AZN) had big years last year, bucking the rest of the market, and each stock saw share gains over the past year.  All three companies have new drugs that were either recently launched or are likely to get final regulatory approval in 2023.  Bayer's stock is up more than 4.5% over the past year, thanks to strong financials and an even stronger pipeline.",https://finnhub.io/api/news?id=cabe0840fcda675de12a9b02cff586e31299462c8275170d2a09a85b29caa96c
company,2023-01-13 11:12:00,"Drug companies plan to raise prices on vital medicines to fund R&D, but they already spend more on shareholder returns",118237890,https://s.yimg.com/ny/api/res/1.2/Le5z5sD0wHX053kGd2b1Ww--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02MDA-/https://media.zenfs.com/en/marketwatch.com/2e64b4dd26b0e756ce32d939ed69e1d5,AZN,Yahoo,Drug companies say they need to raise prices on cancer drugs and other treatments to fund research. But they already spend more on stock buybacks and dividends.,https://finnhub.io/api/news?id=e62fc21448e314b8c46cfba3a906e257ee7e82381a607aae3f35a9b80910304f
company,2023-01-12 08:00:00,Could This New Drug Launch Be a Hit for Viatris?,118206888,https://s.yimg.com/ny/api/res/1.2/..68sHBwZ8y9FkB_mGp4tw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/c60a609ddfa307d35de0e9f6d7fed7fe,AZN,Yahoo,Viatris and Kindeva Drug Delivery could soon launch a generic version of AstraZeneca's Symbicort.,https://finnhub.io/api/news?id=c2854748eb67907a2617d549d293b2cd670b94ef599b97d43b06b6f070628931
company,2023-01-11 16:40:09,AstraZeneca Is Acquiring CinCor Pharma: Market Values Interesting CVR At $3.21,118197566,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1346675527/image_1346675527.jpg?io=getty-c-w750,AZN,SeekingAlpha,AstraZeneca is acquiring Cincor Pharma for $26 per share and an interesting CVR. Learn more about the acquisition and my recommendation.,https://finnhub.io/api/news?id=8bb67817dfade918b11a511b992e5fc7444d1142d1a5acce8362abd8e4a6e454
company,2023-01-11 13:08:25,AstraZeneca's New Asthma Treatment for Adults Gets Green Light from FDA,118200715,https://media.zenfs.com/en/Benzinga/2131c6106e3c1e8ba46f68a8b16d76b0,AZN,Yahoo,"The FDA approved AstraZeneca Plc's (NASDAQ: AZN) Airsupra, formerly PT027, as the first and only rescue medication for as-needed use to reduce the risk of asthma exacerbations. The drug is only approved in adults after the company and its partner Avillion sought approval in patients four and older. Airsupra is a pressurized metered-dose inhaler containing albuterol and budesonide. Current albuterol rescue inhalers alleviate acute symptoms, but do not treat the underlying inflammation in asthma,",https://finnhub.io/api/news?id=a50657feacaab73379a160e405194698daa3b0051684641a281d55fde103710e
company,2023-01-11 13:00:00,3 Dividend Growth Stocks To Buy In January 2023,118195496,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1194025411/image_1194025411.jpg?io=getty-c-w750,AZN,SeekingAlpha,Dividend Growth Stocks can contribute significantly to increasing your additional income in the form of dividends year over year. Click to see my picks!,https://finnhub.io/api/news?id=6d3ab927008736cee2c4af912a3e6379dd9b406063e70b9b3cc90b6148770ee2
company,2023-01-11 11:30:23,Biden administration will select first 10 drugs for Medicare price negotiations by September,118200327,https://image.cnbcfm.com/api/v1/image/106886749-1621619019822-gettyimages-1036131880-pi-1711653.jpeg?v=1673472623&w=1920&h=1080,AZN,CNBC,The federal government for the first time has the power to negotiate Medicare drug prices due to the Inflation Reduction Act.,https://finnhub.io/api/news?id=a745827c2854d6dd489c012c8c538ceedc1d113d50f49d379f14f818a209e438
company,2023-01-11 09:00:00,AIRSUPRA™ (PT027) approved in the US for asthma,118200716,https://media.zenfs.com/en/business-wire.com/fc05f8c41030b2611af3d6713111e8b4,AZN,Yahoo,"WILMINGTON, Del., January 11, 2023--AIRSUPRA™ (albuterol/budesonide), formerly known as PT027, has been approved in the US for the as-needed treatment or prevention of bronchoconstriction and to reduce the risk of exacerbations in people with asthma aged 18 years and older.",https://finnhub.io/api/news?id=c9ebe0da729cb69cf8df491d72488a87bc8685ec2d2c2456d21a5ff77c363d24
company,2023-01-11 08:38:00,FDA approves AstraZeneca’s new treatment for people with asthma,118200717,https://media.zenfs.com/en/marketwatch.com/96d076434b2a015a3010bd2787b8c856,AZN,Yahoo,MARKET PULSE AstraZeneca (AZN) (UK:AZN) said Wednesday that the Food and Drug Administration approved a new therapy that can be used to treat or prevent bronchoconstriction in adults with asthma. Thee company said Airsupra is a first-in-class treatment that is administered in an inhaler using a combination of albuterol and budesonide.,https://finnhub.io/api/news?id=c79aa206f5ffd8ebdbe04c6dc6ed9d4fcc63486e1a27f2b454e868fc38bc6a2a
company,2023-01-18 12:51:05,Indivior: Healthy Defensive In A Difficult Economy,118309428,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1004637310/image_1004637310.jpg?io=getty-c-w750,AZN,SeekingAlpha,"Drug addiction is on the rise but so are treatments for it, like those provided by Indivior for opioid usage. Click here to read my analysis of INVVY stock.",https://finnhub.io/api/news?id=91e8fdfbcd046c7b3ceddf4f1dcb59936f8fc117dd14b8ffb71c54c0081b8cb0
company,2023-01-18 11:38:00,"AstraZeneca PLC ADR rises Wednesday, outperforms market",118324617,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR inched 0.21% higher to $70.89 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the...",https://finnhub.io/api/news?id=59b99ae30279fc998c1d10a6cfce80dd10c18770faba93a886e733cba83f58dd
company,2023-01-18 09:30:00,HUTCHMED Announces Agreement with NHSA for Inclusion of ORPATHYS® in the National Reimbursement Drug List in China,118304300,https://media.zenfs.com/en/globenewswire.com/986b7552bd3e84c96d3efab3e43f8821,AZN,Yahoo,"HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Jan. 18, 2023 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM: HCM; HKEX:13) today announces, following negotiations with the China National Healthcare Security Administration (“NHSA”), ORPATHYS® (savolitinib) has been included in the updated National Reimbursement Drug List (“NRDL”) for the treatment of locally advanced or metastatic non-small cell lung cancer (“NSCLC”) adult patients with MET exon 14-skipping alterations who",https://finnhub.io/api/news?id=1bf7aea4f5080ccfb35ba93952438422e830b4774bdb971e136432a4bc8ecb9b
company,2023-01-18 07:01:00,"AstraZeneca falls Wednesday, still outperforms market",118307286,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"AstraZeneca PLC shares inched down 0.19% to £115.78 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the FTSE...",https://finnhub.io/api/news?id=a7739b7d7fcbc89cefaf370d1439278397ea58a6675c51842d761282383a40ff
company,2023-01-18 04:06:00,One of the greatest cancer drugs ever has suddenly lost its edge. This is why it was vulnerable.,118307287,https://images.mktw.net/im-704968/social,AZN,MarketWatch,"Imbruvica seemed invincible in the marketplace. But a new book, “For Blood and Money,” shows how the drug’s creators left a trap door that led to its undoing.",https://finnhub.io/api/news?id=8a590137ed0fbaf7f7ce217c593aa9e71d033e5315ab84daf9bca937bd123f53
company,2023-01-18 03:11:00,Reunion Neuroscience Taps Robert Alexander as Chief Medical Officer,118306495,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,By Robb M. Stewart Reunion Neuroscience Inc. said Wednesday it appointed industry veteran Robert Alexander as its chief medical officer as the company works...,https://finnhub.io/api/news?id=5c508dfc11484496cbe404de7b92c5e759b3266a4c00287922d7bdf83ee1e99f
company,2023-01-17 18:15:11,Astrazeneca (AZN) Dips More Than Broader Markets: What You Should Know,118299117,https://media.zenfs.com/en/zacks.com/0c6f98f4bf655bec3b199bc1a71b8b85,AZN,Yahoo,"Astrazeneca (AZN) closed at $70.74 in the latest trading session, marking a -0.48% move from the prior day.",https://finnhub.io/api/news?id=c5ee8d1674f803385fa628fa3891e45836a4c8b0061661d0ff7be10a25897e1a
company,2023-01-17 11:38:00,"AstraZeneca PLC ADR falls Tuesday, underperforms market",118307290,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR slumped 0.48% to $70.74 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=e2670ac83704ae0c1400bf8f398f06a8ea6fd3a8c28fd2b291f8f48470b13432
company,2023-01-17 07:01:00,"AstraZeneca falls Tuesday, underperforms market",118307291,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"Shares of AstraZeneca PLC inched down 0.65% to £116.00 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the FTSE...",https://finnhub.io/api/news?id=b896020f340ab883928ce05799a09787cd959d49f5aa601b9c8f4f6e862913e5
company,2023-01-17 02:58:31,Vaxxinity: Potential Strong Upsides Ahead,118288937,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1352251601/image_1352251601.jpg?io=getty-c-w750,AZN,SeekingAlpha,"Vaxxinity shares have plummeted over the past year due to unprecedented market headwinds, both macroeconomic and geopolitical. Read more here.",https://finnhub.io/api/news?id=64dc72139443f785b15735429a66b0f3aee3ed84820c47e1a09e6a14dfd6c230
company,2023-01-16 07:01:00,"AstraZeneca rises Monday, still underperforms market",118307292,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"Shares of AstraZeneca PLC inched up 0.17% to £116.76 Monday, on what proved to be an all-around favorable trading session for the stock market, with the FTSE...",https://finnhub.io/api/news?id=fbeed5d0e28010897a30da1cc9e502133fb411fa151bfacb8c8680e39b107e49
company,2023-01-22 06:02:00,Global drug spending to reach $1.9T by 2027 ��� IQVIA,118424132,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=3c76391a5988e263e2f354cb96e63e2fc29246e463bbe650a3e49030266163ef
company,2023-01-22 02:48:55,Incyte: Making Hay While The Sun Shines,118342226,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1292613072/image_1292613072.jpg?io=getty-c-w1536,AZN,SeekingAlpha,Incyte should experience strong cash inflows from both JAKAFI and OPZELURA over the next 6 years. Read more to see why INCY stock is a buy.,https://finnhub.io/api/news?id=5d1f29385b670841343ee9da22e364f3ca66fc190b642526771475ab8835aa34
company,2023-01-19 11:38:00,AstraZeneca PLC ADR outperforms market despite losses on the day,118324614,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR shed 0.56% to $70.49 Thursday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=a7d6dc78f6d727f69dc3ee7f70b0852596905714c5c2832a5843347aeb99257c
company,2023-01-19 07:01:00,"AstraZeneca falls Thursday, underperforms market",118324616,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"Shares of AstraZeneca PLC slid 1.36% to £114.20 Thursday, on what proved to be an all-around poor trading session for the stock market, with the FTSE 100...",https://finnhub.io/api/news?id=9bd4b75787a86fb70efeb821c02dfcda1da16e2d890182ce1e44a5a7360b28f4
company,2023-01-19 06:01:11,AstraZeneca (AZN) Presents At 41st Annual Healthcare Conference - Slideshow,118318328,https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png,AZN,SeekingAlpha,The following slide deck was published by AstraZeneca PLC in conjunction with this event.,https://finnhub.io/api/news?id=6f67a9a84b58c13b48ea27296c3fab4181c58380b4fd357a8dab35ac50216051
company,2023-01-26 18:20:40,FDA withdraws Covid antibody treatment Evusheld because it's not effective against 93% of subvariants,118385125,https://image.cnbcfm.com/api/v1/image/107177955-1673544125982-gettyimages-1239356546-US-NEWS-CORONAVIRUS-EVUSHELD-TB.jpeg?v=1674793240&w=1920&h=1080,AZN,CNBC,Many take Evusheld as an additional layer of protection because the vaccines do not trigger a strong immune response for them.,https://finnhub.io/api/news?id=39aae28e241de4955be4324f1da24cc51a56dbddc646efdaa78bb9ff284418cd
company,2023-01-26 13:49:00,AstraZeneca’s preventive COVID therapy no longer effective against current variants,118380305,https://media.zenfs.com/en/marketwatch.com/96d076434b2a015a3010bd2787b8c856,AZN,Yahoo,"MARKET PULSE AstraZeneca (AZN) (UK:AZN) said Thursday that the Food and Drug Administration is no longer allowing healthcare providers to prescribe Evusheld, a therapy authorized for pre-exposure prophylaxis of COVID-19, citing its lack of effectiveness against the currently circulating variants.",https://finnhub.io/api/news?id=e56e8c4d5603d01d3498c55387e7e7801dcae4f0da3a93d8deb9fab529e56b12
company,2023-01-26 12:47:04,UPDATE 2-U.S. FDA pulls authorization for AstraZeneca's COVID-19 treatment Evusheld,118380307,https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png,AZN,Yahoo,The U.S. health regulator has withdrawn emergency-use authorization for AstraZeneca's COVID-19 antibody cocktail Evusheld as the treatment is not expected to neutralize the currently dominant XBB.1.5 subvariant of Omicron.  The Food and Drug Administration (FDA) had limited Evusheld's use earlier this month for the same reason and the agency's Thursday announcement sent U.S. shares of London-based AstraZeneca down 1.31% to $65.75.,https://finnhub.io/api/news?id=e79576af3b06b3b57d7d03eeb353cf0353cd2952652c3db5dc6af15d10b62e74
company,2023-01-26 12:38:00,"ADRs End Higher; AstraZeneca, Diageo Trade Actively",118651699,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,By Denny Jacob International stocks trading in New York closed higher on Thursday. The S&P/BNY Mellon index of American depositary receipts edged up 0.5% to...,https://finnhub.io/api/news?id=b6863f8c41d2745d1141e175f2d0367bea50fd6e33ca442d33581d30139998be
company,2023-01-26 11:30:00,IN BRIEF: AstraZeneca loses emergency use authorisation for Evusheld,118424101,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=a13d3b48cd108421071e8b95b0857c2fa301265aaa0fa6681d25d791bc168b3b
company,2023-01-26 07:51:00,AstraZeneca`s preventive COVID therapy no longer effective against current variants,118424102,,AZN,MarketWatch,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=a2774cc34fc53f15e29530e1ebaaee4550943412fe54953c1d53d19c32252345
company,2023-01-26 07:21:00,AstraZeneca continuing to work with FDA to collect data on Evusheld and variants,118424103,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=1eb0c9cec356831bdd230350ad0318d8942652fb919fe7e7a99443cf15ccdfed
company,2023-01-26 07:20:00,AstraZeneca COVID-19 therapy no longer authorized in U.S.,118424104,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=0a5fbb0b4c481b9dd475d4d03b69ec7d2b201b466322017d2de111b84eaffa94
company,2023-01-26 07:08:00,AstraZeneca COVID-19 antibody therapy no longer authorized in U.S.,118424105,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=8a075a73b61d06e96dc6478fe8a912e4d44243d76a6afd48c757b3188c2e6e89
company,2023-01-26 06:40:00,FDA announces Evusheld not currently authorized for emergency use in U.S.,118424106,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=164d906c5af60d6f5214dcf6fe2bee67c5e09368ef9f0ff7a42568efc819e777
company,2023-01-26 06:00:00,"argenx: Trigger Ready, But Waiting For Stronger Earnings Profile",118378079,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1220627489/image_1220627489.jpg?io=getty-c-w1536,AZN,SeekingAlpha,Argenx caught a strong bid in FY22' on the back of advancements in its Efgartigimod [Vyvgart] pipeline for Myasthenia Gravis. Read more here.,https://finnhub.io/api/news?id=c060bc9af4a8935ab8c64cbfe4cd7263af9349ed7aba2b1a2705b79eed784ae3
company,2023-01-26 05:30:00,CinCor CEO: acquisition by AstraZeneca was more than a year in the making,118380308,https://s.yimg.com/ny/api/res/1.2/DkD3ss7dcoaIMU70.BVx0Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/bizjournals.com/de4c5e6359f6d39f0f81bff689bd143b,AZN,Yahoo,"Before CinCor Pharma Inc. agreed to a $1.8 billion acquisition by AstraZeneca plc, it turned down several other offers from the U.K. pharmaceutical giant.",https://finnhub.io/api/news?id=025e9c52e3177e548bb0de169004dc7acf91fceb861d6cb02409a85123f5a339
company,2023-01-26 01:01:00,New Jersey Better Educational Savings Trust`s Top 5 Buys of the 4th Quarter,118424108,,AZN,GuruFocus,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=ef85742c0383a200676105c20f7eee6e536ff559d1a1caddf62e15b6a19c369f
company,2023-01-25 23:40:00,TOP NEWS: AstraZeneca's Enhertu approved in EU for breast cancer form,118424109,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=1e3a0586916868424ae6c8420e674f3c02eef76acec7d993189095a6dc09faaf
company,2023-01-25 23:08:00,"AstraZeneca, Daiichi Sankyo receive EU approval for Enhertu",118424110,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=c0fd60fcccd3f555a5ac9103f09030a1a2cec2784dae7c829d222a867ed0f804
company,2023-01-25 22:39:00,AstraZeneca PLC ADR underperforms Thursday when compared to competitors,118424112,,AZN,MarketWatch,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=a427386bbcfbfee09e515a5cc25eb333505f080d812eed9840828629a81345be
company,2023-01-25 22:39:00,"AstraZeneca, Daiichi Sankyo`s Enhertu gets approval in EU for breast cancer subtype",118424111,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=30d0e7f0f28e4d2873cc478319cf95b797861435d050edda665587acf5f7d064
company,2023-01-25 22:32:00,Novartis downgraded to Neutral from Buy at Citi,118415230,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=4879e88baebc149e5467038d9064538b0b34e7f9526c39a417ffc7fc9a5f6db3
company,2023-01-25 21:00:00,ENHERTU® Approved in the EU as the First HER2 Directed Therapy for Patients with HER2 Low Metastatic Breast Cancer,118424114,,AZN,Business Wire,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=16e7dcaee8b1cdbe0c83188a4277e5f85e14a7ba5c2fe86a9328c41ccef264d3
company,2023-01-25 08:59:01,Amgen (AMGN) to Report Q4 Earnings: What's in the Cards?,118361161,https://media.zenfs.com/en/zacks.com/7bc8bbeae2e0a87a69be234f543981cd,AZN,Yahoo,"Volume growth from Amgen's (AMGN) key drugs like Prolia, Otezla, Repatha and others is expected to have been partially offset by biosimilar/generic competition for mature drugs.",https://finnhub.io/api/news?id=a8f811059d0feb60319fa3d853a6ab8c9afd99602cb80b5efc51214673f0827b
company,2023-01-24 23:33:00,LONDON BROKER RATINGS: Goldman likes UK banks; HSBC cuts Dr Martens,118413328,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=32ca43d5a76aac39f8ac9b7716ef5685fb9fd7406b98651baaa2906fd53bbef8
company,2023-01-24 22:40:00,AstraZeneca PLC ADR outperforms market on strong trading day,118424116,,AZN,MarketWatch,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=661690342337c6e41d4a124d5dbe99b377c890953f4ddcc25c5e445f655d2c72
company,2023-01-24 18:15:11,Astrazeneca (AZN) Dips More Than Broader Markets: What You Should Know,118357740,https://media.zenfs.com/en/zacks.com/1154d43aaeb65735a640003549116295,AZN,Yahoo,"Astrazeneca (AZN) closed at $66.28 in the latest trading session, marking a -1.97% move from the prior day.",https://finnhub.io/api/news?id=3fe2d85be9cb633d8ba29b65e72187a74cb9224c4f1d2598c74c8e04c146e4d8
company,2023-01-24 09:18:02,"The Zacks Analyst Blog Highlights AstraZeneca, NextEra Energy, The Boeing, The PNC Financial Services Group and Centene",118357741,https://media.zenfs.com/en/zacks.com/ef77d5a5eb4e72e4dd31ccfaf4ca4ccd,AZN,Yahoo,"AstraZeneca, NextEra Energy, The Boeing, The PNC Financial Services Group and Centene are part of the Zacks top Analyst Blog.",https://finnhub.io/api/news?id=cb326b7649c09838eb077f4b71b07437e4cf7d64734d0eb6e518699854afbc73
company,2023-01-24 03:48:20,Wall Street flat as earnings roll while FTSE closes in red,118356514,https://s.yimg.com/ny/api/res/1.2/LcGZKe9tnZMQdwV_v7cZmw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzU-/https://s.yimg.com/os/creatr-uploaded-images/2022-12/053dbaa0-85c0-11ed-bafa-14b532c79685,AZN,Yahoo,UK public borrowing increased by more than expected last month as the government ploughed billions into its subsidies for household bills.,https://finnhub.io/api/news?id=56df2d21f06088d4fcf6275c8ea92170f90ecae23b722c211a3dad15210181c0
company,2023-01-24 02:43:00,"Thermo Fisher, AstraZeneca team on CDx  test for Tagrisso",118424117,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=cd4711cc47b5287aff9f8851239b83523e0b8a1369cd604d69ce19cf50adb271
company,2023-01-24 01:00:00,Gilead Sciences: What To Do Ahead Of Q4 2022 Financial Report,118354820,https://media.gettyimages.com/id/1370591144/ru/%D1%84%D0%BE%D1%82%D0%BE/%D0%B2%D1%80%D0%B0%D1%87-%D0%BF%D0%BE-%D0%B2%D1%8B%D0%B7%D0%BE%D0%B2%D1%83-%D0%BD%D0%B0-%D0%B4%D0%BE%D0%BC-%D0%BF%D1%80%D0%BE%D0%B2%D0%BE%D0%B4%D1%8F%D1%89%D0%B8%D0%B9-%D0%BC%D0%B5%D0%B4%D0%B8%D1%86%D0%B8%D0%BD%D1%81%D0%BA%D0%BE%D0%B5-%D0%BE%D0%B1%D1%81%D0%BB%D0%B5%D0%B4%D0%BE%D0%B2%D0%B0%D0%BD%D0%B8%D0%B5.jpg?b=1&s=170667a&w=0&k=20&c=bLDSBIJMQhtTqVDgVXFsk-3L1AsooxcZUwJrZiP6cxQ=,AZN,SeekingAlpha,"As a leader in various therapeutic areas, Gilead Sciences' total revenue was $7,042 million in Q3 2022, up 12.5% QoQ. Read why I rate GILD stock a Sell.",https://finnhub.io/api/news?id=943c8763e21600a0d681d0ab70274594365989427764a1facb0306a266e92e94
company,2023-01-23 23:33:00,LONDON MARKET OPEN: FTSE 100 lags as other indices make headway,118415422,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=6bc8735e6c9b12d264bb1211c1c5485279670bc4d6cf21b9392af2cac190d7ce
company,2023-01-23 22:40:00,AstraZeneca PLC ADR underperforms Tuesday when compared to competitors,118424121,,AZN,MarketWatch,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=af1c977bc64ab7fb38cbe23336aa57ec807d98d8d4aa4ef278d3c464ab2a1556
company,2023-01-23 13:56:06,"Top Analyst Reports for AstraZeneca, NextEra Energy & Boeing Company",118350375,https://media.zenfs.com/en/zacks.com/4431b82fb7536cade95af6a7edc9076b,AZN,Yahoo,"Today's Research Daily features new research reports on 16 major stocks, including AstraZeneca PLC (AZN), NextEra Energy, Inc. (NEE) and The Boeing Company (BA).",https://finnhub.io/api/news?id=c35982c07e2b46757e5717126f6263ca84ec48f52a69c9853dc4d883b4b2c0d3
company,2023-01-23 10:38:03,Lilly (LLY) Jardiance Kidney Disease sNDA Gets FDA Acceptance,118348841,https://media.zenfs.com/en/zacks.com/ca9d72216d7bb42fc496430c3df29b41,AZN,Yahoo,"Eli Lilly's (LLY) sNDA seeks approval for diabetes medicine, Jardiance, to reduce the risk of kidney disease progression and cardiovascular death in adults with CKD.",https://finnhub.io/api/news?id=f640792e923dac9b8f4e5450b462699664f0cebd6dbaf79048e80fc9ad3370f0
company,2023-01-23 07:00:00,"AstraZeneca Begins Tender Offer to Acquire CinCor Pharma, Inc.",118349388,https://media.zenfs.com/en/business-wire.com/cea4df8c5e0dc56a0e7bd34f788bf88e,AZN,Yahoo,"WILMINGTON, Del., January 23, 2023--AstraZeneca is commencing today, through a subsidiary, a tender offer to purchase all outstanding shares of CinCor Pharma, Inc. (CinCor), for $26 per share in cash at closing, plus a non-tradable contingent value right of $10 per share in cash payable upon a specified regulatory submission for a baxdrostat product. On 9 January 2023, AstraZeneca announced that it had entered into a definitive agreement to acquire CinCor. Following the successful closing of the",https://finnhub.io/api/news?id=32893765c852ccd238bd982cedd1d10002a6f9d13fc61cc81d390e12eca4de4f
company,2023-01-23 05:35:00,The Top Healthcare Stocks to Buy With $100,118349389,,AZN,Yahoo,"Bayer Aktiengesellschaft (OTC: BAYR.Y) and AstraZeneca (NASDAQ: AZN) are elite healthcare companies with shares that trade for less than $100 and make excellent long-term investments because of their revenue and earnings growth, promising pipelines, and above-average dividends.  Bayer was down 11.2% in 2022 and currently trades for about $15 a share while AstraZeneca was up 16.4% in 2022 and currently trades for around $70 a share.  Bayer is a huge German life science conglomerate.",https://finnhub.io/api/news?id=8f7b675b07d3e400b064de56476ddd0e9d3492505f87902037f7283cb2f474d8
company,2023-01-23 04:43:00,Interesting AZN Put And Call Options For February 17th,118424122,,AZN,Stock Options Channel,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=61747b58541677d2bb61aaf3a0901217182dfa9d071edaf6c81a3bccd2c07120
company,2023-01-23 02:33:00,CytoSorbents says Canada cleared pivotal study for anti-bleeding technology,118424123,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=e8fef1b3877670862e5b3488da6b7faff393035d6614e02f79a856681e603bd4
company,2023-01-23 02:00:00,GLOBAL BROKER RATINGS: MS cuts Shell; Netflix gets price target bumps,118422118,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=825fbff7b0df6c1b7c025b102f39aeee88e51e05cfbb536485fcb1b2a59bb76a
company,2023-01-23 01:54:00,AstraZeneca starts tender offer to acquire CinCor,118424126,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=6aa97887ea85155cc0309bdad6958a2106786677082e1103ca93519a00065101
company,2023-01-23 01:30:00,AZN Stock Under Pressure,118424127,,AZN,TalkMarkets,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=04014f2aa852f1bd0da29c230f8dadba89b58dfc0ec5328bb11fa0502bcad481
company,2023-01-23 01:05:00,AstraZeneca commences tender offer to acquire CinCor Pharma for $26.00 per share,118424128,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=d00282673e86b4b6ea379fbb0b93857e3179605479f97fe0aea8276494480705
company,2023-01-23 00:20:00,Cantor biotech/biopharma analysts hold analyst/industry conference call,118424129,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=164737cc1d44c01ae311fd4701576a6c711d5f5471fe64ca054748e84eeb483e
company,2023-01-22 23:41:00,LONDON BROKER RATINGS: Jefferies cuts Berkeley; HSBC cuts St James's,118409050,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=793d1b23a86f8d99af6cc94304d1cb4d7a98424be20435923e893fe5dff35eba
company,2023-01-22 22:39:00,"AstraZeneca PLC ADR falls Monday, underperforms market",118424131,,AZN,MarketWatch,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=c49cc62876310ffd597521459fd4735c91b8f10e2ff982e68a1a653cbf0e6dc8
company,2023-01-30 16:58:00,U.S. Appeals Court Sides With Drugmakers on Discount Program,118405285,https://s.yimg.com/ny/api/res/1.2/dKpyc6mrsx_83zs36fzt3g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02MDA-/https://media.zenfs.com/en/wsj.com/94098702cce5c9f524f5b7b3a915fdda,AZN,Yahoo,"The court ruled that drugmakers can limit their shipments of federally discounted drugs to pharmacies, in a blow to hospitals and clinics.",https://finnhub.io/api/news?id=bae43baef6980e96ac6ff15d8d8359d2a2f94bced26bb4ba6f2d8d9c847768d4
company,2023-01-30 15:27:34,UPDATE 1-Drugmakers prevail in dispute over U.S. discount drug program,118405286,https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png,AZN,Yahoo,"Drug manufacturers can limit healthcare providers' use of outside pharmacies for dispensing drugs under a federal drug discount program, a federal appeals court ruled Monday.  The ruling from a three-judge panel of the 3rd U.S. Circuit Court of Appeals based in Philadelphia is a victory for Sanofi SA, Novo Nordisk AS and AstraZeneca PLc .  The companies had sued the U.S. Department of Health and Human Services (HHS) after it ordered them to stop restricting sales of discounted drugs to so-called contract pharmacies.",https://finnhub.io/api/news?id=2a0e1f19241558da216a853e120ac7a616c4a841467a08b4330370696311a79d
company,2023-01-30 12:53:57,Drugmakers prevail in dispute over U.S. discount drug program,118405287,https://media.zenfs.com/en/reuters-finance.com/2359f368eac6a71ae67db5f95f07221b,AZN,Yahoo,"(Reuters) -Drug manufacturers can limit healthcare providers' use of outside pharmacies for dispensing drugs under a federal drug discount program, a federal appeals court ruled Monday.  The ruling from a three-judge panel of the 3rd U.S. Circuit Court of Appeals based in Philadelphia is a victory for Sanofi SA, Novo Nordisk AS and AstraZeneca PLc.  The companies had sued the U.S. Department of Health and Human Services (HHS) after it ordered them to stop restricting sales of discounted drugs to so-called contract pharmacies.",https://finnhub.io/api/news?id=dc0db11e3f692d365befc60c9c88f88a2e8b0b977ffcd444a194a052a03b3e9f
company,2023-01-30 09:38:03,15 Biggest Neuroscience Companies in the World,118399592,https://media.zenfs.com/en/insidermonkey.com/444b6b806e1bc31c1b67c152dca6ac61,AZN,Yahoo,"In this article, we will discuss the 15 Biggest Neuroscience Companies in the World. You can skip our industry overview and go directly to the 5 Biggest Neuroscience Companies in the World. As the name suggests, neuroscience concerns itself with the development, structure, and functions of the nervous system, intending to enhance neurological health. According […]",https://finnhub.io/api/news?id=c4e557a4fc2ab5ec6a921375dc886707e76ebd2626058625acfb60147ab6dc29
company,2023-01-30 08:05:01,Merck (MRK) to Report Q4 Earnings: What's in the Cards?,118398956,https://media.zenfs.com/en/zacks.com/cb27584804ea583a87d27499a6976ec2,AZN,Yahoo,"Investor focus is likely to be on the sales of Merck's (MRK) blockbuster oncology medicine, Keytruda when the company reports Q4 earnings.",https://finnhub.io/api/news?id=036254100ca6741f939b9c3d58dbae8eb8d5cb0599a1506a687ab11e4bd70e85
company,2023-01-30 06:59:22,Is AstraZeneca PLC (AZN) a High Growth Stock?,118405290,https://media.zenfs.com/en/insidermonkey.com/03a6e5ed068a6575327e23896182338c,AZN,Yahoo,"Baron Funds, an investment management company, released its “Baron Health Care Fund” fourth quarter 2022 investor letter. A copy of the same can be downloaded here. In the fourth quarter, the fund increased by 9.08% (Institutional Shares) compared to an 11.54% gain for the Russell 3000 Health Care Index and a 7.56% gain for the S&P […]",https://finnhub.io/api/news?id=509f9b585ca14ad4e7a9195481c97cae66123696e5711b8e1629f2bc912fab49
company,2023-01-30 06:35:00,Daiichi begins Tropion-Lung07 phase 3 trial for lung cancer treatment,118415199,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=c4e4b4d6503c03e4dce5be31ba13cec4c042dcd19e9b19005b500383a56112aa
company,2023-01-30 05:49:00,"AstraZeneca begins late-stage trial of datopotamab, Keytruda combo for NSC lung cancer",118415200,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=757e2869c368714ce383ed8ecfbdcad04b1182d6c7e442d25743f2a8f7cfe3f5
company,2023-01-30 04:25:00,Cantor biotech/biopharma analysts hold analyst/industry conference call,118420706,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=890b88216264c336755c52a9ea67507f2724ee7ba21f0ec3fa414130609bc0bb
company,2023-01-30 03:00:00,TROPION-Lung07 Phase 3 Trial Initiated to Evaluate Datopotamab Deruxtecan in Combination with Pembrolizumab in Patients with Previously Untreated Metastatic Non-Small Cell Lung Cancer,118424091,,AZN,Business Wire,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=f72aae3591da88a406b7152144c9f03646efc919d12ccdd1bdd4534814ca4f99
company,2023-01-30 01:07:00,WHO maintains public health emergency on COVID but sees `inflexion point` ahead,118415202,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=3ef92c22a14c617b058dd394d8778d8708e7f420d5698c3e18f411c9b22924e0
company,2023-01-29 22:40:00,AstraZeneca PLC ADR outperforms competitors on strong trading day,118424094,,AZN,MarketWatch,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=ee6a7dcee7f1684267f4f67b760110c107bb42b3ba4b6e42509baa45fa117604
company,2023-01-29 17:35:40,Veeva Systems: A Leading Provider Of Cloud-Based Solutions For The Pharmaceutical Industry,118397063,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1127069581/image_1127069581.jpg?io=getty-c-w1536,AZN,SeekingAlpha,Veeva Systems is a cloud-based software solution provider for the pharmaceutical and life sciences industries. See why VEEV stock is a Buy.,https://finnhub.io/api/news?id=eef2a8df2e2aaebaf7cf28f3d489cbc1fd6efbcf27afae5d1cfd15a3f3ad615d
company,2023-01-29 08:45:00,Could This Vaccine Become Sanofi's Latest Blockbuster?,118392346,https://s.yimg.com/ny/api/res/1.2/3Iff4HBEaCW95DytKH8TDw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/2c2ae514a6af4c8187b0c933a026b607,AZN,Yahoo,"Sanofi (NASDAQ: SNY) and AstraZeneca's (NASDAQ: AZN) application for the respiratory syncytial virus (RSV) vaccine candidate called nirsevimab was recently accepted for review by the U.S. Food and Drug Administration (FDA) as a protective option for all infants.  Nirsevimab is known by the trade name Beyfortus in the European Union and the United Kingdom, and the FDA expects to make an approval decision on the RSV vaccine in the third quarter of this year.",https://finnhub.io/api/news?id=346364137c12101d6d64f2540fcf664149fdb453986cee1fbfd0bcac35d21948
company,2023-01-29 00:00:33,RQ Bio partners with AstraZeneca in Covid antibody fight,118392347,https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png,AZN,Yahoo,"UK biotech RQ Bio is partnering with AstraZeneca as it races to keep its antibody to protect immunocompromised patients from Covid-19 up to date with the latest variants.  The Anglo-Swedish pharmaceutical company recently launched a trial of a second generation of its Evusheld antibody, as the original appears unable to prevent infection from the XBB 1.5 variant.  The antibodies are used to protect people who do not respond to vaccines, for example, if they have certain cancers.",https://finnhub.io/api/news?id=b4b8779ddb5bc604898107ab5871c5b93065362db13735f39b8bddcd05bf7713
company,2023-01-28 23:48:00,AbbVie: Why The Company Is Still Overvalued,118415209,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=7398192cf03e00ebace9c33c0545f3f190df7ffb80b9d21e0852ef8425f979f2
company,2023-01-28 11:00:00,F-star's Delayed Acquisition Presents A Risky Opportunity,118386109,https://media.gettyimages.com/id/1369691789/photo/business-meeting.jpg?b=1&s=170667a&w=0&k=20&c=GD72mIK4jAahh5R_JoOIh9ubxSeU7ZQr9ACCKhb-7Lw=,AZN,SeekingAlpha,"FSTX seems undervalued, even at the $7.12 takeover bid. CFIUS is delaying the closure of the deal, citing review needed to allay US national security concerns. Read more here.",https://finnhub.io/api/news?id=c077d1b53fa22b34a4eac959433c441f0f2844d7d11fb4c18dadf0dcd3ef5b50
company,2023-01-27 22:01:00,F-star`s Delayed Acquisition Presents A Risky Opportunity,118424097,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=287c1aaa58efd8ccf36286c996a86b062c380dea950aa8bbe34c0d3c364daf60
company,2023-01-27 18:00:11,Astrazeneca (AZN) Stock Sinks As Market Gains: What You Should Know,118385207,https://media.zenfs.com/en/zacks.com/b95cfdd8768bc3c4620e666dbcb0b248,AZN,Yahoo,"Astrazeneca (AZN) closed the most recent trading day at $65.53, moving -0.7% from the previous trading session.",https://finnhub.io/api/news?id=1fb980298e8ec64a71a399e4974862c4f5259785ac5eb92615797445084dffb6
company,2023-01-27 13:56:35,The man behind AstraZeneca’s ‘blockbuster’ cancer drugs,118392349,https://s.yimg.com/ny/api/res/1.2/Eoob0cbCuKeudRrXvyxRJw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD03NTA-/https://media.zenfs.com/en/the_telegraph_818/4972d16015a9410c49cf2e205bc5b263,AZN,Yahoo,"As far as life goals go, defeating cancer might be deemed one of the more fanciful.",https://finnhub.io/api/news?id=c8ce254ceb103af1d7d6c7b68d15e1e9d6e259004abdedfc7e0098455b958df4
company,2023-01-27 10:26:03,FDA Pulls EUA Granted to AstraZeneca's (AZN) Evusheld,118392350,https://media.zenfs.com/en/zacks.com/ef77d5a5eb4e72e4dd31ccfaf4ca4ccd,AZN,Yahoo,AstraZeneca's (AZN) Evusheld is no longer authorized for use in the United States after laboratory data showed that it does not neutralize Omicron subvariants.,https://finnhub.io/api/news?id=d244f8eea83b229a834b034d78aacc9a6bec93d9acce622ced077017b452f0d0
company,2023-01-27 09:01:58,The Cash King In Big Pharma: Pfizer (Rating Upgrade),118383460,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1198972656/image_1198972656.jpg?io=getty-c-w1536,AZN,SeekingAlpha,"Wall Street has gone downgrade happy on Pfizer in January, loudly complaining the end of the pandemic has arrived. Click here to read my most recent analysis.",https://finnhub.io/api/news?id=26feccc2f0d90f3dc852ba584480ef2a94dcf67db17ad0244c196ab1f236a92b
company,2023-01-27 08:14:01,"Pharma Stock Roundup: JNJ Q4 Results Mixed, MRK Keytruda Prostate Cancer Study Ends",118392351,https://media.zenfs.com/en/zacks.com/f91db6bb14dedc17d5edb20f29c41da3,AZN,Yahoo,J&J (JNJ) reports mixed fourth-quarter results. Merck (MRK) discontinues an advanced prostate cancer study on blockbuster drug Keytruda for futility.,https://finnhub.io/api/news?id=650da2ee23e7b9ff71fc38a075512139b1e1226995524fe039fe5974d6d80c7c
company,2023-01-27 06:45:11,7 Dividend Stocks to Buy for a Stable Income Stream,118405291,https://media.zenfs.com/en/investorplace_417/91670c764c5864468a7c400bcda34718,AZN,Yahoo,"A key to successful retirement planning or wealth building is to start early. One critical component of investing is to secure stable cash flows. This is likely through fixed income, rental income, or investment in dividend stocks. With the markets continuing to face macroeconomic headwinds, it’s a good time to look at some dividend stocks to buy for the coming years. I would allocate 50% of my funds toward dividend stocks, though your allocation may vary based on your individual risk profile. I",https://finnhub.io/api/news?id=ba599e41d0ae132da775328e457bd717ab67d4e4f7073d1eacce587bc20a6edb
company,2023-01-26 22:40:00,"AstraZeneca PLC ADR falls Friday, underperforms market",118424099,,AZN,MarketWatch,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=bfd1faacd3938d42750669f846f011d029523d314965d552b51ea06707fc676d
company,2023-02-02 18:00:11,Astrazeneca (AZN) Stock Sinks As Market Gains: What You Should Know,118450907,https://media.zenfs.com/en/zacks.com/a41b81fe729c761f3f94f42ff348f70c,AZN,Yahoo,"Astrazeneca (AZN) closed the most recent trading day at $63.15, moving -0.65% from the previous trading session.",https://finnhub.io/api/news?id=1812d1f7a80302918ea6b3604b546c839846abbe3517b8601cf851498bd88dc0
company,2023-02-02 14:18:07,GSK's Daprodustat Drug for Anemia Due to CKD Gets FDA Nod,118450908,https://media.zenfs.com/en/zacks.com/41b7bdd28f63138df08f17b665d3589a,AZN,Yahoo,GSK announces the FDA approval of daprodustat for the treatment of anemia due to chronic kidney disease (CKD) in adults on dialysis for at least four months.,https://finnhub.io/api/news?id=9bbc270ff4ac7f053648297d410ce7491164c572ee4289c9219abe9d7cb45f3d
company,2023-02-02 09:00:00,TEZSPIRE® approved for self-administration in the US with a new pre-filled pen,118450909,https://media.zenfs.com/en/business-wire.com/dae3795e4518aa32953552059278ca97,AZN,Yahoo,"WILMINGTON, Del., February 02, 2023--AstraZeneca and Amgen’s TEZSPIRE® (tezepelumab-ekko) has been approved in the US for self-administration in a pre-filled, single-use pen for patients aged 12 years and older with severe asthma. TEZSPIRE is the only biologic approved for severe asthma with no phenotype (e.g. eosinophilic or allergic) or biomarker limitation within its approved label.1",https://finnhub.io/api/news?id=79160a0226b24387d1e4187cfd1151c603a059ed4efaf290d2aa405cb36053ed
company,2023-02-01 10:31:03,"Amgen (AMGN) Beats on Q4 Earnings, 2023 Sales View Disappoints",118419894,https://media.zenfs.com/en/zacks.com/65410c79c0b8184da264ed17fda575ce,AZN,Yahoo,"Amgen (AMGN) beats Q4 estimates for earnings and sales. It launches Amjevita in the United States, which is the first biosimilar of Humira to be launched in the country.",https://finnhub.io/api/news?id=9eab0df954e85728fe6fe7260d663b5e0f41bae1e4468262815ec0b5365dc708
company,2023-02-01 08:30:00,3 No-Brainer Dividend Stocks to Buy Hand Over Fist in 2023,118419895,https://s.yimg.com/ny/api/res/1.2/_mvuerSdCF.YXtrx6Bu9Kg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/6324dd2a32bbae158043ba608b33629e,AZN,Yahoo,"Top dividend stocks are capable of delivering above-average returns returns in any type of market.  Which dividend stocks are no-brainer buys for retail investors right now?  AstraZeneca (NASDAQ: AZN), Merck (NYSE: MRK), and Medtronic (NYSE: MDT) are three elite income stocks that have recession-proof businesses, strong growth prospects, and ample free cash flows.",https://finnhub.io/api/news?id=e1e4f80ce989d72dda8df38ba9e060f85aedd5d15da35294b7775ca1bd457f68
company,2023-02-01 05:36:00,AZN Crosses Below Key Moving Average Level,118424082,,AZN,Market News Video,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=ae68b1d0396eeef702eab89df616728964ffdce5d5308e6ac8c77ca539bd3f40
company,2023-01-31 22:40:00,"AstraZeneca PLC ADR falls Wednesday, underperforms market",118424084,,AZN,MarketWatch,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=326bdf5fe6c668a2730c3a8cb6a99204cd6820ed310303bd54d08b316b9efa74
company,2023-01-31 00:25:00,Diabetes drug developer Structure Therapeutics sets terms for $125M US IPO,118420703,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=1046393cbeef9db7d935b65dcaf301707c4c5762dd606603fd3474b1f219339c
company,2023-01-30 22:40:00,AstraZeneca PLC ADR underperforms Tuesday when compared to competitors,118424087,,AZN,MarketWatch,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=96a739411e51848db5872f4584068c593e2b09c5c84a13965696fd0f7f4266d7
company,2023-02-07 10:26:03,AstraZeneca (AZN) to Report Q4 Earnings: What's in the Cards?,118489547,https://media.zenfs.com/en/zacks.com/ef77d5a5eb4e72e4dd31ccfaf4ca4ccd,AZN,Yahoo,"Higher sales of AstraZeneca's (AZN) key medicines, Lynparza, Tagrisso and Imfinzi and Farxiga are expected to have driven sales, partially offset by lower sales of legacy drugs.",https://finnhub.io/api/news?id=a75bafde3a825ff4fb4411a7b983f71737fc5a9e01cdfce6c32629b5ee5da5c9
company,2023-02-07 03:11:00,AstraZeneca says Forxiga approved in EU for heart failure,118489548,https://s.yimg.com/ny/api/res/1.2/hRLlMrvsimDuj0WDmLnZEw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02MDA-/https://media.zenfs.com/en/marketwatch.com/a8df2f966c6423b9c638761384f7e1b3,AZN,Yahoo,AstraZeneca PLC said Tuesday that Forxiga has been approved in the European Union for the treatment of symptomatic chronic heart failure.,https://finnhub.io/api/news?id=ffa8d447e811859ec6c0036977bd1671b06277b382e543738e4c4f77bc43ab33
company,2023-02-06 06:24:43,Hutchmed: We Explore Pharma In China,118478250,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1386962527/image_1386962527.jpg?io=getty-c-w1536,AZN,SeekingAlpha,"HUTCHMED (China) being a part of CK Hutchison Holdings, a huge conglomerate, is developing well. Read more on HCM stock here.",https://finnhub.io/api/news?id=b92ab6b338b8c8344693b0b0349ce69043964bbeb00e3a09dc29b394f3859330
company,2023-02-05 22:17:54,PRESS DIGEST-British Business - Feb 6,118489549,https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png,AZN,Yahoo,"The following are the top stories on the business pages of British newspapers.  The Times - The UK is losing out on investment from AstraZeneca Plc to more competitive countries, Tom Keith-Roach, the head of the company, warned.  - A British semiconductor company, IQE Plc could move overseas unless the government sets out its strategy for the sector in the next six months, its chief executive said.",https://finnhub.io/api/news?id=9daf36a64791aa53d1314341c1348c546fe93f2517a95bffc591fa2ba1f7594b
company,2023-02-10 22:05:00,"Super Bowl ads boost sales of drugs, yet only two companies advertising this year",118585843,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=28c95e712732e7b0775ea99a29b9375806989066d61b112fa6bcc64f1d31fb39
company,2023-02-10 14:32:26,AstraZeneca PLC (NASDAQ:AZN) Q4 2022 Earnings Call Transcript,118527949,,AZN,Yahoo,"AstraZeneca PLC (NASDAQ:AZN) Q4 2022 Earnings Call Transcript February 9, 2023 Operator: Good morning to those joining from the U.K. and the U.S. Good afternoon to those in Central Europe and good evening to those listening in Asia. Welcome, ladies and gentlemen, to AstraZeneca’s Full Year and Q4 2022 Results Conference Call for investors and […]",https://finnhub.io/api/news?id=f3be7e87b746515eefc22245f0f447900581848cba80e550c0b07f3228eeba8e
company,2023-02-10 12:55:04,"Sunak is putting Britain’s life sciences success at risk, warns Covid jab creator",118527143,https://s.yimg.com/ny/api/res/1.2/o7fJoOJuELwT6I8RulENVQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD03NTA-/https://media.zenfs.com/en/the_telegraph_818/ee458c54877bdb7cb58e643359025983,AZN,Yahoo,"Rishi Sunak risks squandering Britain's post-pandemic lead in life sciences, one of the creators of the Oxford Covid-19 vaccine has warned, as ministers are hit with an industry backlash over ""discouraging"" tax policies.",https://finnhub.io/api/news?id=95d5f7fdab71d2dd3f35d723af38791a17e5acd341460ee6f7bbc2e85aed838c
company,2023-02-10 10:20:16,Jeremy Hunt has made Britain a no-go area for investment,118525472,https://s.yimg.com/ny/api/res/1.2/0ig.fgX4sucZ3s5ZJJ7nrw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD03NTA-/https://media.zenfs.com/en/the_telegraph_258/b7136523bdf227a6118ae97de6f9e160,AZN,Yahoo,"The timing couldn’t be more perfect. On Friday, Rishi Sunak and Jeremy Hunt hosted a summit of more than 200 prominent business figures as part of efforts to drum up fresh investment into Britain. And what better backdrop than one of the biggest snubs this Government has ever suffered? AstraZeneca’s usually restrained boss Sir Pascal Soriot confirmed that the pharma giant had chosen to build a new state-of-the-art factory in Dublin rather than the north-west of England because of the Treasury’s",https://finnhub.io/api/news?id=9583f5d6717d41bd35c45558bc0520afe0a16bd0a4b44767ab8f91f30775ff82
company,2023-02-10 10:10:00,IN THE KNOW: AstraZeneca late-stage pipeline impresses Barclays,118650122,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=9bb9af5ff5fd952843895a9284b006a4ee2ae9b5b2a4c86c4085cd20bf6c708c
company,2023-02-10 09:05:02,"Pharma Stock Roundup: AZN, ABBV Mixed Q4 Results, BAYRY's New CEO",118523824,https://media.zenfs.com/en/zacks.com/a1d7049b0977a02a21fd2aa02b46f307,AZN,Yahoo,AstraZeneca (AZN) and AbbVie (ABBV) report fourth-quarter results. Roche (RHHBY) and J&J (JNJ) announce positive data from studies on pipeline candidates for rare diseases.,https://finnhub.io/api/news?id=b856ef029e0f5253d6e26b2a329ccbef9d3bea9eaf05e139f257c9505dbad083
company,2023-02-10 06:55:00,LONDON MARKET CLOSE: Rate worries keep European stocks in check,118594897,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=60e6d6c3d5f5357838a5d796ceb6f55bf4a37269fb2b645596427a7aa1c69a94
company,2023-02-10 05:15:00,AZN June 16th Options Begin Trading,118770723,,AZN,Stock Options Channel,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=fa3f0de9454981ecabeb11aa0e59b9622cbc0bc1cbcd889528a2779f3fa74d60
company,2023-02-10 04:56:52,AstraZeneca PLC 2022 Q4 - Results - Earnings Call Presentation,118523801,https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png,AZN,SeekingAlpha,The following slide deck was published by AstraZeneca PLC in conjunction with their 2022 Q4 earnings call.,https://finnhub.io/api/news?id=1a0bf67a121926e8151813d15b28bd8c1f50f4579f16074f2821a3a82615583f
company,2023-02-10 01:51:00,GLOBAL BROKER RATINGS: LBBW raises Siemens; Jefferies cuts Adidas,118588241,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=486610f0a44c027f50b80167283feae8fb37185bb3ab48541cfcaf3658de291f
company,2023-02-10 01:30:00,"Analysts Are Bullish on Top Healthcare Stocks: AstraZeneca (AZN), AbbVie (ABBV)",118723140,,AZN,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=cfd69aee792669ca085493c0e4bcd9e9fd78201ca83186099bebdf347dbcd176
company,2023-02-10 01:18:00,Medicare mulls rebates in 2025 for drug prices rising faster than inflation,118610760,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=0ab3a739858e7a584faafc6d4765cafa54aa69e80a46b5edb6c754d67b219bca
company,2023-02-10 00:32:00,UPDATE: Hunt disappointed UK loses new AstraZeneca factory to Ireland,118598560,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=9d42653a84b1ae377dd385c8966dc7f2c0da9c03cebeba6825ca5c66fbd4c7dd
company,2023-02-09 20:30:31,AstraZeneca Plc (AZN) Q4 2022 Earnings Call Transcript,118519704,https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png,AZN,Yahoo,"Before I hand the call over to AstraZeneca, I'd like to read the safe harbor statement.  Participants on this call may make forward-looking statements with respect to the operations and financial performance of AstraZeneca.  Although we believe our expectations are based on reasonable assumptions, by their very nature, forward-looking statements involve risks and uncertainties and may be influenced by factors that could cause actual results to differ materially from those expressed or implied by these forward-looking statements.",https://finnhub.io/api/news?id=3c04db34836d3d3999a0935ac7bdc9f1d8e19bdfa4260790d3bafb443de124cf
company,2023-02-09 20:23:46,"As Brits reel from a cost-of-living crisis, the UK stock market quietly booms to an all-time high",118548509,https://image.cnbcfm.com/api/v1/image/107190924-1675853151054-gettyimages-1463404733-ln1_0226_o0u2xbsv.jpeg?v=1676010226&w=1920&h=1080,AZN,CNBC,"The FTSE 100 has hit three all-time highs over the last week, despite continued gloom on the U.K. economy and amid a cost-of-living crisis. ",https://finnhub.io/api/news?id=3adabd85ca128c2de3c100e14d8dbe29debcb38f2e372692025f9667c3e461f0
company,2023-02-09 16:03:37,AstraZeneca Hits Its Stride On Upbeat Guidance With 'Desirable' Growth,118519705,https://media.zenfs.com/en/ibd.com/1c69b937460989827b7e888fe62621e1,AZN,Yahoo,"AstraZeneca's earnings topped forecasts Thursday, but sales came in light. AZN stock rose on its upbeat 2023 guidance.",https://finnhub.io/api/news?id=e0f9b118cb4179eb41aeae18db20e5514591a0e3eadaae3d0c7502b9feedc4be
company,2023-02-09 14:26:20,Garage demolition underway at AstraZeneca’s future Kendall Square home,118519706,https://s.yimg.com/ny/api/res/1.2/oSAWvkS1HTabf4cgZQ02cg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/bizjournals.com/6db676f97616cf85099ae90e64b422c6,AZN,Yahoo,"It's the first step on a years-long, billion-dollar path to build a new research center for the life sciences giant.",https://finnhub.io/api/news?id=7dbece235df316572fffa802ec7ae7a47c8011b4fa8ab5ba50c032d6f9c4f549
company,2023-02-09 12:08:05,Astrazeneca (AZN) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates,118519707,https://media.zenfs.com/en/zacks.com/5577c43e19a1a42f0dedff9c8231b850,AZN,Yahoo,"Although the revenue and EPS for Astrazeneca (AZN) give a sense of how its business performed in the quarter ended December 2022, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.",https://finnhub.io/api/news?id=3f286ce9d7a4bebd7292bf624a816c82786e24f90832933592d26886fa29f49d
company,2023-02-09 11:11:00,"Omicron strains remain dominant globally, and the WHO is monitoring four closely",118519708,https://s.yimg.com/ny/api/res/1.2/yCqsbkxcgYPpXWcodPiB5Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02MDA-/https://media.zenfs.com/en/marketwatch.com/3b87543eb853d3b8158b5c14661b48d1,AZN,Yahoo,"The omicron strain of the coronavirus that causes COVID and its descendent lineages are still dominant globally, and XBB.1.5 is under monitoring.",https://finnhub.io/api/news?id=9b0538f60d695091b1b57e88c762b346f5050bf06c19c3d35ba2e2ee97e5df77
company,2023-02-09 10:24:14,AstraZeneca snubs Britain over £320m drug factory amid ‘discouraging’ taxes,118519709,https://s.yimg.com/ny/api/res/1.2/51vOrQp1PpPRovVOrXt73g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD03NTA-/https://media.zenfs.com/en/the_telegraph_818/0660c9d77add75ef929dd0d7bf6ad1c1,AZN,Yahoo,"AstraZeneca overlooked Britain for a new $400m (£320m) drug factory because of its “discouraging” tax regime, chief executive Pascal Soriot has said.",https://finnhub.io/api/news?id=8f3f592d1a5c8d07031a3734d8db037d9fe7af1e09125b8b3f7d6e0e7acdce23
company,2023-02-09 10:16:59,"Market check: Google stock falls, AstraZeneca stock trades higher amid earnings",118519710,https://s.yimg.com/os/creatr-uploaded-images/2023-02/c89ec6d0-a88c-11ed-bbd7-81eb020f516d,AZN,Yahoo,Yahoo Finance Live’s Brad Smith breaks down how stocks are moving in intraday trading.,https://finnhub.io/api/news?id=bf9437299f6ccf98689ef1178b6e3abfb6cc9b001214df48aed71127564b0c75
company,2023-02-09 09:37:00,2 Top Biotech Stocks to Buy Right Now,118519711,https://s.yimg.com/ny/api/res/1.2/g7Uu8w8XvUeUOiVMvAmJ0A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/00365d25498b13448d3ca6194df32c0c,AZN,Yahoo,"For today, let's highlight two high-quality pharmaceutical stocks that investors may want to consider buying and holding for the long run.  With over 83,000 employees throughout the world, AstraZeneca (NASDAQ: AZN) is a truly global business.  As you would expect from a large-cap pharmaceutical company, AstraZeneca boasts world-class products.",https://finnhub.io/api/news?id=eebba4a6c2c81478df105ee6605e16a137d0de67f9f28957b75589bb989574e1
company,2023-02-09 09:01:10,"AstraZeneca Forecasts Growth In 2023 Earnings, Revenue Despite Fall In COVID-19 Products, Plans To Deliver 15 New Medicines This Decade",118519712,https://media.zenfs.com/en/Benzinga/bca78cb66e24b3617e8ba04e881f6986,AZN,Yahoo,"AstraZeneca Plc (NASDAQ: AZN) has reported Q4 core EPS of $1.38, down 17% Y/Y (-5% constant currency). The company clocked Q4 sales of $11.21 billion, -7% (+1% CC), in line with the consensus. The core gross margin of 77% in the fourth quarter was impacted by inventory write-downs and manufacturing termination fees for Evusheld, its COVID-19 treatment. Fourth-quarter revenue was also hurt by a decline in sales of AstraZeneca's COVID-19 vaccine Vaxzevria. ""In 2023, we expect to see another year o",https://finnhub.io/api/news?id=bdd27da289b1ef64541815f76557ef31f5887af6392a2c5560dd4454c4bb89ac
company,2023-02-09 08:41:00,AstraZeneca Has a Covid Sales Problem. Its Stock Doesn’t.,118519713,https://s.yimg.com/ny/api/res/1.2/RJ2ihRsB1KRwsgcXPNTYrA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02MDA-/https://media.zenfs.com/en/Barrons.com/12a67af0cdeb6defbfd65a884342d811,AZN,Yahoo,The Anglo-Swedish pharma major reported 1% revenue growth as cancer and cardiovascular therapies offset a decline in sales of its Vaxzevria vaccine.,https://finnhub.io/api/news?id=1cb1f011308f256e422f7a4f4e9576f175ad5f43b8845dd1ff427c37f7279462
company,2023-02-09 08:39:01,"AstraZeneca (AZN) Q4 Earnings Beat, Sales Hurt by COVID Jab",118519715,https://media.zenfs.com/en/zacks.com/ef77d5a5eb4e72e4dd31ccfaf4ca4ccd,AZN,Yahoo,AstraZeneca (AZN) beats fourth-quarter estimates for earnings while missing the same for sales.,https://finnhub.io/api/news?id=247b4be9e82c678f89010f07376769ccf9d8e0bc4f90384155bbf48476350089
company,2023-02-09 07:12:51,AstraZeneca chief says industry should not pay for NHS Covid costs,118519717,https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png,AZN,Yahoo,"AstraZeneca’s chief executive said the pharmaceuticals industry should not be made to pay for the “explosion” of NHS costs related to the Covid pandemic, as drugmakers ramp up their criticism of the UK government.  Pascal Soriot said the pricing agreement reached with the industry in 2019 — which stated the NHS would not have to pay more than a 2 per cent increase each year for branded drugs, however much it buys — did not take account of soaring demand from treating Covid patients.  The UK health department’s clawback rose from about 5-10 per cent before the pandemic to 26.5 per cent this year, prompting other pharmaceutical chief executives to warn that it could hit life sciences investment in the UK.",https://finnhub.io/api/news?id=bfa671a218903c4f6bee504efcc0ea501e3ed4116188356de53d2c56e27e69c0
company,2023-02-09 04:58:37,UPDATE 2-European shares gain as upbeat earnings ease recession fears,118516979,https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png,AZN,Yahoo,"The pan-European STOXX 600 ended up 0.6%, after hitting a near one-year high earlier in the session.  Industrials were the biggest to boost to the index, bolstered by a 6.7% gain in Siemens after the builder of trains and industrial software reported better-than-expected earnings and raised its full-year sales and profit guidance.  AstraZeneca Plc rose 4.1% after the British drugmaker projected growth in 2023 and beyond.",https://finnhub.io/api/news?id=ce51b753f339f0d858e306cd18009677b7d3d23ffaa51be271674a5997d60da8
company,2023-02-09 04:48:58,"How To Allocate $5,000 Among 5 Dividend Income And Dividend Growth Stocks And ETFs",118515320,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1367959113/image_1367959113.jpg?io=getty-c-w1536,AZN,SeekingAlpha,"In this article, I will show you a portfolio that consists of 5 picks that provide you with Dividend Income and Dividend Growth. Read more here.",https://finnhub.io/api/news?id=82c1cf1377119178ae55e894c27bc25f5aad65e2b2c958ab6669b6461fef3157
company,2023-02-09 04:33:05,FTSE 100: Astrazeneca swings into profit amid double-digit revenue rise,118519721,https://s.yimg.com/ny/api/res/1.2/N4L_icA0cNXuYFudhYszIw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD03NTc-/https://s.yimg.com/os/creatr-uploaded-images/2022-11/1e1db0c0-60db-11ed-aebd-559b559d163a,AZN,Yahoo,AstraZeneca posted adjusted earnings of $1.38 per share on revenue of $12.2bn.,https://finnhub.io/api/news?id=7c78da8f4b025bffa62aac65ff6ca481ff11c5ea36204f3963f2708b63d4b9e8
company,2023-02-09 04:23:00,"AstraZeneca Beat Expectations on 4Q Profit, But Revenue Is a Miss -- Earnings Review",118671392,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,By Cecilia Butini AstraZeneca PLC reported fourth-quarter results on Thursday. Here is what we watched. REVENUE: Sales at the Anglo-Swedish pharma major...,https://finnhub.io/api/news?id=9d2717927bf22a2c865ca7e9859fabe35116cfc69a3291ecd3be849e36c76152
company,2023-02-09 02:55:34,"As demand for Covid vaccines falls, AstraZeneca lines up 'blockbuster' products for 2023",118518357,https://image.cnbcfm.com/api/v1/image/107191741-1675944116342-GettyImages-1358939142.jpg?v=1675947334&w=1920&h=1080,AZN,CNBC,"Demand for Covid-19 vaccines has dropped, but AstraZeneca has ""blockbuster"" projects in development that are set to make billions of dollars, according to its CFO.",https://finnhub.io/api/news?id=1d246129dd687834703aadea53e22b56a952d417e70c745fa9a8242bf8090b96
company,2023-02-09 02:15:10,AstraZeneca goes for growth with new drugs as COVID sales wane,118519723,https://media.zenfs.com/en/reuters-finance.com/bc619a3814daa8b1a99d4d12d01cc29a,AZN,Yahoo,"AstraZeneca on Thursday said it was poised to grow in 2023 and beyond, banking on its burgeoning line-up of cancer, metabolic and rare disease drugs to pick up the pace from dwindling COVID product sales.  CEO Pascal Soriot said the firm was on a path to deliver at least 15 new medicines this decade and said it expects to kick off at least thirty new late-stage clinical trials in 2023.  But like many other industries and its own peers, AstraZeneca has grappled with higher costs linked to the war in Ukraine and the lingering effects of the pandemic in 2022.",https://finnhub.io/api/news?id=7a5a1f129f97fe2efb4177963e65cf5bbb3a04e037d48d0485a922dd8a99d5d2
company,2023-02-08 23:56:00,"AstraZeneca Swung to 4Q Profit, But Covid-19 Shot Decline Hit Revenue -- Update",118671397,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,"By Cecilia Butini AstraZeneca PLC on Thursday posted a swing to fourth-quarter profit, though it reported lower revenue due to declining sales of its...",https://finnhub.io/api/news?id=4a854e0b6caff58ab17d204cf7ab19c8b8cb796994b5ff8b152c50d5d648ea96
company,2023-02-08 23:15:21,AstraZeneca Q4 core earnings beat estimates despite easing COVID vaccine demand,118519724,https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png,AZN,Yahoo,By Scott Kanowsky,https://finnhub.io/api/news?id=c64bc8392978a4af7954352519d5cd44258592a94c52b2f7612b76c9b2205495
company,2023-02-08 21:34:00,AstraZeneca PLC 4Q EPS 58c,118671399,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,"Corrections &amp; Amplifications This headline was corrected at 0928 GMT to reflect AstraZeneca 4Q Adj EPS $1.38, not 4Q Adj Loss/Shr $17.00 By Cecilia...",https://finnhub.io/api/news?id=01f128062ca5e2513e8765c2489c08f601a2f84d339f756c581aee5543b06e83
company,2023-02-08 11:06:04,"PepsiCo, AstraZeneca, PayPal earnings: 3 things to watch",118511863,https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png,AZN,Yahoo,By Liz Moyer,https://finnhub.io/api/news?id=152cfef7c37b640faa80299ca7266b1aa3eb741f3c017b38f99b9c309d1208ec
company,2023-02-08 01:20:00,AstraZeneca Expected to Swing to 4Q Profit -- Earnings Preview,118671402,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,By Cecilia Butini AstraZeneca PLC is scheduled to report results for the fourth quarter on Feb 9. Here is what you need to know: SALES FORECAST: Sales at the...,https://finnhub.io/api/news?id=3970acde41358100324d99cf4a529db6c7dc9b618a3ef3b17977d5d2aee76e1d
company,2023-02-15 11:38:00,"AstraZeneca PLC ADR falls Wednesday, underperforms market",118671374,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR shed 0.92% to $69.69 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=e2aa2c65e1b3551c71b6b105c7e09535684ca4575736319997b94df5f0df341b
company,2023-02-15 08:03:10,Novo Nordisk: Attractive Market But Likely No Margin Of Safety,118587397,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1288508386/image_1288508386.jpg?io=getty-c-w1536,AZN,SeekingAlpha,Novo Nordisk is the only pure-play and a market leader in the diabetes and obesity care space. Click here to read my most recent analysis of NVO stock.,https://finnhub.io/api/news?id=811be800f4c53b56d3c45caa421d37aa393ecda8d86ef81e6a073587b768cba3
company,2023-02-15 07:17:00,Medicare mulls limiting per month costs for generic drugs at $2,118610732,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=a6b8cf78b81c3f51b5cac2b71fed1624ea3f23eefc552053e92dbe9a40e5d870
company,2023-02-15 07:03:00,Panel backs moving opioid antidote Narcan over the counter,118696178,,AZN,"Associated Press, The",Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=960886374864553d15af965eb6e3738a1901bab78385801e82984c150a6d4836
company,2023-02-15 07:01:00,"AstraZeneca rises Wednesday, still underperforms market",118671378,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"Shares of AstraZeneca PLC inched up 0.43% to £115.68 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the...",https://finnhub.io/api/news?id=a782d60cb9da590972ea1630d279c63bf8701d704911b1d58b035798577d92b0
company,2023-02-15 04:30:00,AstraZeneca's Evusheld not recommended by NHS for vulnerable people,118770695,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=98701ac28a4acd3873f01dfd834f92f6436f9e33fe8323ade0cd440ae85d45a3
company,2023-02-15 01:49:00,GLOBAL BROKER RATINGS: HBSC cuts Michelin; Bryan Garnier likes Danone,118594893,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=592aafcfd3e6ae45007dd9f6385a009ab5658eb12dd82afd13ace7be0b69e43d
company,2023-02-14 23:32:00,LONDON BROKER RATINGS: Bryan Garnier starts Unilever with 'neutral',118591448,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=f4971ee390b421b229a7ac1bb819c996687c5fcb137150c517ec73495208d3b7
company,2023-02-14 11:38:00,"AstraZeneca PLC ADR rises Tuesday, outperforms market",118671380,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR inched 0.90% higher to $70.34 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=04df5347e68e7a809249a8bccd777467c8deda197e68d26275e34f0f12811216
company,2023-02-14 07:01:00,"AstraZeneca rises Tuesday, outperforms market",118671382,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"Shares of AstraZeneca PLC inched up 0.84% to £115.18 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the FTSE...",https://finnhub.io/api/news?id=9cd4e84c729bd4f2771008d2615db6fea8f4a15ffe0c107f31d0937d88246b99
company,2023-02-14 06:06:00,SVB Securities Sticks to Their Buy Rating for AstraZeneca (AZN),118770701,,AZN,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=b952d94312b23e850829b4c85b4f48bd1f92af853f741146ea0c9bc0bd360c0c
company,2023-02-14 02:00:00,"Rilvegostomig, AstraZeneca's Bi-specific Antibody Derived from Compugen's COM902, Expected to Progress into Phase 3",118770702,,AZN,PR Newswire,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=630078aafe91f59bc899e18b339ca963bc15fd17b7e4a9ef7d63bb7043248f72
company,2023-02-14 01:07:00,Compugen: Rilvegostomig expected to progress into Phase 3 this year,118770703,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=daff14b4c036d747db48d92ed2d54da47bfd0775a13dbabcf02cad1fbb7b4164
company,2023-02-13 11:38:00,"AstraZeneca PLC ADR rises Monday, still underperforms market",118671384,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR advanced 1.20% to $69.71 Monday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=3a31ac2cfa1d446438fdadeb1f1ffa88e4b538159be1bdf4198b8dfbbf02c7a3
company,2023-02-13 07:01:00,"AstraZeneca rises Monday, still underperforms market",118671387,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"AstraZeneca PLC shares inched up 0.28% to £114.22 Monday, on what proved to be an all-around positive trading session for the stock market, with the FTSE 100...",https://finnhub.io/api/news?id=247bed05eca9406519f7c8336efeb29c0a06cc09d9d60dd766bbbaf7642bbae0
company,2023-02-13 04:53:00,"AstraZeneca, SOPHiA team up to use AI, machine learning in cancer drugs development",118770705,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=6a48c95fa4d8716e736d1558a2da1416852689253edc9a3098b8150e57f40cd5
company,2023-02-13 04:00:00,SOPHiA GENETICS Expands Partnership With AstraZeneca to Include Multimodal Approaches for Cancer Drug Development,118770706,,AZN,Business Wire,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=0c1090976c0bd5272cda6405d0c3353f14a383c406c296dc056f221f41f31300
company,2023-02-13 03:26:00,Sophia  expands deal with AstraZeneca to include MM approaches to oncology,118770707,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=3d251d3dd92c6901aa2b3bf283526287b285ae385a33a4dd74c2fec705dbf156
company,2023-02-12 18:49:51,AstraZeneca (AZN) Declares $0.98 Dividend,118576164,,AZN,Fintel,,https://finnhub.io/api/news?id=6ca22ae592e868266ca3f6d1c661f88038a03d2157eba9fee1fc2199bc4f14ca
company,2023-02-12 04:00:00,AstraZeneca: Strong 2022 Growth Bodes Well,118563240,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1237690480/image_1237690480.jpg?io=getty-c-w1536,AZN,SeekingAlpha,"AstraZeneca's stock might have sagged in January, but it got a boost recently after its 2022 earnings release. Click here to read why Iâd buy AZN.",https://finnhub.io/api/news?id=9869813b7208e7a805a38e6b22fb7336c840e2afa72707e60d249b3d9359177b
company,2023-02-12 02:10:26,AstraZeneca's (LON:AZN) Dividend Will Be $1.45,118575624,https://media.zenfs.com/en/simply_wall_st__316/bba95900ab96866c17a285be850152bf,AZN,Yahoo,"AstraZeneca PLC ( LON:AZN ) will pay a dividend of $1.45 on the 27th of March. Based on this payment, the dividend...",https://finnhub.io/api/news?id=1828cdf03fbdbb40826e2d18f8ff8391ecbb559d17e0cef94bb223c4e3b5a1fb
company,2023-02-17 22:06:00,COVID vaccine sales to see decline through end of decade as pandemic eases,118738085,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=f1e9d39e67616d3fd810e6114c0210ccbb0c500992d818f611fec27e261d6d07
company,2023-02-17 21:19:27,"Steven Cohen’s Point72 Hedge Fund Backs Salesforce, Broadcom And Meta While Cutting Palo Alto And Workday Stakes",118627532,,AZN,Fintel,,https://finnhub.io/api/news?id=ec9a519c4b12ab6370c147f2cb4a0d0353bb66d23e44fd431e932b3f799dc23b
company,2023-02-17 11:38:00,AstraZeneca PLC ADR outperforms market on strong trading day,118671361,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR advanced 1.50% to $68.97 Friday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...",https://finnhub.io/api/news?id=525106820bb71a62678913640930fac4c0446df06b65af006b1044230f1fac16
company,2023-02-17 07:01:00,"AstraZeneca rises Friday, outperforms market",118671363,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"Shares of AstraZeneca PLC advanced 1.09% to £114.86 Friday, on what proved to be an all-around grim trading session for the stock market, with the FTSE 100...",https://finnhub.io/api/news?id=61e7b3fb74035b3f2d019808d8a06b301db0ca05342143006b849e2c89155c20
company,2023-02-17 05:54:00,UK dividends calendar - next 7 days,118638620,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=86b3c401df84b00f510fb9fd3036e7958aeeea87464bb23a615e6f9807a310a3
company,2023-02-17 03:33:00,10 Sectors Likely To Generate Good Returns In The Next Decade,118632679,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=3944fc41fadbefc26d30b88b8096351f1462f07a96a1d02baf2e87b9f0d5b8f1
company,2023-02-17 02:06:00,This chart offers one reason that European stocks may continue to outperform U.S. equities,118637372,https://images.mktw.net/im-727300/social,AZN,MarketWatch,One of the stories for markets this year has been the outperformance of European stocks to U.S. ones,https://finnhub.io/api/news?id=88f65abd4e879b24f59b47ecd87c96ab3eedde3c68ce029741095b67c081564e
company,2023-02-17 01:22:00,9 February Inflation-Busting Ideal Dividend Dogs,118636086,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=96cc80bfd3932f924d402d3d334ae40f7a7d56ec0644c62982371396247377cb
company,2023-02-17 01:01:00,"Campbell & CO Investment Adviser LLC Buys 1, Sells 4 in 4th Quarter",118635836,,AZN,GuruFocus,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=0a0659947d3dcbf6058a3a4f7bba47ca60efc47caadeab151876ee5b64a5a2c4
company,2023-02-16 11:38:00,AstraZeneca PLC ADR outperforms competitors despite losses on the day,118671367,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR slipped 2.50% to $67.95 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=288e2a62f512a5dc85715872431a5d866d344b57b7341e6a81c9a439964f8393
company,2023-02-16 10:00:00,AstraZeneca and Merck present final results of key secondary overall survival endpoint from Phase III PROpel trial at ASCO GU Cancers Symposium,118619457,https://media.zenfs.com/en/business-wire.com/5734ee2f175a121e5552ba09d0d3390a,AZN,Yahoo,"WILMINGTON, Del., February 16, 2023--Results from the final prespecified overall survival (OS) analysis of the PROpel Phase III trial in metastatic castration-resistant prostate cancer (mCRPC) showed LYNPARZA® (olaparib), jointly developed and commercialized by AstraZeneca and Merck & Co., Inc., known as MSD outside the US and Canada in combination with abiraterone and prednisone or prednisolone demonstrated median OS of 42.1 months versus 34.7 months for abiraterone plus placebo. This result re",https://finnhub.io/api/news?id=5147eca2835726433e9992c900461f3f671f336dc3d0d6f13558df7c1414de93
company,2023-02-16 09:13:00,"Moderna, Pfizer, BioNTech Covid jab patent dispute heads to 2024 trial",118634067,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=e49a40c914701baac22aceeb5fbb4665fffa85a45d9972b19e02dc93658f669e
company,2023-02-16 07:01:00,U.K. stocks rise for fourth session,118634273,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,"U.K. stocks finished up Thursday, with the FTSE 100 Index rising 0.18% at 8,012.53. Of the FTSE 100 constituents, major international banks company Standard...",https://finnhub.io/api/news?id=60e085a8b3162701ed56a1bb99a065c6bc0258bab3a8c672303804a5733c0ae1
company,2023-02-16 07:01:00,"AstraZeneca falls Thursday, underperforms market",118671369,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"Shares of AstraZeneca PLC shed 1.78% to £113.62 Thursday, on what proved to be an all-around positive trading session for the stock market, with the FTSE 100...",https://finnhub.io/api/news?id=31bce4e993ccab27bc0da90c413c223635c270cad5936a7b8c2b42ffa2bfce1b
company,2023-02-16 04:13:00,"AstraZeneca, Merck present final results from Phase III PROpel trial",118689817,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=124b43c44f43aed96968ccbc6a6ffbedd926f43165dcb529e9644b447c605f7e
company,2023-02-16 04:06:00,"Merck, AstraZeneca present final results from Phase 3 PROpel trial",118689818,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=48fc776a40165d977716a03e7886e7eb9244384e7061d53ee3a4a45f0e708bc4
company,2023-02-16 03:00:00,3 Stocks To Buy As U.S. Inflation Stays Sticky,118616031,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1391643917/image_1391643917.jpg?io=getty-c-w1536,AZN,SeekingAlpha,There was good news and bad news on the US inflation front for January 2023. Read more to see 3 stocks to buy in the current situation.,https://finnhub.io/api/news?id=93294c4cc014463dbb3b274082c18e2adca06fae1f162ff16219f2d484064890
company,2023-02-16 02:45:00,"Pfizer, GSK to face FDA AdCom meetings for RSV vaccines from late February",118618036,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=f1eca61019e530b752e4c9d14b715f2b03b5e0660059b46f7634fc504f412698
company,2023-02-16 02:33:50,AstraZeneca: Reiterate Our Growth Pick,118614966,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/57611036/image_57611036.jpg?io=getty-c-w1536,AZN,SeekingAlpha,"AstraZeneca, profit beats expectations, but revenues are down due to lower COVID-19 sales. See why we recommend a buy on AZN stock.",https://finnhub.io/api/news?id=df6508d6799abfaa4c9ff79351cc74d03f1620fa06c41b3d8d9f54d84b000103
company,2023-02-16 01:37:50,MannKind: The Continuing Saga Of What They Say Vs. What They Do,118613524,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1066760018/image_1066760018.jpg?io=getty-c-w1536,AZN,SeekingAlpha,As we approach another pivotal point for MannKind I thought it might be good to review the history of the company. See why I rate MNKD stock a Hold now.,https://finnhub.io/api/news?id=12cff8f805298060727c7f972ce820535fe274df7ee0dcab521ab0d242e7b415
company,2023-02-15 23:03:00,UK drug pricing watchdog declines to recommend AstraZeneca`s COVID therapy Evusheld,118770690,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=3ce9338922816966931a13a9ce85a88aad106ee3d81b68e2ad394a7b3d80067f
company,2023-02-23 12:22:00,"ADRs End Higher; Alibaba, AstraZeneca Trade Actively",118878789,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,By Denny Jacob International stocks trading in New York closed higher on Thursday. The S&P/BNY Mellon index of American depositary receipts edged up 0.5% to...,https://finnhub.io/api/news?id=69f81939409feb0a20591b83e7ee46a63a9c3152405144487a90e860b63b9866
company,2023-02-23 11:38:00,"AstraZeneca PLC ADR falls Thursday, underperforms market",118878790,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR slipped 0.71% to $67.40 Thursday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=8f1ffb442f85c7a692330f9bfd30afd8ba31e4e8a1f6ff1b7246bd2496c0fb98
company,2023-02-23 11:12:04,"Top Research Reports for Exxon Mobil, Coca-Cola & AstraZeneca",118867255,https://media.zenfs.com/en/zacks.com/cd30a5699dbb9af5d207d11c77c79590,AZN,Yahoo,"Today's Research Daily features new research reports on 16 major stocks, including Exxon Mobil Corporation (XOM), The Coca-Cola Company (KO) and AstraZeneca PLC (AZN).",https://finnhub.io/api/news?id=c4f0172822a681ac4cdb0ebc9044a1e09b40bee54678332d9ebb5fc7a4b8d38f
company,2023-02-23 09:15:02,"Ionis (IONS) Q4 Earnings Top Estimates, Sales Lag, Stock Down",118868850,https://media.zenfs.com/en/zacks.com/9d995582658bf49e50317a8120603e3e,AZN,Yahoo,"Ionis (IONS) Q4 loss is narrower than expected. However, sales miss estimates. Revenue guidance for 2023 looks soft. Stock down.",https://finnhub.io/api/news?id=32ecebe731a38ec3df7c9b43d8dea56c3e5a571d63ff1ceb29dcf3c89388704d
company,2023-02-23 07:09:00,Interesting AZN Put And Call Options For April 6th,118903447,,AZN,Stock Options Channel,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=e7580d22e1ca37d172927e3c450f858f8a9b1c82cce96d84c13513b4b28fc397
company,2023-02-23 07:01:00,"AstraZeneca falls Thursday, underperforms market",118878791,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"Shares of AstraZeneca PLC shed 1.12% to £112.10 Thursday, on what proved to be an all-around grim trading session for the stock market, with the FTSE 100...",https://finnhub.io/api/news?id=899a37fe2598d1c70e035833f7812c73b2f5d66b811b11e21ce592770344d1fb
company,2023-02-23 07:00:00,"LONDON MARKET CLOSE: FTSE 100 struggles, but European peers rise",118866235,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=ec86ec0121854f3e7d7bc60f168903d7d18a3eb2ace0db6dfa2c2547db9e046a
company,2023-02-23 00:47:00,AstraZeneca announces license agreement with KYM Biosciences for CMG901,118903449,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=98521262c66e373676e7cb6b36336b9af8a176326a669f6bc7126e22c83dffad
company,2023-02-22 23:17:00,AstraZeneca to pay KYM $63M upfront in license deal for potential gastric cancer therapy,118903451,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=bf5049e6e296884863cd8543f8caee21577127f19218210012fe99b47331fea8
company,2023-02-22 23:02:00,"LONDON MARKET OPEN: Mixed open in London; Rolls-Royce up, Mondi down",118861910,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=b043de8438c79fd229e4835d273f735cc39fa1f3397e437d4f6b5adc5b44d570
company,2023-02-22 23:01:00,AstraZeneca signs USD63 million agreement to address gastric cancer,118903455,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=54df0cf19c676bb20035d468767621b95bb256094e1bbbd1bfbabf3f1a35ec9b
company,2023-02-22 21:27:00,AstraZeneca Signs License Agreement With KYM Biosciences for Gastric Cancer Therapy,118878792,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,By Michael Susin AstraZeneca PLC said Thursday that it has entered into an agreement with KYM Biosciences Inc. regarding an exclusive license agreement for a...,https://finnhub.io/api/news?id=a559add532cb819a7ad552b2cc27bf2c4bd7fc917a4b67684e04c853ec8792c3
company,2023-02-22 20:56:00,LONDON MARKET EARLY CALL: Stocks to rise after uneventful Fed minutes,118850615,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=67a6b83e0cc6639b0374ca5862d247134c9abae4ab132f45b30082ba6d1a2c92
company,2023-02-22 19:01:00,Keymed and Lepu Biopharma Jointly Announce Global Exclusive Licence Agreement with AstraZeneca for CMG901,118903458,,AZN,PR Newswire,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=be76b2c6f3b2b4fe8a2d9fc945470919e84274b303db2829006b4e08dd955a42
company,2023-02-22 11:38:00,AstraZeneca PLC ADR underperforms Wednesday when compared to competitors,118878793,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR shed 1.06% to $68.85 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=bcddf63950ccb1ea4024ed2b4440d6192e5d501f30aee096810364142a3e6e07
company,2023-02-22 07:01:00,"AstraZeneca falls Wednesday, underperforms market",118836001,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"AstraZeneca PLC shares inched down 0.61% to £115.00 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the FTSE...",https://finnhub.io/api/news?id=2804c9f4ac1ca5cc83ad4b14938e30ed3634a5ede77911954e3142b377ffb1bf
company,2023-02-22 05:47:00,UK dividends calendar - next 7 days,118830782,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=09f63051305ce60f592e3a0aca366446c0e03245523a5e758ec74c6819caa1c9
company,2023-02-22 00:49:00,AstraZeneca reports Imfinzi plus Imjudo approved in EU for NSCLC,118840303,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=ffd0dc70d20bc644ecde054a03a18cecd06196bb907dfe1f9d8d61fa53907b42
company,2023-02-22 00:47:00,AstraZeneca says Calquence tablet formulation approved in EU for CLL,118840304,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=eeaf666fcd0d36513fd9e281821a485310b697b90eaefcb0ec64f16b248cb8e5
company,2023-02-21 23:11:00,TOP NEWS: AstraZeneca wins three approvals in EU for cancer drugs,118840305,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=856cad0ee940864443868dd344ff7defb79a938c10a7002ee19c6b14bc977727
company,2023-02-21 22:49:00,AstraZeneca`s blood cancer drug Calquence`s tablet form gets approval in EU,118840306,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=cba54d136164f715fd072516f7dd51965c72c953fd73df0b8fdce5eb3a231b83
company,2023-02-21 22:32:00,"AstraZeneca Imfinzi, Imjudo combo gets approval in EU to treat liver, lung cancers",118840308,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=6e9dbc1c9a74a0ff62951d72e8bfc049b76c3302c760dbeb720c5948bbcea1b7
company,2023-02-21 11:38:00,AstraZeneca PLC ADR outperforms competitors on strong trading day,118836002,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR inched 0.90% higher to $69.59 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the...",https://finnhub.io/api/news?id=05c2c07d82e5bc3553c8849976f55884df53444d7cc5355d481329de041e98ce
company,2023-02-21 07:05:00,"AstraZeneca price target raised to 11,900 GBp from 10,100 GBp at UBS",118840309,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=cf3869f4f605286322237b4665d12a3629e30e46bb0f3d2bafea63c3cf2fa774
company,2023-02-21 07:01:00,"AstraZeneca rises Tuesday, outperforms market",118836003,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"Shares of AstraZeneca PLC inched up 0.26% to £115.70 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the FTSE 100...",https://finnhub.io/api/news?id=7ac314d061bf41271b6b89f2062d2594ed73aece352b33ea743bd954f04866e8
company,2023-02-21 03:59:00,"Ex-Dividend Reminder: AstraZeneca, STERIS and Baxter International",118770658,,AZN,Dividend Channel,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=5b02ae1d9a34e5ece85a0ad917f950b5548f417041038785558f1e80fa122768
company,2023-02-21 03:01:00,"BRIDGER MANAGEMENT, LLC Buys 1, Sells 4 in 4th Quarter",118770661,,AZN,GuruFocus,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=915fe3aafa8a96026c2f0136f3246198c186105a48868dbf6ac460f91b8d103a
company,2023-02-21 03:01:00,Top 5 4th Quarter Trades of HOWE & RUSLING INC,118770659,,AZN,GuruFocus,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=882059135fd7457ce8f727dd5e156c81e04cdb276035931e8e1c3cf0bc388198
company,2023-02-21 00:17:00,LONDON BROKER RATINGS: BoA cuts DS Smith; Jefferies likes JTC,118761281,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=0a174c38b2db43e70af4bc7db56013cecf0362299833f2a64e99f9ea0e7f6ece
company,2023-02-20 23:42:00,AstraZeneca reports protection against RSV in infants with Beyfortus,118770664,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=1e8f391f7f969fa35b360c5809420b146df160330ca7690e7cb839ce7450643b
company,2023-02-20 07:01:00,"AstraZeneca rises Monday, outperforms market",118723693,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"Shares of AstraZeneca PLC inched up 0.47% to £115.40 Monday, on what proved to be an all-around great trading session for the stock market, with the FTSE 100...",https://finnhub.io/api/news?id=6a549b356dca37670188cf23794a831368cb93600a1d0fcbb0dcc7e96560bc33
company,2023-02-27 11:45:04,Are You Looking for a High-Growth Dividend Stock?,118953605,https://media.zenfs.com/en/zacks.com/ace7df31c7fcb10255abe7c990ea373a,AZN,Yahoo,"Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Astrazeneca (AZN) have what it takes? Let's find out.",https://finnhub.io/api/news?id=ca8d3639c13e0683edf551b50df4377e5c813d5ed7459642e1197ec44428fdc7
company,2023-02-27 11:38:00,AstraZeneca PLC ADR outperforms competitors on strong trading day,118973935,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR inched 0.65% higher to $66.80 Monday, on what proved to be an all-around favorable trading session for the stock market, with the...",https://finnhub.io/api/news?id=b40221860f6185540b98750b431f560e816dfab533ec6f551213bd207ba9ddb9
company,2023-02-27 07:01:00,"AstraZeneca falls Monday, underperforms market",118955095,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"Shares of AstraZeneca PLC inched down 0.02% to £110.98 Monday, on what proved to be an all-around great trading session for the stock market, with the FTSE...",https://finnhub.io/api/news?id=b31fc5f460d456872a891522a209ccc181622becf8d75a86b9f440aafba99052
company,2023-02-26 18:05:00,Week In Review: Keymed/Lepu Sign $1.2 Billion Deal Out-Licensing Claudin 18.2 ADC To AstraZeneca,118943755,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1362476720/image_1362476720.jpg?io=getty-c-w1536,AZN,SeekingAlpha,Chengdu Keymed Bio and Lepu Biopharma out-licensed global rights for their partnered Claudin 18.2 antibody drug conjugate to AstraZeneca. Read more here...,https://finnhub.io/api/news?id=2b99becb257f14f8778be88abe6e36cede27534e74ef087689b050ced806d255
company,2023-02-26 07:46:00,Baron International Growth Fund Q4 2022 Quarterly Letter,118940147,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=56cea6cdadb0452c71f180af039e73f34eb2f8e0470f7694869ddd4f52162994
company,2023-02-26 07:17:00,Baron Health Care Fund Q4 2022 Quarterly Letter,118939962,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=642c71aff227a2200763b4f6d8f5efd69ffa3780761feed076b3c309e3f56ae6
company,2023-02-24 11:38:00,AstraZeneca PLC ADR outperforms market despite losses on the day,118935883,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR shed 1.53% to $66.37 Friday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite...",https://finnhub.io/api/news?id=a73b6bf42e5fa38004f17e51b4da2e075fabfbdee8bf3d2b841b896f387204fb
company,2023-02-24 10:30:03,"Pharma Stock Roundup: FDA Updates for SNY, PFE & Others, EU Nod to AZN Cancer Combo",118902353,https://media.zenfs.com/en/zacks.com/8e4a50bc305a474288a0537c03ecd305,AZN,Yahoo,FDA approves Sanofi's (SNY) Altuviiio and grants a priority tag to Pfizer's (PFE) regulatory applications for pipeline candidates.,https://finnhub.io/api/news?id=f1a21df168cb30f683b55911f1dbd962fa4b631465c28b3d59cf1d147c688c47
company,2023-02-24 08:51:00,AstraZeneca prices two EUR750 million fixed-rate notes,118903439,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=90e62a9f96dd0ad84ce06ce723ca1d8ae6e819dd0e1c6d6cea73ad446b82e13b
company,2023-02-24 07:45:00,SVB Securities Reaffirms Their Buy Rating on AstraZeneca (AZN),118903440,,AZN,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=70375e9e8e723fb4aa69412c3db327a01c5cc44d31f588272b70468c07ae30a3
company,2023-02-24 07:01:00,"AstraZeneca falls Friday, underperforms market",118935884,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"Shares of AstraZeneca PLC inched down 0.98% to £111.00 Friday, on what proved to be an all-around dismal trading session for the stock market, with the FTSE...",https://finnhub.io/api/news?id=12182ad9e784754320de3fae8bc37e159a4180acfe9d3df24e4b42d7cdebccf1
company,2023-02-24 04:35:00,TOP NEWS: AstraZeneca closes CinCor buy; Enhertu wins Chinese approval,118903441,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=383f232a25bc9e72f1b72ec012752f5ffea90c788611fedee7d3042fdf417b52
company,2023-02-24 03:58:08,"The Zacks Analyst Blog Highlights ExxonMobil, Coca-Cola, AstraZeneca, CSX and Activision Blizzard",118893855,https://media.zenfs.com/en/zacks.com/68d0630f829e1f0c836d5ef5fd36d932,AZN,Yahoo,"ExxonMobil, Coca-Cola, AstraZeneca, CSX and Activision Blizzard are included in this Analyst Blog.",https://finnhub.io/api/news?id=8d12c0997c430589a8dc8f1394964cf9e82b0be3677a1ce7283474ea8cbda476
company,2023-02-24 03:35:00,Ambrx Biopharma drops 17% to end rally ahead of investor day,118903442,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=25a6b1e610212cb5bcb4f8fe496f81dc31fb57e2411664121e90175216251843
company,2023-02-24 03:10:00,AstraZeneca completes acquisition of CinCor Pharma,118903444,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=8a987e60784ca3274445f7939f41b619735f0730e3e48ff899a28f21a444b0de
company,2023-02-24 03:07:00,AstraZeneca reports Enhertu approved in China for metastatic breast cancer,118903446,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=cef38faa81ac6d908710c23543d99a3a9f11618425b342564ffa47276217caba
company,2023-03-03 11:39:00,"AstraZeneca PLC ADR rises Friday, still underperforms market",119049913,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR inched 0.15% higher to $65.20 Friday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=0afe08c4e28b6bf8118d41e4c5441f1b7ee322f3599673eefaa472694e00daa4
company,2023-03-03 09:43:28,AstraZeneca's Trading Range Makes This Options Trade Appealing,119042271,,AZN,Yahoo,"AztraZeneca (AZN), a U.K. developer of branded prescription therapeutics, ranks first in IBD's diversified medical industry group. But the Composite Rating is only 63. This, combined with the weakening of the market, makes this a solid choice for our familiar short iron condor. With the suspicion that the markets are going to be in a sideways grind, punishing speculation and...",https://finnhub.io/api/news?id=b5d0e13ff4018d7ef60f025fe5b99eaaee2286f2625e21227995305470e7e13d
company,2023-03-03 07:01:00,"AstraZeneca falls Friday, underperforms market",119049914,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"AstraZeneca PLC shares inched down 0.74% to £107.84 Friday, on what proved to be an all-around favorable trading session for the stock market, with the FTSE...",https://finnhub.io/api/news?id=eb60913c7987725f9eb2a95941c20c988f7242c5f91568dcb719b24057e363db
company,2023-03-02 16:28:00,Alexion advances commitment to transform patient outcomes in rare neurological diseases at AAN 2023,119023385,https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png,AZN,Yahoo,"WILMINGTON, Del., March 02, 2023--Alexion, AstraZeneca Rare Disease, will showcase the potential for its pioneering therapies to redefine the treatment landscape for certain rare neurological diseases at the American Academy of Neurology (AAN) Annual Meeting, April 22-27, 2023. The company will present 19 abstracts, including eight oral presentations, across generalized myasthenia gravis (gMG), neuromyelitis optica spectrum disorder (NMOSD), Wilson disease and dermatomyositis.",https://finnhub.io/api/news?id=01394a08db2aaa4bfddf03f5ab5505f6d05b8b8ebbb2c3e411bddfced9faae30
company,2023-03-02 13:15:47,Valneva Shares Updated Data From Now Shelved COVID-19 Vaccine Development Program,119022528,https://media.zenfs.com/en/Benzinga/6e6ac0314e2f10a013900e4c7e2465ad,AZN,Yahoo,"As previously announced, Valneva SE (NASDAQ: VALN) said it would not invest in further COVID-19 vaccine development, VLA2001, without a new partnership. However, it is completing the remaining clinical studies and submissions. Last week, the Committee for Medicinal Products for Human Use of the European Medicines Agency backed VLA2001 approval in adults as a booster dose after at least seven months following primary vaccination with VLA2001 (homologous booster dose) or with an adenoviral vector",https://finnhub.io/api/news?id=0a23e3a0f2842bdfdaf780ea152a619a361abd2d19841b3cf1bf6a80acea99c1
company,2023-03-02 11:38:00,AstraZeneca PLC ADR underperforms Thursday when compared to competitors,119028121,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR slid 0.17% to $65.10 Thursday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=f7ba427060432fc692f47439df8d395fa43ea40af76adf406a0271c00a4da0e0
company,2023-03-02 10:24:50,UPDATE 1-U.S. FDA panel to review expanded use of Merck-AstraZeneca's cancer drug,119017963,https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png,AZN,Yahoo,Merck & Co Inc and British drugmaker AstraZeneca PLC said on Thursday that an independent committee of advisers to the U.S. health regulator will review the companies' application for the expanded use of their drug Lynparza to treat an advanced form of prostate cancer.  The U.S. Food and Drug Administration's (FDA) committee is scheduled to meet on April 28.  The companies' are seeking approval of the drug Lynparza in combination with other medications – biraterone and prednisone or prednisolone –for the treatment of a type of treatment-resistant prostate cancer in adult patients.,https://finnhub.io/api/news?id=1c5bebf8fb7dece2e4ad9f8308856c0034595c0eff02ab1a7308dfa38a6df345
company,2023-03-02 07:20:00,US FDA to discuss AstraZeneca and Merck's Lynparza cancer drug combo,119039071,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=0772cf3d50f2c7e59fa3e823ebfa0db5405a076aa2ad42e352b220e12268c75b
company,2023-03-02 07:01:00,"AstraZeneca rises Thursday, outperforms market",119020287,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"AstraZeneca PLC shares inched up 0.44% to £108.64 Thursday, on what proved to be an all-around positive trading session for the stock market, with the FTSE...",https://finnhub.io/api/news?id=8177b81d08501bf3d865172825b9241d5dca1137958290b1006ef21df823f512
company,2023-03-02 06:16:00,AstraZeneca (AZN) Receives a Buy from SVB Securities,119039073,,AZN,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=9d1eea4d80d7859ab9cb8ea4f7a03572027130d7fcb983173e5d02e3eb6ea406
company,2023-03-02 05:40:00,AstraZeneca (AZN) Shares Cross Below 200 DMA,119039075,,AZN,Dividend Channel,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=912f817aff492ce289063f76f2ce5353f989e4ba185ddfdd2ecd62f4cda1e1bf
company,2023-03-02 03:13:00,"AstraZeneca, Merck provide regulatory update on Lynparza sNDA",119019157,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=121df7877bf21eb6a3e00f972b9e143b2f57ab12639487749632fcdd626f9e89
company,2023-03-02 03:07:00,AstraZeneca says FDA to convene AdCom meeting on sNDA for Lynparza in mCRPC,119019158,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=5f8a1900274f4e0edecf5d7f0c3ab572cb3e18ab36e3612f2ac496d6fd404cf6
company,2023-03-02 01:32:00,Prenetics announces formation of scientific advisory board,119021838,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=d6892054e8ef2d54f9475fd51136d5fcfe10d238f6d59702a5077e7b01025432
company,2023-03-01 22:58:00,Valneva COVID shot shelf life extended; gets EMA nod for booster; shows efficacy in trials,119037131,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=7da591e345fb9eaf79c591248719f8c44ccb7d1bb7d15b0727eaeaf8323681d5
company,2023-03-01 11:38:00,AstraZeneca PLC ADR underperforms Wednesday when compared to competitors despite daily gains,119012673,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR inched 0.05% higher to $65.21 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow...",https://finnhub.io/api/news?id=52bb6591121dfe94105b13b47c38f44eb22a11153cb003a6fffc49061cecfc44
company,2023-03-01 09:38:00,IN BRIEF: AstraZeneca prices three tranche global bond offering,119039086,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=a95d3b92b618bb5d98c51e8839e4c050326e73208e30a3ae1e73cb0be956e7c9
company,2023-03-01 07:01:00,"AstraZeneca falls Wednesday, underperforms market",119012674,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"Shares of AstraZeneca PLC inched down 0.59% to £108.16 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the...",https://finnhub.io/api/news?id=66253aea6ca6b0744397f51a88dfe0a9d2f6aa14e82f857aeb99116bb16499e9
company,2023-03-01 00:42:00,FBI Director says novel coronavirus likely originated from China lab leak,118993603,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=824054490c9ccc5cd48730f9340b14da07e74bc5c45c3a6e08aa6cd333b85529
company,2023-02-28 13:11:03,50 Biggest Public Companies in the World,118971933,https://media.zenfs.com/en/insidermonkey.com/32ff798ba909913d42c23d64aa5210e6,AZN,Yahoo,"In this article, we will be taking a look at the 50 biggest public companies in the world. To skip our detailed analysis, you can go directly to see the 10 biggest public companies in the world. While much maligned, and often rightly so, the biggest public companies in the world aren’t just intrinsically linked […]",https://finnhub.io/api/news?id=627b130d7a85d41e608e1c46a025585f18104c2d17fda457a6749c4f86bd434c
company,2023-02-28 11:54:57,11 Most Promising Cancer Stocks According to Analysts,118971089,https://media.zenfs.com/en/insidermonkey.com/3cc55de33fedd23d4bf65c334111d1ca,AZN,Yahoo,"In this article, we discuss 11 most promising cancer stocks according to analysts. If you want to see more stocks in this selection, check out 5 Most Promising Cancer Stocks According to Analysts. The market for community oncology services worldwide is projected to experience substantial growth, with an estimated increase from $47.95 billion in 2022 […]",https://finnhub.io/api/news?id=8c3498d949a43b404e26fa261d7338ec427f4ed108798cd5ad7c0f1c22b7c936
company,2023-02-28 11:38:00,"AstraZeneca PLC ADR falls Tuesday, underperforms market",119012675,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR slipped 2.43% to $65.18 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=bff7c4a0c3b1dfbb43615ace17bdf05512b28d129ce49fa31889a036ef52a4f7
company,2023-02-28 07:01:00,"AstraZeneca falls Tuesday, underperforms market",118973934,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"Shares of AstraZeneca PLC slipped 1.96% to £108.80 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the FTSE 100...",https://finnhub.io/api/news?id=a48ed591df5f70daf204717353ed20e9c67739885e7afff1a7f5c4dc65ab6d02
company,2023-02-28 01:39:00,"Merck Keytruda combo fails lung cancer trial, sees another setback in prostate cancer",118976047,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=ad0b9496b308a8f541fa83745b1fb16951df4636e3db20759931b34d4bb0108b
company,2023-03-07 11:39:00,AstraZeneca PLC ADR outperforms competitors despite losses on the day,119116257,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR slid 0.42% to $64.29 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=b05d286e486cfafcc46cc11bd0f2c07ca6281d4813fe5e83b75d2849e3fd70bc
company,2023-03-07 07:02:00,"Ionis, AstraZeneca eplontersen application accepted by FDA for nerve damage disorder",119124824,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=e5b14217fd851b395b5b408e9a1b0f96650005df82eff997b64be1b10606f0c2
company,2023-03-07 07:01:00,"AstraZeneca rises Tuesday, outperforms market",119116258,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"AstraZeneca PLC shares rallied 1.01% to £108.50 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the FTSE 100...",https://finnhub.io/api/news?id=da1e1fe18d5023e83cd605efbbc3e19126526d449c63da458bae386031a0219d
company,2023-03-07 05:30:00,Lexicon initiated at buy at Jefferies on uptake of heart failure candidate sotagliflozin,119100991,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=6c801680469198476f0286073df60ac0d0431b091028fd59f496964f1672a5fb
company,2023-03-07 04:24:09,AstraZeneca (AZN) Enhertu Betters Outcomes in Multi-Tumor Study,119098070,https://media.zenfs.com/en/zacks.com/ca9d72216d7bb42fc496430c3df29b41,AZN,Yahoo,AstraZeneca (AZN) and Daiichi Sankyo' Enhertu met the pre-specified criteria for objective response rate and duration of response in the DESTINY-PanTumor02 phase II study.,https://finnhub.io/api/news?id=c9a077dbbe47e84078711981b8755f729ae868f01936aa84b4363a4d8d7e9d1c
company,2023-03-07 03:55:00,Personalis Selected for Clinical Research After Successful Evaluation of Whole Genome-Based Molecular Residual Disease Assay,119100887,,AZN,Business Wire,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=1ee6d331f7e6c865ca95bdbdcd9b360f24fa7795228a40c4eb07f81f805ade77
company,2023-03-07 03:36:00,"Guggenheim starts Mineralys at Buy, sees multibillion-dollar potential for ASIs",119099757,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=841daa7e9a62aa9ae507af4d4cd77ec7be9888d407674388ab8a0bd346cb0673
company,2023-03-07 02:32:00,Ionis: FDA to Review Eplontersen in ATTRv-PN >IONS,119116259,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,By Colin Kellaher Ionis Pharmaceuticals Inc. on Tuesday said the U.S. Food and Drug Administration will review its application seeking approval of its...,https://finnhub.io/api/news?id=0cedd5cadbeae4e82cee1eaf94d42307e68329941e818aa24e9f8724ee5dc9f4
company,2023-03-07 01:37:00,Biden to announce plan to keep Medicare solvent beyond 2050,119099835,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=f2cde5b9d169fc7f9afbda045573f4bfbae3b62fa9fa0877e9d5ebf3b9936fe8
company,2023-03-07 00:50:00,Mineralys Therapeutics initiated with an Outperform at Evercore ISI,119099761,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=4326cb8632b34fa4c23e6bfcc7d4c26240bcef7edecaffb45e6e7c0cbb337e8c
company,2023-03-06 20:00:00,"Genomic Vision launches FiberSmart®, AI-powered software for automating genomic analysis",119124834,,AZN,Business Wire,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=fac568c94aa110a5789cd4aa899f7aa7d04a38a51b28908e895cde6ebbd364d8
company,2023-03-06 12:03:25,"AstraZeneca-Daiichi Sankyo's Flagship Cancer Drug Shows Meaningful, Durable Responses In Other Solid Tumor Setting",119088674,https://media.zenfs.com/en/Benzinga/bd17e5443b07ca4118fd725aeb62b86b,AZN,Yahoo,AstraZeneca Plc (NASDAQ: AZN) and Daiichi Sankyo (OTC: DSNKY) reported high-level results from an analysis of the ongoing DESTINY-PanTumor02 Phase 2 trial of Enhertu (trastuzumab deruxtecan) The study met the prespecified target for objective response rate (ORR) and demonstrated durable response across multiple HER2-expressing advanced solid tumors in heavily pretreated patients. Related: AstraZeneca-Daiichi Sankyo's Enhertu Cuts Risk Of Death By 36% VsTrastuzumab In Metastatic Breast Cancer. En,https://finnhub.io/api/news?id=558dad2a6255a13f24d89f46c3fa6034dc132c6e632a87d173e1da81aae68247
company,2023-03-06 11:38:00,AstraZeneca PLC ADR underperforms Monday when compared to competitors,119116260,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR dropped 0.98% to $64.56 Monday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...",https://finnhub.io/api/news?id=39a3884ba0816d6b29b501ab8e9df0f645b60ec4aa7e7a338c9afe1d09289536
company,2023-03-06 07:01:00,"AstraZeneca falls Monday, underperforms market",119116261,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"Shares of AstraZeneca PLC inched down 0.39% to £107.42 Monday, on what proved to be an all-around poor trading session for the stock market, with the FTSE...",https://finnhub.io/api/news?id=54faceff3afeef265e86c6698ded18d79f580b2b6a69596d42aa23e08693161d
company,2023-03-06 07:00:00,ENHERTU® (fam-trastuzumab deruxtecan-nxki) Showed Clinically Meaningful and Durable Responses Across Multiple HER2-expressing Tumor Types In DESTINY-PanTumor02 Phase II Trial,119088849,https://media.zenfs.com/en/business-wire.com/603371cc59d79f545392b877de3db123,AZN,Yahoo,"WILMINGTON, Del., March 06, 2023--Positive high-level results from an analysis of the ongoing DESTINY-PanTumor02 Phase II trial showed AstraZeneca and Daiichi Sankyo’s ENHERTU® (fam-trastuzumab deruxtecan-nxki) met the prespecified target for objective response rate (ORR) and demonstrated durable response across multiple HER2-expressing advanced solid tumors in heavily pretreated patients.",https://finnhub.io/api/news?id=6c1086795d4e7a7ee2fb0dc2ede500bc05ab062a961781a827908965b87843d7
company,2023-03-06 02:58:00,4 AI Stocks That Are Revolutionizing Healthcare,119084189,,AZN,InvestorPlace,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=fc6e92a0e6924c06d6ffb6434ff8519e6051f5c3de99475765bc97f73cf57e0c
company,2023-03-06 02:33:00,AstraZeneca says cancer drug Enhertu showed positive results,119080625,,AZN,Yahoo,"Enhertu--trastuzumab deruxtecan, which it is jointly developing and commercializing with Daiichi Sankyo--had met prespecified criteria for objective response rate and duration of response.",https://finnhub.io/api/news?id=3359e63adf757782f61596cc4b71f6c273497ee6172ec49d500567e9911969ab
company,2023-03-06 01:11:00,"AstraZeneca, Daiichi Sankyo announce Enhertu met the prespecified target for ORR",119085940,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=434e0ab09866dfe02a25b1f095b5a0c4e983dc283c4bf6af23cc035b833d8e08
company,2023-03-06 00:50:00,AstraZeneca says Enhertu met prespecified criteria for ORR in DESTINY-PanTumor02,119085941,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=c0c5c3babb468cde13d785858c8600bfeeb0834249047b8c514f4b42a5cae398
company,2023-03-05 23:03:00,"AstraZeneca, Daiichi Sankyo`s Enhertu shows promise in multiple cancer types in trial",119085942,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=f648bc5ad93cbdb9972866e0e39e91403896c1a417d8a463e0a0121c08c46f92
company,2023-03-05 22:29:00,TOP NEWS: AstraZeneca hails Enhertu phase 2 trial results,119085943,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=26898e52c64b96efbfc6a71a72f62c6c58efc7b6833d0ec35d118ba11fc2e99e
company,2023-03-05 21:51:00,LONDON BRIEFING: Stocks called flat; AstraZeneca positive test results,119084081,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=10a6f9aac01b9e1ecfb7e67757a06e7b2778a418eb62f368ddc0b23041df062e
company,2023-03-05 03:50:28,Those who invested in AstraZeneca (LON:AZN) five years ago are up 159%,119074492,https://media.zenfs.com/en/simply_wall_st__316/bba95900ab96866c17a285be850152bf,AZN,Yahoo,"When you buy a stock there is always a possibility that it could drop 100%. But on the bright side, if you buy shares...",https://finnhub.io/api/news?id=90eef1b2b5cb107c73ad673773aaf5b76a1241c9be5bcea818948970492bcae7
company,2023-03-04 21:23:39,Lexicon Pharma: Advancing A Worthwhile Pipeline But Commercialization Remains A Key Risk,119074001,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1359314170/image_1359314170.jpg?io=getty-c-w1536,AZN,SeekingAlpha,Lexicon is getting closer to FDA approval for sotagliflozin. Click here to read my analysis of LXRX stock.,https://finnhub.io/api/news?id=f2a7dbe324d76297ab2ce58738180531064e2f4079d13dddab586dcac60db6ff
company,2023-03-04 07:48:00,Pharma R&D funding soared to a new record in 2022 as oncology candidates dominate pipelines,119067845,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=69d3fdf96e049c2b8a406c98e7da2ba8923ebd6bc71940433530147baed03db3
company,2023-03-10 11:38:00,AstraZeneca PLC ADR outperforms competitors on strong trading day,119181393,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR inched 0.14% higher to $64.19 Friday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=532eca38c3befc2bae56dab86f404eabb8a4241ff0e7b2420be003b85ad10f6a
company,2023-03-10 10:26:03,AstraZeneca (AZN) Posts Positive Data From Lung Cancer Studies,119161205,https://media.zenfs.com/en/zacks.com/ef77d5a5eb4e72e4dd31ccfaf4ca4ccd,AZN,Yahoo,Data from late-stage label expansion studies show that AstraZeneca's (AZN) cancer drugs are effective for treating non-small cell lung cancer indications.,https://finnhub.io/api/news?id=ac3831799bab0c452602bd6e7f4859c3a139ca2c37888fa838886b7067c237ab
company,2023-03-10 07:01:00,"AstraZeneca falls Friday, still outperforms market",119181394,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"Shares of AstraZeneca PLC dropped 1.55% to £106.98 Friday, on what proved to be an all-around rough trading session for the stock market, with the FTSE 100...",https://finnhub.io/api/news?id=e65c3b77ddef3e02d67c53cdf6153a088b9db65e1c3d6179efcf0ca244ec2183
company,2023-03-10 04:38:09,"Zacks Industry Outlook Highlights J&J, Novo Nordisk, AstraZeneca, Novartis and Sanofi",119159332,https://media.zenfs.com/en/zacks.com/74bab520128f201c7e6cc3f67385e761,AZN,Yahoo,"J&J, Novo Nordisk, AstraZeneca, Novartis and Sanofi have been highlighted in this Industry Outlook article.",https://finnhub.io/api/news?id=151095ace8cb9523458a06e8452e4c9111b1f2216ba43421617bb68296c00b3b
company,2023-03-10 02:08:19,Compugen Ltd. (NASDAQ:CGEN) Q4 2022 Earnings Call Transcript,119162815,https://media.zenfs.com/en/insidermonkey.com/d7b54ab6c172424f8eb29273c1277201,AZN,Yahoo,"Compugen Ltd. (NASDAQ:CGEN) Q4 2022 Earnings Call Transcript February 27, 2023 Operator: Ladies and gentlemen, thank you for joining us today. Welcome to Compugen’s Fourth Quarter and Full Year 2022 Results Conference Call. At this time, all participants are in a listen-only mode. An audio webcast of this call is available in the Investors section […]",https://finnhub.io/api/news?id=d931bc26b54612246ce08ae3b9fda4ab9d857791ec34e4c83c8864902033f36b
company,2023-03-09 22:15:00,AstraZeneca (AZN) Receives a Buy from SVB Securities,119168541,,AZN,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=723476cc57d66d920485ffa947bbfe522291e2ea439c5204587cd0fd80dd1b55
company,2023-03-09 11:38:00,"AstraZeneca PLC ADR falls Thursday, still outperforms market",119181395,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR slipped 0.03% to $64.10 Thursday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=04a5333c3d60cdc61dac7cea5d71d326ce27c58ceb230983d1cbe224cb65d6e6
company,2023-03-09 10:36:52,AstraZenceca's Tagrisso Shows Survival Benefit In Early-Stage Lung Cancer Settings,119136136,https://media.zenfs.com/en/Benzinga/132597686a7bf2d4362a0d4a9520d370,AZN,Yahoo,"AstraZeneca Plc (NASDAQ: AZN) released topline data from the ADAURA Phase 3 trial demonstrating Tagrisso (osimertinib) demonstrated a statistically significant and clinically meaningful improvement in overall survival (OS) compared to placebo. The study included the adjuvant treatment of patients with early-stage (IB, II, and IIIA) epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC) after complete tumor resection with curative intent. In May 2020, AstraZeneca anno",https://finnhub.io/api/news?id=d338c026f7034c04fb34fca432558f678f4ff15fba6b2eac5a209a2eda2ee40a
company,2023-03-09 10:34:47,AstraZeneca's Immunotherapy Imfinzi Shows Improvement In Survival Chances In Lung Cancer Patients,119136137,https://media.zenfs.com/en/Benzinga/ebba956f97cacb89ee658181b31c18cd,AZN,Yahoo,"In a trial, lung cancer patients treated with AstraZeneca plc's (NASDAQ: AZN) immunotherapy Imfinzi (durvalumab) pre- and post-surgery lived significantly longer without the disease progressing or recurring than those treated with chemotherapy. The late-stage study compared patients with resectable, early-stage, non-small cell lung cancer treated with Imfinzi and chemotherapy before surgery and as monotherapy after surgery to patients treated with chemotherapy pre-surgery. Topline results from a",https://finnhub.io/api/news?id=d62b4c2514d938cc2fdfc0f5202bd33fe60fdbb51a00d7740822db7bddd4f01d
company,2023-03-09 08:00:01,5 Large Drug Stocks to Watch as Sector Picks Up in 2023,119135449,https://media.zenfs.com/en/zacks.com/ca9d72216d7bb42fc496430c3df29b41,AZN,Yahoo,"Drug/biotech companies are likely to see significant advances in innovation in 2023. In the Large-Cap Pharmaceuticals industry, J&J (JNJ), Novo Nordisk (NVO), AstraZeneca (AZN), Novartis (NVS), and Sanofi (SNY) are worth retaining in your portfolio.",https://finnhub.io/api/news?id=5ec2a142ac6e02588d6cee97630369a501b0987999136cfba3b2ef878306ad61
company,2023-03-09 07:11:00,TAGRISSO® (osimertinib) demonstrated strong overall survival benefit in the ADAURA Phase III trial for adjuvant treatment of patients with early-stage EGFR-mutated lung cancer,119136139,https://media.zenfs.com/en/business-wire.com/fa2efb800d5ea42670725d76d52fbe39,AZN,Yahoo,"WILMINGTON, Del., March 09, 2023--Positive high-level results from the ADAURA Phase III trial showed AstraZeneca’s TAGRISSO® (osimertinib) demonstrated a statistically significant and clinically meaningful improvement in overall survival (OS), a key secondary endpoint, compared to placebo in the adjuvant treatment of patients with early-stage (IB, II and IIIA) epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC) after complete tumor resection with curative intent.",https://finnhub.io/api/news?id=32e9e3ccd2b2c35f9c52f9cb61d57a182f0265e35ca37a89b3e4366ba2a465ed
company,2023-03-09 07:00:00,IMFINZI significantly improved event-free survival in AEGEAN Phase III trial for patients with resectable non-small cell lung cancer,119132898,https://media.zenfs.com/en/business-wire.com/38a483deeda65ee74404b1f9c915faa1,AZN,Yahoo,"WILMINGTON, Del., March 09, 2023--Positive high-level results from a planned interim analysis of the AEGEAN Phase III, placebo-controlled trial showed that treatment with AstraZeneca’s IMFINZI® (durvalumab) in combination with neoadjuvant chemotherapy before surgery and as adjuvant monotherapy after surgery demonstrated a statistically significant and clinically meaningful improvement in event-free survival (EFS) versus neoadjuvant chemotherapy alone followed by surgery for patients with resecta",https://finnhub.io/api/news?id=4a110788dcabb555c371e712a627208d74df4ec88fce79482f014b89190fc881
company,2023-03-09 01:15:00,AstraZeneca announces ADAURA trial meets secondary endpoint,119148459,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=e6abc163a545d33a4334418a5ef695359968addfeaedf0e944111fce11994131
company,2023-03-09 01:09:00,AstraZeneca announces AEGEAN trial demonstrated statistical significance,119148460,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=cdc47bbaf2395a80934bc29a40df691b45ae089c5b83fed86a0d2e1283477f3a
company,2023-03-09 00:54:00,AstraZeneca says Tagrisso showed `strong` overall survival benefit in trial,119148463,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=41b9b83e300f6c7b410419393d21d2a2f4c048820961701bfd1282ab1d3952e6
company,2023-03-09 00:52:00,AstraZeneca says Imfinzi significantly improved event-free survival in AEGEAN,119148465,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=661ba2d14f4b80541a587d2d988e2fc1e08b90c5cd283e1bf3bc2d3063890401
company,2023-03-09 00:34:00,AstraZeneca hails trial results of cancer drugs Imfinzi and Tagrisso,119148466,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=f95f0de9385b8ea52d7a45e92cbc8ec260ee3a5fb7a727f5be3bdfba417ebf63
company,2023-03-08 23:27:00,AstraZeneca Tagrisso improves overall survival in lung cancer patients in phase 3 trial,119148467,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=08bb7c4e096c8882898a83d2baf379113ecb234c7fd78e20abc9a5d1351b59d2
company,2023-03-08 22:52:00,AstraZeneca`s Imfinzi shows event-free survival benefit in lung cancer patients in trial,119148468,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=65f3260d8177621778db831371b19ebe81eadf6b9dbb9885fe030491b6a98690
company,2023-03-08 21:59:00,AstraZeneca Imfinzi Phase 3 Trial Returns Positive Results,119181396,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,By Joe Hoppe AstraZeneca PLC said Thursday that a Phase 3 trial showed that its Imfinzi product significantly improved event-free survival in patients with...,https://finnhub.io/api/news?id=d0a41a994f7803c967474ab1d9ca3254a57fad1bbfbb8c86879ce0e84b631ce7
company,2023-03-08 11:38:00,AstraZeneca PLC ADR underperforms Wednesday when compared to competitors,119116255,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR slipped 0.26% to $64.12 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=2ee8c7ed2b84cc984afbe86470582fb6a6a3aadce3a20483ad8728fd3480069d
company,2023-03-08 08:15:59,"Sanofi, AstraZeneca Tee Up A Rival To Pfizer In The Multibillion-Dollar RSV Race",119117540,https://media.zenfs.com/en/ibd.com/39552a8c730cc984b85b9f305609e672,AZN,Yahoo,Sanofi stock could shine in 2023 as the French pharma tees up a rival to Pfizer's experimental RSV vaccine for newborn babies.,https://finnhub.io/api/news?id=7fbab69bff7833400b2f9b45de6181f94ee2aaac1a66561f200ba485845bbf9a
company,2023-03-08 07:01:00,"AstraZeneca falls Wednesday, underperforms market",119116256,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"AstraZeneca PLC shares inched down 0.26% to £108.22 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the...",https://finnhub.io/api/news?id=73ce00dee69867d2d67c61cf70236cced6a383eb4168d2eb40745395d6bdd0ef
company,2023-03-08 05:51:52,Roche: Ongoing Pipeline Issues Sap Growth And Increase M&A Likelihood,119108228,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1300036753/image_1300036753.jpg?io=getty-c-w1536,AZN,SeekingAlpha,Roche hasn't scored the sort of big wins that change investment theses or drive lasting changes in sentiment. Find out our recommendation on RHHBY stock.,https://finnhub.io/api/news?id=8aecc435878230c8dda4a55d9e22fa1d6e276f9a05560e94df24885fe54c93c3
company,2023-03-08 05:21:00,3 No-Brainer Stocks to Buy With $400 Right Now,119129073,https://s.yimg.com/ny/api/res/1.2/V8YlMcwR1wdFgYz2UGp6VA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/dfdc242a9f6a440b166cf97110fc2967,AZN,Yahoo,A reasonably small amount of money can go a long way when it's invested in innovative businesses.,https://finnhub.io/api/news?id=ad0e53da17c23c16da48ceb7e8af70f4413145bb55ea9f538de70a6f9935876c
company,2023-03-08 03:30:00,Genprex's Gene Therapy: Potential Breakthrough For Diabetes And Lung Cancer,119107130,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1298111593/image_1298111593.jpg?io=getty-c-w1536,AZN,SeekingAlpha,Genprex has a strong financial position with zero debt and a cash balance of $29.52 million. Check out why I'm bullish on GNPX stock.,https://finnhub.io/api/news?id=6d4496221f61a13dfa5630142533e4af9f0d962437ec48ccc858e52919b8c28b
company,2023-03-08 02:36:00,Genprex`s Gene Therapy: Potential Breakthrough For Diabetes And Lung Cancer,119117992,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=7242340f930c289b7a5022f73ef9b5f0e6a2135e10eeacce73d5d9739340a23d
company,2023-03-08 02:16:38,Full Year 2022 Sophia Genetics SA Earnings Call,119127866,https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png,AZN,Yahoo,Full Year 2022 Sophia Genetics SA Earnings Call,https://finnhub.io/api/news?id=c793c0e7f85bea3ed0981553d7d7f4bd6b883cb228c11eb16e0aae3bd4905db4
company,2023-03-15 12:39:00,"AstraZeneca PLC ADR falls Wednesday, underperforms market",119267872,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR dropped 0.78% to $64.58 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=55b2d94b33ad686c6e651f02960b1fc3f2a0931e60fab354b006c3d2da4980d3
company,2023-03-15 11:45:03,Astrazeneca (AZN) Could Be a Great Choice,119254580,https://media.zenfs.com/en/zacks.com/a41b81fe729c761f3f94f42ff348f70c,AZN,Yahoo,"Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Astrazeneca (AZN) have what it takes? Let's find out.",https://finnhub.io/api/news?id=9a5076610499516645a1ed54da9cec4cc8c107d8f5d460bb1c6a2878ea4b06dc
company,2023-03-15 10:22:02,AstraZeneca (AZN) Stock Up 5% in a Year: What Awaits in 2023?,119252681,https://media.zenfs.com/en/zacks.com/ef77d5a5eb4e72e4dd31ccfaf4ca4ccd,AZN,Yahoo,AstraZeneca (AZN) expects total revenues to increase in the low-to-mid single-digit percentage in 2023 at CER.,https://finnhub.io/api/news?id=0b6893f3a98799adadb0c3e7f70795c9ec335dca2e7a7533b135bb8645a3b956
company,2023-03-15 09:01:00,"AstraZeneca falls Wednesday, still outperforms market",119267873,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"AstraZeneca PLC shares inched down 0.39% to £106.44 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the FTSE...",https://finnhub.io/api/news?id=c708ac81d1739e19107bfe0d341dda3afb7539e0c52489e4dd20799ece77ac65
company,2023-03-15 03:44:00,"GLOBAL BROKER RATINGS: HSBC says 'hold' Terna and Snam, 'buy' Enel",119252617,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=09f4d4095df0aaaeb19ce547e345b8bbef1d2c97d816925efae826a8ffc7defd
company,2023-03-15 02:00:00,FOCUS-How GSK plans to replenish its depleted medicine cabinet,119246749,https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png,AZN,Yahoo,GSK's chief scientist says an overhaul of the drugmaker's R&D unit has begun delivering results - citing an RSV vaccine and promising hepatitis B and asthma treatments - and pledged a tighter focus than his predecessor on infectious disease and HIV.  Tony Wood only took the helm of R&D last August.,https://finnhub.io/api/news?id=dd012c8200a497518dca13866ffe6e40dbdc0de88b541a9a2869a6982f186925
company,2023-03-15 01:36:00,LONDON BROKER RATINGS: Jefferies rates Future at 'hold'; Spirent upped,119255760,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=c04576f20d504305bd850aa9c2705c9e1ee035805c60ead5bff6e50eb6219636
company,2023-03-14 21:06:00,AstraZeneca price target lowered to 124 GBp from 126 GBp at Berenberg,119263885,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=fbfd37e35fc490656b9ff1051ccfbba85437f1149ddbce203cebada9b50d5b1a
company,2023-03-14 12:39:00,"AstraZeneca PLC ADR falls Tuesday, underperforms market",119267874,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR sank 0.14% to $65.09 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=fe75811ac2ba10713826affe79df3dc9f1cade459d4ba03edf2155cda3063fd5
company,2023-03-14 09:01:00,"AstraZeneca remains steady Tuesday, underperforms market",119267875,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"Shares of AstraZeneca PLC were unchanged Tuesday at £106.86 , on what proved to be an all-around great trading session for the stock market, with the FTSE...",https://finnhub.io/api/news?id=1dfaf00d93eb139f9666811b4fdb7373e7c7ba8f8433329b6529423f0ba3dfc4
company,2023-03-13 19:58:45,Silence Therapeutics: Breaking The Silence On An Under-The-Radar Mid-Stage SiRNA Platform,119215258,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1372188563/image_1372188563.jpg?io=getty-c-w1536,AZN,SeekingAlpha,Silence Therapeutics is an underfollowed British siRNA company focusing on cardiovascular and autoimmune diseases. Read why we rate SLN stock a speculative Buy.,https://finnhub.io/api/news?id=9083dcb1924d541611f8d3d24b551e28175c9ebc78c239b8a3d06e72c85e217a
company,2023-03-13 18:15:10,Astrazeneca (AZN) Gains As Market Dips: What You Should Know,119212954,https://media.zenfs.com/en/zacks.com/d0d4ab152198da2f423d92da8a7d22ee,AZN,Yahoo,"Astrazeneca (AZN) closed the most recent trading day at $65.18, moving +1.54% from the previous trading session.",https://finnhub.io/api/news?id=b983bf93f75434d92f753d5d71c3f00a41fe6cda4b5e3e4d85bd88ba2962357a
company,2023-03-13 12:39:00,AstraZeneca PLC ADR outperforms market on strong trading day,119218117,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR rallied 1.54% to $65.18 Monday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=13f89f773bc1559f6de19ae7fdb9a2670723b74255fefe73f3ee134fd42f5fc3
company,2023-03-13 09:01:00,AstraZeneca outperforms market despite losses on the day,119218118,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"Shares of AstraZeneca PLC inched down 0.11% to £106.86 Monday, on what proved to be an all-around poor trading session for the stock market, with the FTSE...",https://finnhub.io/api/news?id=cf6e47a709571f29e60179493f0134f201d01e190644e0e1f231bb09bc13f78f
company,2023-03-17 18:00:10,Astrazeneca (AZN) Stock Moves -0.56%: What You Should Know,119295604,https://media.zenfs.com/en/zacks.com/d0d4ab152198da2f423d92da8a7d22ee,AZN,Yahoo,"In the latest trading session, Astrazeneca (AZN) closed at $65.61, marking a -0.56% move from the previous day.",https://finnhub.io/api/news?id=662ab23d9f0ce48302e510ac838450ce20fc7d9d91644fe6544f55c43ef92b9b
company,2023-03-17 12:39:00,"AstraZeneca PLC ADR falls Friday, still outperforms market",119347649,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR slipped 0.56% to $65.61 Friday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=73c6a09faec72fdc22dbac339d85fdcdef70759a570edd8c1bb0d6329ace252d
company,2023-03-17 09:45:00,2 Steady Stocks to Buy and Hold Forever,119294610,https://s.yimg.com/ny/api/res/1.2/ZchtSvLmXRpa5mEI2S.2Zg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/e9902e28b1537f0659d46617634c68ab,AZN,Yahoo,"There is nothing like a bear market to emphasize the importance of investing in solid, reliable, and steady companies that can deliver consistent revenue and earnings for a long time.  Two such companies are AstraZeneca (NASDAQ: AZN) and Visa (NYSE: V).  U.K.-based AstraZeneca is a drugmaker with a vast, diversified portfolio of over three-dozen products across six major segments.",https://finnhub.io/api/news?id=4c9d40c284ad6000df1c2a76e1bbb2c8eccb8ca4ac5e86e6bd6696f8eff9a13e
company,2023-03-17 09:01:00,"AstraZeneca rises Friday, outperforms market",119347650,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"Shares of AstraZeneca PLC inched up 0.15% to £108.14 Friday, on what proved to be an all-around grim trading session for the stock market, with the FTSE 100...",https://finnhub.io/api/news?id=10765df8041d74811cf91b2a99368bc8c342b6d1c5f0346f35ac209520ccc93a
company,2023-03-17 02:19:43,Is AstraZeneca PLC (AZN) a Solid Prospective Investment?,119295606,https://media.zenfs.com/en/insidermonkey.com/2a8f83a29f8d598ad48e587692fcad66,AZN,Yahoo,"Artisan Partners, an investment management company, released its “Artisan Global Equity Fund” fourth quarter 2022 investor letter. A copy of the same can be downloaded here. In the fourth quarter, its Investor Class fund ARTHX returned 15.95%, Advisor Class fund APDHX posted a return of 15.98%, and Institutional Class fund APHHX returned 16.04%, compared to a […]",https://finnhub.io/api/news?id=20b7ed19ab6d96b9b88afd05015a8e88445d183366a84abec488dbc1dbc255d7
company,2023-03-16 12:39:00,"AstraZeneca PLC ADR rises Thursday, still underperforms market",119278170,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR rallied 2.17% to $65.98 Thursday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=8794d9116842a1e69492c8cc56e6d7511fd56e86bf9be44fa5ebaae1bac1d7dd
company,2023-03-16 09:01:00,"AstraZeneca rises Thursday, outperforms market",119278171,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"Shares of AstraZeneca PLC advanced 1.45% to £107.98 Thursday, on what proved to be an all-around great trading session for the stock market, with the FTSE...",https://finnhub.io/api/news?id=65d0987c4cdd6d08b962d2044de96ddd1321650bbdd1dd3e010572ab634ffdce
company,2023-03-16 04:54:00,JPMorgan biotech/pharma analysts to hold KOL analyst/industry conference call,119272992,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=b97c9172af8989afb21f50cd85f2a8fdd5d054666450123c1b45a9688c3f50d7
company,2023-03-23 18:15:10,Astrazeneca (AZN) Outpaces Stock Market Gains: What You Should Know,119381935,https://media.zenfs.com/en/zacks.com/21b1f011539d3e31c28282071d344177,AZN,Yahoo,"Astrazeneca (AZN) closed the most recent trading day at $67.26, moving +1.04% from the previous trading session.",https://finnhub.io/api/news?id=ef5d1f90d18c6211c5d9a78becef4ebc4c8a3af1a76fbbe508d65d044ca63642
company,2023-03-23 18:05:05,BOE: Discounted Global Covered Call Fund,119382340,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/96502248/image_96502248.jpg?io=getty-c-w1536,AZN,SeekingAlpha,BlackRock Enhanced Global Dividend Trust shares some similarities with BDJ but has a sizeable portion of its portfolio outside the US. See why BOE CEF is a Buy.,https://finnhub.io/api/news?id=6a5c30fab0723e7bd0d437e490dbf82371014dff3d4f311b058734a166bedf69
company,2023-03-23 14:40:27,7 Blue-Chip Stocks to Buy for Capital Preservation,119421847,https://media.zenfs.com/en/investorplace_417/49ba12efc6cb6e5091872131a59d98b4,AZN,Yahoo,"The financial sector-driven panic sent investors to the refuge of safe assets, including blue-chip stocks. In general, blue-chip stocks have a low beta and this supports capital preservation. Additionally, most blue-chip stocks have an attractive dividend yield. So, today, my focus is on names that are undervalued. Even if there is a meaningful correction in the broad markets, these blue-chip stocks are likely to remain resilient. Once market sentiments reverse, these stocks can deliver healthy",https://finnhub.io/api/news?id=e774a7ffd7500567f827f1e6fb0616b03b0eeaf6c47ae2b411f3907dad6d4480
company,2023-03-23 12:39:00,"AstraZeneca PLC ADR rises Thursday, outperforms market",119484466,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR advanced 1.04% to $67.26 Thursday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=08df3b51efabad3245540500a0c3257a885d82aa8fdbccd8108c186fd1a52c24
company,2023-03-23 09:01:00,"AstraZeneca rises Thursday, outperforms market",119484468,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"AstraZeneca PLC shares inched up 0.20% to £109.98 Thursday, on what proved to be an all-around grim trading session for the stock market, with the FTSE 100...",https://finnhub.io/api/news?id=983013fa3f5fb78fbcc7c5e5626a2d668b30a888d36cff2fe78a002709d5cdc4
company,2023-03-23 09:00:01,These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar,119380320,https://media.zenfs.com/en/zacks.com/f541c90e0d995722d10914cb76a7c653,AZN,Yahoo,Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.,https://finnhub.io/api/news?id=b550981380f487ba0086af699ac563a06980e1565a718e09713cce39181a8ef0
company,2023-03-23 05:06:00,"3 Exceptionally Safe Dividend Stocks That Can Turn $400,000 Into $1 Million by 2030",119369482,https://s.yimg.com/ny/api/res/1.2/zFlcEXwV4iUd0UbazmRztA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/a25f45716910565339144fd9b53be16f,AZN,Yahoo,These historically profitable dividend-paying stocks are ideal for risk-averse investors wanting to take advantage of a bear market discount.,https://finnhub.io/api/news?id=8b7b68f8c685783d3b74468e24349ad7fb25b0d81d05fbef2dd43154fc9fb19c
company,2023-03-23 01:51:00,AstraZeneca says Calquence conditionally approved in China for first indication,119376917,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=bddefe7721825a96b6db34dc3c432308f210531af35ecee6beeb35207b3dcd77
company,2023-03-23 01:30:00,AstraZeneca`s blood cancer drug Calquence gets conditional approval in China,119376918,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=5026d72b85fe914a427b8a4cd3fd419a99e64250a08795b37b21b1cc8963c719
company,2023-03-23 00:58:00,TOP NEWS: AstraZeneca's Calquence receives first approval in China,119376919,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=d148d9eef6c2fa6f9ac5ac0dfed549d39fd757984d3a07f78ec88b948f17dd07
company,2023-03-22 21:36:00,White House seeking alternative supply chains for pharmaceutical ingredients,119376555,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=a1e9137cac110ece01dbe8320634665529ae6699b4202f704e64c176ef7b7891
company,2023-03-22 12:39:00,AstraZeneca PLC ADR underperforms Wednesday when compared to competitors,119484470,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR dropped 0.63% to $66.57 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=51bc43253ff9971d52ceba4604752537e64c27a9058e8a0aaf0ca3557931b57b
company,2023-03-22 09:01:00,"AstraZeneca rises Wednesday, outperforms market",119484472,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"Shares of AstraZeneca PLC inched up 0.66% to £109.76 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the...",https://finnhub.io/api/news?id=645d230a85aba81b427ac0e2f18b131cd3f2db8051e24e4e1b6217845196ea58
company,2023-03-22 07:51:00,UK dividends calendar - next 7 days,119352529,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=8038e3a9d4837b9b8e4afa815d27cf7b54b8e20d1500d0345c4a0728924627c4
company,2023-03-22 05:51:09,Here's What is Driving Amgen (AMGN) Stock's Outperformance,119360932,https://media.zenfs.com/en/zacks.com/65410c79c0b8184da264ed17fda575ce,AZN,Yahoo,"Amgen's (AMGN) key drugs like Prolia, Repatha and Otezla are driving sales. It is also rapidly advancing its robust pipeline.",https://finnhub.io/api/news?id=bd2c32d2cc9cdfc838a3214d6aa6018d11ca76732e13d85b8006f61af245f88c
company,2023-03-21 23:40:00,Oppenheimer emerging biotech analyst to hold analyst/industry conference call,119358134,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=5b33c728e2874cbe22c2dac09b249f7e7b1db9d27ff2902d9e40954cac8d9ee5
company,2023-03-21 12:39:00,"AstraZeneca PLC ADR rises Tuesday, still underperforms market",119347645,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR inched 0.37% higher to $66.99 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the...",https://finnhub.io/api/news?id=8068bbe0da822ecebb3427fa31eaed47610e8ef86eb6e2c1ece78789aaf97a1c
company,2023-03-21 09:01:00,"AstraZeneca rises Tuesday, still underperforms market",119347646,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"AstraZeneca PLC shares advanced 1.06% to £109.04 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the FTSE 100...",https://finnhub.io/api/news?id=403a15bc8870bbd7e49a49f8e91eb16377d58b93790777ef7d3e963652e13683
company,2023-03-20 12:39:00,"AstraZeneca PLC ADR rises Monday, outperforms market",119347647,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR rallied 1.72% to $66.74 Monday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=95154b878569a221766131557868c75e5dea3f712c7680e7179964fd83c57702
company,2023-03-20 09:01:00,"AstraZeneca falls Monday, underperforms market",119347648,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"Shares of AstraZeneca PLC inched down 0.22% to £107.90 Monday, on what proved to be an all-around great trading session for the stock market, with the FTSE...",https://finnhub.io/api/news?id=9af784a5533665859037659d4b84de653564af01f8c90103f6378548f7f3c521
company,2023-03-27 13:21:11,AstraZeneca-Ionis Partnered Rare Disease Drug Data Shows Sustained Benefit; Drug Under FDA Review,119439212,https://media.zenfs.com/en/Benzinga/771fb33c021df21dd964e120c2adedca,AZN,Yahoo,"Ionis Pharmaceuticals Inc (NASDAQ: IONS) released topline results from the 66-week analysis of Phase 3 NEURO-TTRansform study of Ionis and AstraZeneca Plc's (NASDAQ: AZN) eplontersen in patients with hereditary transthyretin-mediated amyloid polyneuropathy (ATTRv-PN) that leads to peripheral nerve damage and motor disability. At 66 weeks, patients treated with eplontersen demonstrated a statistically significant and clinically meaningful change from baseline versus an external placebo group on t",https://finnhub.io/api/news?id=15303007e8455bbe4d50d2c90f5d7e6114cf22e015321f1c39e44e4b57bccdee
company,2023-03-27 12:39:00,"AstraZeneca PLC ADR rises Monday, outperforms market",119484458,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR rallied 1.21% to $68.73 Monday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...",https://finnhub.io/api/news?id=d18a41c5a43759ad9d8a4cbbaa331aa5a888b4118eaef9500690d39483d6222c
company,2023-03-27 11:42:03,Ionis (IONS) Posts New Upbeat Data From Amyloidosis Drug Study,119439215,https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0,AZN,Yahoo,"Ionis (IONS) reports positive long-term phase III study data, supporting the benefits of eplontersen as a treatment for hereditary transthyretin-mediated amyloid polyneuropathy (ATTRv-PN).",https://finnhub.io/api/news?id=8a9eeba01350afd1a2ab9405c01589156914d448739f0609c453a53929cef88e
company,2023-03-27 08:25:00,Oppenheimer emerging biotech analyst to hold analyst/industry conference call,119441776,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=882adbd9dca51b28c94d71e1214ee0f6c9f322a2a6eb720e9592d435f756be9f
company,2023-03-27 07:00:00,Eplontersen demonstrated sustained benefit in Phase III trial for hereditary transthyretin-mediated amyloid polyneuropathy (ATTRv-PN) through 66 weeks,119431551,https://media.zenfs.com/en/business-wire.com/b10ee47c4fc264bfd129568a1573855f,AZN,Yahoo,"WILMINGTON, Del., March 27, 2023--Positive high-level results from the NEURO-TTRansform Phase III trial in patients with hereditary transthyretin-mediated amyloid polyneuropathy (ATTRv-PN) showed eplontersen met its co-primary endpoints through 66 weeks. The results were consistent with the positive 35-week findings announced in June 2022.1",https://finnhub.io/api/news?id=250e67d192f66d5bb7849e5d11b435d864e092f390bea83744f8fa4fcfc041d9
company,2023-03-27 02:36:00,"Ionis, AstraZeneca report positive outcomes from eplontersen trial",119437578,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=65033585acb7cd570ae9b957a22444255eb3acbb0c8a3ba901531c4b9b667bb9
company,2023-03-27 00:18:00,Ionis Pharmaceuticals announces NEURO-TTRansform study met co-primary endpoints,119437579,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=0220cbb57277b9b55e2607397dce5f6c2dc55045ad50bb20be75e9a62b4733b1
company,2023-03-26 23:52:00,TOP NEWS: AstraZeneca hails eplontersen; Enhertu wins another approval,119437581,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=e3aeb779b868052caa5238e4633c0fd7c994105b103626e57f56644de171f44c
company,2023-03-26 22:54:00,LONDON BRIEFING: Stocks called higher as banking crisis fears ease,119436374,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=df6131c210abb946b4ff79b0341c6e44f5709dc7b445e1246b4fd1e0e31b1c0a
company,2023-03-24 14:29:06,"Regeneron's (REGN) Dupixent Meets Pivotal COPD Study Goal, Up 7%",119422226,https://media.zenfs.com/en/zacks.com/c0c563b233f28a1874a33c46aadaa70e,AZN,Yahoo,Regeneron's (REGN) share price rose after it reported data from a late-stage study showing that treatment with Dupixent led to a 30% decline in chronic obstructive pulmonary disease exacerbations.,https://finnhub.io/api/news?id=261ef40b290eb6c48591a4989a3310aeaeacc77df1a35437422e056e32776db1
company,2023-03-24 12:39:00,AstraZeneca PLC ADR underperforms Friday when compared to competitors despite daily gains,119484460,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR inched 0.97% higher to $67.91 Friday, on what proved to be an all-around favorable trading session for the stock market, with the...",https://finnhub.io/api/news?id=a0267ae7f18875bc581164c33be9a44fc37f5b5edac23fd4111da3aa828c5522
company,2023-03-24 09:01:00,"U.K. stocks continue losing streak, fall for second day",119443406,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,"U.K. stocks finished lower Friday, with the FTSE 100 Index falling 1.26% at 7,405.45. Among FTSE 100 constituents, major international banks company Standard...",https://finnhub.io/api/news?id=596222a8ac2a4dc0e50ee71a9e181fd8ebebff8be573764e052bc91ac9890d10
company,2023-03-24 09:01:00,"AstraZeneca rises Friday, outperforms market",119484462,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"Shares of AstraZeneca PLC inched up 0.75% to £110.80 Friday, on what proved to be an all-around grim trading session for the stock market, with the FTSE 100...",https://finnhub.io/api/news?id=f6ac0da5667c102f0909f953f0ba53e276f3efb6fab32eecd2974bf8e04b0ad5
company,2023-03-24 08:04:00,FDA draft guidance impacts companies using accelerated approval for oncology drugs,119436832,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=5705548bc4d513e6d4787a654b926151c37e9402f033545223bb9307bbcd520f
company,2023-03-31 12:39:00,"AstraZeneca PLC ADR rises Friday, still underperforms market",119578411,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR inched 0.30% higher to $69.41 Friday, on what proved to be an all-around positive trading session for the stock market, with the...",https://finnhub.io/api/news?id=9a85e08c43e9ea5f16e26c1e5a0c2f47d135eb178ade115c0c9978ef3a6e5dd4
company,2023-03-31 11:45:03,This is Why  Astrazeneca (AZN) is a Great Dividend Stock,119545146,https://media.zenfs.com/en/zacks.com/b95cfdd8768bc3c4620e666dbcb0b248,AZN,Yahoo,"Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Astrazeneca (AZN) have what it takes? Let's find out.",https://finnhub.io/api/news?id=d7de266b32beb4563a66de3c16ebcbda2177310d6d57ef01f6c08a6fb7288e15
company,2023-03-31 05:27:00,AstraZeneca Ultomiris gets EMA backing for expanded use,119539007,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=fb0208a46e8363fd317f2a6d197a3ca5dc4305527fa5233e0a68f1dce6f91a31
company,2023-03-31 03:38:00,Samsung Bioepis` biosimilar to AstraZeneca`s Soliris backed for EU approval,119539008,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=55a5fa7f8a84d1d40008d722e7915cf3b3235c2e9d7d3e31f930dc9c4042d731
company,2023-03-30 12:39:00,AstraZeneca PLC ADR underperforms Thursday when compared to competitors despite daily gains,119578412,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR inched 0.82% higher to $69.20 Thursday, on what proved to be an all-around great trading session for the stock market, with the...",https://finnhub.io/api/news?id=bee32bbd11924bc1709f2933502713bd6e4272334f8ac26daab1125aa5f0e03d
company,2023-03-30 08:43:05,7 Growth Stocks That Pay Generous Dividends,119573580,https://media.zenfs.com/en/investorplace_417/2aa5b82f6b8eb344514d3d320123006e,AZN,Yahoo,"When it comes to dividend-paying growth stocks, it can be difficult to find names that are both high-growth and high-yield. This makes sense, given that companies with high dividend yields are typically paying out a large portion of their earnings as a dividend, leaving little capital to fund growth. That said, there are quite a few stocks that, while not exactly “high-yield,” have annual yields above that of the S&P 500 (1.69%), plus offer the opportunity for growth. Hitting this “sweet spot,”",https://finnhub.io/api/news?id=60c7c2ce1df94b4fa45ea4a0b18a9ccb5bd40dba08c0290f18a20870a3ce969d
company,2023-03-30 01:46:00,AstraZeneca completes agreement with KYM Biosciences for CMG901,119522370,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=94e22b6de0f8ac660b4b1b0cc5658bad6ab831f8ef84300f5fff1300c99629e4
company,2023-03-30 01:03:00,"AstraZeneca, KYM Biosciences complete licensing deal for cancer drug CMG901",119522371,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=87694a8baea9d634ef44a753944795a0d00b9d1c673d0521ab8650403fcedb62
company,2023-03-30 00:27:00,AstraZeneca signs exclusive global license deal with KYM Biosciences,119522372,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=20b32ef6b5345bbb0821be48f789fd0e348550f541941abdaadf6ac487c9760f
company,2023-03-29 22:57:00,LONDON BRIEFING: Stocks add to rebound; SSE ups earnings guidance,119517039,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=648b50ef81c07575bab2ebafb89a4b840661f290fdb625ba9c28d5d6da8b941c
company,2023-03-29 22:23:00,AstraZeneca Completes KYM Solid Tumors Treatment Deal,119578413,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,By Michael Susin AstraZeneca PLC said Thursday that it has completed an exclusive global license agreement with KYM Biosciences over the CMG901 treatment for...,https://finnhub.io/api/news?id=0b0af8a6dee2e089469ad0d43e61b7c276d2481287662ad70aafce95577950e9
company,2023-03-29 18:15:10,Astrazeneca (AZN) Gains But Lags Market: What You Should Know,119511116,https://media.zenfs.com/en/zacks.com/ace7df31c7fcb10255abe7c990ea373a,AZN,Yahoo,"In the latest trading session, Astrazeneca (AZN) closed at $68.64, marking a +0.06% move from the previous day.",https://finnhub.io/api/news?id=d1626d8947efa80d1d8fb21a2680d7863242711f87a3a971ce5710c8285ea27c
company,2023-03-29 17:00:39,"Pieris Pharma Pushes Elarekibep Data Readout, Investors React Negatively",119501696,https://media.zenfs.com/en/Benzinga/d416a38ebc5715a70d1cbd8f5ffa1f57,AZN,Yahoo,Pieris Pharmaceuticals Inc (NASDAQ: PIRS) reported Q4 earnings and provided updates across its pipeline. The investors are reacting to the further pushback of the timeline for the readout from the Phase 2a study of elarekibep to mid-2024 from prior guidance of the third quarter of 2023. Pieris is collaborating with AstraZeneca Plc (NASDAQ: AZN) to develop elarekibep for asthma patients. AstraZeneca has communicated that completion of the Phase 2a study remains an important priority and that addi,https://finnhub.io/api/news?id=1f32c1f2fcbd29c06cfb6b4ec158e44f279ea7e09bcdd69df6d7096e14b77264
company,2023-03-29 12:39:00,"AstraZeneca PLC ADR rises Wednesday, still underperforms market",119502689,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR inched 0.06% higher to $68.64 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the...",https://finnhub.io/api/news?id=b30cc5016499b32b4979dcfbb820008c79c5c52ac7f63723b835928f4a8b22ac
company,2023-03-28 12:39:00,AstraZeneca PLC ADR underperforms Tuesday when compared to competitors,119484456,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR shed 0.19% to $68.60 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite...",https://finnhub.io/api/news?id=1e9af071856ed11a781cec22d9c6a038fd440ccd974bf23a74a81b48a5ed8f09
company,2023-03-28 07:11:00,WHO updates COVID vaccine guidance; low priority for children and adolescents,119475803,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=d58b3faecb2d3bd2f97741559e45da98ef4556701509fed55cdc495756572da7
company,2023-04-04 18:15:10,Astrazeneca (AZN) Gains As Market Dips: What You Should Know,119621064,https://media.zenfs.com/en/zacks.com/d0d4ab152198da2f423d92da8a7d22ee,AZN,Yahoo,"Astrazeneca (AZN) closed the most recent trading day at $70.25, moving +0.49% from the previous trading session.",https://finnhub.io/api/news?id=b9494777868e8de8cc74205f903773885c73975dac635d4234456c8ebe595af5
company,2023-04-04 12:39:00,AstraZeneca PLC ADR underperforms Tuesday when compared to competitors despite daily gains,119687326,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR inched 0.49% higher to $70.25 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=8836b91558fd3b69ac45a9af8cb1a8a5a385ecc4586017cad6c4b0b439fd9371
company,2023-04-03 12:39:00,"AstraZeneca PLC ADR rises Monday, outperforms market",119595328,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR inched 0.72% higher to $69.91 Monday, on what proved to be an all-around mixed trading session for the stock market, with the Dow...",https://finnhub.io/api/news?id=0a1403b4a62c8543577691d9436f92cca87959f71b2e7742afba69d4d6c664d5
company,2023-04-03 12:09:04,AstraZeneca (AZN) Ultomiris Gets CHMP Nod for New Rare Disease,119592334,https://media.zenfs.com/en/zacks.com/ef77d5a5eb4e72e4dd31ccfaf4ca4ccd,AZN,Yahoo,CHMP recommends AstraZeneca's (AZN) Ultomiris for the treatment of patients with neuromyelitis optica spectrum disorder who are anti-aquaporin-4 antibody positive.,https://finnhub.io/api/news?id=9a3885c4a05ca0b5a6a58adc7d073065d2381e1d39266c56f8364577e7e0cf95
company,2023-04-03 02:15:00,"Arvinas appoints Page as SVP, Global Head of Oncology Strategy, Program Leader",119594568,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=bdb16505833edfd796da39c07d1e81f1c6cf8ca69e92378ce8c1b223a07f078d
company,2023-04-03 02:03:00,AstraZeneca says Ultomiris recommended for approval in EU for NMOSD,119614219,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=59745e0463d282065890f58644839b4793d7893868cbdfe6d0dff3ef531741b4
company,2023-04-02 23:45:00,TOP NEWS: AstraZeneca's ultomiris recommended for EU approval,119614221,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=909a176076a48f944be44e35a06541edbe1e9c232e2a058afe2cfc71cafb823c
company,2023-04-02 23:24:00,"Harbor Capital Appreciation Fund Buys AstraZeneca, Ups Nvidia Holding",119594358,,AZN,GuruFocus,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=89e0e031370080b9bfa2af3eb55be7e4b051ca056bdca4c2f3059b63bcb5d1f6
company,2023-04-02 22:19:00,AstraZeneca's Ultomiris Recommended for Marketing Authorization in EU,119595330,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,By Michael Susin AstraZeneca PLC said Monday that its treatment for patients with neuromyelitis optica spectrum disorder has been recommended for marketing...,https://finnhub.io/api/news?id=4d7493dc46a5fc13732212a2ec896324ff1f2e2dbcc652f64d77c78e8b9e0c30
company,2023-04-01 12:47:25,"Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) Q4 2022 Earnings Call Transcript",119557792,https://media.zenfs.com/en/insidermonkey.com/f65ba16d8d81c23c1b64b41b5ef5389c,AZN,Yahoo,"Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) Q4 2022 Earnings Call Transcript March 29, 2023 Operator: Hello and welcome to the Pieris Pharmaceuticals, Inc. Year-End 2022 Conference Call and Webcast. . A question-and-answer session will follow the formal presentation. As a reminder, this conference is being recorded. It is now my pleasure to turn the call over to […]",https://finnhub.io/api/news?id=190b2701ed653df399ce6b083def4b5369e063852dec7f81aed1c0eae161f1e3
company,2023-04-07 07:34:00,Steven Cohen Loads Up on Esperion Therapeutics as Shares Slide,119671771,,AZN,GuruFocus,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=08542f14a3464aea87698ebabef75a2f67965e92ed5522c9823a364c4c57d530
company,2023-04-07 05:20:00,2 Top Biotech Stocks to Buy Right Now,119667608,https://s.yimg.com/ny/api/res/1.2/MFSW4UiBK.dZyDnJLuIxPQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04NDk-/https://media.zenfs.com/en/motleyfool.com/826ac4eefe90420d471db09a902499fd,AZN,Yahoo,"Pharmaceutical companies can be great long-term investments.  Because of the major industry risk that comes with patent expirations, investors need to be sure that they are picking pharmaceutical companies with strong product pipelines.  Here are two big pharma stocks with robust product portfolios and pipelines for long-term income investors to consider for their portfolios.",https://finnhub.io/api/news?id=d98d5f7c2dafce2b03d2b502e2c6d98631c7716ef120ad67f6f96f149297e174
company,2023-04-07 04:34:38,Estimating The Fair Value Of AstraZeneca PLC (LON:AZN),119665258,https://media.zenfs.com/en/simply_wall_st__316/bba95900ab96866c17a285be850152bf,AZN,Yahoo,"Key Insights Using the 2 Stage Free Cash Flow to Equity, AstraZeneca fair value estimate is UK£139 AstraZeneca's UK£117...",https://finnhub.io/api/news?id=f1b2f9bcc2a5ac5ba549a0c1821c14e6b6d401f0fe09f76357fdec3776479cdd
company,2023-04-06 21:17:00,"Catalyst Watch: Eyes on inflation data, big bank earnings",119672241,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=fc4e87ccf78251422abc64f6d20dbb962e96e3492a23902c61608b354daae5c3
company,2023-04-06 14:38:34,"McDonald's, U.K. Pharma Giant Hit New Highs",119662714,https://media.zenfs.com/en/ibd.com/3c98a48f861899f139bc161292cb3db4,AZN,Yahoo,"Dow Jones component McDonald's hit new highs Wednesday while U.K. pharma giant AstraZeneca scored a breakout. In addition, MCD stock broke out from a 281.77 buy point, according to MarketSmith. Shares formed a 97-day consolidation and powered higher last month, up nine days in a row before pulling back this week.",https://finnhub.io/api/news?id=b916e7969c4537aae002bd7c333457e593499895d1c74ee1fb94df15291ae58e
company,2023-04-06 12:39:00,"AstraZeneca PLC ADR rises Thursday, still underperforms market",119687322,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR inched 0.40% higher to $72.34 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the...",https://finnhub.io/api/news?id=8f16986a31ba2d4c54e38cf1dd1b54a7fcbcde9e6d6e5ceb345501b30d49f3b9
company,2023-04-06 10:01:02,Pharma Stock Roundup: J&J's $8.9B Offer for Talc Litigation Settlement & Other Updates,119661232,https://media.zenfs.com/en/zacks.com/a1d7049b0977a02a21fd2aa02b46f307,AZN,Yahoo,J&J (JNJ) offers a $8.9 billion settlement to resolve its talc lawsuits. FDA approves Merck's (MRK) Keytruda plus Seagen's Padcev for a bladder cancer indication.,https://finnhub.io/api/news?id=003f968b6468a56ae713adaffd786e43b3cb5d06145beca757bd5123ab4276d1
company,2023-04-06 08:03:00,LONDON MARKET CLOSE: Stocks end shortened week on positive note,119651315,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=8daf2e83bb5b44c9c310a8407bee1ca8f092c2ac253d6c6c0a6937cc92fcbca4
company,2023-04-06 07:38:00,FDA forces pre-term birth drug off the market after 12 years,119652508,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=36b4531d32d650b41ea739b23b3a10be33d6d7d3825b7ab427eacf3df35d3aeb
company,2023-04-06 05:48:09,"The Zacks Analyst Blog Highlights Mastercard, AstraZeneca, Philip Morris, TJX and Citigroup",119659637,https://media.zenfs.com/en/zacks.com/2858010fcfdfdbd35c3937ec893dd95a,AZN,Yahoo,"Mastercard, AstraZeneca, Philip Morris, TJX and Citigroup are included in this Analyst Blog.",https://finnhub.io/api/news?id=9a44308c0e191b34145c2212a2743080400792148b946a93b211f3eab79b310b
company,2023-04-06 03:11:00,Pfizer posts 82% efficacy for maternal RSV vaccine in full data release,119651316,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=095572d8adfcc544c611505bcb474d44e0921a5b084821cb83212ec434a0cfc2
company,2023-04-06 01:10:00,"Analysts Are Bullish on Top Healthcare Stocks: AstraZeneca (AZN), Sanofi (SNY)",119651317,,AZN,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=1713aa08ac1773c55401a2c647f5cf434f54d3c14ddf5bcbf040342d86e18bdd
company,2023-04-06 00:40:00,7 Very Undervalued Penny Stocks to Buy in April 2023,119657653,,AZN,InvestorPlace,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=c6a4cb00bd05607233cdc456e82c6193c297d2b4ccbdae3ad8320f8f054a3987
company,2023-04-05 23:59:00,GSK ordered by UK court to pay more royalties to AstraZeneca on Zejula sales - report,119651318,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=1b1be6d08169cdbc3d69a3ff551175ad368f0064bb307293916fdacdf6c4f9d9
company,2023-04-05 23:37:00,LONDON MARKET OPEN: European stocks edge higher in cautious trade,119651319,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=e92de05fd4067f8c33d0576277aced5e0e7bc10b99873bb5637878c8bccc2571
company,2023-04-05 22:55:00,TOP NEWS: AstraZeneca's cancer drug Lynparza approved by NHS England,119651320,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=ffadefa3926ed9ad01e3312308145099ba4df8e6145846ffa5a8d7704f1c5811
company,2023-04-05 22:29:00,"GSK unit ordered to pay AstraZeneca royalties on Zejula sales, Reuters says",119672430,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=a0656c115c54498bb1c5860722fc9ded2a016a14b121ce2d67857dfb40151643
company,2023-04-05 21:16:00,WHO chief expects COVID emergency to end this year,119654047,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=e745477481cf89928da696ac613e754e736ead79a46ce8f78c503a4b890dc76c
company,2023-04-05 17:14:27,"Unusual Call Option Trade in AstraZeneca (AZN)  Worth $1,645.00K",119639920,,AZN,Fintel,,https://finnhub.io/api/news?id=51950caf8be1f843f261877019a17f9e87c7dce475c179e79c6285cf06170257
company,2023-04-05 16:02:15,Medical Behemoth AstraZeneca Flirts With Breakout On Fresh Hope In Ovarian Cancer,119639542,https://media.zenfs.com/en/ibd.com/ca0ceaa3c6a5ec8249cb9fdbd0744826,AZN,Yahoo,"AstraZeneca said Wednesday a combination of its drugs Lynparza and Imfinzi met the goal of a key study, leading AZN stock to surge.",https://finnhub.io/api/news?id=6e13b03edc279bac4a66265bbd2dd8c67b392f3e72aeac05ac33721de4029160
company,2023-04-05 15:36:07,"Top Analyst Reports for Mastercard, AstraZeneca & Philip Morris",119639543,https://media.zenfs.com/en/zacks.com/3ea5fe8f453988cfb4ec32d13667aebf,AZN,Yahoo,"Today's Research Daily features new research reports on 16 major stocks, including Mastercard Incorporated (MA), AstraZeneca PLC (AZN) and Philip Morris International Inc. (PM).",https://finnhub.io/api/news?id=f0df2e15375028751c676d84993bdcbee917ae52a4f61e9b79dedd15b78b8cb0
company,2023-04-05 12:41:00,IN THE KNOW: AstraZeneca needs competitor data for context - Shore,119638807,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=d6119622830713f86737ee31c4256db3d4099c2f2b22a08d009165517093fa64
company,2023-04-05 12:39:00,"AstraZeneca PLC ADR rises Wednesday, outperforms market",119687323,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR rallied 2.56% to $72.05 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...",https://finnhub.io/api/news?id=8708b1c2440fbcd09a26ea1eed27e2d7df44d9ae06eb93e86bea627cfe10691c
company,2023-04-05 12:25:04,AstraZeneca's (AZN) Drug Combo Meets Ovarian Cancer Study Goal,119639545,https://media.zenfs.com/en/zacks.com/06708d71c63051ca48bf1855727f077b,AZN,Yahoo,"Interim data from a late-stage study shows that AstraZeneca's (AZN) cancer drugs, Lynparza and Imfinzi improved progression-free survival in certain patients with advanced ovarian cancer.",https://finnhub.io/api/news?id=dd90042146dcc19ce9f5b1d0f44faa27b929130c01512b91050705e3e93136e4
company,2023-04-05 09:44:56,UK court orders GSK to pay AstraZeneca royalties on total sales of Zejula,119639547,https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png,AZN,Yahoo,"A UK court on Wednesday ordered GSK's Tesaro to pay rival AstraZeneca royalties on total sales of ovarian cancer drug Zejula, in a win for the Anglo-Swedish drugmaker.  Tesaro had argued the royalty was payable only on sales that are for uses claimed or covered by the licensed patents, after AstraZeneca filed a UK lawsuit against GSK in 2021, asking for a bigger share of sales from Zejula.  In October 2012, Tesaro entered into license agreements with AstraZeneca, giving it exclusive rights to certain methods of treating patients with Zejula, developed by Tesaro with help from technology licensed from AstraZeneca.",https://finnhub.io/api/news?id=4bf4837ff5c2e5f0ac830bf7f61eaaa11fb819897aeb159587da33c0f1f07ea9
company,2023-04-05 08:45:07,AstraZeneca' Cancer Drug Combo Meets Goal In Late-Stage Ovarian Cancer Study,119639548,https://media.zenfs.com/en/Benzinga/ca976d859cda3f6b3bc9d2030360fc77,AZN,Yahoo,"AstraZeneca Plc (NASDAQ: AZN) announced topline data from a planned interim analysis of the DUO-O Phase 3 trial of a combination of Lynparza (olaparib), Imfinzi (durvalumab), chemotherapy, and bevacizumab. The combo therapy improved progression-free survival in newly diagnosed patients with advanced ovarian cancer without certain mutations. Also Read: AstraZeneca's Immunotherapy Imfinzi Shows Improvement In Survival Chances In Lung Cancer Patients. In an additional arm, Imfinzi, chemotherapy plu",https://finnhub.io/api/news?id=405db6b16de2369c010e028ad5e6d3bfbe44bfd2ecff997e6f1d480f9dc1cf2f
company,2023-04-05 08:01:00,U.K. stocks climb Wednesday,119638827,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,"U.K. stocks climbed Wednesday, as the FTSE 100 Index finished up 0.37% at 7,662.94. Of the FTSE 100 constituents, general mining company Polymetal...",https://finnhub.io/api/news?id=476d4c53348d7391efaf7376a61e826e67be10ace2e1d5fd8d4cd099dbde91d9
company,2023-04-05 08:01:00,LONDON MARKET CLOSE: Risk-off mood prevails but FTSE 100 outperforms,119632077,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=613cc9a83a4e4454c0e141c01efef9a75bddb25e8de3eacb974235cd1dc6a78e
company,2023-04-05 07:02:00,What You Missed On Wall Street This Morning,119631652,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=623a65b240049f043284ed0b4be91edad7080212bcd5d6efc598515f5106fb7c
company,2023-04-05 05:30:00,"Drug giant AstraZeneca teams up with Hong Kong Science Park to drive biotech, medical research growth",119627199,,AZN,Yahoo,"AstraZeneca, one of the world's leading pharmaceutical companies, has signed a second collaboration agreement with Hong Kong Science and Technology Parks (HKSTP) as the city moves to position itself as a trailblazer in life science innovation. Along with the wider Greater Bay Area, Hong Kong aims to attract the best health talent and drive growth in the fields of medical research, drug development, and clinical trials. The collaboration will involve AstraZeneca and HKSTP supporting and providing",https://finnhub.io/api/news?id=9673596d5a6bdefbb5d319bac4f61cb2147facaed774b0639ff8ab5514ebecb4
company,2023-04-05 02:59:15,RPT-UPDATE 1-AstraZeneca says drug combo meets goal in late-stage ovarian cancer trial,119625655,https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png,AZN,Yahoo,"AstraZeneca on Wednesday said a combination of its cancer drugs Imfinzi and Lynparza met the main goal in a late-stage trial in patients with advanced ovarian cancer.  Lynparza, jointly developed with U.S.-based Merck & Co , was approved last year by the U.S. Food and Drug Administration as a treatment for early-stage breast cancer with certain mutations.",https://finnhub.io/api/news?id=e50aaa05a5c87a94cb4dc7e19694887adb1d051b948bc18f402414d4c3234e84
company,2023-04-05 02:39:27,UPDATE 1-AstraZeneca says drug combo meets goal in late-stage ovarian cancer trial,119625656,https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png,AZN,Yahoo,"AstraZeneca on Wednesday said a combination of its cancer drugs Imfinzi and Lynparza met the main goal in a late-stage trial in patients with advanced ovarian cancer.  Lynparza, jointly developed with U.S.-based Merck & Co , was approved last year by the U.S. Food and Drug Administration as a treatment for early-stage breast cancer with certain mutations.",https://finnhub.io/api/news?id=0d82a4f70f600790525bfe9e0ae829bfaf9151695fdb79deb44c2370a4983cb0
company,2023-04-05 01:42:00,AstraZeneca says Lynparza/Imfinzi combo met endpoint in ovarian cancer study,119638813,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=1732b789474486b5616af36cfaebd7f4d8fee5f660bab7be2bc76795e4046165
company,2023-04-05 00:13:00,AstraZeneca receives positive interim trial results for Imfinzi drug,119638815,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=f3d4a0acd37c2c3bd9ee74a473c20a415469147c0bd4c0111de29e06afa9937a
company,2023-04-04 23:58:00,"AstraZeneca Imfinzi, Lynparza combo improves progression-free survival in ovarian cancer trial",119638816,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=db838f3bc00caed850515b475e939a41578c3ba07a3d8c6b7ace6584bdcbdbdf
company,2023-04-04 23:34:00,What You Missed On Wall Street On Wednesday,119638820,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=fb7a6d9a8bf454151211a1c8e17b295135b9dde68b9a94548c857f37ea7a6307
company,2023-04-04 22:12:00,"AstraZeneca's Lynparza, Imfinzi Ovarian Cancer Treatment Met Primary Endpoint in Phase 3 Trial",119687325,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,By Joe Hoppe AstraZeneca PLC said Wednesday that its Lynparza and Imfinzi combination met its endpoint in the treatment of patients with advanced ovarian...,https://finnhub.io/api/news?id=1e65054e3e0bbe107e4753350c0302c50e304ad1f8cd9c39f50542cf18485391
company,2023-04-12 16:05:00,"Fusion Pharmaceuticals Announces IND Clearance for FPI-2068, a Jointly Developed Novel Targeted Alpha Therapy",119736916,https://media.zenfs.com/en/cnwgroup.com/0796e710ed9ac44fd246d58354c717a5,AZN,Yahoo,"Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, today announced the clearance of investigational new drug (IND) applications for [225Ac]-FPI-2068 (FPI-2068) and corresponding imaging analogue [111In]-FPI-2107 (FPI-2107) to the U.S. Food and Drug Administration (FDA). Fusion is jointly developing FPI-2068 with AstraZeneca (LSE/STO/Nasdaq: AZN) under the companies' multi-asset collabora",https://finnhub.io/api/news?id=3e126dd173dde13db966a4e0f3d176ab1aafe99f0cfb243ff544dcfe2501367e
company,2023-04-12 12:59:00,Fusion Pharma Shares Edge Up 4.3% on FDA Clearance of FPI-2068,119754364,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,By Denny Jacob Fusion Pharmaceuticals Inc. shares edged up 4.3% to $4.35 in aftermarket trading Wednesday after it said the U.S. Food and Drug Administration...,https://finnhub.io/api/news?id=a5511afc351885773f23392e72df1e59c9a90c736d71945e9774609259996d36
company,2023-04-12 12:39:00,AstraZeneca PLC ADR outperforms competitors on strong trading day,119754365,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR rallied 2.19% to $73.76 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=3f47ad679c0d6258aa618c495ee59e937cd9f6f518d1631dc4a4349ed3135a3a
company,2023-04-12 09:00:01,These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar,119736917,https://media.zenfs.com/en/zacks.com/023168c7ea091c342492be3899b280af,AZN,Yahoo,Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.,https://finnhub.io/api/news?id=8503f8839efe0bc686957092978fa78b4d170edc514c0cd183aafc6699d55bee
company,2023-04-12 05:56:00,AstraZeneca COVID shot production is expected to resume in India,119728234,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=f41ee8dce22fe31452271d09329ace62550badcd6c37e3f1ebe3632ae4ea1b25
company,2023-04-11 23:09:00,Fusion Pharmaceuticals receives IND clearance for Alpha therapy FPI-2068,119743958,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=1e44467f68c750f0036192d1a2bb72be96a84e0743c5551e905931645be706d2
company,2023-04-11 13:13:05,"AstraZeneca (AZN), Sanofi Simply RSV Antibody Agreement Terms",119724321,https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0,AZN,Yahoo,AstraZeneca (AZN) and Sanofi (SNY) revise the contractual terms of the agreement for Beyfortus. Sanofi will have full commercial control of Beyfortus in the United States.,https://finnhub.io/api/news?id=1a7bea92ece6f3baa5eac4f13da269a6cab18c888b7ab3337df757df21a372a4
company,2023-04-11 10:51:25,12 Best Covid Treatment Stocks to Buy Today,119724373,https://media.zenfs.com/en/insidermonkey.com/b59f475277cb8c4b57fab9a05923d82d,AZN,Yahoo,"In this piece, we will take a look at the 12 best covid treatment stocks to buy today. For more stocks, head on over to 5 Best Covid Treatment Stocks to Buy Today. If there’s one thing that can be said for sure, it’s that the coronavirus pandemic has changed the world. The deadly disease, […]",https://finnhub.io/api/news?id=fd0f172fc848f1ff1c605cdb4fcfd12850983672dad9f0febd405312d292ac29
company,2023-04-11 07:00:00,AstraZeneca reinforces commitment to advancing science for patients with chronic kidney disease and hyperkalemia at NKF Spring Clinical Meeting 2023,119736920,https://media.zenfs.com/en/business-wire.com/9cddb8adab512ec117fa05acd897ed28,AZN,Yahoo,"WILMINGTON, Del., April 11, 2023--AstraZeneca will showcase five real-world evidence (RWE) studies from its industry-leading Cardiovascular, Renal and Metabolism (CVRM) portfolio, reinforcing its commitment to advancing science in chronic kidney disease (CKD) and hyperkalemia (HK), at the National Kidney Foundation (NKF) Spring Clinical Meeting April 11-15, 2023.",https://finnhub.io/api/news?id=96f0e23a2190431e59b3906e97689db16aafd510452b150703a9f65363ea4a29
company,2023-04-11 05:09:00,"Street Wrap: Today`s Top 15 Upgrades, Downgrades, Initiations",119717698,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=983829a7b1db5ead74317395f388844715a2256ed085ce161252055b4316e23e
company,2023-04-11 02:36:00,"AstraZeneca price target lowered to 11,900 GBp from 12,700 GBp at Guggenheim",119728238,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=216a4b32b58d3f718a1a3c99277b8f87ea07da54dbb7887a3a216b2901176e5c
company,2023-04-11 01:33:00,"AstraZeneca updates arrangements with Sobi, Sanofi for nirsevimab in U.S.",119721745,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=9721cbd450101dd34ee64ae22d5893b9491b533618ca343abdca2b91a04b1039
company,2023-04-11 00:28:00,LONDON BROKER RATINGS: Redburn likes Shell; Barclays raises Persimmon,119717720,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=89ceac91d2b2bfd84c4e2b6129a0d9315ea878b470b0b2fa1ec05b8bd07860b3
company,2023-04-10 23:57:00,TOP NEWS: Sanofi wins US drug control from AstraZeneca in Sobi deal,119719185,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=53c730ff6096aa9b8cae4f9623bbb4328dc72ae2fa38bb509111388e1185fe9b
company,2023-04-10 23:52:00,"Sanofi to get commercial control of RSV therapy nirsevimab in US, AstraZeneca to record $0.7B gain",119728242,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=c0b9ce6368cea565cc87019b6f9d5b3d553263b046d776e5bae94ecfa638af78
company,2023-04-10 23:41:00,AstraZeneca upgraded to Overweight from Equal Weight at Morgan Stanley,119728243,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=3160b6573828be95d1d38357671869b560d72867a3ff29c954775276245bdf87
company,2023-04-10 22:55:00,"LONDON BRIEFING: Harbour Energy, BP to team up on carbon capture",119718773,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=3fc2fcdd0a56116e612cfd75c2a024712f14809f3e1d6eade86a9585b4e7f459
company,2023-04-10 22:24:00,Sanofi Gets Full Commercial Control on Virus Medication From AstraZeneca in U.S.,119712999,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,By Cecilia Butini Sanofi SA and AstraZeneca PLC said Monday that Sanofi would retain full commercial control on an antibody treatment for respiratory...,https://finnhub.io/api/news?id=2c4caca29795a78a4580718947c6073bd83c813e84d0e9bfdb86aafd92f01b65
company,2023-04-10 18:15:10,Astrazeneca (AZN) Stock Sinks As Market Gains: What You Should Know,119713197,https://media.zenfs.com/en/zacks.com/3496571a811465d910e99bd171c71a94,AZN,Yahoo,"Astrazeneca (AZN) closed at $72.07 in the latest trading session, marking a -0.37% move from the prior day.",https://finnhub.io/api/news?id=4bf9c7dd2874bf57b5738735594b84d8955174c235df8c1d13606c090e14423f
company,2023-04-10 12:39:00,AstraZeneca PLC ADR underperforms Monday when compared to competitors,119708399,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR slid 0.37% to $72.07 Monday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...",https://finnhub.io/api/news?id=986d1e828fdfa2a49d9a979a8cb3fa96ba8a4c79cb60cae8ab2cd99574bab59f
company,2023-04-10 08:55:12,"The Zacks Analyst Blog Highlights J&J, AstraZeneca, Merck, Seagen and Pfizer",119713198,https://media.zenfs.com/en/zacks.com/f3f15a36f635cd8200884e1a968d4c3d,AZN,Yahoo,"J&J, AstraZeneca, Merck, Seagen and Pfizer are part of the Zacks Top Analyst Blog.",https://finnhub.io/api/news?id=5541cc66264efb067f067ba1b21ba56d1ca5067db94c4b705a6a23cc4884e858
company,2023-04-10 05:31:00,U.S. launches $5B program to speed up development of next-gen COVID vaccines,119717908,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=1b40a0028225f1427081f74fb49088f5ab3682f51314603e7295c9ec39f65220
company,2023-04-10 04:26:10,GSK Vs. Bristol-Myers Squibb: Who's More Underrated By Mr. Market,119701387,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1365749374/image_1365749374.jpg?io=getty-c-w1536,AZN,SeekingAlpha,"GSK's dividend yield is 3.58%, slightly higher than Bristol-Myers Squibb's 3.22%. BMY's EBITDA margin was 43.7% for 2022, 11.4% more than GSK. Read more here.",https://finnhub.io/api/news?id=e40a30d8690c0777466a7237fc2ec01321a46e522555e287a37fdb3d28ebec26
company,2023-04-10 03:28:00,GSK Vs. Bristol-Myers Squibb: Who`s More Underrated By Mr. Market,119703326,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=dfdd9a0ae6c915f7604373695064ece219a6010fb74e1318c733583f7d341ce4
company,2023-04-16 11:50:00,"IMFINZI-based treatment before and after surgery reduced the risk of disease recurrence, progression events or death by 32% in resectable non-small cell lung cancer in the AEGEAN Phase III trial",119790673,https://media.zenfs.com/en/business-wire.com/64d8231528eb1acf5b4b3b46239dd61f,AZN,Yahoo,"WILMINGTON, Del., April 16, 2023--Positive results from the AEGEAN Phase III trial showed that treatment with AstraZeneca’s IMFINZI® (durvalumab) in combination with neoadjuvant chemotherapy before surgery and as adjuvant monotherapy after surgery led to a statistically significant and clinically meaningful improvement in event-free survival (EFS) versus neoadjuvant chemotherapy alone followed by surgery for patients with resectable early-stage (IIA-IIIB) non-small cell lung cancer (NSCLC).",https://finnhub.io/api/news?id=b475125c27a54bcf379ab0a4c4df0f3c000f723e110366d6f8b7dfe5ecb2ec93
company,2023-04-15 23:33:00,AstraZeneca presents results from AEGEAN Phase III trial,119802391,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=bb403115ae59a25bfc7533484e608a1173de14ec593c772832b449e15657e181
company,2023-04-14 18:59:00,FTC Alerts Nearly 700 Companies About Potential Penalties for Misleading Claims,119768041,https://s.yimg.com/ny/api/res/1.2/ZBZFF1.qt8wEhxbmDy2eAA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02MDA-/https://media.zenfs.com/en/wsj.com/fd32b3c073771257b88ae4af7d600187,AZN,Yahoo,Marketers will likely review their practices to avoid risking penalties that could stretch into the hundreds of millions of dollars,https://finnhub.io/api/news?id=713df4ee1e3fe2a85f969da4ad386065d168959e7fe381cd26bba021e808afb8
company,2023-04-14 12:39:00,"AstraZeneca PLC ADR falls Friday, underperforms market",119767562,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR shed 1.22% to $73.86 Friday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=48d72b35242afe6e2d18ebaf50689c0943dd329bdbc9a5fae009f7be1b9a5edc
company,2023-04-14 07:28:52,IXJ: Healthcare Dashboard For April,119758940,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1352512002/image_1352512002.jpg?io=getty-c-w1536,AZN,SeekingAlpha,Pharmaceuticals/biotechnology is the only subsector with good value and quality scores. Learn why IXJ ETF is a global alternative to XLV.,https://finnhub.io/api/news?id=3e1497d980159205854ca5be0ce96e950af7a4af7736e591ef154c9488579fbe
company,2023-04-14 03:10:00,New analysis of Phase II data at AACR assesses ImaginAb's investigational CD8 ImmunoPET technology's ability to predict response in immunotherapy,119777517,https://media.zenfs.com/en/prnewswire.com/4eacba00df88ee1b62f5d670d4b60645,AZN,Yahoo,"ImaginAb Inc., a global biotechnology company developing 89Zr crefmirlimab berdoxam (CD8 ImmunoPET™) imaging agent and radiopharmaceutical therapies (RPT) announces a poster presentation at AACR 2023 (# 3577 / 2 Poster PET, MRI, and CT Imaging April 18, 2023) of an independent analysis undertaken by AstraZeneca (LSE/STO/Nasdaq: AZN), on data from ImaginAb's IAB-CD8-201 'iCorrelate' Phase II study. The analysis shows baseline and early on-treatment CD8 ImmunoPET/CT may be able to distinguish resp",https://finnhub.io/api/news?id=8bbe62a9e0198a3f1b6a0fd2e3dbdf320bd90f31ab16c1a8d426269781bd1d0b
company,2023-04-14 02:56:00,"3 Best Stocks to Buy Now, 4/14/2023, According to Top Analysts",119760015,,AZN,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=3466923dd2b5edfe49cb3330024590377f457eeb528fdd582c656b13f1219481
company,2023-04-14 00:37:00,Ghana 1st in world to approve new malaria vaccine by Oxford,119759936,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=0098cc36acdfb00757eadf4f6bae45f003b53a7e1489c49f79df4e2cd87e2bf8
company,2023-04-13 23:24:00,TOP NEWS: AstraZeneca Covid antibody neutralises variants of concern,119764053,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=5a864183df23efabcdf53ef37cc388ea645f1d7ee1f68d00d438965976ba15bb
company,2023-04-13 12:38:00,"AstraZeneca PLC ADR rises Thursday, still underperforms market",119754362,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR rallied 1.37% to $74.77 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=31614252d138834f8654a1430a43611bd0de56b4a46bca0f70ccefb2078726a8
company,2023-04-13 11:03:00,AstraZeneca Stock Sees Relative Strength Rating Rise To 85,119749685,https://media.zenfs.com/en/ibd.com/c0cfcba9d362bfd8713ce3997b701f20,AZN,Yahoo,"AstraZeneca  now clears that threshold, with a jump from 80 to 85 Thursday.  When looking for the best stocks to buy and watch, be sure to pay attention to relative price strength.  AstraZeneca ADR is still within a buy range after breaking past a 72.22 buy point in a flat base.",https://finnhub.io/api/news?id=88aaeec906b7ad885a08748568ff16892437c704db4e632e6562bb4122689687
company,2023-04-13 09:47:01,Fusion (FUSN) to Begin Clinical Study on Targeted Alpha Therapy,119749687,https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0,AZN,Yahoo,"Fusion (FUSN) surges after investigational new drug application clearance by the FDA for its targeted alpha therapy FPI-2068, co-developed with AstraZeneca.",https://finnhub.io/api/news?id=1d31484e8e6ad365a9093af58f71e71c0dcbebdad38cad2c445b1efde6c8ce15
company,2023-04-13 07:10:00,AZN June 2nd Options Begin Trading,119743954,,AZN,Stock Options Channel,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=63691f74a1b3d877108871cd2e6a1cd900663fc57179b2c34a1c4f3e49623ac3
company,2023-04-13 03:09:00,AstraZeneca price target raised to $85 from $75 at Argus,119743955,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=efe5b4bf2d7ea4f9697051524f9a876c25143a2cdbeddbe100c57ba85a6131ba
company,2023-04-12 20:03:00,SK Bioscience Rallies After Clinical Trials of Covid-19 Vaccine Booster,119754363,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,By Kwanwoo Jun SK Bioscience Co Ltd.'s shares rallied Thursday after the global phase 3 clinical trials confirmed the efficacy and safety of its Covid-19...,https://finnhub.io/api/news?id=0d479498b0b0d9b1276a34bc3812be311aedbf8b204bfa15dac58857d8508051
company,2023-04-20 12:39:00,AstraZeneca PLC ADR outperforms market despite losses on the day,119845752,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR dropped 0.41% to $74.53 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=df7c8ce413a02f4310824b8276b36fc4d133e59573990592f85850d164badf8a
company,2023-04-20 09:50:01,Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick,119853456,https://media.zenfs.com/en/zacks.com/03fca48475577988aa4e0db94f484b4e,AZN,Yahoo,"Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.",https://finnhub.io/api/news?id=0c0861513cc5e4a4c267ab956d3631801dbc6a9be6d3ed43d584e48355f397ff
company,2023-04-20 06:41:00,"UK earnings, trading statements calendar - next 7 days",119837242,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=8da61b2768af56560c0453401bdc8dc8316c2bc3be88270fac92b63f5a31c3f5
company,2023-04-20 06:39:00,UK shareholder meetings calendar - next 7 days,119837638,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=46a4d6b146a5b5303a19cc4c773253a5c3ba52c9dce95a2f383891fd58107fcd
company,2023-04-19 18:00:10,Astrazeneca (AZN) Dips More Than Broader Markets: What You Should Know,119853457,https://media.zenfs.com/en/zacks.com/46ebfcbff417ac1bbde85ad33fa0d4be,AZN,Yahoo,"In the latest trading session, Astrazeneca (AZN) closed at $74.84, marking a -0.24% move from the previous day.",https://finnhub.io/api/news?id=ff18213f1b98a8cf138a15aab7eb9f3fbab3c12b926c427cec173e5041e6d741
company,2023-04-19 12:39:00,AstraZeneca PLC ADR underperforms Wednesday when compared to competitors,119845753,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR dropped 0.24% to $74.84 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=fe3d5a0e2b9082077ddf22890277b8b1bd92396498d0cdd3594223b23ce37cbd
company,2023-04-19 07:03:35,"Citigroup, Ryanair Bemoan Lingering Brexit Woes: New Economy",119823106,https://s.yimg.com/ny/api/res/1.2/jkcxbP2a87IQmm.79OmXIA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/bloomberg_markets_842/e131ad3e8e0f1d4209f2b10e915ef5e4,AZN,Yahoo,"(Bloomberg) -- The new Brexit Deal for Northern Ireland between the UK and the European Union represents progress but isn’t enough to fully eliminate disruption caused by Britain’s exit from the bloc, business leaders said at the Bloomberg New Economy Gateway Europe event near Dublin.Most Read from BloombergWorthless Degrees Are Creating an Unemployable Generation in IndiaAirline Blunder Sells $10,000 Asia-US Business Class Tickets for $300India Passes China as World’s Most Populous Nation, UN S",https://finnhub.io/api/news?id=e99b982d105a9b71ee287d19c405def2c06fb707b23f0c7879fdff959767a0f3
company,2023-04-19 09:15:00,Could This Rare-Disease Drug Candidate Become a Blockbuster?,119853459,https://s.yimg.com/ny/api/res/1.2/etVxjrRVurbBlE3.wjqh7Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/bb0536b823123e5d1b204857d151083c,AZN,Yahoo,This drug candidate could be a great treatment option for patients with a potentially deadly disease.,https://finnhub.io/api/news?id=f2bcdec1805d469fa759584c666dad6d29e5c29732b938f1be53fdd5b8c1ed1e
company,2023-04-18 14:00:39,Why AstraZeneca Shares Are Trading Higher Today?,119819225,https://media.zenfs.com/en/Benzinga/e3dede4bfc7997c7c9033d8e285fb407,AZN,Yahoo,"AstraZeneca plc's (NASDAQ: AZN) vaccine head highlighted the confidence that the company's new COVID-19 antibody treatment could protect immunocompromised patients against all known virus variants. Laboratory studies show that the antibody, dubbed AZD3152, neutralizes all known variants of COVID-19. AstraZeneca has support from regulators to make the treatment available by the end of this year, Reuters reported citing Iskra Reic's interview. Depending on additional encouraging data and regulator",https://finnhub.io/api/news?id=a23d7a2094db8336a38cf8fb37da50d52db3d1654ec1546a7406b13d67c186b4
company,2023-04-18 12:39:00,"AstraZeneca PLC ADR rises Tuesday, outperforms market",119845754,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR advanced 1.89% to $75.02 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=b227e1bf313e84b7b5068088e913e134c1cb2c5a590e87374e6587bca132c4d5
company,2023-04-18 07:45:49,AstraZeneca confident new COVID antibody protects against known variants,119819226,https://media.zenfs.com/en/reuters.com/6616bcd9363082981d855e06b3996ad9,AZN,Yahoo,"AstraZeneca is confident that its new version of COVID-19 antibody treatment could protect immunocompromised patients against all known virus variants, its vaccines head said.  Laboratory studies show the antibody, called AZD3152, neutralizes all known variants of COVID-19 and AstraZeneca has support from regulators to make the treatment available by the end of this year, Iskra Reic said in an interview on Tuesday.  AstraZeneca plans, pending more positive data and regulatory approval, to make the antibody available by the end of 2023.",https://finnhub.io/api/news?id=a1e355f965f93c9a22637ffd2c9d45414a3035dbc3e49ac3a61e4bd122e3dd76
company,2023-04-18 04:30:00,"Analysts Offer Insights on Healthcare Companies: AstraZeneca (AZN), Relay Therapeutics (RLAY) and 23andMe Holding (ME)",119829166,,AZN,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=0af615dd67737aafc389b8b8de986505d1995f2341834b13f17edc1ce1b6aead
company,2023-04-17 18:15:10,Astrazeneca (AZN) Stock Sinks As Market Gains: What You Should Know,119809459,https://media.zenfs.com/en/zacks.com/c2fdcaac033e049c74f38d188afcc9f9,AZN,Yahoo,"In the latest trading session, Astrazeneca (AZN) closed at $73.63, marking a -0.31% move from the previous day.",https://finnhub.io/api/news?id=3a3d48a6f04108a3d7aacbd2c0b90e051adb1f1bbe39cc0fc4184758ddeab612
company,2023-04-17 16:15:00,Shanghai Cellular Biopharmaceutical Group presents first data from Phase I trial evaluating a novel CAR-T in advanced liver cancer at AACR Annual Meeting,119809460,https://media.zenfs.com/en/cnwgroup.com/0c928cab072bc04a141b35b2e9f2a2dd,AZN,Yahoo,"Shanghai Cellular Biopharmaceutical Group Ltd. (the Company, or Shanghai Cellular Bio), a company engaged in the drug development of immunotherapies for cancer and stem cell therapies for degenerative diseases, today presented data from the First-in-Human (FIH) Phase I trial evaluating C-CAR031 at the 2023 American Association for Cancer Research (AACR) Annual Meeting.",https://finnhub.io/api/news?id=05554c76f97305025275dfdc3cc28308b9a249623ddbfc4aebc2f8a5f04d1672
company,2023-04-17 12:39:00,AstraZeneca PLC ADR outperforms competitors despite losses on the day,119845755,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR slid 0.31% to $73.63 Monday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=c28d7ea03da844ac60d07bef8271d03a6629f5507a10d77bad82225ba00bf154
company,2023-04-17 12:00:00,GRAIL Presents New Data Demonstrating That Methylation Assay Detects Residual Hematologic Cancer After Treatment at American Association for Cancer Research (AACR) Annual Meeting 2023,119830737,,AZN,Business Wire,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=281abf2f07abf28689c4f351491927ee784ee136ee0cda70987935efc40db6e0
company,2023-04-17 11:45:03,Astrazeneca (AZN) is a Top Dividend Stock Right Now: Should You Buy?,119809461,https://media.zenfs.com/en/zacks.com/5ecaf2a9bf082a5f3a554e6526b34be0,AZN,Yahoo,"Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Astrazeneca (AZN) have what it takes? Let's find out.",https://finnhub.io/api/news?id=7d27a746f0f3012b7231998c9d4e5148fb0fb9cce492497abedc7927279d80f6
company,2023-04-17 09:43:35,Pfizer Vs. AstraZeneca: Which Is Better For Long-Term Investors?,119801952,,AZN,SeekingAlpha,,https://finnhub.io/api/news?id=76a291b6f42e5d4b5f9d92e25a81deb68fad3695ce0be7a543e29d4447bdfde6
company,2023-04-16 23:03:00,"GRAIL, AstraZeneca present new data on methylation assay",119830740,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=19d89ad14582db6d0fe40df6fb46786167b2167f6584eb8f992e44feca621eb2
company,2023-04-16 22:52:00,"LONDON BRIEFING: Possible offers for Network International, John Wood",119801448,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=790499ca20023310bb5b0a38a2a3e041560ca16ec087fec72c4a1f82bc8c0325
company,2023-04-16 21:45:00,AstraZeneca reports positive results for lung cancer drug combination,119802390,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=727495a0bf876677fae6253a5b5429f7c3bc8c21e575501815fa67a9fadbfcab
company,2023-04-24 12:49:59,EU outlines plan to take control of medicine production in health crises,119908922,https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png,AZN,Yahoo,Proposal for compulsory licensing risks ire of pharmaceutical groups keen to protect patents and revenue,https://finnhub.io/api/news?id=9353a2788e14ba321a39570e28f8406c1272f63be4673cdc803fad0da3e5dbfc
company,2023-04-24 12:39:00,"AstraZeneca PLC ADR rises Monday, outperforms market",119926848,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR inched 0.28% higher to $75.81 Monday, on what proved to be an all-around mixed trading session for the stock market, with the Dow...",https://finnhub.io/api/news?id=24b5b8401b0804ec8f886f5736b593f7dfd7fd0d68a8764834c1430022351928
company,2023-04-24 10:51:02,Can Amgen (AMGN) Keep the Earnings Streak Alive in Q1?,119908923,https://media.zenfs.com/en/zacks.com/65410c79c0b8184da264ed17fda575ce,AZN,Yahoo,"Volume growth from Amgen's (AMGN) key drugs like Prolia, Repatha and Evenity, among others is expected to have been partially offset by biosimilar/generic competition for mature drugs.",https://finnhub.io/api/news?id=ac9f50964ab84ba1b0ccd5ed8c0cabe45d91ae252995662219600790d2ab25b5
company,2023-04-24 07:00:00,NEURO-TTRansform Phase III results presented at AAN showed eplontersen demonstrated consistent and sustained improvement in all measures of disease and quality of life through 66 weeks,119908924,https://media.zenfs.com/en/business-wire.com/4a7387edc4330c3bdd2f2613cfa183e6,AZN,Yahoo,"WILMINGTON, Del., April 24, 2023--Detailed results from the NEURO-TTRansform Phase III trial in patients with hereditary transthyretin-mediated amyloid polyneuropathy (ATTRv-PN) showed AstraZeneca and Ionis’ eplontersen met all co-primary endpoints and secondary endpoints at 66 weeks versus an external placebo group.1",https://finnhub.io/api/news?id=555bdda675d1ac5e3ebf1934b73851439845f25382f8cb486d2252eb7915a62d
company,2023-04-24 06:48:00,UK shareholder meetings calendar - next 7 days,119916301,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=e5e56fcf0ee56b95db91b63eae7a7a2c80ad7c5190ea86920b718e54fed9c970
company,2023-04-24 06:47:00,"UK earnings, trading statements calendar - next 7 days",119914702,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=045a073ea267893adda59d1ce14a658d36a05f239400d781b3cde043a01e595a
company,2023-04-24 03:50:00,AstraZeneca/Sanofi`s RSV preventing therapy Beyfortus gets approval in Canada,119957860,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=0dc0b87c62ce940c013f5ced8ec1b26a6e1ed68d9fcc3a60a1dd52960027cc1a
company,2023-04-24 02:10:00,"AstraZeneca, Ionis announce eplontersen trial met all endpoints",119928703,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=5167e2092b133e3ac18f24605c300dc879626b4bc193c3d69e125153017896c4
company,2023-04-21 12:39:00,AstraZeneca PLC ADR underperforms Friday when compared to competitors despite daily gains,119926850,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR rose 1.44% to $75.60 Friday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=4f654762b6025f44b540569ace40100af42e64a450964d0620a9f07b8d77861b
company,2023-04-21 11:17:04,Mineralys: New IPO And A Leader In The Hypertension Drug Development Space,119869250,,AZN,SeekingAlpha,,https://finnhub.io/api/news?id=fa7d6528e9e385bad68600b182235da58fbaf6b4f48cb7c56d307d5b04eb8f79
company,2023-04-21 10:10:02,Merck (MRK) to Report Q1 Earnings: What's in the Cards?,119876474,https://media.zenfs.com/en/zacks.com/cb27584804ea583a87d27499a6976ec2,AZN,Yahoo,"Investor focus is likely to be on the sales of Merck's (MRK) blockbuster oncology medicine, Keytruda when the company reports Q1 earnings.",https://finnhub.io/api/news?id=c47b9d7c603a962be12ad0f5dd45b79f7243a83567b9f01e4c41dbad1b7a8d13
company,2023-04-21 08:32:00,"Earnings Week Ahead: Amazon, Meta Platforms, Alphabet, Coca-Cola, Boeing, and more",119868296,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=7b5d1a1eba315838a32653301dce0a7b204eb1db04060a6a6033253c51d13efa
company,2023-04-21 02:00:00,ClearBridge International Value Strategy Q1 2023 Portfolio Manager Commentary,119861632,,AZN,SeekingAlpha,,https://finnhub.io/api/news?id=48fb0f4c915f07d3cc3948b74c6b234cc38f2ff8104dc180e8c658c75f2be86c
company,2023-04-28 15:35:03,AstraZeneca Plc (AZN) Q1 2023 Earnings Call Transcript,120023637,,AZN,Yahoo,"Before I hand over to AstraZeneca, I'd like to read the safe harbor statement.  The company intends to utilize the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995.  Participants on this call may make forward-looking statements with respect to the operations and financial performance of AstraZeneca.",https://finnhub.io/api/news?id=c93ec8ecf7c1a2680f2a967785e340c7a1988b97cbeb2981b2cd7a54945c22b1
company,2023-04-28 12:47:04,"Pharma Stock Roundup: MRK & Others Post Q1 Results, LLY Drug Shines in Obesity Study",120018609,https://media.zenfs.com/en/zacks.com/9883d206905e7516b2353476e213e60c,AZN,Yahoo,"Merck (MRK), Eli Lilly (LLY), AstraZeneca (AZN) and others report first-quarter results. J&J (JNJ) provides an update on the IPO of its Consumer Health segment, Kenvue.",https://finnhub.io/api/news?id=0ec0a88b38df6e0070fa49acac16f671fa3cf97af8991e7863df9c8c085a4df8
company,2023-04-28 12:39:00,AstraZeneca PLC ADR underperforms Friday when compared to competitors,120022608,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR shed 0.76% to $73.22 Friday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=1cfbe8930f8e7562dd555d8485faa02f16ec0b00ad1dd98b0d880707a05613b2
company,2023-04-28 11:52:03,"Amgen (AMGN) Q1 Earnings Beat Estimates, 2023 View Raised",120016030,https://media.zenfs.com/en/zacks.com/65410c79c0b8184da264ed17fda575ce,AZN,Yahoo,Amgen (AMGN) beats estimates for earnings but misses the same for sales. It raises its earnings and sales guidance for 2023.,https://finnhub.io/api/news?id=5145dfe493d7f405a04afa3c16ec76f883e6838ee834ebf05e5b563fd83976a6
company,2023-04-28 03:08:00,GLOBAL BROKER RATINGS: HSBC cuts Santander; DZ Bank likes Meta,120010909,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=9c4e28066d7a2210a0378a24b3de790f7a2497290de7f213cf09442d8846609b
company,2023-04-28 01:14:00,"Merck, AstraZeneca Lynparza wins limited label expansion endorsement",120037537,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=cca0f56ff6925f14a701be120a11b52796717e73a14c022fb6a7aa61a579d79e
company,2023-04-27 22:26:00,"AstraZeneca price target raised to 14,000 GBp from 13,500 GBp at JPMorgan",120037540,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=06620eaa56b4402118f8867df282930f6aa9df5ee127a21e27dbc821b7b90582
company,2023-04-27 22:16:14,Europe stocks markets set for higher open as earnings boost sentiment,119998401,https://image.cnbcfm.com/api/v1/image/107186372-1675162376571-gettyimages-1238669803-20220214_liverpool_street_skyline_007.jpeg?v=1682662574&w=1920&h=1080,AZN,CNBC,European stock markets are set to open higher on Friday as investors digest corporate earnings. ,https://finnhub.io/api/news?id=97f6db1b9dbba5cd8ecaa19300ec7cc4bbc10b21e298b8d48db65c3d26967db5
company,2023-04-27 16:44:35,FDA Casts Doubt on Merck/AstraZeneca's Cancer Drug for Prostate Cancer Ahead of Adcomm Meeting,119970746,https://media.zenfs.com/en/Benzinga/1cb332e095213ac7749d40a119f0ac79,AZN,Yahoo,"The FDA's Oncologic Drugs Advisory Committee will be meeting tomorrow, Friday, 28 April, to discuss the supplemental new drug application (sNDA) for Lynparza (olaparib) in combination with abiraterone and prednisone or prednisolone for metastatic castration-resistant prostate cancer (mCRPC). In 2017, AstraZeneca Plc (NASDAQ: AZN) and Merck & Co Inc (NYSE: MRK) collaborated to co-develop and co-commercialise Lynparza and Koselugo (selumetinib) for multiple cancer types. Ahead of the meeting, the",https://finnhub.io/api/news?id=0ab639af8407b14ca8ada5e3e6f645971718f2cff2e3f646c967c6302b13c876
company,2023-04-27 11:40:03,"AstraZeneca (AZN) Q1 Earnings Beat, COVID Products Hurt Sales",119970388,https://media.zenfs.com/en/zacks.com/ef77d5a5eb4e72e4dd31ccfaf4ca4ccd,AZN,Yahoo,AstraZeneca (AZN) beats first-quarter estimates for earnings while missing the same for sales. The company reaffirms its 2023 guidance.,https://finnhub.io/api/news?id=04e2d88c1141cd413ea6b30bff0250345321ebca805bff458233791cf9282639
company,2023-04-27 10:37:24,AstraZeneca chief warns high tax Britain now ‘very unattractive’,119970748,https://s.yimg.com/ny/api/res/1.2/wI1G5xo6lr6h.KAKKye85g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD03NTA-/https://media.zenfs.com/en/the_telegraph_258/f9d75e88cc4dde349c6bac2188d74951,AZN,Yahoo,"High taxes are making Britain ""very unattractive"" for business, the boss of the country's biggest drugmaker has warned, as he said that China was likely to shape the medicines of the future.",https://finnhub.io/api/news?id=d28597b3899e97ec5bc1be42b71c0d71255552e9a66caaad58747121a6bff47c
company,2023-04-27 09:33:06,"Drugmakers scout for deals, ramp up research spending",119970749,https://media.zenfs.com/en/reuters-finance.com/62c9ed0e76cbaed749d6b1c8d7715fc3,AZN,Yahoo,"Drugmakers including Merck & Co, AstraZeneca Plc and AbbVie Inc said on Thursday they are open to acquisitions and reported a ramp up in research and development spending as the industry's larger players look for new sources of future revenue.  Several top drugs such as AbbVie flagship Humira have begun to face competition from new rivals or are expected to lose patent protections in the next few years, and deals could be a quick fix to address the loss of revenue from older therapies.  Merck recently announced a $10.8 billion deal to buy Prometheus Biosciences Inc.",https://finnhub.io/api/news?id=ce71141136786b5a90df91eb97201b5214b56666a167baafc240f92251847d65
company,2023-04-27 07:57:19,"AstraZeneca's COVID-19 Vaccine Loses Shine, Cancer Drug Imfinzi & Emerging Markets Stabilize Q1 Revenues",119970750,https://media.zenfs.com/en/Benzinga/ad70444f3a34f8b0d3641dd770f384c0,AZN,Yahoo,"AstraZeneca Plc (NASDAQ: AZN) has reported Q1 FY23 core EPS of $1.92, up 1% Y/Y (+6% on constant currency), better than the consensus of $1.07. The company clocked Q1 sales of $10.88 billion, -4% (flat CC), beating the consensus of $10.75 billion. The company said that total revenue was stable, despite a decline of $1.46 billion from COVID-19 medicines. Excluding COVID-19 medicines, revenue increased by 15%, and product sales increased by 16% Core Gross margin of 83%, up four percentage points,",https://finnhub.io/api/news?id=d4bb6202d5b6e1471f1a335162e3dbb53207a1007186be5b3eb4394c7bc5511f
company,2023-04-27 06:23:13,Trending tickers: Meta | Unilever | AstraZeneca | Taylor Wimpey,119954464,https://s.yimg.com/ny/api/res/1.2/TGEqUZOACXzjGs6a3P8Iig--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://s.yimg.com/os/creatr-uploaded-images/2021-10/5a1654e0-3843-11ec-bffe-0b88e0ef384c,AZN,Yahoo,The latest investor updates on stocks that are trending on Thursday.,https://finnhub.io/api/news?id=cb496e903b8386505ba68f588bab5a328a9318b9828d935e9c04c75570e438ba
company,2023-04-27 05:04:57,AstraZeneca hunts for more China deals after signing partnerships,119970753,https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png,AZN,Yahoo,"AstraZeneca is exploring potential deals in China, declaring the market “completely open” to foreign drugmakers.  Pascal Soriot, AstraZeneca’s chief executive, has just returned from two weeks in the country, where the Anglo-Swedish drugmaker has signed three licensing partnerships in recent months.  AstraZeneca is the largest foreign pharmaceutical company by sales in China.",https://finnhub.io/api/news?id=bd26a237afc1372dfe66facf7da62c2163c06850b05934960884acaa8503fcc1
company,2023-04-27 04:51:00,"AstraZeneca's Profit, Revenue Beat Expectations Despite Covid-19 Slump -- Earnings Review",120022610,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,By Cecilia Butini AstraZeneca PLC reported first-quarter results on Thursday. Here is what we watched. REVENUE: Revenue declined to $10.88 billion from...,https://finnhub.io/api/news?id=238dd8dea920d7819b4f643d715673f99e8dd6518292f7c9e485b71b8cbbc6ba
company,2023-04-27 04:40:00,Unusually active option classes on open April 27th,119957822,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=e95d46106120da8ccd431c3da5f4a990c286bcda873576992d3c17b1d3aec289
company,2023-04-27 03:56:00,AstraZeneca (AZN) Receives a Buy from SVB Securities,119957824,,AZN,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=d32e0b4070eeadc45f8371c6418846c643fb0b9d973d72f2fa61906fe22db444
company,2023-04-27 02:53:00,GLOBAL BROKER RATINGS: Berenberg cuts Dassault; HSBC cuts S&N,119957399,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=35d18a03d0489ecafa0e3bd51ddbb69d7a5a9f56c68d34ffb06ece1ce6ca884a
company,2023-04-27 02:50:00,"3 Best Stocks to Buy Now, 4/27/2023, According to Top Analysts",119957827,,AZN,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=92d3c9d68b3158c7d90634f7d5fe4fa5d12082700b7134880a1529caaa21fdce
company,2023-04-27 02:22:09,"UPDATE 2-AstraZeneca first quarter profit, revenue beat expectations",119949781,https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png,AZN,Yahoo,"AstraZeneca on Thursday beat expectations for its first -quarter profit and revenue, helped by sales of its roster of drugs in emerging markets.  AstraZeneca's performance in emerging markets was particularly strong, CEO Pascal Soriot said in a statement.  Excluding sales of its COVID-19 products, sales grew 22% to $3.1 billion in emerging markets on a constant currency basis.",https://finnhub.io/api/news?id=b7ba954fed3fd8928496a6d8c4fcb9017e7d2db9d8d2eadda6d6e2bdaa6a6aad
company,2023-04-27 02:18:28,AstraZeneca beats estimates on strong emerging market sales as COVID wanes,119970755,https://media.zenfs.com/en/reuters-finance.com/329d7ab8a63d36f289a4a244a2fdea6b,AZN,Yahoo,"LONDON (Reuters) -AstraZeneca on Thursday beat expectations for first-quarter profit and revenue, as buoyant sales of cancer treatment Imfinzi and strong demand for its roster of drugs in emerging markets helped to offset dwindling COVID product sales.  The company's sales and outlook highlight the rapid decline of its COVID vaccine, its best-selling product in 2021 at the height of the pandemic, which has struggled to compete with rival shots developed by Pfizer and Moderna.  AstraZeneca's current strategy is focused on areas such as cancer, cardiovascular, kidney, rare and respiratory diseases.",https://finnhub.io/api/news?id=a4536c22eb388ca946da625a6d8ce4a59b2c3882a33e35d4c7f3e6cef57c584e
company,2023-04-27 02:00:00,"Analysts` Opinions Are Mixed on These Healthcare Stocks: AstraZeneca (AZN), BioMarin Pharmaceutical (BMRN) and Sanofi (SNY)",119957830,,AZN,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=e159c60bff6301631a382d57be31d769731ff940171535cf6cf2b0af8669cc8a
company,2023-04-27 01:01:00,Astrazeneca: Q1 Earnings Snapshot,119957831,,AZN,"Associated Press, The",Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=e7f9b6278154ca12c38dce09449230580bc6fa2a1f06dfcb573c247363c73523
company,2023-04-27 00:57:00,AstraZeneca sees FY23 core EPS up high single to low double-digit percentage,119957832,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=d041555a3682f4d3a51c1ea1d17d37d25f58b057d79e5c5ec1d7e3cb7b5ea517
company,2023-04-27 00:55:00,"AstraZeneca reports Q1 core EPS $1.92, consensus $1.07",119957833,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=7d7d26d763e64c807921c92768b742ff230375211404845486c8c29392df91ff
company,2023-04-27 00:26:00,TOP NEWS: AstraZeneca profit jumps despite Covid-19 sales decline,119957834,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=4eda5f3a6602475d87282844f0666e7660ca0478398a487a435b8ed6f1f71f90
company,2023-04-27 00:17:00,AstraZeneca Q1 sales boosted by cancer drugs amid COVID products wane,119957835,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=11f278127a8a1757dc142c44de025aca3253386ed9a7a9599ee134b037d99b89
company,2023-04-27 00:05:00,LONDON MARKET OPEN: Stocks lower amid worries for health of US economy,119957836,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=4b3afc517f26d9b4d08aea3b4d1d91a07e24f663ded09c9e35cdbbf53f4eced1
company,2023-04-26 22:52:00,LONDON BRIEFING: AstraZeneca revenue dips as Covid medicines decline,119957837,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=9c04a8f36c7fdbf1723b621ac7e7aa37666d3d249b1769e36528e92b323473ef
company,2023-04-26 22:32:00,AstraZeneca 1Q Revenue Consensus Was $10.60B,120022612,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,"By Cecilia Butini AstraZeneca PLC on Thursday reported a rise in profit for the first quarter, but said a decline in sales of its Covid-19 medicines hurt...",https://finnhub.io/api/news?id=ddddcfc2676402463affa7f8770ec8fc26c3f3abfab7adc7bb0342e02b0f5b58
company,2023-04-26 21:59:00,LONDON MARKET EARLY CALL: Lower call as US bank sector worries weigh,119957838,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=b00c9a550133d13abf4b09f6cd674c14c475cb330674bb9d27fb6d3a88288f06
company,2023-04-26 21:35:00,"GET READY: Astra, Barclays, LSEG, Schroders and Unilever at 0700 BST",119957839,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=02cb2072fe0ed4c74b1bb2961fb3e82b048cfd313c4923393a5fb64fe0a89d12
company,2023-04-26 21:20:00,AstraZeneca beats Q1 top and bottom line estimates; reaffirms FY23 outlook,119957840,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=6e8aa2baf77bbd89ba7150333902cac7ad85c5c2ca0f8eeb35a1a05396c272b0
company,2023-04-26 21:19:00,Aspen Tech plunges to 9-month low on Q3 results; William Blair downgrades stock,119981357,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=9d830e2ed3b84b1f0efdbc6d9cf8e2142460c0b9b33b974bfcb8fd688fe40bfc
company,2023-04-26 20:41:23,European markets open lower; banks choppy after results beat expectations,119950123,https://image.cnbcfm.com/api/v1/image/107014183-1644587562136-gettyimages-1284106394-0g1a3168_2020110580009386.jpeg?v=1682570483&w=1920&h=1080,AZN,CNBC,"European markets opened lower Thursday, with concerns over the global banking sector still casting a shadow over investor sentiment.",https://finnhub.io/api/news?id=8bc0c844b7e9f614aa86858a6e435a42edaeb7be520cf413f5508450e3706dd6
company,2023-04-26 20:30:00,GLOBAL BRIEFING: Samsung posts weakest profit in 14 years in Q1,119957841,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=44c8ce8cf3666132a5eb0585bf5bfe79988b769eb9ce6488d1c255f767628a1f
company,2023-04-26 18:29:39,7 Low-Risk Stocks to Buy if You Only Want to Beat Inflation,120074501,https://media.zenfs.com/en/investorplace_417/a0f6d2f321918071f3e08aec2de55e9a,AZN,Yahoo,"If you’re looking for some low-risk stocks for inflation-proofing, investing in historically stable companies with robust cash flows and dividends is the best bet right now. A recession is on the cards later this year, and if you are only worried about protecting what you have while having returns that can beat inflation, I would not recommend investing in many of the hotter growth stocks this year. Now don’t get me wrong — growth names are an essential part of your portfolio and they can substa",https://finnhub.io/api/news?id=7398a1477f9aa89686bbd1e1e4fc354165e940411008abcb12e979a24e6b70bf
company,2023-04-26 12:39:00,"AstraZeneca PLC ADR falls Wednesday, underperforms market",120022614,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR slid 2.66% to $73.65 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=40d8fabf7f6dbc9364ce9edd0615af9456ce7726a88883e708e5bbb8c39ffa80
company,2023-04-26 08:36:12,Why AstraZeneca (AZN) Might Surprise This Earnings Season,119949783,https://media.zenfs.com/en/zacks.com/ef77d5a5eb4e72e4dd31ccfaf4ca4ccd,AZN,Yahoo,AstraZeneca (AZN) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.,https://finnhub.io/api/news?id=88fda470fc381e30c9b752f3e7cfdf5a2176fcf78490ad80e0b820dd7c85abc6
company,2023-04-26 08:21:00,"Pfizer, BioNTech hit new 52-week lows",119957842,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=583007860eb6213b711dea93c055bdadbd9c49cfa72587ee94d6683f301ad5b8
company,2023-04-26 08:03:00,LONDON MARKET CLOSE: Tech shines but tepid trade elsewhere,119957843,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=f02775df78993d1b95f31697b85b86e9693da59e1c84aac00fdaa317babe0fbf
company,2023-04-26 08:01:00,U.K. stocks extend losing streak for third session,119943196,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,"U.K. stocks finished lower Wednesday, with the FTSE 100 Index dropping 0.49% at 7,852.64. Among FTSE 100 constituents, technical services company...",https://finnhub.io/api/news?id=ceccd74832461e6888e35e699d7c9d99836d935165169bc0d35cbd49dba76498
company,2023-04-26 07:47:00,Will AstraZeneca Q1 results bring positive surprise?,119957844,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=f5535f57f1dbce936bc5eab174f28af0d394c9db64a05f8f2dc715e174c9ec97
company,2023-04-26 07:41:00,"Merck, AstraZeneca dip as FDA reviews cancer drug ahead of AdCom meeting",119957845,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=48cd2ac9a2aa38e7462499329a09e220da14999510cf74ace4a089eec4a66641
company,2023-04-26 06:52:00,"UK earnings, trading statements calendar - next 7 days",119957846,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=68f24c300598b55e8246cbe082ef2422cb126a7369f7a1bf2c0f3f29deeac6a1
company,2023-04-26 06:12:00,Notable earnings before Thursday`s open,119957847,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=adac0f4be7263a27e8f51053dd120e7e36d3371b3f4068cdf537078763550ec9
company,2023-04-26 04:32:00,EU publishes proposed reforms for pharma industry,119957848,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=c795f4e4b500619999f1bd65cb14ef1432b14bd429939cbe862a4d74e21a77f3
company,2023-04-26 02:53:00,Novartis` iptacopan improves hemoglobin levels in rare blood disorder trial full data,119957849,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=9458e2e68f11494935c67cc4c8a4b413cec347ff284c477004d705c7c4150f9b
company,2023-04-26 02:50:00,AstraZeneca's 1Q Sales Expected to Dip -- Earnings Preview,120022619,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,By Cecilia Butini AstraZeneca PLC is scheduled to report results for the first quarter on Thursday. Here's what you need to know: SALES: The Anglo-Swedish...,https://finnhub.io/api/news?id=39b351c317bf0ea38d387d175004ced7caa8d0ec71669a3ae9ad2666f13a915c
company,2023-04-26 02:30:00,Novartis iptacopan improves hemoglobin levels in rare blood disorder trial full data,119957851,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=871dcc19dded2be58de03c6ecebee429094726161e5f107db1f878657297485c
company,2023-04-25 12:39:00,AstraZeneca PLC ADR outperforms market despite losses on the day,119926847,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR slipped 0.20% to $75.66 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=1b67d6fe4ff2883a1d94f131c4b804ed709fdfa75e215f91ee3c324db6be537e
company,2023-04-25 09:41:01,AstraZeneca (AZN) to Report Q1 Earnings: What's in the Cards?,119927772,https://media.zenfs.com/en/zacks.com/ef77d5a5eb4e72e4dd31ccfaf4ca4ccd,AZN,Yahoo,"Higher sales of AstraZeneca's (AZN) key medicines, Lynparza, Tagrisso, Imfinzi and Farxiga are expected to have driven sales, partially offset by lower sales of legacy drugs.",https://finnhub.io/api/news?id=a31037b01880cfad9e7c440f0f32a617038d10b230dd3c07b187c50a765a729f
company,2023-04-25 06:52:00,UK shareholder meetings calendar - next 7 days,119916299,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=b957823845a950d91875eda686ac942c33a8e23853708d39772e97b128229f8a
company,2023-05-02 05:28:00,"IN BRIEF: AstraZeneca Chair Michel Demare buys GBP230,000 in shares",120122490,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=8cf857166d73c9e5fce0712cd1400f93dcdd1b0bb963d7dbc12ee788817f94b2
company,2023-05-02 02:06:00,AstraZeneca says disappointed with FDA Lynparza vote outcome,120122492,,AZN,MarketWatch,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=733df021c12a0301fc64d2fabbf8fe1afe8773b8cec108d0240f270ea1571016
company,2023-05-02 00:06:00,AstraZeneca bemoans ODAC judgement on use of Lynparza drug for cancer,120122493,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=dcea6e55da1a162291adccca1ecb03df9c21ba781fa7bdade00cf0fc85a3eea4
company,2023-05-01 23:40:00,AstraZeneca PLC ADR outperforms competitors on strong trading day,120122495,,AZN,MarketWatch,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=01b40917b2a1e83f44aeef8a0549adebc3d97b0528d2a6a28eb22dcbe5def786
company,2023-05-01 05:56:00,SVB Securities Remains a Buy on AstraZeneca (AZN),120089364,,AZN,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=316310c52aefcf36a528f9f551cb063589b108822554c2a109d2e44efe42327b
company,2023-05-01 03:35:00,"AstraZeneca ""disappointed"" with US ODAC's guidance on Lynparza",120081629,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=07f848148ed3d084aefa894495c60c59ef972bbed0cc571a80379fc9f3b829fa
company,2023-05-01 02:39:12,AstraZeneca (AZN) Presents at the 2023 American Association for Cancer Research (AACR) - Slideshow,120077452,https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png,AZN,SeekingAlpha,The following slide deck was published by AstraZeneca PLC in conjunction with this event.,https://finnhub.io/api/news?id=1e1ab52208f3f418ee8775a0418070507d3b5cf59c80a682786266e079d6d06f
company,2023-04-30 23:40:00,AstraZeneca PLC ADR outperforms market on strong trading day,120089369,,AZN,MarketWatch,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=9047f86a96949e908d40daa55736081882f0c455c558e8a226ec2c52e354fd93
company,2023-04-30 00:00:01,GSK struggles to make investors believe its growth story,120067929,,AZN,Yahoo,Industry watchers say UK-listed rival AstraZeneca has a stronger pipeline and benefits from its oncology expertise,https://finnhub.io/api/news?id=749a828bcd4a4543573dc659859659fa8a3dc249a8ae3946ce7ac7c88b121a4b
company,2023-04-29 21:53:06,27 Largest Biotech Companies in the US,120066562,https://media.zenfs.com/en/insidermonkey.com/b5dad9919dcf999502a6a0d2fc5a1f43,AZN,Yahoo,"In this article, we take a look at 27 largest biotech companies in the US. You can skip our detailed analysis of the biotech industry and go directly to the 5 Largest Biotech Companies in the US. The largest biotech companies in the US have a total market cap of $88 trillion. Latest Developments in […]",https://finnhub.io/api/news?id=1c88312f585716d7e65015addc46c9783ad8f961f7a60a18a6b2d39dd896ff7a
company,2023-05-06 04:15:00,GSK: Add This Cheap Chip Play To Your Portfolio,120206620,,AZN,TalkMarkets,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=2fd39f10c8a0a523f8078b5a8e1e37a4efb13cb3a9ff884ad7259a86a01d795a
company,2023-05-06 01:54:00,3 Low-Volatility Stocks for a Stable Investment Strategy,120203510,,AZN,InvestorPlace,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=918760649b46f936c34f7e81ca9727b414eb08147368ed17e354d8445cd5a690
company,2023-05-05 12:39:00,"AstraZeneca PLC ADR rises Friday, still underperforms market",120281978,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR rallied 1.20% to $75.27 Friday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=7508061bdb8c8fa044f5b63deb801367942ad3b2a78da2b770f8a69d675a2eed
company,2023-05-05 08:01:00,"AstraZeneca rises Friday, still underperforms market",120281979,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"Shares of AstraZeneca PLC inched up 0.61% to £119.22 Friday, on what proved to be an all-around great trading session for the stock market, with the FTSE 100...",https://finnhub.io/api/news?id=e561363b0039ac19e857065c5234152ce571a4175c265159878322b55225525a
company,2023-05-05 04:58:00,WHO ends global public health emergency status for COVID-19,120177951,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=f343e30cd5f99c7138d2d68e434dcf62e31a7d6aec7fa416ebf50c2257d958b5
company,2023-05-05 03:08:00,FibroGen stock falls ~10% after roxadustat fails phase 3 trial for anemia,120178350,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=c38b3aaabf1ed816d4247eaa5abb63f0329987f0b1d3b2622bbcc09ee3f28441
company,2023-05-05 02:35:00,FibroGen announces MATTERHORN study did not meet primary efficacy endpoint,120178351,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=f836908f6dc3aeee79414bccd96e8f9e5db8359833d5ca3e1f4970bb4027030a
company,2023-05-04 12:39:00,"AstraZeneca PLC ADR falls Thursday, still outperforms market",120281981,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR sank 0.28% to $74.38 Thursday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=5f9c274e775b1194485f69252554c43a52ff908abe8a8c3d7dcdbcdb60485c60
company,2023-05-04 12:20:00,Baron Health Care Fund Q1 2023 Shareholder Letter,120154282,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1413600685/image_1413600685.jpg?io=getty-c-w1536,AZN,SeekingAlpha,"Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing.",https://finnhub.io/api/news?id=b5222c6026790f30b504854323119e66a4358f9f23cd2d18929af3fafe218129
company,2023-05-04 08:01:00,"AstraZeneca falls Thursday, still outperforms market",120281983,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"AstraZeneca PLC shares inched down 0.29% to £118.50 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the FTSE...",https://finnhub.io/api/news?id=9a3e37567e26f7321d4bb3782add583f33abef31835b67338766e35264bc566e
company,2023-05-04 06:37:00,June 23rd Options Now Available For AstraZeneca (AZN),120157429,,AZN,Stock Options Channel,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=35cdf3768648c9b0bbfd538b9f7fb2d5b83f156a57f0111a891dd5e0055cf7b5
company,2023-05-04 06:04:00,AstraZeneca management to meet with TD Cowen,120157430,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=79ad3558d57c1b09e9546027f0361ec9189563b581653da817c997133a7279f8
company,2023-05-04 05:54:00,Ionis Pharma upgraded at Citi after quarterly update,120149009,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=2e2df1033c8bf83572e6ccf4dcaa0b9864ebf8f211c6c1adf834af638f865c48
company,2023-05-04 04:10:04,Q1 2023 Ionis Pharmaceuticals Inc Earnings Call,120145005,https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png,AZN,Yahoo,Q1 2023 Ionis Pharmaceuticals Inc Earnings Call,https://finnhub.io/api/news?id=7b59c35b589d983a0e43ddc6425bdc6a5ba2a989ef99784e10e8636e1296dc6e
company,2023-05-04 03:53:00,Pieris Pharmaceuticals completes safety review for 10 mg dose of elarekibep,120157432,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=17443d1d151bc3be3c148edfb093f4ddfa25ac05c53b3676475db52173c7107e
company,2023-05-04 01:12:00,"AstraZeneca chair says increasing CEO`s pay wards of rivals, FT reports",120157433,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=75cc8a501a4b82a24b1cb1d12ff0a24a9e1d10f7120eea8291118c8f9560c4ce
company,2023-05-04 00:30:00,Baron International Growth Fund Q1 2023 Quarterly Letter,120143605,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/515158258/image_515158258.jpg?io=getty-c-w1536,AZN,SeekingAlpha,Baron International Growth Fund gained 3.75% (Institutional Shares) during the first quarter of 2023. Click here to read the full fund letter.,https://finnhub.io/api/news?id=5955b4def0013eee90e57084d00c7566fbc16a69822b2b59c885dc64a606d1b6
company,2023-05-04 00:00:05,AstraZeneca chair says it is paying CEO enough to ward off US rivals,120147348,https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png,AZN,Yahoo,"The new chair of AstraZeneca believes the drugmaker has extinguished the threat of chief executive Pascal Soriot quitting for lucrative roles in the US, saying that the benefit of increasing his pay in recent years outweighed the criticism from some shareholders.  Under Soriot, who has led AstraZeneca for more than a decade, the group has become the most valuable company on the London market, with a market capitalisation of £185bn.  Sales of its innovative cancer drugs has helped propel the group to three times the size of UK rival GSK.",https://finnhub.io/api/news?id=86862e22747520d8501a82866eb6dbf2b6989f6d8d52cc3d8201ae39e6c5ec04
company,2023-05-03 21:30:00,WHO meeting is set to decide whether to end COVID emergency,120154386,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=cb27eb61f00c161735bf8db3c861806863f50976b11da1bae0649bf62e6aaa17
company,2023-05-03 14:25:00,ADRs End Mostly Lower; Sernova Gains on AstraZeneca Collaboration,120281984,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,By Sabela Ojea International stocks trading in New York closed mostly lower Wednesday. The S&P/BNY Mellon index of American depositary receipts fell 0.02% to...,https://finnhub.io/api/news?id=1b45a1ebe63dda2fcc525bd6167bcc92eb3ba36da653da2acb9f7e4417d0c360
company,2023-05-03 13:34:47,AZN Stock Today: This Options Trade Boosts AstraZeneca Stock Yield To 21% Annualized,120135703,,AZN,Yahoo,"AstraZeneca is a group leader that is showing an improving Relative Strength Rating. So, let's look at how a covered call trade on AZN stock might take shape. Income investors can further enhance the yield on the stock through the use of covered calls.",https://finnhub.io/api/news?id=dda22f9dba06d348b74b24304ec81681d255be3417404d4f28a6ad6a4d24360f
company,2023-05-03 12:39:00,AstraZeneca PLC ADR outperforms market on strong trading day,120281985,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR rose 1.21% to $74.59 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=5c2956e8fcc4ab5e8b5c96ef66467c50c625d107022271fb755eeaa29c958e44
company,2023-05-03 11:45:03,Why Astrazeneca (AZN) is a Top Dividend Stock for Your Portfolio,120135704,https://media.zenfs.com/en/zacks.com/c2fdcaac033e049c74f38d188afcc9f9,AZN,Yahoo,"Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Astrazeneca (AZN) have what it takes? Let's find out.",https://finnhub.io/api/news?id=5467fd790c995b0a7419c1a40983e49c88cd757abe3a622aab523b048ac61a87
company,2023-05-03 09:29:00,US approves 1st vaccine for RSV after decades of attempts,120129104,,AZN,"Associated Press, The",Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=d6df621e449473d731c1ece687fcd6b4ffb6ec6d1da43b4a1507acd1b81f917e
company,2023-05-03 08:01:00,"AstraZeneca rises Wednesday, outperforms market",120281986,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"AstraZeneca PLC shares inched up 0.93% to £118.84 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the FTSE...",https://finnhub.io/api/news?id=4af30074949911a6c5e5f8ceb7f3a9cba760706d83cfcb7bfc55b0c93ca847a7
company,2023-05-03 07:01:00,Sernova Shares Jump With AstraZeneca Collaboration,120281987,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,By Robb M. Stewart Sernova's shares rallied Wednesday after the biotechnology company entered a preclinical research collaboration with AstraZeneca to...,https://finnhub.io/api/news?id=7a6cfb49d863462850903ccf242b61745a7c1f6743864ce2a6cac42c96a7eae1
company,2023-05-03 03:24:00,"Sernova, AstraZeneca to Collaborate to Evaluate Potential Therapeutic Cell Applications",120281988,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,By Robb M. Stewart Biotechnology company Sernova said Wednesday it entered a preclinical research collaboration with AstraZeneca to evaluate the use of its...,https://finnhub.io/api/news?id=feed384400ebcd2bbbdcf674e4b7a598f4cd3a219c051200925a614ee8cfd55e
company,2023-05-03 03:13:00,VGK: 5 Reasons I Like This European ETF,120136847,,AZN,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=d9f8527aa085d65958a0a14d511c97784894453e519593b848db67401e8e27f8
company,2023-05-03 02:27:00,"Sernova, AstraZeneca enter collaboration for therapeutic cell applications",120122487,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=81cc3fb0d75712731bb6c2653c695bf8d6d6f0c8d57faf16bfb0093ccb6ab057
company,2023-05-03 01:12:00,"Fentanyl overdose deaths rose 279%, oxycodone deaths fell in 5 years",120122488,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=4e7cdba0cfdef6ac4068db0ab9b51c69d63b0b7165b535f18684d450009c9bd1
company,2023-05-10 12:39:00,"AstraZeneca PLC ADR falls Wednesday, underperforms market",120281967,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR shed 0.28% to $74.87 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=1c2ed12f20fa004d6b8f7906d428cbc0dce2b48dbac4fc43ecc20818d585953b
company,2023-05-10 08:01:00,"AstraZeneca falls Wednesday, underperforms market",120281969,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"Shares of AstraZeneca PLC inched down 0.79% to £118.20 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the FTSE...",https://finnhub.io/api/news?id=694287b6fcaefb6642d48abd618d377dfe57751f67035aa7ae9b117c03ae78d4
company,2023-05-10 01:45:00,AstraZeneca`s Ultomiris approved in EU for adults with NMOSD,120287449,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=f11d5cd5d2c6c1ca13a91e74effeadb8a9f096c2b18edea6f64c2c0f3f297b6f
company,2023-05-09 23:50:00,AstraZeneca's Ultomiris approved in EU for autoimmune disease NMOSD,120287451,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=af5ea0f40c3078eb4bd153d08f465ae062705ee81fc4d5df876badc21a972d07
company,2023-05-09 23:50:00,AstraZeneca`s Ultomiris gets expanded approval in EU for rare nervous system disorder,120287450,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=d82c204e0f524bac4697d9430568775c9ec27482548786ccda8c544f4e1ac74d
company,2023-05-09 23:44:00,AstraZeneca Ultomiris gets expanded approval in EU for rare nervous system disorder,120287452,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=541cb18adf77247ac05121d5363969f5cfa9086ac59c1c347e827ed6aa25c682
company,2023-05-09 16:09:59,15 Biggest Immunotherapy Companies in the World,120248234,https://media.zenfs.com/en/insidermonkey.com/152faade4bb55ed2f80bad06096a951e,AZN,Yahoo,"In this article, we will take a look at the 15 biggest immunotherapy companies in the world. If you want to see more companies in this selection, go to the 5 Biggest Immunotherapy Companies in the World. The immunotherapy industry is a rapidly growing field that is focused on developing treatments that harness the power […]",https://finnhub.io/api/news?id=8f2ad8892373ea11de72ee1fef425193dffda9002847b675f7de14867872dc5b
company,2023-05-09 12:39:00,"AstraZeneca PLC ADR falls Tuesday, still outperforms market",120281971,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR slumped 0.33% to $75.08 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=5587eda4b3d41851b12bd120156a3e09f80c9647edd10dbb9f1198e83fd70c6d
company,2023-05-09 11:37:00,FARXIGA extended in the US to reduce risk of cardiovascular death and hospitalization for heart failure to a broader range of patients,120241843,https://media.zenfs.com/en/business-wire.com/16c163c101e098e066eabda9ae2735c8,AZN,Yahoo,"WILMINGTON, Del., May 09, 2023--AstraZeneca’s FARXIGA (dapagliflozin) has been approved in the US to reduce the risk of cardiovascular (CV) death, hospitalization for heart failure (hHF) and urgent heart failure (HF) visits in adults with HF. The approval by the Food and Drug Administration (FDA) was based on positive results from the DELIVER Phase III trial.1 FARXIGA was previously approved in the US for adults with HF with reduced ejection fraction (HFrEF).",https://finnhub.io/api/news?id=2e6fc0126ef3e4ed5263b0a7d3bdde6ff2de239733f817a0e72828eaa59e53f8
company,2023-05-09 08:01:00,AstraZeneca outperforms market despite losses on the day,120281973,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"Shares of AstraZeneca PLC inched down 0.07% to £119.14 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the FTSE...",https://finnhub.io/api/news?id=99bce134b8058e06286c6a18f965d56203c58e2851e58dde723f1b6621e58e79
company,2023-05-09 06:55:00,AstraZeneca put volume heavy and directionally bearish,120287455,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=1f2cf2c03da35473434a1fbedd2deaa268dfab68024c07337305bd3615976223
company,2023-05-09 03:16:00,GLOBAL BROKER RATINGS: Peel Hunt says 'buy' IAG; RBC lifts Intertek,120242434,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=88ace8aea24b2450ef02156443975ecf4c14985a943c660fa4ad62d05bb26f53
company,2023-05-09 01:44:00,AstraZeneca says Farxiga extended in U.S. to reduce risk of cardiovascular death,120287458,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=ef03aa6ee5abc903b291422e44e75ee9810f989d5356f8662823769df1011bac
company,2023-05-09 00:29:00,LONDON BROKER RATINGS: RBC raises Intertek; Davy likes Greencoat UK,120242828,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=8a8774f35fbbb96dc7f7fca6836c1980ba4dc6513345dc9f28632b9342bcc9c9
company,2023-05-09 00:09:00,TOP NEWS: AstraZeneca's Farxiga approved in US to treat heart failure,120287461,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=ea5204b0e0dca493f0d074c73f50499ba20668b254b70f98c90397fd26ea826e
company,2023-05-08 23:42:00,AstraZeneca`s Farxiga gets FDA approval to reduce risk of death due to heart failure,120287462,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=78115e00c644a31d0e0d779deb35745a5de826bf4e2c505e9d9b9fbd73e62355
company,2023-05-08 23:35:00,AstraZeneca Farxiga gets FDA approval to reduce risk of death due to heart failure,120287464,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=14c901f11eb3bcdce075dc4e523d0746080bdc2e1936d8f6895b868f130486db
company,2023-05-08 22:16:00,AstraZeneca Gets Broader Approval for Heart Failure Treatment in US,120281974,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,By Christian Moess Laursen AstraZeneca said Tuesday that its Farxiga treatment has been approved in the U.S for use on patients with heart failure. The...,https://finnhub.io/api/news?id=9b3f2fb2ca8fbbbcb89abb9195066a998a340477e27bcdea2ac8525016e9438b
company,2023-05-08 22:15:00,AstraZeneca price target raised to 135 GBp from 124 GBp at Berenberg,120287465,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=ba9104b2c00627c59c6c69dd3bcb986930b838801c03f42af05425bfa83cf3e8
company,2023-05-08 12:39:00,"AstraZeneca PLC ADR rises Monday, still underperforms market",120281976,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR inched 0.08% higher to $75.33 Monday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=2565ebdcb967a1c6bc9e31cbf35c4230ebb1408d924b26d0abe6e28ef4b7ff66
company,2023-05-08 03:45:00,The 7 Best Mutual Funds to Invest in for May 2023,120240965,,AZN,InvestorPlace,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=1ef59f1a2c6457b1286b2ad72e457e1501c8e97d4227b2c952edc048a203a739
company,2023-05-08 02:20:00,AstraZeneca reports Koselugo approved in China for inoperable PN in NF1 patients,120287467,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=8b7feea79eb5cf66dccb0a8111bd786f520f27f1a012aaa66ea5a5712b40a591
company,2023-05-07 23:39:00,"AstraZeneca, Merck`s Koselugo gets approval in China for rare genetic disorder in kids",120287469,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=8fc1c4576561219c385565036586636e51bc2df264d6691c4647a815794bf4fe
company,2023-05-14 08:00:00,Is AstraZeneca Stock a Buy for Growth Investors?,120344463,,AZN,Yahoo,"Just 14% of drugs in development (according to a 2018 study) ever make it to market, so investing in pharmaceuticals is a bit of a shot in the dark.  This is why I'd advise most investors to consider only the most dominant and established pharmaceutical companies for their portfolios.  British drugmaker AstraZeneca (NASDAQ: AZN) is one such company.",https://finnhub.io/api/news?id=8ae166d3dde295050936a05d07cab96abe2dd4d2fe85d1dcb89d7fd6f30bd8f7
company,2023-05-13 23:56:00,How The Pharmaceutical Industry Is Using AI,120342278,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1423708201/image_1423708201.jpg?io=getty-c-w1536,AZN,SeekingAlpha,Industry-leading pharmaceutical firms are adopting AI to drive value for the future of their enterprise. Several companies in the PPH ETF are currently integrating AI into their operations.,https://finnhub.io/api/news?id=0fde7cecbff2505a55e1ce8d9da56410bb9c3ddec3c00f209fc4237c5402c8ce
company,2023-05-12 23:04:00,Cancer therapies spending set to surge through end of decade,120338285,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=20fef99a5ede16904c01c88acab5b668fccd3fcb0df23af653860f221e663dcd
company,2023-05-12 18:48:48,25 Best US Cities for People With Allergies,120325644,https://s.yimg.com/ny/api/res/1.2/ulJtFMYDPOkTDSP8hT76Zw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04ODM-/https://media.zenfs.com/en/insidermonkey.com/9f94113e14aa0946c2ff76540598f8e6,AZN,Yahoo,"In this article, we will take a look at the 25 best US cities for people with allergies. If you want to see more cities in this selection, go to the 5 Best US Cities for People With Allergies. According to Allied Market Research, the market for allergy treatments was valued at $24.6 billion in […]",https://finnhub.io/api/news?id=527159e9708a087079fa65b487d2fac07c4e05a9feffac63966c6ea1e82deb90
company,2023-05-12 04:50:51,Sanofi Says Its RSV Shot Significantly Cut Hospitalization Risk In Newborns,120314819,https://media.zenfs.com/en/ibd.com/39552a8c730cc984b85b9f305609e672,AZN,Yahoo,Sanofi said Friday its shot significantly reduced the risk of babies becoming hospitalized with RSV. The results could stoke Sanofi stock.,https://finnhub.io/api/news?id=413a6af1c0c1b0af32e457ac18ce1a6f38c7fc1a35283d22482dfda67fe4c9af
company,2023-05-12 13:14:24,Directors’ Deals: AstraZeneca chair bets on upward momentum,120327661,https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png,AZN,Yahoo,"AstraZeneca is the jewel in the FTSE 100’s crown.  The pharmaceutical group now has a market capitalisation of £182bn.  This places it firmly ahead of Shell, the index’s second-largest constituent, with a market cap of £161bn.",https://finnhub.io/api/news?id=b486b1f5296548fcc9a452cf7fc9e166045da21f370cc26406cca9b970297162
company,2023-05-12 12:39:00,"AstraZeneca PLC ADR remains steady Friday, still outperforms market",120404619,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR were unchanged Friday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index...",https://finnhub.io/api/news?id=e2a3b2e28abd4df8c68bd14a19d3d61a6f5f993fa15572cdd7c07da3c07cd744
company,2023-05-12 11:53:50,"Sanofi, AstraZeneca Release Real-World Data For Respiratory Syncytial Virus Antibody",120324465,https://media.zenfs.com/en/Benzinga/69588479d67116817e5ab3f69f6747f3,AZN,Yahoo,"The race to tap the respiratory syncytial virus (RSV) this season intensifies as Sanofi SA (NASDAQ: SNY) and AstraZeneca Plc (NASDAQ: AZN) have revealed data from a real-world trial of their candidate nirsevimab, a long-acting antibody. In November, nirsevimab was approved in Europe, dubbed Beyfortus, to prevent RSV-LRTD in newborns and infants during their first RSV season. The phase 3 HARMONIE study recruited over 8,000 infants 12 months and younger. Infants who received a single dose of the a",https://finnhub.io/api/news?id=9d062d0d3b1de72fd235e829907d4b1935684d74f0e8ebaf98df6d670f10ec51
company,2023-05-12 09:12:01,"Pharma Stock Roundup: BAYRY Mixed Q1 Results, AZN, RHHBY Regulatory/Pipeline Updates",120325646,https://media.zenfs.com/en/zacks.com/9883d206905e7516b2353476e213e60c,AZN,Yahoo,Bayer (BAYRY) announces mixed Q1 results. AstraZeneca's (AZN) Ultomiris gets approval for a new rare disease indication in the EU.,https://finnhub.io/api/news?id=d0eabb4832a93aedfc353463d10e8282334d67e30990575407b1eb5a21f03488
company,2023-05-12 08:01:00,"AstraZeneca rises Friday, outperforms market",120404620,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"Shares of AstraZeneca PLC inched up 0.72% to £120.10 Friday, on what proved to be an all-around favorable trading session for the stock market, with the FTSE...",https://finnhub.io/api/news?id=be5e953b43f354557501c5a8700f2d4faa85e4bdf5a1295db8434a2c78cc871c
company,2023-05-12 07:30:00,"LaNova Medicines Announces Global Exclusive License Agreement with AstraZeneca for LM-305, a Novel GPRC5D-Targeting Antibody Drug Conjugate",120322672,,AZN,PR Newswire,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=f4b783dd68d0c339679f2fc0954c848ac40ac7d97bf4a3bf8a88c6ee7e2c8baf
company,2023-05-12 06:34:00,LaNova Medicines reports global exclusive LM-305 license pact with AstraZeneca,120322674,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=3dca3caed617695634522b43c1ff076d5d57eb09d3383d14e56a45ecacc10e3b
company,2023-05-12 02:50:00,Capital One biotech analysts to hold an analyst/industry conference call,120319513,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=2ebacfed45f3e9e8028a471945c17d210371cbdd504261e1dcbcc234f77df8ee
company,2023-05-12 02:35:00,Celcuity gedatolisib combo shows promise in phase 1b trial in breast cancer patients,120317826,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=a88f4f71d14d614d2d53188ed4148b9157bb13b8143219a9964ad5630fbe480c
company,2023-05-11 13:41:28,"Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) Q1 2023 Earnings Call Transcript",120305658,https://media.zenfs.com/en/insidermonkey.com/a3355b66f8b9be42d814254460df8013,AZN,Yahoo,"Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) Q1 2023 Earnings Call Transcript May 10, 2023 Operator: Good day, ladies and gentlemen. And welcome to the Pieris Pharmaceuticals to host First Quarter 2023 Investor Call. [Operator Instructions] At this time, it is my pleasure to turn the floor over to your host Tom Bures, CFO. Sir, the floor is […]",https://finnhub.io/api/news?id=0ce353e80aa138f598cbd31021ea539df0c02fa214389b3358b4703944a64856
company,2023-05-11 12:39:00,"AstraZeneca PLC ADR falls Thursday, underperforms market",120404621,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR sank 0.19% to $74.73 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=4e800e8dae805032705ef7c9d10303007f5dd9201e3966d96b9c139ae4ff56c5
company,2023-05-11 08:39:06,Top Healthcare Stocks for May 2023,120308157,https://s.yimg.com/ny/api/res/1.2/TLg_qRIr.04wdDa9wvDSZw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD03NjM-/https://media.zenfs.com/en/investopedia.com/d97a87d571d4fef7512c500c1e1f0863,AZN,Yahoo,"Top healthcare stocks include Azenta Inc. for best value, ShockWave Medical for fastest growth, and Viking Therapeutics for most momentum.",https://finnhub.io/api/news?id=7b360987e4a649ae5f64732854e7ff9b493a9c4b8013d169aaee571c1fd79cad
company,2023-05-11 08:01:00,"AstraZeneca rises Thursday, outperforms market",120404622,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"Shares of AstraZeneca PLC inched up 0.88% to £119.24 Thursday, on what proved to be an all-around grim trading session for the stock market, with the FTSE...",https://finnhub.io/api/news?id=2054e3b52cad99448a64455e63f7d4b5fefa80c0cfe5a33115586eb7e5bb01b6
company,2023-05-11 06:52:00,June 30th Options Now Available For AstraZeneca (AZN),120303717,,AZN,Stock Options Channel,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=9bed4fff55324e01809614a2bf5e5e33c16d07b01f6a8831fe144370245f5322
company,2023-05-10 23:19:12,Unusual Call Option Trade in Astrazeneca plc - ADR (AZN)  Worth $261.13K,120291219,,AZN,Fintel,,https://finnhub.io/api/news?id=2265668df2116667a4c58fb015145e34a276334dcfee051ef6e93a268056d225
company,2023-05-18 17:43:42,The 7 Next Trillion-Dollar Companies to Invest in Now,120490337,https://media.zenfs.com/en/investorplace_417/c94826697eb5138724ce1cfa146ba378,AZN,Yahoo,"In the last decade, few companies have touched the magic trillion-dollar valuation. Apple (NASDAQ:AAPL), Amazon (NASDAQ:AMZN), and Alphabet (NASDAQ:GOOG, NASDAQ: GOOGL) are the names worth mentioning. While these businesses will continue to create value, I am more interested in finding the next trillion-dollar companies. An interesting point to note is that most of the trillion-dollar valuation companies in the last decade were from the technology sector. Of course, there are potential opportuni",https://finnhub.io/api/news?id=748fbedc3e36d1a6e56dd7332f1775348d4409f5ccab3e9dc82131d103b7a4b3
company,2023-05-18 12:39:00,AstraZeneca PLC ADR underperforms Thursday when compared to competitors,120512919,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR shed 0.66% to $74.21 Thursday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=3b527211df649926785a3884b04abb5b7c331c63e1040d61f0d07531498d21a7
company,2023-05-18 08:01:00,"AstraZeneca rises Thursday, outperforms market",120512921,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"Shares of AstraZeneca PLC inched up 0.45% to £119.78 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the...",https://finnhub.io/api/news?id=d71463970cbdae8b897258afa625adf73cc8d4a532e7b7c3affa7f0ecd56da30
company,2023-05-18 07:29:23,Baron Health Care Fund Reduced AstraZeneca PLC (AZN) on Competition Concerns,120413442,https://media.zenfs.com/en/insidermonkey.com/8577738f84a3c852cf540caf7ca4aba5,AZN,Yahoo,"Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2023 investor letter. A copy of the same can be downloaded here. The first quarter was difficult for the fund, as it failed to participate in the broader market rally and declined 3.69% compared to the 3.27% decline for the benchmark Russell […]",https://finnhub.io/api/news?id=43800ed1b458b25448d57e86817df905eef151249441ef50594c3c7d33e16490
company,2023-05-18 06:26:00,FDA advisers back RSV vaccine for pregnant women that protects their newborns,120428711,,AZN,"Associated Press, The",Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=756b817619c12b9193954e787ceba501632572230f9e072c1b5e2224ab78ab3f
company,2023-05-18 06:22:00,Supreme Court rules against Amgen in Repatha patent dispute with Sanofi/ Regeneron,120418514,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=acb5f80ee815fbbac80585b098b9a9db54ae8da277a2b87428212291f6122de6
company,2023-05-18 06:16:00,Supreme Court rules against Amgen in Rapatha patent dispute with Sanofi/ Regeneron,120418515,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=a4e5dc10449f7f5220cf0b00e7e09cf1d343ee747af6028511d73381d847fe2b
company,2023-05-18 04:40:00,Unusually active option classes on open May 18th,120419813,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=51eae4c556a1e42e3ff80b9f6f3bef364a5002f13a6c25c7f6b01f8abb095191
company,2023-05-18 03:23:00,FibroGen stock rises after roxadustat matches Sepo in Chinese trial for anemia,120426825,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=e204c6ef4faa850357e0d6154cb273086c86bce47533c81072425be52c9fca6b
company,2023-05-18 02:00:00,Revvity Announces New License Agreement for Next-Generation Base Editing Technology,120428717,,AZN,Business Wire,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=3e971fdda37b50fc2ff58c6df8d96d1750f3cd12967408434a0ec836c7fa839c
company,2023-05-18 01:46:00,"Revvity licenses gene editing tech to AstraZeneca for cancer, immune-mediated therapies",120428718,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=a75411865f88fed0ef99ef4ff07c98885ffc1fcd846b5359f62a14fbe2d6c852
company,2023-05-18 01:06:00,Revvity announces new license agreement with AstraZeneca,120428720,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=1209d89ff95872f44d3579ed8ac80a362c69bf8bdf2a62221c972596d2d44fd7
company,2023-05-17 21:18:00,WHO recommends updating COVID shots to add XBB.1 variants,120428723,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=2271fedf1655bb2f60c734622a7e54cd99a0a908c1a7922f2313350f0920e6bf
company,2023-05-17 12:39:00,"AstraZeneca PLC ADR falls Wednesday, underperforms market",120404612,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR slumped 0.77% to $74.70 Wednesday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=b91afef22876ec754ec54f51136894181fbc79d4c34f3981589d5d6c789d5f9a
company,2023-05-17 10:15:16,"AstraZeneca' Tagrisso/Chemo Combo Therapy Delays Treatment Resistance, Disease Progression In Certain Type Of Advanced Lung Cancer",120406951,https://media.zenfs.com/en/Benzinga/f2e20dfdec65f7b24c0f0c14a5d73aa8,AZN,Yahoo,AstraZeneca Plc (NASDAQ: AZN) has reported topline data from the Phase 3 FLAURA2 trial of Tagrisso (osimertinib) in combination with chemotherapy for locally advanced (Stage IIIB-IIIC) or metastatic (Stage IV) epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC). The results showed that Tagrisso plus chemotherapy demonstrated a statistically significant and clinically meaningful improvement in progression-free survival (PFS) compared to Tagrisso alone. Related: Ast,https://finnhub.io/api/news?id=cc18d8e67ad86f93eb154fdfa32eea7dd74378f572c1139bf311ad2bfb185d43
company,2023-05-17 08:01:00,"AstraZeneca falls Wednesday, underperforms market",120404613,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"AstraZeneca PLC shares dropped 1.21% to £119.24 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the FTSE 100...",https://finnhub.io/api/news?id=698af2f934b609fa0a415ab4af257637d7bf24d0fd23ab409f450cd74f37ac21
company,2023-05-17 07:00:00,TAGRISSO® (osimertinib) plus chemotherapy demonstrated strong improvement in progression-free survival for patients with EGFR-mutated advanced lung cancer in FLAURA2 Phase III trial,120406952,https://media.zenfs.com/en/business-wire.com/224be942723f4bb0c97046cffd51fb79,AZN,Yahoo,"WILMINGTON, Del., May 17, 2023--Positive high-level results from the FLAURA2 Phase III trial showed AstraZeneca’s TAGRISSO® (osimertinib) in combination with chemotherapy demonstrated a statistically significant and clinically meaningful improvement in progression-free survival (PFS) compared to TAGRISSO alone for patients with locally advanced (Stage IIIB-IIIC) or metastatic (Stage IV) epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC).",https://finnhub.io/api/news?id=a00db5f94236fb474d3e206ca7e62da3966b6d2e525cbed88eb2ff0e46d8293e
company,2023-05-17 05:08:57,"AstraZeneca's Tagrisso, chemo combination shows promise in lung cancer trial",120406953,https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png,AZN,Yahoo,"The combination of AstraZeneca's cancer drug, Tagrisso, with chemotherapy to treat patients with a type of lung cancer showed positive results in a late-stage trial, the company said on Wednesday.  The drug maker said patients on the combined treatment showed a meaningful improvement in progression-free survival, or how long a patient lives without the disease getting worse after treatment, than patients given only Tagrisso.  The trial was on patients with locally advanced or metastatic epidermal growth factor receptor-mutated non-small cell lung cancer.",https://finnhub.io/api/news?id=7cd1478735dea6039af3f0a07275f24d24f6c7704685aa69dfc4847ad95078c3
company,2023-05-17 02:06:00,AstraZeneca announces Tagrisso combination demonstrates statistical significance,120394514,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=721ba54bc9dee14e6128798a3f020bd31707e22d62d604be61900619ee264f15
company,2023-05-17 00:53:00,AstraZeneca's Tagrisso plus chemotherapy effective against lung cancer,120394515,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=adc57c18ec83b9885f03f604c38cd1eb840b59e96276d67baafad087afdac6cc
company,2023-05-17 00:46:00,AstraZeneca Tagrisso chemo combo cuts risk of lung cancer progression in trial,120394516,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=9237f1aef05747446556c2795449e41f87752cabbbd0f4a7c1b58850c213f720
company,2023-05-16 22:51:00,AstraZeneca Tagrisso Drug In Combination With Chemo Showed Strong Improvement In Trial,120404614,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,By Christian Moess Laursen AstraZeneca said Wednesday that trial results showed that its Tagrisso drug in combination with chemotherapy demonstrated strong...,https://finnhub.io/api/news?id=77f134dca6ffedccd3a515a3c52f4df9020545f8eadda675a37a9e6d8ae32be4
company,2023-05-16 20:55:30,Pieris Pharmaceuticals: Expanding Elarekibep (AZD1402) Trial Finally Has Active And Completed Sites,120384256,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/57611043/image_57611043.jpg?io=getty-c-w1536,AZN,SeekingAlpha,Pieris' expanding Elarekibep trial finally has active/completed sites. Read more to see my thoughts on PIRS stock and why it is a Buy.,https://finnhub.io/api/news?id=faccd7f62c48dc9ab9bd267fd9e78722511a6530b62c71350d1467acf4575207
company,2023-05-16 12:46:23,Is AstraZeneca Overvalued After Publishing Q1 2023 Financial Results?,120375557,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1411581322/image_1411581322.jpg?io=getty-c-w1536,AZN,SeekingAlpha,"We continue our coverage of AstraZeneca with a 'hold' rating for the next 12 months. Demand for some AZN innovative drugs is high, click for our view.",https://finnhub.io/api/news?id=9553430708fdb8d883fe2597d8d791fc8b6a5b720d873ef91da137ee1e720c27
company,2023-05-16 12:39:00,AstraZeneca PLC ADR outperforms market on strong trading day,120404615,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR inched 0.39% higher to $75.28 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=63f748b72df2bde1d383119a5143be04c189ebba067a3a09e6d9d563067754c7
company,2023-05-16 09:12:03,UPDATE 1-AstraZeneca to leave leading U.S. drug lobby group,120385942,https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png,AZN,Yahoo,"AstraZeneca has decided to leave the main U.S. drug lobby group, the Pharmaceutical Research and Manufacturers of America (PhRMA), and pursue other ways of engaging in advocacy at the state and federal level, the company said.  AstraZeneca decided not to continue its membership after a recent assessment of whether it was ""the most productive and effective use of (company) resources"", a spokesperson for the British drugmaker said in an emailed statement.  PhRMA said in a separate emailed statement that AstraZeneca had decided not to renew its membership for the second half of 2023.",https://finnhub.io/api/news?id=133f3f0ac856feb30197add13ab99f7adf927c2ec6561d435fcbba1bc5ed3839
company,2023-05-16 08:01:00,"AstraZeneca rises Tuesday, outperforms market",120404616,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"AstraZeneca PLC shares inched up 0.58% to £120.70 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the FTSE 100...",https://finnhub.io/api/news?id=ffc5dbd2a06ae4d1acc3ecd8753e0beed3612aa6ff7f84d258c748efe2bbe159
company,2023-05-16 07:38:01,AstraZeneca to leave leading U.S. drug lobby group,120385943,https://media.zenfs.com/en/reuters-finance.com/50f8df62c0699027a5e584da165d340e,AZN,Yahoo,"LONDON (Reuters) -AstraZeneca has decided to leave the main U.S. drug lobby group, the Pharmaceutical Research and Manufacturers of America (PhRMA), and pursue other ways of engaging in advocacy at the state and federal level, the company said.  AstraZeneca decided not to continue its membership after a recent assessment of whether it was ""the most productive and effective use of (company) resources"", a spokesperson for the British drugmaker said in an emailed statement.  PhRMA said in a separate emailed statement that AstraZeneca had decided not to renew its membership for the second half of 2023.",https://finnhub.io/api/news?id=75d9c54f6ee3a4491c13b689db8c587d7f480cccf4a320aef078d8d23eed8d0f
company,2023-05-16 06:55:46,AstraZeneca PLC (LON:AZN) Is Up But Financials Look Inconsistent: Which Way Is The Stock Headed?,120385944,https://media.zenfs.com/en/simply_wall_st__316/bba95900ab96866c17a285be850152bf,AZN,Yahoo,"AstraZeneca's (LON:AZN) stock is up by 4.2% over the past three months. However, the company's financials look a bit...",https://finnhub.io/api/news?id=450409d5d6333d46ed874abeb3feba54fbeb9c9023567d9804eb00615f8df003
company,2023-05-16 03:54:00,AstraZeneca to exit leading U.S. drug industry group PhRMA,120370601,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=7f6ccefebf040001ee2212365f1e252046a428d317ee386840552e3e850514d0
company,2023-05-15 22:05:00,AI Meets Biotech: Transforming the Drug Development Process,120379287,,AZN,InvestorPlace,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=d582caf0a6948b87a1ab6769dac0fa4d7eb2491ae9f5bae5c969d085399f8ee1
company,2023-05-15 12:39:00,"AstraZeneca PLC ADR rises Monday, still underperforms market",120404617,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR inched 0.35% higher to $74.99 Monday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=e3c6d3f4a349177edbbee0790b999024f41902d424dd28330ffd3980263d4b68
company,2023-05-15 08:01:00,"AstraZeneca falls Monday, underperforms market",120404618,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"Shares of AstraZeneca PLC inched down 0.08% to £120.00 Monday, on what proved to be an all-around great trading session for the stock market, with the FTSE...",https://finnhub.io/api/news?id=97c95660e29a07017a749756c4822380d3788dd96f8b15362e2cd3435d9c1df7
company,2023-05-22 12:39:00,AstraZeneca PLC ADR outperforms competitors despite losses on the day,120512911,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR shed 0.45% to $74.45 Monday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite...",https://finnhub.io/api/news?id=c201bc731a926084d16ebd40f521cab0a25fc87c9cf54514d88eec0e88600ac0
company,2023-05-22 08:01:00,"AstraZeneca rises Monday, outperforms market",120512913,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"Shares of AstraZeneca PLC inched up 0.22% to £120.36 Monday, on what proved to be an all-around positive trading session for the stock market, with the FTSE...",https://finnhub.io/api/news?id=ed201a90bfa9488c600de50275f6dd5f4743c7c6db131fb787132fbb8fb06b9f
company,2023-05-22 05:00:00,Pfizer Yielding 4.5% Is Getting Added To My Dividend Harvesting Portfolio And Maybe The Main Account,120479559,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1341266246/image_1341266246.jpg?io=getty-c-w1536,AZN,SeekingAlpha,Pfizer has fallen through the $40 level and looks very enticing as its dividend yield sits at 4.5%. See why I added PFE stock to my portfolio.,https://finnhub.io/api/news?id=eec8b276c841ca67d7336fe733ff572ae7d6998bb011f6ba13f1a5b059c28b3a
company,2023-05-21 23:42:00,IN BRIEF: AstraZeneca hires LSEG CFO Anna Manz as non-exec director,120486049,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=869bc65975f115e85d95ce96b8da9293e369cbb6ba22594ac994010e0a87d6c3
company,2023-05-21 07:01:00,Billions of dollars at stake as FDA shortcut allows half-proven drugs - report,120472958,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=a50e5b8a8c0517c654a3de5252893321a2f0444c3f5d49324a52104d8618c929
company,2023-05-21 05:05:00,Week In Review: LaNova Sells Pre-Clinical ADC To AstraZeneca In $600 Million Deal,120471866,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1418835107/image_1418835107.jpg?io=getty-c-w1536,AZN,SeekingAlpha,Shanghaiâs LaNova Medicines has sold global rights for a pre-clinical antibody drug conjugate candidate to AstraZeneca for $600 million plus royalties on sales. Read more here...,https://finnhub.io/api/news?id=5aab13bc651cbcdb1ffcffb10e1dc0e0824c4d406bf34ee3fd5f50b7775ccee7
company,2023-05-19 16:09:00,An AstraZeneca executive said the quiet part about China out loud,120457906,https://media.zenfs.com/en/quartz.com/73efe13e1cb9d84be8832a7dd7c8e06d,AZN,Yahoo,"AstraZeneca has big business in China. The British pharmaceutical company is the biggest drugmaker in the country, where it makes 13% of its revenue.",https://finnhub.io/api/news?id=9faa0c76b13cc3046291594efb2df2189f1db4530610534bdf44a7564dbfc950
company,2023-05-19 12:39:00,"AstraZeneca PLC ADR rises Friday, outperforms market",120512915,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR inched 0.78% higher to $74.79 Friday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=8c61c8fc94e26551550df9dfe6433f7069235d88601f3aa8ff92fcc4ed102b25
company,2023-05-19 12:30:24,Olema Oncology: Best Contrarian Oncology Play For 2023,120453107,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1423758523/image_1423758523.jpg?io=getty-c-w1536,AZN,SeekingAlpha,"Olema, clinical-stage biopharma, targeting ER+ breast cancer, has promising clinical data and a solid cash position. Click here to read why OLMA stock is a buy.",https://finnhub.io/api/news?id=58a0f0a854f0f16e64284ef45b84035e0b69adc2ecb12cc69ac977862b2058e6
company,2023-05-19 11:46:08,"DeSantis Vs. Disney, Alibaba Spinoffs Cloud Business, Apple Bans Internal ChatGPT Use: Today's Top Stories",120446501,,AZN,Yahoo,"Bloomberg Alibaba's Cloud Business Spinoff - What's Going On With Alibaba Stock Friday Alibaba Group Holding Limited's (NYSE: BABA) move to fully spin out a potentially transformative $12 billion cloud business has fueled speculation of it succumbing to market or political realities. Analysts value the cloud business at upwards of $30 billion, a prime beneficiary of a post-ChatGPT frenzy mirroring the success of Amazon.Com Inc's (NASDAQ: AMZN) cloud unit Amazon Web Services. Alibaba splurged ten",https://finnhub.io/api/news?id=2848196debab10ec88c956c3069ef9d5a5a9523b5b7e81975c0e172556d250ea
company,2023-05-19 11:45:03,Why Astrazeneca (AZN) is a Great Dividend Stock Right Now,120448490,https://media.zenfs.com/en/zacks.com/45c083e4721b0d0d1f6e431ec0bb5cc1,AZN,Yahoo,"Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Astrazeneca (AZN) have what it takes? Let's find out.",https://finnhub.io/api/news?id=a26aaeda0ddb42a631badeb18f82a05f89d4c15d6bdb159cf942f1c4070667e9
company,2023-05-19 11:27:21,3 Undervalued Pharma Stocks to Buy for High Total Returns,120498774,https://media.zenfs.com/en/investorplace_417/5b06085ec403fd81519de4f4d5892664,AZN,Yahoo,"Throughout financial history, equity markets have navigated bull and bear cycles. The same holds true for various sectors. After an extended bull market, there tends to be a price and time correction phase in various sectors. One secret to successful investing is to identify sectors that have been depressed for an extended period. Stocks in this sector tend to be undervalued, and once sentiments reverse, the rally can be massive. My focus in this column is on undervalued pharma stocks to buy. To",https://finnhub.io/api/news?id=55c46d161acbe5553777448cd164e768b0db40c4e6b66ee229c82d2c8cbf1b63
company,2023-05-19 10:25:43,"AstraZeneca's China Executive Seeks Loyalty to ""Love the Communist Party"" In China",120448492,https://media.zenfs.com/en/Benzinga/c22a96e2996b8f297c7d0e14331de2fa,AZN,Yahoo,"During an event held in the city of Wuxi to commemorate its 30th year in China, AstraZeneca Plc's (NASDAQ: AZN) China president, Wang Lei, said the company will seek to be a patriotic company in China that ""loves the Communist Party."" Wang, who also holds the position of global executive vice president, commented at the event, Reuters reported citing a person familiar with the matter and photos shared. Also Read: One More Quits US Pharma Lobby Group: AstraZeneca Follows Teva, AbbVie Footsteps. A",https://finnhub.io/api/news?id=ad424ab8e023ef4210671537401cc8edb255b017627aee7064052bae21af79a1
company,2023-05-19 08:01:00,"AstraZeneca rises Friday, outperforms market",120512917,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"Shares of AstraZeneca PLC inched up 0.27% to £120.10 Friday, on what proved to be an all-around positive trading session for the stock market, with the FTSE...",https://finnhub.io/api/news?id=5c19a29bd44b203071b409e297f4b568a959b281b45810c648c07f03207d8949
company,2023-05-19 05:53:00,"Astra China head says company seeks to `love the Communist Party,` Reuters says",120448424,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=12b1eafe4b204bd5f76b8f389e8ef4f802119d408c5a87b1970e93eb39fb87ba
company,2023-05-19 05:33:17,"AstraZeneca's China boss says drugmaker will seek to ""love the Communist Party""",120442870,https://media.zenfs.com/en/reuters-finance.com/37b52f211626104667c748413506d980,AZN,Yahoo,"Global drugmaker AstraZeneca will seek to be a patriotic company in China that ""loves the Communist Party"", its China president said at an event on Friday.  Wang Lei, who is also the company's global executive vice president, made the comments at an event in the eastern city of Wuxi which the firm organised to celebrate its 30th year in China, according to a person familiar with the matter and photos shared with Reuters.  While many local companies have in recent years publicly pledged allegiance to the ruling Chinese Communist Party as President Xi Jinping strengthened the party's role throughout Chinese society and its economy, such messaging is still unusual from foreign companies.",https://finnhub.io/api/news?id=8daa6f5370b7ec4e22e3c964c42546382ddb7e10a975d2a017f3b2d6bdfa6311
company,2023-05-26 11:21:31,12 Best Growth Stocks to Buy and Hold in 2023 According to Billionaire Rajiv Jain,120566980,https://s.yimg.com/ny/api/res/1.2/EexWtJjmqtO8OAuZDCnjXw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD0xMjAw/https://media.zenfs.com/en/insidermonkey.com/156754f3b080b1723bfd45ff767b0262,AZN,Yahoo,"In this article, we discuss 12 best growth stocks to buy and hold in 2023 according to billionaire Rajiv Jain. If you want to see more stocks in this selection, check out 5 Best Growth Stocks to Buy and Hold in 2023 According to Billionaire Rajiv Jain. Bloomberg reported on May 23 that Rajiv Jain, […]",https://finnhub.io/api/news?id=84e39a628acc10815a0280053f989de50fb0704703f675bfd9777c496ad7d300
company,2023-05-26 08:44:00,"Health authorities to target next COVID shot to new strain, WSJ says",120570183,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=4a98acfb5a09fd47c5070f4e03919e77eea1ab941703284c3f571fcaaf5e1e81
company,2023-05-26 07:00:00,IMFINZI® (durvalumab) plus LYNPARZA® (olaparib) and IMFINZI alone both significantly improved progression-free survival in advanced endometrial cancer when added to chemotherapy,120562560,https://media.zenfs.com/en/business-wire.com/1083c0d614f26705af471afade10e67e,AZN,Yahoo,"WILMINGTON, Del., May 26, 2023--Positive high-level results from the DUO-E Phase III trial showed IMFINZI® (durvalumab) in combination with platinum-based chemotherapy followed by either IMFINZI plus LYNPARZA® (olaparib) or IMFINZI alone as maintenance therapy both demonstrated a statistically significant and clinically meaningful improvement in progression-free survival (PFS) compared to standard-of-care chemotherapy alone in patients with newly diagnosed advanced or recurrent endometrial cance",https://finnhub.io/api/news?id=561585545fcdec9687b89151c54c5c79a65f3a9ddd91fde96452231847e031b7
company,2023-05-26 05:34:00,TOP NEWS: AstraZeneca's Ultomiris wins another approval in Japan,120572095,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=73affaef31ddc0e5a1717f6d73a1f9bcd65c687a5b8e03300df9c39ba89a2806
company,2023-05-26 04:40:00,Unusually active option classes on open May 26th,120568269,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=1e5ecbb01eefd366538e07e55714ce4f7b55e56c130b05f300316f712c86e0b4
company,2023-05-26 04:25:00,TD Cowen pharma/biotech analysts hold an analyst/industry conference call,120570461,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=95a1f011294a9e01a64863124222cc67d32e52e6ebbb3223817f565854938a54
company,2023-05-26 04:24:00,Stocks facing most buy and sell pressure into Russell rebalancing,120566498,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=813b2106a5b533a191fa4d86d247b89710f1d8a57c15927b5e35f71a4fca2e61
company,2023-05-26 04:03:00,AstraZeneca price target lowered to $80 from $85 at Argus,120572100,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=b8afbc33944dd70b086115e464690d96175716ba920f17afccc46b9e8e24af3a
company,2023-05-26 03:46:00,"Amazon's Prime Video Trolls Netflix's Password Crackdown, Tesla Data Leak Exposes Safety Nightmare, Elon Musk's Brain Chip Company Gets FDA Nod For Human Trial: Top Stories For Today",120567491,,AZN,Benzinga,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=dd73698e1eb9c45e4a26b8c3ef4e48d98f886ef2e407f63bdc26fe1542157320
company,2023-05-26 03:02:00,"IN THE KNOW: AstraZeneca's DUO-E positive, but ""mature OS"" data needed",120572103,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=3efd8eef23064623928fe9ec599baa085d1dd9f593fbbcb5d28f08f3bf7d7553
company,2023-05-26 02:10:00,AstraZeneca announces results from Imfinzi plus Lynparza trial,120572105,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=c08897dceff920ff02a31f4d2784a1f92bfba7a39455f84c5ff05686ea2c2729
company,2023-05-26 01:48:00,AstraZeneca announces high-level results from DUO-E Phase III trial on Imfinzi,120572106,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=bc4bc25213f355b197170d32fabc9693479c1be360bc7c60310639c1e8d4be08
company,2023-05-26 01:42:00,Elon Musk's Neuralink gets FDA nod to start human trial of brain implant,120568276,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=74a4d809f90a3dc6b24e024b5857bcffdfca430ef065274dfd760fed1bf4fd07
company,2023-05-26 01:42:00,AstraZeneca says Ultomiris approved in Japan for prevention of NMOSD relapses,120572107,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=c61770de25e21dff67ba66ab5335af485d6038ceddb4ce0f3a53542b3996e870
company,2023-05-26 01:19:00,AstraZeneca/Merck's Cancer Drug Combo Shows Positive Results In Endometrial Cancer,120572109,,AZN,Benzinga,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=a53645f06056abb897bce3ce0237a6c9dc51e620e1c30ae822b19c1a6eb10cf1
company,2023-05-26 01:02:00,"AstraZeneca's Imfinzi, Lynparza cuts risk of uterus cancer progression in phase 3 trial",120572110,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=c7e308a3d0b33af2f86ac6728fc8cca675c8134a2f981f59ffec8c06858a06d1
company,2023-05-26 00:55:00,"AstraZeneca Imfinzi, Lynparza cuts risk of uterus cancer progression in phase 3 trial",120572111,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=248b7c6b6e98c6b8b222a089323e03d8b6d864cab69ec2e517b6c61d385550ef
company,2023-05-25 23:59:00,AstraZeneca's Ultomiris gets approval in Japan for expanded use in rare nervous system disorder,120572112,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=3e7a723c652cfd715a86432007f63e801ce9e7880099a0862c585fb7c33ab9c8
company,2023-05-25 23:53:00,AstraZeneca Ultomiris gets approval in Japan for expanded use in rare nervous system disorder,120572115,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=f02c007f9b2feb77d77c41bbd16b0c54c0076edf6d608cc8c83007f146eca9fe
company,2023-05-25 23:40:00,"AstraZeneca PLC ADR rises Friday, still underperforms market",120587419,,AZN,MarketWatch,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=388046582290b0d0347e2a7ab16ec135ec847c830837da2eae52421e3b0534c7
company,2023-05-25 23:14:00,AstraZeneca's Imfinzi plus Lynparza effective for endometrial cancer,120572116,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=bc56a47a2e970f750c2a2fb7bef3536b16d35e43ed1380c2053a397f1790d0d1
company,2023-05-25 22:57:00,"LONDON BRIEFING: UK retail sales up; Hunt ""comfortable"" with recession",120568006,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=01cf8ac295108ad6bcf2fce727f60f78055e1eed5bfbc05ac1b919cc698a7954
company,2023-05-25 07:02:29,AstraZeneca: Think Medium-To-Long Term,120543312,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1291387370/image_1291387370.jpg?io=getty-c-w1536,AZN,SeekingAlpha,"AstraZeneca's price has moved sideways in the past month, after showing good progress for some time. See why AZN stock is still a buy for me.",https://finnhub.io/api/news?id=42d9145a471ae292aeac31bb61f7764cabfccd1237b9c0b0591c0dc9af2a4266
company,2023-05-25 07:00:00,AstraZeneca will highlight momentum of practice-changing cancer medicines across its robust pipeline at ASCO 2023,120541719,https://media.zenfs.com/en/business-wire.com/7368c8e8dd1113028af4d23264e854e3,AZN,Yahoo,"WILMINGTON, Del., May 25, 2023--AstraZeneca advances its ambition to revolutionize cancer care with new data across its industry-leading portfolio of cancer medicines at the American Society of Clinical Oncology (ASCO) Annual Meeting, June 2 to 6, 2023.",https://finnhub.io/api/news?id=cd63054a340228e538303c6a0ee4713f518dfb0508deda5977fe06ea57009032
company,2023-05-24 23:40:00,"AstraZeneca PLC ADR falls Thursday, underperforms market",120572118,,AZN,MarketWatch,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=e7d03c72390a7ba074f0496b576d7cab9b7763db2a565e8ea22f301ed341decd
company,2023-05-24 13:49:54,AstraZeneca-Spin Off Entasis Secures FDA Approval For First Pathogen-Targeted Therapy Addressing Acinetobacter,120527247,https://media.zenfs.com/en/Benzinga/e9d4ef0cbdff074e03ea4b704597975a,AZN,Yahoo,"Innoviva Inc's (NASDAQ: INVA) affiliate Entasis Therapeutics Inc received FDA approval for Xacduro (sulbactam and durlobactam for injection), co-packaged as a treatment for hospital-acquired pneumonia. The approval covers patients 18 years and older for hospital-acquired and ventilator-associated bacterial pneumonia (HABP/VABP) caused by difficult-to-treat bacteria strains known as Acinetobacter baumannii-calcoaceticus complex. Innoviva acquired Entasis Therapeutics in May 2022 for $2.20 per sha",https://finnhub.io/api/news?id=af308d4f23f4fd91e050aae16c7776144e80d98f7653b258db0c8d69fc3ffeee
company,2023-05-24 08:37:00,"As Debt Ceiling Talks Wobble, Investors Look To May Fed Minutes, Nvidia Earnings For Direction",120527660,,AZN,Benzinga,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=0104b877fd33154976d0caa7b524b9146ae2647708c138a2cd766a834a8f2029
company,2023-05-23 23:40:00,AstraZeneca PLC ADR underperforms Wednesday when compared to competitors,120544897,,AZN,MarketWatch,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=307025fbc97f038f0fbf7d30a742ebd26d1fa7fd7bf3fdba08d57da384b79909
company,2023-05-23 14:15:00,New AstraZeneca Data Presented at ATS 2023 Strengthen the Body of Evidence Supporting Early Intervention With BREZTRI in COPD,120503998,https://media.zenfs.com/en/business-wire.com/e93b571249af9e6d16269e9f1d673bfe,AZN,Yahoo,"WILMINGTON, Del., May 23, 2023--Results from the EROS real-world retrospective study showed that initiating fixed-dose triple-combination therapy BREZTRI AEROSPHERE® (budesonide/glycopyrronium/formoterol fumarate) within 30 days of a qualifying moderate or severe exacerbation in patients with COPD (chronic obstructive pulmonary disease) is associated with a decreased risk of future exacerbations by 24% vs. delaying treatment by one to six months, and by 34% vs. delaying treatment six months to o",https://finnhub.io/api/news?id=feaaa7f63ba6374f8274aa10ad199d0f7ac2f9944701b0983d803c3638d4bca5
company,2023-05-23 12:39:00,"AstraZeneca PLC ADR falls Tuesday, still outperforms market",120512908,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR sank 0.51% to $74.07 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=eec0e348d30bb8c2b7005eb7edcb8f6d8a7a16b611ad313b64b57144bc16d772
company,2023-05-23 08:41:00,10 Health Care Stocks Whale Activity In Today's Session,120501925,,AZN,Benzinga,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=6774928ddad6b2181ded25de92fd480d587024a29ba9b675375367a3bbd98843
company,2023-05-23 08:01:00,"AstraZeneca falls Tuesday, still outperforms market",120512910,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"Shares of AstraZeneca PLC inched down 0.02% to £120.34 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the FTSE...",https://finnhub.io/api/news?id=d8d0a5a9c9223592e4c23e0e46a954461e5268ffd9d0a229a629d77fc31e9f8e
company,2023-05-23 00:39:00,"Moderna, BioNTech other Covid vaccine makers jump amid China Covid scare",120514928,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=fad668c01f62ed0177eb6b97a705c00ee142cb63a3bab92b52cd5ebb93590966
company,2023-05-30 08:16:00,Rotation Out Of Healthcare And Biotech Stocks: Age Of Disruption?,120614231,,AZN,TalkMarkets,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=3e75ef0550987f884e0f6f5d687c95b3991771311b2b53ea97e9bb60439a357b
company,2023-05-30 05:43:00,BioLight announces joint cooperation agreement with AstraZeneca's Alexion,120619041,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=16d7dd1e26758275da948972827b468587f9fd9e0a3cf3a4c8c51699e3a7d383
company,2023-05-30 04:04:00,"Kiyatec and AstraZeneca Announce a Multifaceted Research Agreement to Generate Novel Preclinical Data Using Kiyatec’s 3D Spheroid Screening Platform, KIYA-PredictTM",120619042,,AZN,Business Wire,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=2a7bb7cfc95cf9b7ac6a3432f2363b49b170b19de986b65f0b7e733cf0f58978
company,2023-05-30 03:23:00,Catalyst Pharmaceuticals appoints Thompson to board of directors,120614200,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=fd320270973701e44e92fa8f11d8597fb6c4de4833c6fd166a7a16c04bf1dd70
company,2023-05-30 03:05:00,Bolt Biotherapeutics and AstraZeneca Rare Disease partner in retinal disease R&D,120619044,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=e209213073572a9199c924d6711bfc67973842df898c2b34467117275b18da03
company,2023-05-29 23:40:00,"AstraZeneca PLC ADR falls Tuesday, underperforms market",120619046,,AZN,MarketWatch,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=ee1309cd0692cf42b9f108bd3a19bc51ee6816cd2031ddd252f8739b5b63e452
company,2023-05-29 23:33:00,Nestle hires LSEG's Anna Manz as CFO as Rogers ends eight-year term,120614455,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=bdb9c1cf6dd84511bd2344e158bd8bc03f0c12613ddc2aa030466a54b4f1852d
company,2023-05-29 22:24:00,Oppenheimer biotech analyst to hold a reception,120616066,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=09626c437766390c804e459da5921cff37bf9bd1321d149b0fb3cb9eca301c4f
company,2023-05-29 07:48:00,AstraZeneca (AZN) Drug Combo Meets Endometrial Cancer Study Goal,120601478,https://media.zenfs.com/en/zacks.com/ef77d5a5eb4e72e4dd31ccfaf4ca4ccd,AZN,Yahoo,AstraZeneca (AZN) reports statistically significant results from a late-stage study evaluating the combination of Imfinzi and Lynparza in patients with advanced endometrial cancer.,https://finnhub.io/api/news?id=e805736f20b9db753faffb1c7df026252a9e47ed03a03733ce1a6294b19e6ad5
company,2023-05-28 09:15:00,Want to Grow Richer? These Stocks Have Doubled in the Past 5 Years,120593135,,AZN,Yahoo,"Shares of AstraZeneca (NASDAQ: AZN) and Merck (NYSE: MRK) have both more than doubled over the last five years.  With a $228 billion market capitalization, AstraZeneca is the sixth-largest pharmaceutical company in the world and the second-biggest international-based drugmaker behind Novartis (NYSE: NVS).  As you'd guess would be the case for a major player in the pharmaceutical industry, the British drugmaker possesses a remarkable product portfolio.",https://finnhub.io/api/news?id=c46d982b9d85a9ce075c819f4e2f6f46762ac872e2aeab71f8b22aed4c270221
company,2023-06-03 08:00:00,LYNPARZA® (olaparib) and IMFINZI® (durvalumab) combination reduced risk of disease progression or death by 37% vs. chemotherapy and bevacizumab in patients with advanced ovarian cancer without tumor BRCA mutations in the DUO-O Phase III trial,120689220,https://media.zenfs.com/en/business-wire.com/b4634dd32ce3af9528acf328ad1ea398,AZN,Yahoo,"WILMINGTON, Del., June 03, 2023--Positive results from a planned interim analysis of the DUO-O Phase III trial showed that treatment with a combination of LYNPARZA® (olaparib), IMFINZI® (durvalumab), chemotherapy and bevacizumab demonstrated a statistically significant and clinically meaningful improvement in progression-free survival (PFS) versus chemotherapy plus bevacizumab (control arm) in newly diagnosed patients with advanced high-grade epithelial ovarian cancer without tumor BRCA mutation",https://finnhub.io/api/news?id=761a12a7e1df4ed9b440648ea0c4f27d72dec2c67549a0c89e517231633e7f02
company,2023-06-03 07:17:00,AstraZeneca interim analysis of DUO-O trial shows statistically significant PFS,120691738,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=8174f3f741d37091569275ff1136a41b6dac127493fae8df4054f4d0c03516f9
company,2023-06-03 03:56:00,SVB Securities Sticks to Their Buy Rating for AstraZeneca (AZN),120691740,,AZN,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=ef6fa25e1e26b6dfc09eda528848314070e9b079d4100d6755880f5adb1dca59
company,2023-06-02 15:56:00,IMFINZI® (durvalumab) plus chemotherapy significantly improved pathologic complete response in gastric and gastroesophageal junction cancers in MATTERHORN Phase III trial,120680309,https://media.zenfs.com/en/business-wire.com/a432c8b9d6bd511a5de0955edb3287cb,AZN,Yahoo,"WILMINGTON, Del., June 02, 2023--Positive high-level results from a planned interim analysis of the MATTERHORN Phase III trial showed treatment with AstraZeneca’s IMFINZI® (durvalumab) added to standard-of-care FLOT (fluorouracil, leucovorin, oxaliplatin, and docetaxel) neoadjuvant (before surgery) chemotherapy demonstrated a statistically significant and clinically meaningful improvement in the key secondary endpoint of pathologic complete response (pCR) versus neoadjuvant chemotherapy alone fo",https://finnhub.io/api/news?id=77e12e0f728f25110f746bb497827b162e35423cdd06b1d5612768d765d393be
company,2023-06-02 13:25:00,AstraZeneca PLC ADR underperforms Friday when compared to competitors,120805587,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR dropped 0.34% to $72.59 Friday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=ad05b2b194f15c084e454fb28428b9848890460200903503372035600e2ce85d
company,2023-06-02 12:53:00,"Top Research Reports for Exxon Mobil, AstraZeneca & Netflix",120680312,https://media.zenfs.com/en/zacks.com/77d37cb7cc7eef89199b3f03ad9461d5,AZN,Yahoo,"Today's Research Daily features new research reports on 16 major stocks, including Exxon Mobil Corporation (XOM), AstraZeneca PLC (AZN) and Netflix, Inc. (NFLX).",https://finnhub.io/api/news?id=6d7b033c937466a1ff7c62b81d2c0b89ee4bcbebb9181b9fe0ed3b422b7cddf2
company,2023-06-02 12:39:00,FDA Expands AstraZeneca (AZN) Lynparza Label in Prostate Cancer,120672693,https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0,AZN,Yahoo,"Following FDA's label-expansion approval, AstraZeneca's (AZN)/Merck's (MRK) Lynparza is the first PARP inhibitor approved in combination with a new hormonal agent in mCRPC.",https://finnhub.io/api/news?id=9239db2b4a11915341ae15917d89374233756fcf472fcd6f81e0287309498ab0
company,2023-06-02 12:35:00,Ionis (IONS) Posts Two-Year Upbeat Data From HAE Drug Study,120674344,https://media.zenfs.com/en/zacks.com/c8704ffaba0234da981fa842a48f77b5,AZN,Yahoo,Data from a mid-stage study shows that treatment with Ionis' (IONS) donidalorsen over a two-year period resulted in consistent and sustained protection from HAE attacks.,https://finnhub.io/api/news?id=5a58f6c79f7751b4b104525cc0a0797f7d3570d504079b70b2431d82fb4bd19f
company,2023-06-02 10:14:00,"Pharma Stock Roundup: FDA Okays PFE RSV Jab for Elderly, AZN Ends Brazikumab Studies",120669667,https://media.zenfs.com/en/zacks.com/9883d206905e7516b2353476e213e60c,AZN,Yahoo,FDA approves Pfizer's (PFE) RSV vaccine for older adults and AstraZeneca (AZN) and Merck's (MRK) Lynparza for BRCA-mutated metastatic castration-resistant prostate cancer,https://finnhub.io/api/news?id=e2cd6eea119a4a0b2fe8c3ab95be9aeebce6061ab024c1804479e66b27e521f1
company,2023-06-02 09:40:05,Here's Why Astrazeneca (AZN) is a Strong Value Stock,120670878,https://media.zenfs.com/en/zacks.com/b95cfdd8768bc3c4620e666dbcb0b248,AZN,Yahoo,"Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.",https://finnhub.io/api/news?id=d9868c54c54cfa5eeb3fc80d9a7298b48c7d0b40bf38498eac7a197f9badcad8
company,2023-06-02 09:04:00,AstraZeneca sees positive results for Imfinzi in gastric cancers,120682738,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=f22c5d4d957fe55afc5df3e35aba3c4b1bce629070b161c35a5eb9109590ff68
company,2023-06-02 08:13:00,AstraZeneca Says Imfinzi Data Shows Improved Response in Gastric Cancers,120805588,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,By Michael Susin AstraZeneca said late Friday that interim analysis of the phase III study regarding its Imfinzi drug together with chemotherapy...,https://finnhub.io/api/news?id=a1a4215d641db4349c750fa6250836b0b40bbf01c65bde46a7c7ca96c3a88c12
company,2023-06-02 08:01:00,"AstraZeneca rises Friday, still underperforms market",120805589,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"AstraZeneca PLC shares inched up 0.67% to £117.48 Friday, on what proved to be an all-around favorable trading session for the stock market, with the FTSE...",https://finnhub.io/api/news?id=0103fcc77d9e873da20a1670520ebe0afc8634981e51fdecefcef47e08691566
company,2023-06-02 07:07:00,AstraZeneca says Imfinzi plus chemotherapy showed clinical benefit in trial,120682739,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=bb372c5e3ef5f326de6b22f02c29f7fdf59f414a6b2eefbde26a94538ce114d7
company,2023-06-02 05:06:00,3 Nasdaq 100 Stocks That Are Surefire Buys in June,120665006,https://s.yimg.com/ny/api/res/1.2/6L0T9BTZZPGMmJmqV0F0Xw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDE-/https://media.zenfs.com/en/motleyfool.com/258d458be40f8a985ad17e6fab6eec94,AZN,Yahoo,These phenomenal businesses have the tools and intangibles to make patient shareholders a lot richer.,https://finnhub.io/api/news?id=81a8acd39718162e10502a3986225957ad7acd9c978da2e7a85995c9309ef680
company,2023-06-02 02:34:00,Analysts Offer Insights on Healthcare Companies: Ionis Pharmaceuticals (IONS) and AstraZeneca (AZN),120674065,,AZN,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=b8b6a1fcdb9f953d28305fe1bfffbc9815a062c843c9464768768886d3fea395
company,2023-06-02 00:55:00,Oppenheimer biotech analyst to hold a reception,120679379,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=086230cd9ef7a222e6c074fd1496c6441cfb9f73161603984e43a88393bc3de1
company,2023-06-02 00:20:00,AstraZeneca's Imfinzi shows positive response in gastric cancers,120682743,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=eecda89de19d702664ffb29f4f1c8b320d66f9e336d861b16a3fd59d8c4ccc44
company,2023-06-01 23:34:00,Cantor Fitzgerald biotech to hold analyst/industry dinner meeting,120678026,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=7ee6e46d4288f6c37edb977dbceab07545949a353471cad5d8cc6a7f9ea904d4
company,2023-06-01 22:58:00,AstraZeneca's IMFINZI plus chemo improved pathologic response in Phase III trial,120682746,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=302d6dcf9ccfed9b69b26a2edef847249bdcbe15e19f3e19f3c0bcb5386d670a
company,2023-06-01 22:00:00,Germany Is Cooling. 3 Stocks to Put Your Money In.,120714533,https://images.barrons.com/im-791687/social,AZN,MarketWatch,"Germany’s industrial machine, diminished or not, still offers attractive names like Siemens, SAP, and Deutsche Telekom.",https://finnhub.io/api/news?id=fa32c54a29161f449b8d0d6d27f0abc3f0442f0c4f1918de2f8e69aad5fa0cf1
company,2023-06-01 10:40:00,AstraZeneca (AZN) Discontinues Brazikumab Development,120645917,https://media.zenfs.com/en/zacks.com/ef77d5a5eb4e72e4dd31ccfaf4ca4ccd,AZN,Yahoo,AstraZeneca (AZN) announces its decision to discontinue the development of brazikumab for all indications under its inflammatory bowel disease program.,https://finnhub.io/api/news?id=1e2baf2c4f3b2efa99a8517bd459a5d8dcfbcc6f508ae366a64473d8293824d8
company,2023-06-01 07:28:37,"Lexicon Pharmaceuticals Secures Key FDA Approval, But Heavy Lifting Remains",120643891,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1359314170/image_1359314170.jpg?io=getty-c-w1536,AZN,SeekingAlpha,Lexicon Pharmaceuticals received FDA approval to market its heart failure drug Inpefa. Read why I think LXRX remains as a high-risk proposition for investors.,https://finnhub.io/api/news?id=1bbea5e65dac74444681a17b640c0fe0c63b08fdaeb05762ed150945f64dec17
company,2023-06-01 07:00:00,LYNPARZA® (olaparib) plus abiraterone approved in the US for the treatment of BRCA-mutated metastatic castration-resistant prostate cancer,120642918,https://media.zenfs.com/en/business-wire.com/7a8e01a91dc19977d813529efeb8a08c,AZN,Yahoo,"WILMINGTON, Del., June 01, 2023--AstraZeneca and Merck & Co., Inc’s, known as MSD outside the US and Canada, LYNPARZA® (olaparib) in combination with abiraterone and prednisone or prednisolone has been approved in the US for the treatment of adult patients with deleterious or suspected deleterious BRCA-mutated (BRCAm) metastatic castration-resistant prostate cancer (mCRPC).",https://finnhub.io/api/news?id=1222c0a8f088eb9f43cefbf87c73dbd6b8df8be2926f90386c7e322736dfa92e
company,2023-06-01 04:44:00,Merck and Astra's Lynparza prostate cancer treatment gets US approval,120649583,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=67543045575ba6603e7894dc5ce791cf2f2f889b2375e63ce4197c0ea17da6da
company,2023-06-01 02:36:25,UPDATE 1-AstraZeneca to stop developing Crohn's disease drug,120639038,https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png,AZN,Yahoo,"British drugmaker AstraZeneca said on Thursday it would stop developing its drug brazikumab to treat inflammatory bowel diseases, including Crohn's disease and ulcerative colitis.  The company said the discontinuation was due to a delay in the drug's development timeline, affected by global events and ""the context of a competitive landscape"".  AstraZeneca regained the rights to brazikumab from Allergan in 2020 following U.S. drugmaker AbbVie's $63 billion tie-up with Allergan.",https://finnhub.io/api/news?id=88c282e515210eec7f41a3167ea222c5a653073859c2eaba48f9dd305fbf40d1
company,2023-06-01 02:15:00,"AstraZeneca, Merck announce LYNPARZA + abiraterone approved for BRCAm cancer",120649588,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=caf896903a7d051b0d6b715dd0aa2d445ee3b7266f7ee68edf2cf6b8cdf4467b
company,2023-06-01 01:54:00,Merck and AstraZeneca's Lynparza prostate cancer combination approved by FDA,120649589,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=7266ef6652836c950ee2343a8863f570d15bf76fe4d88584a694026b6db65622
company,2023-06-01 01:52:00,AstraZeneca halts AbbVie-partnered bowel disease drug program,120650546,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=4910c3ce798e9179a67775e2c47cda8d1036a961df2be4672b058ab85d7142b3
company,2023-06-01 01:38:00,AstraZeneca discontinues brazikumab IBD development program,120650547,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=43ab64d3a53c70fdaad432405567c712fcb86fdde844290b070243b4e827f6f0
company,2023-05-31 23:40:00,AstraZeneca PLC ADR underperforms Thursday when compared to competitors,120682747,,AZN,MarketWatch,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=09611e1cd053f183db266497050b4410ee8f0f92f9717ca88530f297b7863b25
company,2023-05-31 23:07:00,TOP NEWS: AstraZeneca discontinues brazikumab; Lynparza wins approval,120650548,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=3ec9a1c07d13a061898ccb9869a26125c813a1253211bd60eb014a6b36a48abb
company,2023-05-31 23:03:00,LONDON BRIEFING: Higher open as US debt limit bill passes House,120644322,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=3de146b74fcf87f4bbb4300b6d0a57da21134ced86ff5983c8cc87ce75d00347
company,2023-05-31 22:29:00,AstraZeneca Discontinues Brazikumab Inflammatory Bowel Disease Development Program,120805591,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,By Anthony O. Goriainoff AstraZeneca said Thursday that it was discontinuing the brazikumab inflammatory bowel disease development program after reviewing...,https://finnhub.io/api/news?id=7da5c8324686e315d1170b9d4179c20330cab8df54e36779d4c8a5fccaecc5f4
company,2023-05-31 22:02:00,AstraZeneca halts bowel disease drug program,120650550,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=d6661d3b7fefd117b2d4e8a12674cc1cd31a6f323a3043aaa67422c4d4b9fab5
company,2023-05-31 00:27:00,AstraZeneca/Merck's Lynparza gains expanded prostate cancer indication,120650551,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=de650da643b7f24ebaa84f999f70cede6c25763298d8f8b48d8e6760651ff1cc
company,2023-05-30 23:41:00,"AstraZeneca PLC ADR rises Wednesday, outperforms market",120650552,,AZN,MarketWatch,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=2801897a2f7194ff38ee75d2ca721a3b12e5efd878b270a6f4f61a5bce640ec8
company,2023-06-07 13:25:00,"AstraZeneca PLC ADR falls Wednesday, still outperforms market",120805579,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR slid 0.12% to $73.31 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...",https://finnhub.io/api/news?id=ea3fe3a62be2589fcbe6b9bcc97e4a3625d2548c08e93a30c93ee3e803f3a38c
company,2023-06-07 08:01:00,"AstraZeneca falls Wednesday, underperforms market",120805580,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"AstraZeneca PLC shares inched down 0.66% to £117.54 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the FTSE...",https://finnhub.io/api/news?id=e23d26b7da2912479039919cc7db175b968aec74256a751227e9542d24a9c227
company,2023-06-07 02:24:00,Zentalis price target raised to $50 from $45 at Stifel,120760049,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=4377bd4c7c38fd919b5bcaf6407090204caaab90bf249e6c3443ae012b262e1c
company,2023-06-06 21:30:00,Analyst Creates Bullish Pitch On Ionis Pharmaceuticals Citing 'Strategic Pivot Underway',120763605,,AZN,Benzinga,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=9e0e670aede77ca1ea75c9c11262898f17796a255e73725b652c18e08794fd74
company,2023-06-06 21:24:00,This Is What Whales Are Betting On AstraZeneca,120763606,,AZN,Benzinga,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=cb3eb39ba0f0b4c3441b6f2b95664fdbe9aaf262468b0a6fea13d85ada89384c
company,2023-06-06 21:00:00,Genomic Vision Provides Strategy Update,120763608,,AZN,Business Wire,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=339de3e7f07b516648d9113ee9b878da3f84b838cd7b3bdf351e354a094c763a
company,2023-06-06 13:25:00,"AstraZeneca PLC ADR rises Tuesday, still underperforms market",120805581,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR inched 0.27% higher to $73.40 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the...",https://finnhub.io/api/news?id=6b596ae8e906d86a16adfa432ec09ce4d11854d02e25bff7b1428f94f5dc1b6d
company,2023-06-06 09:54:23,UPDATE 1-US FDA staff flag no new safety issues for Sanofi-AstraZeneca's preventive RSV therapy,120728532,https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png,AZN,Yahoo,"The U.S. Food and Drug Administration's staff reviewers on Tuesday raised no new concerns on Sanofi and partner AstraZeneca's experimental therapy to prevent respiratory syncytial virus (RSV) infections in infants.  The RSV prevention antibody, nirsevimab, showed an overall favorable safety profile in clinical trials, FDA staff said in documents published ahead of the health regulator's advisory committee meeting on Thursday.",https://finnhub.io/api/news?id=a29474e8d41ccb6f73bee1ba984f560c60bfb4bc52279861f7df490ffa35703d
company,2023-06-06 08:01:00,"AstraZeneca rises Tuesday, still underperforms market",120805582,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"Shares of AstraZeneca PLC inched up 0.32% to £118.32 Tuesday, on what proved to be an all-around great trading session for the stock market, with the FTSE...",https://finnhub.io/api/news?id=e80613c8f1497e5df9d770c68355b41903fee1cf71bfdb4f2c26e3ee73d384bd
company,2023-06-06 03:20:41,ASCO,120726236,https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png,AZN,SeekingAlpha,The following slide deck was published by AstraZeneca PLC in conjunction with this event.,https://finnhub.io/api/news?id=165b1a222512f7d476b4dc8fc8442d1f9eff6c2bf7f08bc735af3d4e35457e33
company,2023-06-06 03:17:10,AstraZeneca PLC (AZN) ASCO Investor Event,120726237,https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png,AZN,SeekingAlpha,"AstraZeneca PLC (NASDAQ:NASDAQ:AZN) ASCO Investor Event June 5, 2023 7:00 PM ETCorporateParticipantsAndy Barnett - VP Global Head of IRRoy Herbst - Deputy Director, Yale Cancer CenterPascal...",https://finnhub.io/api/news?id=9a98723753d8bd5b0addfe891cad07a5ecf64ba314e477263946649ac8adf39a
company,2023-06-05 13:25:00,AstraZeneca PLC ADR outperforms competitors on strong trading day,120805583,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR inched 0.84% higher to $73.20 Monday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=548685c6d3d9ba4e27a2682567e25f07bdcf65aec7503cd8cda3b19a0c1cc4ea
company,2023-06-05 10:24:00,AstraZeneca (AZN) Anticoagulant Drug Study Meets Efficacy Goal,120708766,,AZN,Yahoo,"At the interim analysis, AstraZeneca's (AZN) drug Andexxa showed superior hemostatic efficacy or in other words improved control of bleeding with targeted anticoagulation reversal versus usual care.",https://finnhub.io/api/news?id=3bce50c8ab126b5ae37a5f92f83acbcf3d46b2f81f15a0d29f2f4147e5859c9a
company,2023-06-05 10:15:08,AstraZeneca's Tagrisso Significantly Enhances Survival in Certain Post Surgery Non-Small Cell Lung Cancer Patients,120707392,https://media.zenfs.com/en/Benzinga/e7e84591a53bdf3e36e5212365b9bfad,AZN,Yahoo,"AstraZeneca plc's (NASDAQ: AZN) Tagrisso (osimertinib) cuts the risk of death by 51% in patients with a certain form of lung cancer diagnosed early enough to remove their tumor surgically, trial data showed. Data from the ADAURA Phase 3 trial showed Tagrisso demonstrated a statistically significant and clinically meaningful improvement in overall survival (OS), compared to placebo in the adjuvant treatment of patients with early-stage epidermal growth factor receptor-mutated (EGFRm) non-small ce",https://finnhub.io/api/news?id=185a25a2d0d9f8e2de189044f9d8d12774a002078cfeed175756c655fabcd9a2
company,2023-06-05 09:45:06,Why Astrazeneca (AZN) is a Top Growth Stock for the Long-Term,120713961,https://media.zenfs.com/en/zacks.com/ace7df31c7fcb10255abe7c990ea373a,AZN,Yahoo,"Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.",https://finnhub.io/api/news?id=4ea7ebff6fe1d663cbc264e958f275489da72e636289faeea0847306d2a727f9
company,2023-06-05 08:32:00,$100 Invested In AstraZeneca 10 Years Ago Would Be Worth This Much Today,120719195,,AZN,Benzinga,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=66ddfc52e8fb9c855becb44663749e7b315d23065b82d7faf881617d4cdd03ed
company,2023-06-05 08:05:00,Datopotamab deruxtecan combinations showed encouraging tumor responses in patients with advanced non-small cell lung cancer in TROPION-Lung02 Phase Ib trial,120705997,https://media.zenfs.com/en/business-wire.com/b63398eac805cb328f9913eaa33b1bdf,AZN,Yahoo,"WILMINGTON, Del., June 05, 2023--Updated results from the TROPION-Lung02 Phase Ib trial showed, with additional enrolment and follow-up from the initial presentation, that datopotamab deruxtecan (Dato-DXd) in combination with pembrolizumab with or without platinum-based chemotherapy demonstrated promising clinical activity and no new safety signals in both previously untreated or pretreated patients with advanced or metastatic non-small cell lung cancer (NSCLC) without actionable genomic alterat",https://finnhub.io/api/news?id=ef706806f43cfec4d548a4cc291a560d71cb9a4520a375511ad5028f71fd77bf
company,2023-06-05 08:01:00,"AstraZeneca rises Monday, outperforms market",120805584,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"AstraZeneca PLC shares inched up 0.39% to £117.94 Monday, on what proved to be an all-around dismal trading session for the stock market, with the FTSE 100...",https://finnhub.io/api/news?id=152ce8ff2a1d831bdcc8b5e78607d1bfb0f8d61e667418e5e7dae4b43ac03a5a
company,2023-06-05 08:00:00,ENHERTU® (fam-trastuzumab deruxtecan-nxki) demonstrated clinically meaningful and durable responses in patients across multiple HER2-expressing advanced solid tumors,120705998,https://media.zenfs.com/en/business-wire.com/ab4be014f626df3a90195debdb73f26d,AZN,Yahoo,"WILMINGTON, Del., June 05, 2023--Positive results from an interim analysis of the ongoing DESTINY-PanTumor02 Phase II trial showed that ENHERTU® (fam-trastuzumab deruxtecan-nxki) demonstrated clinically meaningful and durable responses across a broad range of HER2-expressing advanced solid tumors in previously treated patients.",https://finnhub.io/api/news?id=b6cefd131ada8905d076c7e3eb3ff72c5111a1498a66477562dd7a0791ec9b4e
company,2023-06-05 07:59:00,AstraZeneca and Daiichi Sankyo report progress in cancer drug trials,120719196,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=935620831d8b23a98534bf1c0381bec44203415f7a177db72b81817cb51c88b3
company,2023-06-05 07:16:27,AstraZeneca PLC (LON:AZN) is largely controlled by institutional shareholders who own 87% of the company,120705660,https://media.zenfs.com/en/simply_wall_st__316/bba95900ab96866c17a285be850152bf,AZN,Yahoo,"Key Insights Given the large stake in the stock by institutions, AstraZeneca's stock price might be vulnerable to their...",https://finnhub.io/api/news?id=a90d20a0ec2f6fcb78a55bb9bdd1c12ed2ec96f9e4ca4dd51cd01f55a116ddff
company,2023-06-05 07:00:00,ANDEXXA Phase IV Trial Stopped Early After Achieving Pre-specified Criteria on Hemostatic Efficacy Versus Usual Care,120705661,https://media.zenfs.com/en/business-wire.com/98af9ac93dedbb14849d1c5e1b8ba45a,AZN,Yahoo,"WILMINGTON, Del., June 05, 2023--ANNEXA-I, a post-marketing Phase IV trial to assess the efficacy and safety of ANDEXXA (andexanet alfa) in patients on oral FXa inhibitor treatment including apixaban and rivaroxaban experiencing an intracranial hemorrhage, will be stopped early.1 The decision is based on achieving pre-specified stopping criteria of superior hemostatic efficacy, the ability to limit the expansion of a potentially life-threatening bleed in the brain, versus usual care.1,2",https://finnhub.io/api/news?id=6ef08c3db9034d4653d46ac56abf4c6e8622d1e42c79bb87fb922970a295b04a
company,2023-06-05 06:14:00,"Stocks Mixed, Week Ahead, OPEC Cuts, Palo Alto Networks Joins S&P 500, AstraZeneca Lung Cancer Trial - 5 Things To Know",120705417,https://s.yimg.com/ny/api/res/1.2/vrSkH6cTJYkdnK8L53vCdg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzU-/https://media.zenfs.com/en/thestreet.com/743881ff763a3ef22425f0c5c0e85218,AZN,Yahoo,"Stock futures edge higher as jobs report, debt deal boost global markets; Week Ahead: inflation data, Treasury bond sales in focus; Saudi Arabia agrees steep production cuts as OPEC seeks to 'stabilize' global markets; Palo Alto Networks leaps on S&P 500 inclusion, DISH Networks slumps and AstraZeneca unveils 'unprecedented' data from late-stage lung cancer trial.",https://finnhub.io/api/news?id=0fc1b0370292b4029dbad071853ebbc04eb39b49393a5ff8d2b3577c98e58ff1
company,2023-06-05 04:23:00,"AstraZeneca Cancer Drug Enhertu Shows Clinically Meaningful, Durable Response in Trial",120713538,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,By Elena Vardon AstraZeneca said Monday that the phase II trial for its cancer drug Enhertu showed clinically meaningful and durable responses across...,https://finnhub.io/api/news?id=bd47667f2da37cf006c232c452f5bb5d6e3e63d798a68ba10a0f6e79d0c10cdb
company,2023-06-05 04:05:00,Datopotamab Deruxtecan Combinations Showed Encouraging Tumor Responses in Patients with Advanced Non-Small Cell Lung Cancer in TROPION-Lung02 Phase 1b trial,120719198,,AZN,Business Wire,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=769de267bd113da7b2e6a0ef92c04560232ed7d91614708a6bbfdef066e6ec8f
company,2023-06-05 04:00:00,ENHERTU® Demonstrated Clinically Meaningful and Durable Responses in Patients Across Multiple HER2 Expressing Advanced Solid Tumors,120719201,,AZN,Business Wire,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=cd18d27b92b09e69491e28ea39df4b5e69297d8b85f4f71f98bc59031cc5cb42
company,2023-06-05 04:00:00,"At BIO 2023, Canada Showcases Multiple Strengths as a Biopharma Powerhouse",120719200,,AZN,Business Wire,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=9ce475cf256967ef9e99a578303e1986c66701a19c74f7c175b71a740a2285d9
company,2023-06-05 03:33:00,AstraZeneca announces updates results from TROPION-Lung02 Phase Ib trial,120719202,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=1d04bfed22eb2a576b7ae23b97429e4f53ac5df4b593d33113fa064f5a02304b
company,2023-06-05 03:23:00,AstraZeneca says Enhertu showed ORR of 37.1% in DESTINY-PanTumor02 Phase 2 trial,120719203,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=058f2d145b10cc4db06226a6471d44d6aed37f6202c8de10256c0faf9313379f
company,2023-06-05 03:18:00,AstraZeneca reports interim analysis from DESTINY-PanTumor02 trial,120719205,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=2d1e40eae6742cde82f3b38a537c75326ce8810771c5a08d525def3d6ef935cc
company,2023-06-05 02:10:00,AstraZeneca announces ANNEXA-I trial will be stopped early,120719208,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=cbdbe9c4c597337200525563f530b34e0b94af75de8a9d6a4e8d41eb929a4eaa
company,2023-06-05 01:52:00,AstraZeneca says Andexxa trial stopped early after hitting pre-specified target,120719209,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=e0b474989e844e555f5f7dc61e4b3775c28bf36b1cd0cfbe8c21cc53b906076a
company,2023-06-05 01:25:00,Cantor Fitzgerald biotech to hold analyst/industry dinner meeting,120720353,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=1ecf2ce0871529c18b8a8f69ac964d48f1eec49321966e2b57bb84edb56db9f3
company,2023-06-05 00:48:00,"AstraZeneca stops Andexxa trial early, Tagrisso reduces death risk",120719210,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=6bca3c939176dbd6586c87a9a42890f72be53ecfa8498e76b55d11005950ac7c
company,2023-06-04 22:26:00,AstraZeneca to Stop Intracranial Hemorrhage Drug Trial After Criteria Met,120805586,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,By Elena Vardon AstraZeneca said Monday that a phase four trial for its Andexxa drug for patients experiencing intracranial haemorrhage will be stopped early...,https://finnhub.io/api/news?id=cb6bad8f92319ef673aa1a750bc69ad2e15961af671a426e7ba32132cb42f517
company,2023-06-04 20:37:00,GLOBAL BRIEFING: Saudi Arabia to cut oil output to boost prices,120711367,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=27d050909a7eba5b698747b3e5d02a6c2a521676ce4ed5bcf40ea1d2d12133eb
company,2023-06-04 08:04:02,AstraZeneca's Tagrisso slashes death risk in certain post-surgery lung cancer patients,120700609,https://media.zenfs.com/en/reuters.com/265f8948bc3de78ddb0a4233af7498c4,AZN,Yahoo,"AstraZeneca's lung cancer therapy, Tagrisso, cut the risk of death by more than half in patients with a certain form of lung cancer who were diagnosed early enough to have their tumour surgically removed, trial data showed.  The drug has regulatory approvals across multiple geographies for certain patients with so-called non small cell lung cancer (NSCLC) who have a mutation of the EGFR gene.  The latest data, presented at the American Society of Clinical Oncology (ASCO) meeting, establishes Tagrisso as the backbone treatment for EGFR-mutated lung cancer, said Susan Galbraith, executive VP of oncology R&D at AstraZeneca in a statement.",https://finnhub.io/api/news?id=d0ca6f50a14b08ccf5035a12a8dd8b79e7ff454814b602c871fe3f8fec4f2a56
company,2023-06-04 08:00:00,"TAGRISSO® achieved unprecedented survival in early-stage EGFR-mutated lung cancer, with 88% of patients alive at five years in ADAURA Phase III trial",120698391,https://media.zenfs.com/en/business-wire.com/54059c13935d230a357d7d6e6ad893c2,AZN,Yahoo,"WILMINGTON, Del., June 04, 2023--Positive results from the ADAURA Phase III trial showed AstraZeneca’s TAGRISSO® (osimertinib) demonstrated a statistically significant and clinically meaningful improvement in overall survival (OS), compared to placebo in the adjuvant treatment of patients with early-stage (IB, II and IIIA) epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC) after complete tumor resection with curative intent.",https://finnhub.io/api/news?id=fd16674fc9256a2b568c6000907dc6e4391a81cd2c32b1c4e725749e0cb3a192
company,2023-06-04 03:50:00,AstraZeneca’s cancer pill Tagrisso halves mortality risk in lung cancer,120700973,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=84c0e5b3414bb83afb25bea314310e776b9cf91542ee92d641a33df0a4a5d280
company,2023-06-04 03:30:00,Wall Street Breakfast: The Week Ahead,120698237,https://static.seekingalpha.com/uploads/2023/6/3/stock_market___generic_13__5_.jpg,AZN,SeekingAlpha,Investors head into next week with the debt ceiling crisis resolved for the near term.,https://finnhub.io/api/news?id=53b32f5589ce875fff458b1a890f740bc67e95765ab4201ed25b912884262d3f
company,2023-06-04 03:25:00,AstraZeneca says TAGRISSO achieved 'unprecedent' survival in EGFRm,120700974,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=245e9ae4b1c19d2c5719a621770647848b975830c3348d8575822bb0a9d56e19
company,2023-06-04 00:00:47,AstraZeneca defies geopolitics to bet on China,120697083,,AZN,Yahoo,"AstraZeneca’s chief executive returned from a recent trip to China exuberant about an “explosion” of biotech companies in the country and the potential for his business to deliver drugs discovered there to the world.  Pascal Soriot said the market was “completely open” for pharma investment.  “It’s hard to not be impressed by the progress that has been made in China over the last few years,” he added on a press call in April.",https://finnhub.io/api/news?id=80ab60b964f7ddf9be51609ac06aa3ebcd1a0a47899c30f76a4d6a46f2030d7c
company,2023-06-10 06:10:00,AI Meets Biotech: Transforming the Drug Development Process,120809087,,AZN,InvestorPlace,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=658677456823d634c80c5e87646db2d652144262f6ec5cac5f9048b8a085e3af
company,2023-06-09 13:43:00,"FDA Panel Endorses AstraZeneca (AZN), Sanofi's RSV Antibody",120799126,,AZN,Yahoo,The FDA's AMDAC unanimously recommends AstraZeneca (AZN)/Sanofi's (SNY) nirsevimab as full immunization against RSV disease for all infants.,https://finnhub.io/api/news?id=1a229eff538131019297838a1507b82404362e3bccae6d5196d5380809af2672
company,2023-06-09 13:25:48,New Data Show Roche's Self-Administered Blood Disorder Candidate Achieves Disease Control,120795748,,AZN,Yahoo,"Roche Group Holdings AG's (OTC: RHHBY) data from the global phase 3 COMMODORE 1 and 2 studies evaluating crovalimab compared to eculizumab, a current standard of care in paroxysmal nocturnal hemoglobinuria (PNH), were presented at the European Hematology Association Hybrid Congress. In the COMMODORE 2 study, 79.3% of participants randomized to be treated with crovalimab achieved hemolysis control from week five to week 25 compared with 79.0% with AstraZeneca Plc's (NASDAQ: AZN) Soliris (eculizum",https://finnhub.io/api/news?id=50f859b1f23c2e09c37162ef0302b74bde8ce3c627e6183f943ae2a5d803cc4f
company,2023-06-09 13:24:00,AstraZeneca PLC ADR underperforms Friday when compared to competitors,120805572,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR shed 0.26% to $74.06 Friday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite...",https://finnhub.io/api/news?id=e8d35ae1a68e6147a505f1f4413d172bdfe99a3755a4c1bce0a72702d794f805
company,2023-06-09 11:56:46,"Netflix Gains Subs From Password Sharing Crackdown, Mark Zuckerberg Discusses AI at Latest Employee Met, Privacy Breach Risk in Nvidia's AI Technology Stirs Concern: Today's Top Stories",120793635,,AZN,Yahoo,"Financial Times Privacy Breach Risk in Nvidia's AI Technology Stirs Concern Among Researchers Researchers found that an Nvidia Corp (NASDAQ: NVDA) artificial intelligence software feature is susceptible to manipulation leading to the compromise of private information. Robust Intelligence analysts found that the ""NeMo Framework,"" which allows developers to work with a range of large language models, could easily break through so-called safety guardrails. After using the Nvidia system on their own",https://finnhub.io/api/news?id=fcb62a318143507f46404bbf3a5f86e63c9b1561f642f7f9ff27ea319fd4117b
company,2023-06-09 10:44:45,AstraZeneca's Add On Treatment With Standard Care Improves Hemoglobin Levels In Rare Blood Disorder,120792810,,AZN,Yahoo,"AstraZeneca Plc (NASDAQ: AZN) released data from the Phase 3 ALPHA trial of danicopan as an add-on to the standard of care for paroxysmal nocturnal hemoglobinuria (PNH). The data showed that danicopan as an add-on to the standard of care C5 inhibitor therapy Ultomiris (ravulizumab) or Soliris (eculizumab) demonstrated a statistically significant and clinically meaningful increase in hemoglobin levels and maintained disease control in PNH patients, compared to placebo plus established C5 inhibito",https://finnhub.io/api/news?id=dad7c74c96065f2353c10aba6bad0804ae1cbd69f11ff86e795136892c9f626b
company,2023-06-09 10:14:54,AstraZeneca Inks Over $2B Agreement For Cell Therapies Targeting Diabetes,120792811,,AZN,Yahoo,"AstraZeneca plc (NASDAQ: AZN) has entered into a collaboration, exclusive option, and license agreement with Quell Therapeutics to develop multiple engineered T-regulator (Treg) cell therapies for Type 1 Diabetes (T1D) and Inflammatory Bowel Disease (IBD) indications. Under the terms of the agreement, Quell’s proprietary toolbox of Treg cell engineering modules, including its Foxp3 Phenotype Lock, will be leveraged to develop autologous multi-modular Treg cell therapy candidates for major autoim",https://finnhub.io/api/news?id=a51db637ede08966e4052f9eb2d7180b4e9ab97de97bf7f61c18084bbc17db55
company,2023-06-09 10:07:06,Unanimous Support for AstraZeneca and Sanofi's Nirsevimab: Next Generation RSV Treatment on the Horizon,120792812,,AZN,Yahoo,The FDA's Antimicrobial Drugs Advisory Committee has voted unanimously 21 to 0 that AstraZeneca plc (NASDAQ: AZN) and Sanofi SA's (NASDAQ: SNY) nirsevimab has a favorable benefit-risk profile to prevent respiratory syncytial virus (RSV) lower respiratory tract disease (LRTD) in newborns and infants born during or entering their first RSV season. The committee also voted 19 to 2 in support of nirsevimab's favorable benefit-risk profile for children up to 24 months of age who remain vulnerable to,https://finnhub.io/api/news?id=0b97d5486dfd4e75a98397b8951417ee0f7ca802b31eb228d717f3c1b519df62
company,2023-06-09 08:01:00,AstraZeneca outperforms market despite losses on the day,120805573,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"AstraZeneca PLC shares inched down 0.32% to £117.12 Friday, on what proved to be an all-around poor trading session for the stock market, with the FTSE 100...",https://finnhub.io/api/news?id=4b4cdc1acfebf13ad7b1681f569a43aa9bf92be4331b737445d49a76cf865e16
company,2023-06-09 03:43:00,"AstraZeneca (NASDAQ:AZN), Sanofi RSV Antibody Wins FDA Advisors’ Nod",120799726,,AZN,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=8be59529116fbebad6aa0f85df0aa6e0d8e01c0066d6a69c61a469b595fc2977
company,2023-06-09 02:18:00,AstraZeneca in pact with Quell Therapeutics for Treg cell therapies,120794085,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=eb96c625dc8652f9b020400f4b985e868d3232a2df693fb324a4c03d3faeb6ce
company,2023-06-09 02:00:13,UK cell therapy start-up agrees AstraZeneca partnership worth up to $2bn,120789018,https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png,AZN,Yahoo,"One of the most promising UK biotech start-ups, Quell Therapeutics, has signed a research collaboration and licensing deal with AstraZeneca to develop treatments for two autoimmune diseases.  The pharma giant will pay Quell $85mn upfront and up to $2bn more if it meets various development and commercialisation milestones over the next few years.  The technology developed by Quell allows the manipulation of a patient’s immune response by genetically engineering “regulatory T-cells” or Tregs.",https://finnhub.io/api/news?id=c24777db45c1b1551ea8c122e8ee0b1e545243b0e2d2360cc39c9451f9f43ffa
company,2023-06-09 01:43:00,AstraZeneca announces Treg cell therapy agreement with Quell Therapeutics,120801470,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=e4b617584ec2236e9565497678a7a0fc16d9bff1b12380b02906f56b98399621
company,2023-06-09 01:41:00,AstraZeneca reports danicopan met primary endpoint in Phase 3 ALPHA trial,120801471,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=54524e2a4d3ceed4e1e9df2cfc2f47bce822f3087bcb71fac3ab3339d54f95e8
company,2023-06-09 01:23:00,US FDA committee recommends Sanofi's RSV disease treatment in infants,120793484,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=4e29448cf4a5940b1c03b291156332071d5186e90e082f6ecd3a1c50de075b7e
company,2023-06-09 00:11:00,TOP NEWS: AstraZeneca hails deal with Quell; positive danicopan data,120801473,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=d09d7117b6f34f69877c49da8abde092b357737a74b900eb217d02ea1b9630bc
company,2023-06-08 22:55:00,LONDON BRIEFING: Network International agrees to GBP2.2 billion buyout,120793660,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=0cbb489abb6b86ce4f31ebc52b2b8dc65f77f551471ef64dd2feb8a342747273
company,2023-06-08 22:40:00,AstraZeneca Says Nirsevimab Recommended for RSV Prevention in Infants by FDA Body,120805574,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,"By Joe Hoppe AstraZeneca said Friday that its nirsevimab antibody has been recommended for the prevention of respiratory syncytial virus, a lower respiratory...",https://finnhub.io/api/news?id=26bdb64300c7b7746c2d0195e887c14ec232c0e01ec809f1d42fcacdc7077c2b
company,2023-06-08 22:22:00,AstraZeneca Reaches Agreement With Quell Therapeutics for Treg Cell Therapies,120805575,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,"By Anthony O. Goriainoff AstraZeneca said Friday that it has reached an agreement to develop, manufacture and commercialize engineered T-regulatory, or Treg,...",https://finnhub.io/api/news?id=2fa09db54c2f453d8e3e3ad86e894ae7594c19ff0f6f492b12f50942b52404a2
company,2023-06-08 21:53:00,AstraZeneca hails RSV drug nirsevimab recommendation by FDA committee,120798092,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=653a4c0c96185661abd7f8f3c8e6c55733bac5c924c2ba5c5e90521e504db771
company,2023-06-08 16:21:31,UPDATE 3-US FDA panel backs Sanofi-AstraZeneca's preventive RSV therapy,120785869,https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png,AZN,Yahoo,"The U.S. Food and Drug Administration advisers on Thursday backed the use of Sanofi and partner AstraZeneca's experimental antibody to prevent respiratory syncytial virus (RSV) infections in infants.  The advisers voted unanimously in favor of using the antibody, nirsevimab, in newborns and infants to prevent infections in their first RSV season.  In a separate 19-2 vote, the panel backed the therapy's use in children aged up to two years who are vulnerable to severe illness through their second RSV season.",https://finnhub.io/api/news?id=42154ff87b14168a342a44e370d04023e5f8252386de5b3d27db182db00672f2
company,2023-06-08 13:25:00,AstraZeneca PLC ADR outperforms market on strong trading day,120805576,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR rose 1.28% to $74.25 Thursday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=1b168c0fde91d729755a8be150f118731097e67c3faf3cb06c30b244941a9073
company,2023-06-08 12:23:00,"FDA advisers vote in favor of AstraZeneca, Sanofi antibody for infant RSV protection",120805577,https://s.wsj.net/public/resources/MWimages/MW-GP644_MicroS_ZG_20180906154215.jpg,AZN,MarketWatch,Advisers to the U.S. Food and Drug Administration voted unanimously Thursday to recommend a monoclonal antibody developed by Sanofi and AstraZeneca to...,https://finnhub.io/api/news?id=997cff4526b6523148d01dab4725d1517e9d0360dc116fc1c997f6bdcd1d3b6c
company,2023-06-08 11:17:50,"FDA advisors recommend AstraZeneca, Sanofi antibody to protect babies from RSV",120781091,https://image.cnbcfm.com/api/v1/image/107253488-1686240314719-gettyimages-1333345431-dsc03832.jpeg?v=1686251870&w=1920&h=1080,AZN,CNBC,"If the Food and Drug Administration approves nirsevimab, it will be the first medical intervention available in the U.S. that can protect infants from RSV. ",https://finnhub.io/api/news?id=31626e439649cec308bd1d56a4cd1a318a02006fbade4c3dcd9efd3261b852dd
company,2023-06-08 11:14:20,Top Healthcare Stocks for June 2023,120774182,,AZN,Yahoo,"Top healthcare stocks include Theravance Biopharma for best value, Dr Reddy's Laboratories for fastest growth, and Viking Therapeutics for most momentum.",https://finnhub.io/api/news?id=1b01dfb7b353fa0d9a066cca3caf42772cf43888e1969bb00152e6fda0a27652
company,2023-06-08 08:01:00,"AstraZeneca falls Thursday, still outperforms market",120805578,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"Shares of AstraZeneca PLC inched down 0.03% to £117.50 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the...",https://finnhub.io/api/news?id=034f4219edd65fb6e6594909d70af5370ed9501beccc02541ca97e082389e607
company,2023-06-08 06:41:00,AZN July 28th Options Begin Trading,120784527,,AZN,Stock Options Channel,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=feae84dbb9b31b567a42796dffb675a60b4d57f534c678d8d31d0e45db6ebe00
company,2023-06-08 04:40:00,Unusually active option classes on open June 8th,120775485,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=08b0e1e044ea8a93e480c3c3fa7bbf2864d13732276ac11256f88605e7130db6
company,2023-06-08 02:12:00,"AstraZeneca, Sanofi win FDA advisory committee backing for RSV therapy nirsevimab",120801476,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=b48a1b1cb1af5f83702b288595a1895c90eef32116e4585c6a450056dd7f2fa4
company,2023-06-08 00:30:00,AstraZeneca/Sanofi's RSV drug recommended by FDA AdCom,120784529,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=a78cf65cce10a772fc60a48bbd58d567d1927ba5a60f6dc82e7f31c237b982e2
company,2023-06-07 22:22:00,"FDA panel back approval of AstraZeneca, Sanofi RSV drug, Bloomberg says",120779943,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=8666a5fcd98fa5f5a20adb7b1544751ea0b72981567a1f343c786e8552d679fa
company,2023-06-07 21:49:00,Iberdrola plans to invest EUR4.00 billion in digitalisation by 2030,120775010,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=d660d4371376c60386d81d3f27dc14d00cead5afe6d393d388a5f65ae13a2445
company,2023-06-15 13:25:00,"AstraZeneca PLC ADR rises Thursday, outperforms market",120939618,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR rose 2.54% to $74.62 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=a55e79cdc8c8868814f48a0725aaf6a1f37bdefa21919cd5fc2d825a441cf3ea
company,2023-06-15 08:02:00,LONDON MARKET CLOSE: Europe mixed after ECB hike and hawkish Fed,120888666,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=87ddc8b69c872150025818076886866bb680fa305653680e84daa5a8a58c145e
company,2023-06-15 08:01:00,"AstraZeneca rises Thursday, outperforms market",120939619,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"AstraZeneca PLC shares rose 1.53% to £116.86 Thursday, on what proved to be an all-around great trading session for the stock market, with the FTSE 100 Index...",https://finnhub.io/api/news?id=524e01ceaca7fd1caf403b78365bf95ab55fba2174ae7c789d17611aa488b5ad
company,2023-06-14 13:24:00,"AstraZeneca PLC ADR falls Wednesday, underperforms market",120939620,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR slipped 1.83% to $72.77 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=baebfd566e9d10877e965bb87ac84eb317105a59b79b4cf8bfdfa2ffdaa2cb57
company,2023-06-14 09:36:00,"U.K. stocks continue winning streak, climb for third session",120867717,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,DowJones,"U.K. stocks finished higher Wednesday, with the FTSE 100 Index increasing 0.10% at 7,602.74. Among FTSE 100 constituents, medical equipment/supplies company...",https://finnhub.io/api/news?id=26216b72ea6449f698520d249921f402381e629c0e6e34ed978847fb69163c86
company,2023-06-14 08:01:00,"AstraZeneca falls Wednesday, underperforms market",120872310,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"Shares of AstraZeneca PLC shed 1.96% to £115.10 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the FTSE...",https://finnhub.io/api/news?id=614120f6edccb8fe3be449d1b559d33f536875b62191f998f1c292ce065b0c8a
company,2023-06-13 22:55:00,AstraZeneca put volume heavy and directionally bearish,120888759,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=7355a6528ffa82ccce954c9a1db52bcad7ce191f9595db52b98a1c6ac3216809
company,2023-06-13 22:08:00,"Investor Opportunities Ahead of Clinical Updates, Says Analyst Initiating Coverage on Ambrx Biopharma with 'Buy' Rating",120874545,,AZN,Benzinga,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=6f700abff46573951dfecb00a57fc9e5d81f44bd6c328d465f15b8708261667f
company,2023-06-13 18:00:21,Astrazeneca (AZN) Gains But Lags Market: What You Should Know,120856868,https://media.zenfs.com/en/zacks.com/737ffb82e07dc8bffb77e72d153c91f2,AZN,Yahoo,"Astrazeneca (AZN) closed the most recent trading day at $74.13, moving +0.38% from the previous trading session.",https://finnhub.io/api/news?id=0e8b2cf9273e92f113e235a6078abfb4af256ff2e77757f171eb43a2ec65dc2c
company,2023-06-13 14:28:00,"AstraZeneca PLC ADR rises Tuesday, still underperforms market",120872312,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR inched 0.38% higher to $74.13 Tuesday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=66d9ed8bc9a984188e80efe7f20522463ddefd47a9a7c4282c31018fd141665a
company,2023-06-13 10:14:00,AstraZeneca (AZN) Breast Cancer Combo Drug Gets Priority Review,120845816,https://media.zenfs.com/en/zacks.com/ef77d5a5eb4e72e4dd31ccfaf4ca4ccd,AZN,Yahoo,"The FDA grants priority review status to AstraZeneca's (AZN) capivasertib/Faslodex combination for the treatment of adult patients with HR-positive, HER2-negative locally advanced breast cancer.",https://finnhub.io/api/news?id=efadcf8d642af40fb05802201392c4f43c64af1ee0cd02853759290815f42437
company,2023-06-13 08:01:00,"AstraZeneca falls Tuesday, underperforms market",120872314,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"Shares of AstraZeneca PLC inched down 0.76% to £117.40 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the...",https://finnhub.io/api/news?id=c92df8351ba858447d45b397b4c99fde138153ebea030d84bce2ab6e3de09fe7
company,2023-06-13 07:00:00,AstraZeneca announces innovative partnership with Vanguard Renewables to decarbonize its United States sites,120843350,https://media.zenfs.com/en/business-wire.com/38455ff13800853b771ee5c19ac1bd97,AZN,Yahoo,"WILMINGTON, Del., June 13, 2023--In a first-of-its-kind collaboration, AstraZeneca is partnering with Vanguard Renewables to deliver renewable natural gas to all its U.S. sites.",https://finnhub.io/api/news?id=5848093de9f38c01276f5a147fa442896ae869e810b798825e42c4effd05a649
company,2023-06-13 07:00:00,AstraZeneca turns to cows to cut U.S. carbon footprint,120843348,https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png,AZN,Yahoo,"Drugmaker AstraZeneca is switching to biogas produced from cow manure and food waste in the United States, it said on Tuesday, in a deal to cut its carbon emissions there.  The Anglo-Swedish drugmaker said the long-term agreement with Massachusetts-based Vanguard Renewables would enable it to transition to biogas from natural gas and cut its emissions across its U.S. research and manufacturing sites.  ""Doing the right thing costs a little bit more, but it is not punitive,"" said Pascal Soriot, chief executive of AstraZeneca, which makes 26 medicines in the U.S.",https://finnhub.io/api/news?id=a153f02141597ac0500e0e0772b88988e6621f037faed62f9fc5a3cb1ea8f167
company,2023-06-13 06:52:15,Top 20 Most Profitable Pharmaceutical Companies In The World,120841576,https://media.zenfs.com/en/insidermonkey.com/05091c2b4af540bdca13bdc30e634918,AZN,Yahoo,"In this article, we will be covering the top 20 most profitable pharmaceutical companies in the world. If you wish to see the top ones, head straight to the Top 5 Most Profitable Pharmaceutical Companies In The World. Undoubtedly, the pharmaceutical industry stands as one of the most financially rewarding and essential sectors worldwide, leading […]",https://finnhub.io/api/news?id=f9453e0ad0f9118449511fe1790b1a08bef5c3c5e71d8572193ad52a813a0e87
company,2023-06-13 05:44:00,AstraZeneca to decarbonize its U.S. footprint by turning cow manure into renewable natural gas,120872315,https://images.mktw.net/im-799330/social,AZN,MarketWatch,"In a first for the pharma sector, AstraZeneca will tap renewable natural gas for its U.S. manufacturing sites by the end of 2026.",https://finnhub.io/api/news?id=f0999fb1181e5dfea81fbc752b8287fd763db09d283d7d86c2149ff6142d2c1f
company,2023-06-13 04:40:00,Unusually active option classes on open June 13th,120844443,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=edc6dd9fdd39a3857c95387d3d7793d93e6447c0925c5b0162730ae8514bfa5b
company,2023-06-13 02:23:00,AstraZeneca announces partnership with Vanguard Renewables,120869611,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=5689a9aade0418b123ce0598d7724a45d61bcbb7adf82aab07e0ae73763ed837
company,2023-06-13 01:55:00,AstraZeneca reports Soliris approved in China for adults with refractory gMG,120869613,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=01c475fda1d578ffc3dec3ce630e136caab1be83831b539f16bd414775a7e7e1
company,2023-06-13 01:00:00,Pharma chiefs warn red tape and NHS levy risk Britain missing out on billions,120839685,https://s.yimg.com/ny/api/res/1.2/CeAtuYPvKPlOL9HwDGfWGQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD03NTA-/https://media.zenfs.com/en/the_telegraph_818/60ed5d396c48ea6cc858ab7ed29c2b43,AZN,Yahoo,"Britain risks missing out on billions of pounds of pharmaceutical investment because bosses are struggling with red tape and a sky-high NHS levy, an industry group has warned.",https://finnhub.io/api/news?id=de09231d7c1b95568c46c62479cc4a41d10cc4696eca0178fa4c9714b15e6893
company,2023-06-12 23:41:00,AstraZeneca wins approval in China for Soliris in myasthenia gravis,120869615,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=a878f379ed6f5b11608bb6f90be42e94b505ebd00656991b76ac466e0f5987cb
company,2023-06-12 22:28:00,AstraZeneca's Soliris Treatment Approved in China for Adults With gMG,120872317,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,"By Joe Hoppe AstraZeneca said Tuesday that its Soliris disease treatment has been approved in China for adults with refractory generalized myasthenia gravis,...",https://finnhub.io/api/news?id=479ed0ab028841ed9fde7aa2f7a6f4c2eed10ba9c065971618f4f1fd1cc9de9a
company,2023-06-12 18:15:23,Astrazeneca (AZN) Stock Sinks As Market Gains: What You Should Know,120837412,https://media.zenfs.com/en/zacks.com/5ecaf2a9bf082a5f3a554e6526b34be0,AZN,Yahoo,"Astrazeneca (AZN) closed the most recent trading day at $73.85, moving -0.28% from the previous trading session.",https://finnhub.io/api/news?id=1fb80e22082761b1b7265c06cf07a964f2a54cd959ff41751ed348eb5a76fd8f
company,2023-06-12 13:25:00,AstraZeneca PLC ADR underperforms Monday when compared to competitors,120872319,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR dropped 0.28% to $73.85 Monday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=fd64ee8955bba5a6697c8a38bc7a9f3ff6fc4fb5e88537e4ad267b6c6d34222b
company,2023-06-12 09:48:00,AstraZeneca (AZN) & Quell to Co-Develop Autoimmune Cell Therapies,120827289,https://media.zenfs.com/en/zacks.com/06708d71c63051ca48bf1855727f077b,AZN,Yahoo,AstraZeneca (AZN) enters into a collaboration agreement with Quell Therapeutics to co-develop novel cell therapy options in major autoimmune indications for an upfront payment of $85 million.,https://finnhub.io/api/news?id=6a5dd48b4a243d45a8c59aaa2b78616e54755dfd914cd4d6b8ccaf21b0a53dd8
company,2023-06-12 08:01:00,"AstraZeneca rises Monday, outperforms market",120872320,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"Shares of AstraZeneca PLC advanced 1.01% to £118.30 Monday, on what proved to be an all-around favorable trading session for the stock market, with the FTSE...",https://finnhub.io/api/news?id=29c3b92f85129b9c1137db65b1321f8065c188de1b634f7e5727a3c421ab25f1
company,2023-06-12 07:00:00,Capivasertib in combination with FASLODEX® (fulvestrant) granted Priority Review in the US for patients with advanced HR-positive breast cancer,120825616,https://media.zenfs.com/en/business-wire.com/2b3f5e1eaf33a47cd47726c9825f359a,AZN,Yahoo,"WILMINGTON, Del., June 12, 2023--AstraZeneca’s New Drug Application (NDA) for capivasertib in combination with FASLODEX® (fulvestrant) has been accepted and granted Priority Review in the US for the treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative locally advanced or metastatic breast cancer following recurrence or progression on or after an endocrine-based regimen.",https://finnhub.io/api/news?id=3b6ea242e9a85ee33d931f02038a89a38c11be6242f9e2b78e8282bf01eb03aa
company,2023-06-12 03:16:00,AstraZeneca (AZN) Receives a Buy from Bank of America Securities,120830582,,AZN,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=bd6756b3733859076fc610f678da5756181076110488fa60c46f9c1e7148bacf
company,2023-06-12 02:04:00,"AstraZeneca announces FDA acceptance, priority review for capivasertib NDA",120830584,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=395c2df63ed729d9485fd86d9f5225654b80dc3bab21bbbec9bb801cf342005c
company,2023-06-12 01:59:00,AstraZeneca's capivasertib-Faslodex combination granted Priority Review in U.S.,120830585,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=c81b194f3f08f88d10a3701c2291e1deee0474f802ab1243b0eb5d1eb07e9f59
company,2023-06-11 23:39:00,AstraZeneca breast cancer drug capivasertib gets priority review in US,120830586,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=4665b72b88d0d3655e9502c2429a6894d9667730d6096d82799cdd7e67703af7
company,2023-06-11 21:53:00,"Macro Muddle Coming Up As Market Exceeds Expectations, Small Caps Gain Ground",120832256,,AZN,TalkMarkets,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=9072050a678518b62c772b6d5fe7ec65e0b03151527e93db45af9ded0c264b26
company,2023-06-19 13:53:37,AstraZeneca plots to sell AI drug unit to the Chinese,120950173,https://s.yimg.com/ny/api/res/1.2/BxhehUvPpvAKaeyTFDQLYA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD03NTA-/https://media.zenfs.com/en/the_telegraph_818/8f03f96f2646b75967d3f97501a747b2,AZN,Yahoo,AstraZeneca’s pioneering artificial intelligence (AI) research centre could fall into foreign ownership under reported plans for the drugs giant to spin off and separately list its Chinese division.,https://finnhub.io/api/news?id=a7bbf5f90c2522d2912e3924b90b48607855c58782dc3ecfcdb81f298d77d8eb
company,2023-06-19 11:50:27,AstraZeneca/China: break-up deal would reflect necessity not choice,120953443,https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png,AZN,Yahoo,"China is known for its prowess in gymnastics.  As tensions heighten between the US and China, AstraZeneca may offer its own twist by carving out its Chinese business.  Chief executive Pascal Soriot has pushed AstraZeneca harder and faster into China than any other big foreign drugmaker.",https://finnhub.io/api/news?id=ccb4599aca66cbdf241691ad3b7e40c037bbfbda364b240aded559343d819151
company,2023-06-19 08:01:00,"AstraZeneca falls Monday, underperforms market",120950375,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"AstraZeneca PLC shares shed 1.20% to £116.46 Monday, on what proved to be an all-around grim trading session for the stock market, with the FTSE 100 Index...",https://finnhub.io/api/news?id=88a8c925a39c5a2972e44ca563cbcdd92e69abf9412eb0b95968f8dcc656beab
company,2023-06-19 06:02:00,"AstraZeneca could break out and separately list China business, FT reports",120946494,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=149bbf73c91010faaeaaddbc7c54a58673890d27eb4138a06a1c9511d12e4736
company,2023-06-19 00:09:00,LONDON MARKET OPEN: Stocks falter amid weaker outlook for China,120946495,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=58f1be023bb560e450153c87d814f6fa8e51a66213136133da41f10bdfffde44
company,2023-06-19 00:00:43,AstraZeneca could spin off China business,120942758,https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png,AZN,Yahoo,"AstraZeneca is protecting itself from US-China tensions.  Plus, corporate America has poured a lot of money into diversity plans over the past three years, but now it’s pulling back.  US secretary of state Antony Blinken is wrapping up a trip to China.",https://finnhub.io/api/news?id=a74341bdfc096d628001a2e6c360bb7409bd8947146bd12b4074ae1075da8503
company,2023-06-18 23:42:00,AstraZeneca weighs China unit spinoff amid geopolitical risks - report,120946497,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=e79f6043ff786d15b4e1cf2c132b56c198237d4790879ded584d4feed1e510ab
company,2023-06-18 22:53:00,LONDON BRIEFING: Severn Trent deal sized up by CMA; Coca-Cola HBC buys,120946499,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=77de1e3ca2e35c853b0f90b3e91300962a679765559fbbb1180e4643e5d6f069
company,2023-06-18 22:52:00,AZN Stock: China Business Spin-Off in the Works; Politics at Play,120946500,,AZN,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=87f6e65471aeb729d849c0abd0e9cb538c69e2b01218838f698f29a59d049477
company,2023-06-18 22:22:00,Why is AstraZeneca (NASDAQ:AZN) Mulling Spin-Off of China Business?,120946502,,AZN,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=8c8fd4a053851ba53beee56828541ae7c44404faf299e5f99e7f3a8f501ae110
company,2023-06-18 22:00:00,PRESS: AstraZeneca drafts plan to spin-off in China - FT,120946504,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=b318c5af7620286c2bee1f9761af57e59d41c1518cf66b650f4cab1b26624d76
company,2023-06-18 21:55:00,LONDON MARKET EARLY CALL: Stocks to fall but pound rises ahead of BoE,120946505,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=c8b4a9bbfeeff252aeb00726567f7df46973394e2006ced10bd3924ce77b44f3
company,2023-06-18 16:15:46,AstraZeneca planning China business spin off -FT,120942759,https://media.zenfs.com/en/reuters-finance.com/cb931d4116bb62f1f949f98a9565c865,AZN,Yahoo,"The company would seek to be a patriotic company in China that ""loves the Communist Party"", its China president said in May. Last year, the country accounted for 13% of AstraZeneca's total sales, and the company is China's biggest drugmaker.  The spin off could protect AstraZeneca from tensions between China and other global powers, while the company retained control of the business, the FT's report said.  AstraZeneca said it did not comment on ""rumours or speculations around future strategy or M&A.""",https://finnhub.io/api/news?id=06fa3dfbf6e46b004de197ac4fc708ecd921960091d1bb24d7cf686a05bd41d1
company,2023-06-18 16:00:42,AstraZeneca drafts plan to spin off China business amid tensions,120942760,https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png,AZN,Yahoo,Anglo-Swedish drugmaker views listing a separate unit in Hong Kong as potential shelter from global strife,https://finnhub.io/api/news?id=9ff308963bba546123f06f2e8f790782dd3dfab2019582f1196a39fe4448cb77
company,2023-06-18 05:00:00,How HS2 haunts ambitious plans for Britain’s golden triangle,120934855,https://s.yimg.com/ny/api/res/1.2/smgVl2qTPWGcvZ0gzCI1Bw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD03NTA-/https://media.zenfs.com/en/the_telegraph_818/38e48788a6efa753c9068a6cf60cd317,AZN,Yahoo,"The rivalry between Oxford and Cambridge stretches back centuries, with each university town famously dismissing their opposite as “the other place”.",https://finnhub.io/api/news?id=eadfcee63ae760a4a98aecf35fdd934b26ae3b5f55743dff4f85e32b7bb50844
company,2023-06-18 03:05:00,Week In Review: Cullgen Signs $1.9 Billion Protein Degrader Deal With Astellas,120935194,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1418835107/image_1418835107.jpg?io=getty-c-w1536,AZN,SeekingAlpha,San Diego-Shanghai company Cullgen will collaborate with Japan's Astellas Pharma to discover multiple innovative protein degraders in a deal worth up to $1.9 billion. Read more here...,https://finnhub.io/api/news?id=4e2e9085e69b65ca284def1fac9217ff0e60085f19d6aada296816636fea9b8d
company,2023-06-16 23:06:00,Biologic drugs will lead European pharmas to surpass US counterparts in sales,120931684,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=74d818ea12455fca0c2f56d26d926b56ba28a8a010e27146b10a596a3ab89003
company,2023-06-16 13:25:00,AstraZeneca PLC ADR outperforms competitors on strong trading day,120939615,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR inched 0.80% higher to $75.22 Friday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=136a86adc3e4f104703a4f8c5cf890aa7eb8249684a7fbd4c2899d54c34fa88c
company,2023-06-16 10:07:00,2 Best Biotech Stocks to Buy Right Now,120911341,,AZN,Yahoo,"When done right, investing in pharmaceutical companies can be a lucrative endeavor.  This is because as long as there are diseases and infections, medicines and vaccines will always remain in high demand.  Dating back to Astra's founding in 1913 in Sweden, AstraZeneca (NASDAQ: AZN) has more than a century of corporate history.",https://finnhub.io/api/news?id=7e05bdc1c2a9df9c45287f47a7aef370158b510eea32a1742588b6bcf05b4d7e
company,2023-06-16 08:01:00,"AstraZeneca rises Friday, outperforms market",120939616,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"AstraZeneca PLC shares inched up 0.87% to £117.88 Friday, on what proved to be an all-around favorable trading session for the stock market, with the FTSE...",https://finnhub.io/api/news?id=3625ae97e419dc590fcfbbe8c78e824351f8fb130704e323826999ad904afcaa
company,2023-06-16 04:40:00,Unusually active option classes on open June 16th,120911266,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=c2911936f1b73b42055dad139c422bfe4db1fd67c6109820f0d84ed13e3a8541
company,2023-06-15 21:44:00,FDA panel recommends updated COVID-19 vaccines targeting XBB.1.5 subvariant,120917401,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=aa7a26a8fe9c53025a895027fbc09578407ec9392750b6feb9de539ee82db475
company,2023-06-23 13:24:00,AstraZeneca PLC ADR underperforms Friday when compared to competitors,121082971,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR slid 2.47% to $72.12 Friday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite...",https://finnhub.io/api/news?id=c1a4c8f55f1e70147c46d17c3f904a3f0428974e5aa73edb96988b4cb65c0562
company,2023-06-23 10:50:00,Pieris (PIRS) Declines as AZN Halts Study of Asthma Candidate,121019079,https://media.zenfs.com/en/zacks.com/4718122d03716403704541c667907c4e,AZN,Yahoo,"Pieris' (PIRS) shares nosedive as its partner decides to discontinue a phase IIa study evaluating elarekibep for treating asthma, based on non-clinical safety data from a toxicology study.",https://finnhub.io/api/news?id=19690359dc3ecfab86eee22d3c915c5564e3119bcea67a9b018283715345af29
company,2023-06-23 08:12:00,This Is What Whales Are Betting On AstraZeneca,121028675,,AZN,Benzinga,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=47606feba3798bee50d307e8a316b4fb77c03d9c9066b3aec5a90f0ce719bfe8
company,2023-06-23 08:05:00,"IN THE KNOW: GSK inks Zantac settlement but ""not a full stop"" on saga",121019571,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=76469a80383f9fe0a966e4ef4e3fe6f49c1667a85f92ad1349fbf23bcc395765
company,2023-06-23 08:01:00,"AstraZeneca falls Friday, underperforms market",121082972,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"Shares of AstraZeneca PLC shed 1.53% to £114.22 Friday, on what proved to be an all-around dismal trading session for the stock market, with the FTSE 100...",https://finnhub.io/api/news?id=9f3cff7d01fc677211a6295475a4e3238c6169682426594a69ee42dc04a395a2
company,2023-06-23 04:40:00,Unusually active option classes on open June 23rd,121019299,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=76716dadaf948e9001ee7fbef86ace9dc366864b8c227beb0ee251394b6385b3
company,2023-06-22 21:23:00,Fusion Pharmaceuticals is Future Pillar of Cancer Treatment: Analyst,121026248,,AZN,Benzinga,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=ea6145eadba6446ee40c06b55aa23a26f4c210d4b18e7fdb4b83b4a719441706
company,2023-06-22 14:00:00,Is AstraZeneca a Top Stock to Buy Right Now?,121004039,,AZN,Yahoo,The pharma specialist's top-shelf clinical pipeline and product portfolio should be tremendous growth drivers in the years ahead.,https://finnhub.io/api/news?id=810b200a307782af1c0c7c7825ed7ff50b687dec45ece016559781de872c6178
company,2023-06-22 13:25:00,"AstraZeneca PLC ADR rises Thursday, still underperforms market",121008319,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR inched 0.78% higher to $73.95 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the...",https://finnhub.io/api/news?id=b7d471234a6b44f3045b7d67977182515a0d985f7d032891d502439fc6cd2ceb
company,2023-06-22 08:01:00,"AstraZeneca rises Thursday, outperforms market",121008320,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"Shares of AstraZeneca PLC inched up 0.12% to £116.00 Thursday, on what proved to be an all-around rough trading session for the stock market, with the FTSE...",https://finnhub.io/api/news?id=99a8ca41be8244b85a0b0a9413c8efada6c0c2b065174eafa7ef0226a100cb76
company,2023-06-22 06:36:00,Interesting AZN Put And Call Options For August 4th,121002863,,AZN,Stock Options Channel,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=06942c790772c458cd9770528b27db142f538f72e8e1b87d4781086f44afeed6
company,2023-06-22 04:08:00,"European Drug Authority Raises Thyroid Cancer Safety Signal For Novo Nordisk Drugs, Including Hyped Semaglutide",120997412,,AZN,Benzinga,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=533bc8b1fe63f2bd9c0adc9e3dc720b27657053182e2154eecd7e5e4f074d4ac
company,2023-06-22 02:07:00,Novo Nordisk falls after safety signal linked to weight loss drug class,120997413,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=b900ce54f3f3a9cb2ce8dac70ebf22fbe78e441d57c009c27f54d2beb59b61d3
company,2023-06-21 16:07:48,SandboxAQ to launch 'AQBioSim' division to focus on A.I.-assisted drug development,120989523,https://image.cnbcfm.com/api/v1/image/107260568-16873913061687391302-29986587201-1080pnbcnews.jpg?v=1687392468&w=1920&h=1080,AZN,CNBC,"Jack Hidary, SandboxAQ CEO, joins 'Last Call' to discuss the use case for A.I. in the healthcare industry and how the technology is being utilized to develop life saving drugs.",https://finnhub.io/api/news?id=e34f122fb5d641a7d440490ad4f1374cb2ba941655bf80054d40c5b20bbe0f94
company,2023-06-21 14:05:00,FDA Expands Pfizer's (PFE) Talzenna Label in Prostate Cancer,120987439,https://media.zenfs.com/en/zacks.com/1e2f63f10f05b0390ba8b63bd4ef031c,AZN,Yahoo,"Following FDA's label-expansion approval, Pfizer's (PFE) Talzenna is the first PARP inhibitor approved in combination with existing standard of care for treating HRR gene-mutated mCRPC.",https://finnhub.io/api/news?id=c5677ff5c20f929c61248545e84ae9c61409aa53cab95c7ec96e9a70611aeb69
company,2023-06-21 13:25:00,"AstraZeneca PLC ADR falls Wednesday, still outperforms market",120993052,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR shed 0.77% to $73.38 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=8548158e0628c7b3e903fd4891b436754329d00bbbe0632b01bbc555f6993bb6
company,2023-06-21 08:35:00,"$1000 Invested In This Stock 10 Years Ago Would Be Worth $3,100 Today",120981695,,AZN,Benzinga,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=f0e172b7894d33dbac2577feb5a0e111ab89e25e8f7b22a5e98df25ca7c7f150
company,2023-06-21 08:01:00,"AstraZeneca falls Wednesday, underperforms market",120993053,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"Shares of AstraZeneca PLC inched down 0.43% to £115.86 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the FTSE...",https://finnhub.io/api/news?id=39382311f2dd0eab2edcf888613b295910a4bb4b20d789558f42a891108bdef3
company,2023-06-21 07:48:00,What Does AstraZeneca's Debt Look Like?,120981696,,AZN,Benzinga,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=45d8ed362020fc42e99baff3c5b4c3404d4b86a31ee7fb68a85d9acf3dd35392
company,2023-06-21 05:00:00,Argenx's Vyvgart Hytrulo Becomes First FDA Approved Subcutaneous Option For Generalized Myasthenia Gravis,120977229,,AZN,Benzinga,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=80a6c3552a93182eab5b9fe91e0195bdd1315af391072c0178ae93f82377d98f
company,2023-06-21 03:57:00,Pieris sinks 60% as AstraZeneca halts mid-stage trial for Asthma candidate,120981699,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=9dd26d583d562e8d89e1eb9854e386759a9b637fedf920ae510f716dcf2c5546
company,2023-06-21 03:17:00,Pieris Pharma Shares Halted as Partner Discontinues Asthma Treatment Trial,120993054,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,By Adriano Marchese Pieris Pharmaceuticals shares were halted in premarket trading after its partner AstraZeneca decided to discontinue and cease dosing in...,https://finnhub.io/api/news?id=5b5de2cd20432cf88ba0f6156f7f5bc50a394f1e37a01dcdeb118eb59a1e8975
company,2023-06-20 18:15:21,Astrazeneca (AZN) Dips More Than Broader Markets: What You Should Know,120969398,https://media.zenfs.com/en/zacks.com/a41b81fe729c761f3f94f42ff348f70c,AZN,Yahoo,"In the latest trading session, Astrazeneca (AZN) closed at $73.95, marking a -1.69% move from the previous day.",https://finnhub.io/api/news?id=7032cb5f10f05d514a01946055e88fdc162f6f0b41ce998ee0d39eec6c1c53ad
company,2023-06-20 13:25:00,"AstraZeneca PLC ADR falls Tuesday, underperforms market",120967339,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR slid 1.69% to $73.95 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite...",https://finnhub.io/api/news?id=8910b21a522860ca43c635df7243e3a805b7cc5eeadeaf371deddb1740e8c273
company,2023-06-20 11:31:00,AstraZeneca (AZN) May Reportedly Spin-Off its Chinese Business,120958266,https://media.zenfs.com/en/zacks.com/ef77d5a5eb4e72e4dd31ccfaf4ca4ccd,AZN,Yahoo,AstraZeneca (AZN) reportedly plans to spin-off its China business and list it separately in Hong Kong to protect itself from rising tensions between the United States and China.,https://finnhub.io/api/news?id=531b2e5d90fa12efbd15c18bce58476525c43d954585d1077b3acf6364acf0e8
company,2023-06-20 11:07:28,"Spotify to Launch New Expensive Subscription Plan, Chinese Vendors Bypass US Embargo to Supply Nvidia AI Chips, Eddie Wu To Succeed Daniel Zhang As Alibaba's CEO: Today's Top Stories",120956234,https://media.zenfs.com/en/Benzinga/01fdfea4c66518287ba72685b36eb1dc,AZN,Yahoo,"Bloomberg Spotify to Launch New Expensive Subscription Plan, 'Supremium,' Amid Competition with Apple and Amazon Spotify Technology S.A. (NYSE: SPOT) is eying a more expensive subscription option likely to include high-fidelity audio to drive more revenue and appease investors. Dubbed ""Supremium,"" the new tier will be Spotify's most expensive plan and likely offer a HiFi feature it first announced it was working on in 2021. To augment its current ""Premium"" tier, Spotify will offer subscribers ex",https://finnhub.io/api/news?id=6ccc1940a39ff9aa710c83ec6eb540992986939c837634b4bdd30febbeddedeb
company,2023-06-20 10:23:28,AstraZeneca Mulls China Business Unit Spin-Off Amid Geopolitical Tensions,120956235,https://media.zenfs.com/en/Benzinga/d425ea60d78329c4bef5e7051c877fe1,AZN,Yahoo,"European drugmaker AstraZeneca plc (NASDAQ: AZN) is reportedly drafting a plan to spin off its China business, and listing a separate unit in Hong Kong is considered an option amid mounting geopolitical tensions. Last month, during an event held in Wuxi to commemorate its 30th year in China, AstraZeneca's China president, Wang Lei, said the company will seek to be a patriotic company in China that ""loves the Communist Party."" In 2022, China accounted for 13% of the company's overall sales. The s",https://finnhub.io/api/news?id=310687424fab1e9bbeae842151a51031dcdef0de263edd9507ee192edcf1de99
company,2023-06-20 08:45:00,AstraZeneca call volume above normal and directionally bullish,120966355,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=07535193f7fe996241e06ba07ce85bab6cb937b33e5910ea07f0aaec103742f6
company,2023-06-20 08:01:00,AstraZeneca outperforms market despite losses on the day,120967340,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"Shares of AstraZeneca PLC inched down 0.09% to £116.36 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the FTSE...",https://finnhub.io/api/news?id=93d5185e7a38d5e712a3baebeb7dc799872b9540a1366cf26661e1324e30422c
company,2023-06-20 03:27:45,AstraZeneca: What's Next? (Rating Downgrade),120954050,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/57611036/image_57611036.jpg?io=getty-c-w1536,AZN,SeekingAlpha,AstraZeneca is considering spinning off its China operations and listing a separate division in Hong Kong or Shanghai. Read why we're neutral on AZN stock.,https://finnhub.io/api/news?id=8c5a3aaf6e3606102d533e50574edfbb3515e583ec1ea3b3e1014c4575df9d6a
company,2023-06-20 03:00:02,Drugmakers aim to strike down Medicare drug-price negotiations at Supreme Court ,120955527,https://image.cnbcfm.com/api/v1/image/107257719-1686851349999-gettyimages-1132310017-wm2_7857_20190226114130053.jpeg?v=1687258802&w=1920&h=1080,AZN,CNBC,The lawsuits are the opening salvo in a historic and potentially decisive battle over Medicare's efforts to bring rising drug prices under control. ,https://finnhub.io/api/news?id=0d9e94a7331b8ea1619d5c7464309bf23014f84104a23c84cf46adf791bfd822
company,2023-06-27 18:00:24,Astrazeneca (AZN) Stock Sinks As Market Gains: What You Should Know,121083649,https://media.zenfs.com/en/zacks.com/45c083e4721b0d0d1f6e431ec0bb5cc1,AZN,Yahoo,"Astrazeneca (AZN) closed at $71.67 in the latest trading session, marking a -0.08% move from the prior day.",https://finnhub.io/api/news?id=64deb6ae4af1c6181dfc554d271c073951d1bb3583d4ee2159987d5bcf0969bc
company,2023-06-27 13:25:00,AstraZeneca PLC ADR underperforms Tuesday when compared to competitors,121082964,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR sank 0.08% to $71.67 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=0d7ff27d23dbf0e8a0c814c054b06f6e351c84b6f4ef0711629b213e9bf4c30f
company,2023-06-27 08:01:00,"AstraZeneca falls Tuesday, underperforms market",121082966,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"Shares of AstraZeneca PLC inched down 0.90% to £111.90 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the...",https://finnhub.io/api/news?id=2e9706ff1c927371e55cb1d8bce5e722ca9f530743f771f7abb2b640e7f483c8
company,2023-06-27 06:18:00,Price Over Earnings Overview: AstraZeneca,121068664,,AZN,Benzinga,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=62bb9397f4d83c5b53401831923582ac01c1d4446845914489c3e97a99fc9d4c
company,2023-06-27 03:51:00,AIM ImmunoTech announces approval in the Netherlands to begin Phase 1b/2 study,121068666,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=818ce5f30fa37c9e53b82523038679d6bb95515a4c28cc0644028e2b8540c30b
company,2023-06-27 03:45:00,Largest borrow rate increases among liquid names,121068667,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=b47324bd9d54fec86b6fe18db4ffd961df466c65f087084d46311953aa781d3d
company,2023-06-27 01:40:00,AstraZeneca says Xigduo XR approved in China for adults with type-2 diabetes,121068668,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=ca8014f0c9b912f10b32e823a41ff132ff3ae9e544917f375a27776ea78d49d9
company,2023-06-26 23:19:00,AstraZeneca's diabetes combination treatment approved in China,121068669,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=223d308d2ea5fbaed6f926b4844e1affcdd0567d8d790652c397a55449d3c89a
company,2023-06-26 22:55:00,AstraZeneca put volume heavy and directionally bearish,121090231,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=b2abbcd2aa02472e8c4fefb38ff714738e3d1b67c77feff8e96cea0bf56d26b2
company,2023-06-26 18:15:22,Astrazeneca (AZN) Dips More Than Broader Markets: What You Should Know,121062667,https://media.zenfs.com/en/zacks.com/d0d4ab152198da2f423d92da8a7d22ee,AZN,Yahoo,"Astrazeneca (AZN) closed the most recent trading day at $71.73, moving -0.54% from the previous trading session.",https://finnhub.io/api/news?id=098841eaf8840133980a420c0354140f883d2121fc4c0fbda1aa578c68ea02b3
company,2023-06-26 13:25:00,"AstraZeneca PLC ADR falls Monday, still outperforms market",121082968,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR sank 0.54% to $71.73 Monday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite...",https://finnhub.io/api/news?id=d40adb34ce87fe3d229d9eda6fc1dfcaabf38705006f54fa5c1a3691ed7bb2d4
company,2023-06-26 10:28:58,AstraZeneca Seeks Expanded Use For Soliris As First Targeted Therapy For Pediatric Patients With Autoimmune Neuromuscular Disease,121050585,https://media.zenfs.com/en/Benzinga/5c5d68ea352fb6b088300bdca49faa94,AZN,Yahoo,"The European Union has recommended for marketing authorization of AstraZeneca Plc's (NASDAQ: AZN) Soliris (eculizumab) for expanded use in refractory generalized myasthenia gravis (gMG) in children and adolescents. gMG is a rare, chronic autoimmune neuromuscular disease causing severe weakness and loss of muscle function. Soliris was first approved in the EU in 2017 for certain adults with gMG and is also approved for certain adults with gMG in the U.S., China, and Japan. If approved, Soliris wo",https://finnhub.io/api/news?id=4a84cab6be2a29b0c6e02c69769e39bf458f5d096268b7c8d7eaf915e4994f9e
company,2023-06-26 08:54:00,Post-COVID-19: How the COVAX Initiative Could Redirect its $2.6B Surplus to Fight Future Pandemics,121052140,,AZN,Benzinga,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=80af5168dd21215a9ad19d7115ce0c5f7c0e069b2f8d89e396c20b64d781ab3b
company,2023-06-26 08:34:00,Amazon targets Ohio for big AWS operations expansion,121060163,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=179ca23c289e15439c6cb553fb5897795d064dfa122c8bc77c2ccd4a4b5ef063
company,2023-06-26 08:01:00,"AstraZeneca falls Monday, underperforms market",121082969,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"Shares of AstraZeneca PLC slid 1.14% to £112.92 Monday, on what proved to be an all-around rough trading session for the stock market, with the FTSE 100...",https://finnhub.io/api/news?id=610d69bd764c81939fbc72d76cb4c89fb86944254258e249faaa28a5ae67b71e
company,2023-06-26 05:44:00,Interesting AZN Put Options For August 18th,121060165,,AZN,Stock Options Channel,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=cd592546fa392ef35a67ed987c4499f5f8730c4c059492738de01cdd64422568
company,2023-06-26 01:29:00,AstraZeneca's Soliris recommended for EU approval by CHMP for children with gMG,121060169,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=b5705a26a00a0b8f9e5ace34f882c944325078781b8beceaa54b17e31754eb22
company,2023-06-26 00:43:00,"Large Cap Biopharma Buffeted By Big Gov, Choppy Days Ahead",121058560,,AZN,TalkMarkets,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=6439151289bdbfdeb183e234c678a9b45f7d412c560fadf2339c2d9edc224a85
company,2023-06-26 00:13:00,Innate Pharma announces first patient dosed in MATISSE trial,121048763,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=4d31cfc4e9da8a91fe75ff17687f2dadf4ae8949003d3d32c9febdffc3ffb245
company,2023-06-25 23:39:00,EU committee recommends expanded approval for AstraZeneca's Soliris,121060176,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=f542c7ff6835495a35c43001499af96346c3cad190aee8fdcd1923f106136df8
company,2023-06-25 21:00:00,First Patient Dosed in Phase 2 MATISSE Trial of IPH5201 in Early Stage Lung Cancer,121048767,,AZN,Business Wire,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=3fb9c15dd67a25c01001edac2474e038fcefd666acde388a25e234b9c8b0dcff
company,2023-06-25 21:00:00,Innate Pharma: First Patient Dosed in Phase 2 MATISSE Trial of IPH5201 in Early Stage Lung Cancer,121048765,,AZN,Business Wire,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=77877e58c52100f30509c5a2fc8670522f7c14ba181010588f1c0a71bb394479
company,2023-06-25 07:03:00,What is behind big pharma's underperformance?,121037591,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=8087d15b1e8dd9add3d7e3a2e964c3b48980f9f1edb78d518508be2fa39b8cde
company,2023-06-25 01:45:00,Week In Review: AstraZeneca Considers Spinning Off China Ops Into Separate Company,121033756,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/155151969/image_155151969.jpg?io=getty-c-w1536,AZN,SeekingAlpha,The biotech world had a busy week. Click to read about the latest Deals and Financings & Trials and Approvals in biotech.,https://finnhub.io/api/news?id=bafe788ded41aa1d44b0c81ac7e911f2542ece6e71a31ad3120d163bf6ebea8b
company,2023-07-01 05:06:00,4 Unparalleled Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip,121163210,https://s.yimg.com/ny/api/res/1.2/8s9DlLLHL8GizK9yw.pj4g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/424e681d95dd108b4f561ff9c4e3172c,AZN,Yahoo,"It's been a wild two years for Wall Street.  After rocketing to record-closing highs in 2021, all three major stock indexes stumbled into a bear market last year.  The innovation-focused Nasdaq Composite (NASDAQINDEX: ^IXIC) was hardest hit, with the index shedding a third of its value.",https://finnhub.io/api/news?id=2df089693140f624fff04d1d9b4f6dc99438ffdca5ba2458afe40c144f9daa2c
company,2023-06-30 13:25:00,"AstraZeneca PLC ADR rises Friday, still underperforms market",121167238,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR rallied 1.02% to $71.57 Friday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=ab5e1eab4a86341972e86394c9824e4d5424011f8f7a1f75a7d55cef7e0ab3e8
company,2023-06-30 08:01:00,"AstraZeneca rises Friday, still underperforms market",121167240,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"Shares of AstraZeneca PLC inched up 0.36% to £112.76 Friday, on what proved to be an all-around great trading session for the stock market, with the FTSE 100...",https://finnhub.io/api/news?id=67f332192c343bebd14e2309a85d037dd4456a977c04631e4317497e80ebcb76
company,2023-06-30 07:45:00,Medicare revises guidance on drug price negotiations amid lawsuits,121143519,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=9995d69366d1eb03a503aedbca7566d037f9ef099dec3aaed5ff87e49f1a862a
company,2023-06-29 13:24:00,AstraZeneca PLC ADR underperforms Thursday when compared to competitors,121167242,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR slipped 0.16% to $70.85 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=fc807ac1c0667c73a3e50606187126982e625aecf1f4c50acc677b6e80d6b193
company,2023-06-29 09:15:00,IMFINZI® (durvalumab) plus IMJUDO® (tremelimumab-actl) demonstrated sustained overall survival benefit in advanced liver cancer with an unprecedented one in four patients alive at four years in HIMALAYA Phase III trial,121115351,https://media.zenfs.com/en/business-wire.com/bc11bfc0a16bf1e78870ef5150b3e673,AZN,Yahoo,"WILMINGTON, Del., June 29, 2023--Updated results from the HIMALAYA Phase III trial showed AstraZeneca’s IMFINZI® (durvalumab) plus IMJUDO® (tremelimumab-actl) demonstrated a sustained, clinically meaningful overall survival (OS) benefit at four years for patients with unresectable hepatocellular carcinoma (HCC) who had not received prior systemic therapy and were not eligible for localized treatment.",https://finnhub.io/api/news?id=8a076b0a421f15403b96e16dcf8d05673de54275a67d2980897414d6a3a335a8
company,2023-06-29 08:41:00,AstraZeneca's Imfinzi/Imjudo Combo Shows Sustained Overall Survival Benefit At Four Years In Liver Cancer,121118781,,AZN,Benzinga,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=ecd3516944e11e6ab8ca6e95eef03ad36e5641fe7bddb2da971c12606382923b
company,2023-06-29 08:01:00,"AstraZeneca rises Thursday, outperforms market",121167243,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"AstraZeneca PLC shares inched up 0.02% to £112.36 Thursday, on what proved to be an all-around poor trading session for the stock market, with the FTSE 100...",https://finnhub.io/api/news?id=3887b00bab7deabaeeb06b5d18250bfd0c89c6a7cc9970efe6d80883a582ebe8
company,2023-06-29 06:26:00,SEC charges five individuals with insider trading before Alexion-Portola merger,121148803,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=da55d10ca6756ff6213cdbe52ac4764c7614e9a41a09639874bb90d1eec190e8
company,2023-06-29 05:45:00,AstraZeneca Sees Positive Phase 3 Trial Data for Imfinzi Cancer Treatment,121167244,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,"By Chris Wack AstraZeneca said a Phase III trial showed its Imfinzi durvalumab plus Imjudo demonstrated a sustained, clinically meaningful overall survival...",https://finnhub.io/api/news?id=4f7382b6ff570efbf915954b0c4620976f30ed46dfb4d86a447d77d58ca7e811
company,2023-06-29 05:31:00,AstraZeneca's Advanced Liver Cancer Treatment Data Shows Improved Survival Rates,121167245,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,By Michael Susin AstraZeneca said Thursday that phase III studies showed that Imfinzi plus Imjudo provided a sustained and clinically meaningful overall...,https://finnhub.io/api/news?id=2345ac57c750d2223aee3f6e452f74108a8b46716556768b7cb7830736097342
company,2023-06-29 04:24:00,AstraZeneca: Imfinzi + Imjudo demonstrate meaningful OS benefit for HCC patients,121148805,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=e02a6cb4046c195f70fa52f244164e46cc206c4b806eec022418ecd69a74dcf7
company,2023-06-29 04:20:00,AstraZeneca says Imfinzi/Imjudo show sustained OS benefit in HIMALAYA trial,121148806,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=4b40f9c35890619a65392b86f4044645eb949bc9be0f178b0f4bc304e0363f2e
company,2023-06-28 13:24:00,"AstraZeneca PLC ADR falls Wednesday, underperforms market",121167246,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR dropped 0.99% to $70.96 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=dc9bce2fed64f2938c22d744963895ea1da55af9be54b68f7a8424bdc3de39cf
company,2023-06-28 09:00:06,How to Find Strong Medical Stocks Slated for Positive Earnings Surprises,121099722,https://media.zenfs.com/en/zacks.com/d2f7ed3d1940141716bfd200f5c94c6b,AZN,Yahoo,Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.,https://finnhub.io/api/news?id=37e66ff29d81d98f4507011e7e434973724d6d8a27fc4742d0623d2a00279d30
company,2023-06-28 08:01:00,"AstraZeneca rises Wednesday, still underperforms market",121167247,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"Shares of AstraZeneca PLC inched up 0.39% to £112.34 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the...",https://finnhub.io/api/news?id=823463dfa3bf19ff144bf032f200f9a2fbfb6903f76e4f55cadaa1716dda8137
company,2023-06-28 04:19:00,Genprex jumps ~15% on third FDA fast track tag for lead asset,121090224,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=421806e4913e36fc34e81cabd148caf54f7e846c49ac40358905c5f33c5f8fec
company,2023-06-28 02:54:00,IN BRIEF: AstraZeneca invests USD400 million in reforestation,121090226,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=0536edf67e1b23750944744f79691b17c8c42e19f4e9f4bfe7634ddca18a3fa9
company,2023-06-28 02:00:00,AstraZeneca announces $400 million investment in reforestation and biodiversity in support of climate action and human health,121099723,https://media.zenfs.com/en/business-wire.com/c7be092559034d5a9a5dcebccbc9d2a1,AZN,Yahoo,"CAMBRIDGE, United Kingdom, June 28, 2023--Expansion of AZ Forest for climate action and human health",https://finnhub.io/api/news?id=6895c3d3e0308acdf62706a0ba50b760717f6e5a15286d87262da8d254a1762d
company,2023-06-28 00:24:00,AstraZeneca announces $400M investment in AZ Forest program,121090227,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=703d2e8b370b9031558f963be353b8ca767f9a8b46051c170b5f2ee3464b46af
company,2023-06-27 23:50:00,AstraZeneca Unusual Options Activity For June 28,121148810,,AZN,Benzinga,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=56587e867692aedbbe50f910fc4c3d7ba26f596714a2ea8a80d06e6afd6973b7
company,2023-07-05 16:41:06,Moderna announces China investment as country opens doors to foreign pharma,121217084,https://s.yimg.com/ny/api/res/1.2/xXaM.CJya5gc2TIhF0l8rw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://s.yimg.com/os/creatr-uploaded-images/2022-03/80d89c40-a6df-11ec-bffd-8047d43d6280,AZN,Yahoo,China signals a warmer welcome for Western pharma giants just as Treasury Secretary Janey Yellen leaves for Beijing.,https://finnhub.io/api/news?id=7cfc8195bb7dd2d372d8d6aae155e9f6fc79deb1159383a1b56330381a428efc
company,2023-07-05 13:25:00,"AstraZeneca PLC ADR rises Wednesday, outperforms market",121219420,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR rallied 2.77% to $67.06 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=b4e795ce8863775cea2fe1dd5389b9a12b6b7efdb406d6384b545d9195e2ad98
company,2023-07-05 09:44:47,"AstraZeneca, Moderna Stocks Rise",121214596,https://media.zenfs.com/en/wsj.com/7b2c285183be07ca3c4e8242b25a59a8,AZN,Yahoo,Two large drugmakers are advancing in early trading Wednesday. + AstraZeneca's New-York listed ADR rose 2.6% shortly after the open; shares in the drugmaker sold off Monday after it reported mixed results in a trial for an experimental cancer drug.,https://finnhub.io/api/news?id=70d7ae5382cb64e36aa99750484d1072989a5e081f63b704aa729fe97d1ad27e
company,2023-07-05 08:01:00,U.K. stocks weaken for third day,121215320,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,"U.K. stocks fell Wednesday, as the FTSE 100 Index finished down 1.03% at 7,442.10. Among FTSE 100 constituents, food retail company Ocado Group PLC saw the...",https://finnhub.io/api/news?id=847d52c79f06890f1b2b0b2aeaa08f2cf1ed5f3482c209722d3932623aef4a20
company,2023-07-05 08:01:00,"AstraZeneca rises Wednesday, outperforms market",121219421,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"Shares of AstraZeneca PLC inched up 0.38% to £106.20 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the FTSE...",https://finnhub.io/api/news?id=ff0043bcc75db9a249455e30d2fcb63de67e8f59f895e9147f2e5a7ed9d4978a
company,2023-07-05 05:05:53,Moderna strikes deal to develop mRNA drugs in China ,121212593,https://image.cnbcfm.com/api/v1/image/107261606-1687528288751-gettyimages-1244086916-pekiaridis-notitle221018_npjbu.jpeg?v=1688562353&w=1920&h=1080,AZN,CNBC,The deal is the biotech company's first agreement with China after the Asian nation repeatedly refused to accept mRNA vaccines from U.S.-based manufacturers. ,https://finnhub.io/api/news?id=a801f6f287418aa0df203d34f2ad085230de157b78f1edb6455c20b136f9e0bf
company,2023-07-05 03:53:31,"Stocks making the biggest moves in the premarket: Rivian, UPS, Coinbase and more",121207190,https://image.cnbcfm.com/api/v1/image/107251913-1686070785274-gettyimages-1496426735-0j5a1147_eqiucnwm.jpeg?v=1688558011&w=1920&h=1080,AZN,CNBC,These are the stocks posting the largest moves premarket.,https://finnhub.io/api/news?id=ca2a269ee272eb6f0ff44d0e4f0e55466bc9e2a44f813aa84fe70f2fbf796a67
company,2023-07-05 03:15:00,GLOBAL BROKER RATINGS: Kepler Cheuvreux cuts Deutsche Boerse to 'hold',121209467,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=ed830977b04a436e08f6bd443a9c011d2bd6c824f6a8bc23488e30b8f11c271d
company,2023-07-05 02:32:00,"AstraZeneca weakness a buying opportunity, says TD Cowen",121214179,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=ddd002bd30f2e7ae7fbda5b469c2dd6ed9f3009236efd85e293c5d1327644e07
company,2023-07-05 00:34:00,LONDON BROKER RATINGS: UBS likes Pearson; Liberum cuts Naked Wine,121211535,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=6729fa706bb6d9aa51ec2d7b34726c456a2388d6cb26c452d7b5b736e1a3af08
company,2023-07-04 22:31:00,Biotech Blues: Stay Balanced Through July Earnings Season,121214181,,AZN,TalkMarkets,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=94f82acac4f79fa0ed779467b25f94fe4ec5dd41578ee61190a8792bc4941c42
company,2023-07-04 21:34:41,Europe stocks set for lower open as economic gloom returns; Fed minutes due,121205393,https://image.cnbcfm.com/api/v1/image/107260264-1687366882437-gettyimages-1258902768-fed_hearing_015_062123.jpeg?v=1688535281&w=1920&h=1080,AZN,CNBC,European markets were set to dip at the open amid concerns over the economic outlook. ,https://finnhub.io/api/news?id=e8600125b6ee0c35e469da74ae534840ed11fffdd6dc70753649170d9ce431a2
company,2023-07-04 10:41:00,AstraZeneca (AZN) Down 9% on Mixed Lung Cancer Study Results,121202765,https://media.zenfs.com/en/zacks.com/ef77d5a5eb4e72e4dd31ccfaf4ca4ccd,AZN,Yahoo,"While AstraZeneca's (AZN) late-stage study evaluating an experimental lung cancer treatment showed improvement in progression free survival, it did not meet the threshold for statistical significance in overall survival.",https://finnhub.io/api/news?id=5db2bcfceba278c14ea02fc5068f1fb4b5f8a9ad5c1055e225dfd94532823e00
company,2023-07-04 08:01:00,"U.K. stocks continue losing streak, fall for second day",121215520,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,"U.K. stocks finished lower Tuesday, with the FTSE 100 Index dropping 0.10% at 7,519.72. Of the FTSE 100 constituents, major international banks company...",https://finnhub.io/api/news?id=f54ee0257c46c1b2e95f8f064cbf3218bebd200dfda1410f0bd00bc9b7e626c3
company,2023-07-04 08:01:00,"AstraZeneca rises Tuesday, outperforms market",121219423,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"Shares of AstraZeneca PLC rallied 1.99% to £105.80 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the FTSE 100...",https://finnhub.io/api/news?id=135f9c9eef595ddc512f373557bd5eebc40cef1ecad84ec4d7c4d03f45f5f8f5
company,2023-07-04 07:49:00,LONDON MARKET CLOSE: Tepid close after quiet day with US market closed,121196870,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=50dcc2411e011529690bbbb3c9007123310056919c6cac96c4d06d1964276f79
company,2023-07-04 03:08:00,LONDON MARKET MIDDAY: Stocks higher amid US holiday-thinned trade,121200158,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=b9a12836130333318e2db48e6599dd04f653ec2874137ece93a665a113c44821
company,2023-07-04 02:51:00,GLOBAL BROKER RATINGS: Deutsche Bank cuts Astrazeneca to 'hold',121196849,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=4dd3d11aa56f27667c3e9fae23822de470ce5fcc8f9120c52ea237899dddc2cb
company,2023-07-04 02:48:00,AstraZeneca downgraded to Hold from Buy at Deutsche Bank,121200160,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=45674ace330562abc6253bf323686d8032807e73f4f15ea33ffa82bf79f91311
company,2023-07-04 02:32:00,"AstraZeneca selloff on lung cancer data overdone, says Berenberg",121200161,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=f27b794cfc4ca70cad67a7de47f1747bb7288eb3281823cbdf5498a1875250ae
company,2023-07-04 00:27:00,"LONDON BROKER RATINGS: Dunelm, AstraZeneca and Persimmon cut",121196853,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=261303d3a8b201c615751a0953da3adba1cb2e1119b3d8f2cf2c1c48897e8662
company,2023-07-03 21:57:30,Europe stocks close slightly higher as investors await earnings season; OMV shares up 7%,121203327,https://image.cnbcfm.com/api/v1/image/107234507-1683093866740-gettyimages-1248287665-UK_LSE.jpeg?v=1688450624&w=1920&h=1080,AZN,CNBC,"European markets closed slightly higher Tuesday, with investors in a cautious mood ahead of data releases and the start of second-quarter earnings season.",https://finnhub.io/api/news?id=56c0aa6291832215e53d958cfb76aacf5920db5aa4e37fdb3c171e176a8d108b
company,2023-07-03 14:26:14,These Were Monday's 2 Stock Movers That Investors Cared About the Most,121187666,https://s.yimg.com/ny/api/res/1.2/SahRIeHJ05EL5HkHk3tM6w--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD03MjE-/https://media.zenfs.com/en/motleyfool.com/96ed377c5cce389e6ad162e5c27e9f94,AZN,Yahoo,"Modest gains came for the Nasdaq Composite (NASDAQINDEX: ^IXIC), Dow Jones Industrial Average (DJINDICES: ^DJI), and S&P 500 (SNPINDEX: ^GSPC) alike, as a favorable summer sentiment among many investors continued to build momentum.  Coinbase Global (NASDAQ: COIN) got a big boost as institutional investors look to have the U.S. Securities and Exchange Commission grant approval for some interesting new investments.",https://finnhub.io/api/news?id=0a7d39a7428e2072dc34e8a6d4eeefb1bf3eb658a2d3e00fdc983e4be832f0e9
company,2023-07-03 14:01:00,"ADRs End Mostly Higher; AstraZeneca, Novartis Trade Actively",121217795,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,By Denny Jacob International stocks trading in New York closed mostly higher on Monday. The S&P/BNY Mellon index of American depositary receipts edged up...,https://finnhub.io/api/news?id=b19b97b1c53385853c7c77d811f3c134ff7687a4599b02533e84398e99c582be
company,2023-07-03 11:18:24,AstraZeneca: Today's Hit On Lung Cancer Data - Justified Or Overblown?,121187748,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1372767222/image_1372767222.jpg?io=getty-c-w1536,AZN,SeekingAlpha,AstraZeneca stock took a hit today after the company released data from a key lung cancer study. See whether today's selloff in AZN was justified.,https://finnhub.io/api/news?id=22ed4523bf77ba0669f0e97c4b3844f8b5254671aa40811ab6245f277503dcc1
company,2023-07-03 11:02:00,AstraZeneca Stock Is Sinking. A Cancer Drug Showed Disappointing Results.,121193025,,AZN,Yahoo,American depositary receipts of AstraZeneca were falling Monday after the drugmaker reported disappointing results from a Phase 3 trial of a lung- cancer drug.,https://finnhub.io/api/news?id=ef6617df5002fed791f7da6ec3281a7dddd05222080e85309cbcb67b3b80e5ed
company,2023-07-03 06:53:01,"Stocks to Watch Monday: Tesla, Apple, Nio, AstraZeneca",121182716,https://s.yimg.com/ny/api/res/1.2/qDx339o_IqA36qqGOFVHPQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02MDA-/https://media.zenfs.com/en/wsj.com/da5f4f51d1eb2db80103e5a2d9e520ad,AZN,Yahoo,**↗️** [**Tesla (TSLA)**](https://www.wsj.com/market-data/quotes/TSLA): The electric carmaker's stock rose 6.5% premarket after the company posted [a record quarter for sales.](https://www.wsj.com/articles/tesla-deliveries-to-show-whether-price-cuts-are-paying-off-2f2aac93) Other U.,https://finnhub.io/api/news?id=a9c1bc3aadaa0cdfcc3cae1894611a3132f270866d56600c5b2454915c8ce56c
company,2023-07-03 10:18:00,Health Care Slips as AstraZeneca Slides -- Health Care Roundup,121219426,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,Health-care companies fell amid development setbacks for some major drugmakers. AstraZeneca and Daiichi Sankyo shares plunged after the British drugmaker and...,https://finnhub.io/api/news?id=9051c7725c28743a3e7e0bc6b5ffc3def38236ace1142ec282e25b938364701e
company,2023-07-03 09:17:35,"AstraZeneca Plummets, Sacrificing A Breakout, On Mixed Results In Lung Cancer Treatment",121182711,https://media.zenfs.com/en/ibd.com/9ef576aa421756f409208f7cebc4ddbc,AZN,Yahoo,"AstraZeneca and Daiichi Sankyo reported mixed results Monday from a final-phase study of their lung cancer treatment, and AZN stock tumbled.",https://finnhub.io/api/news?id=2ae0705db978dfa11cb45bb239c5d3bfa814e9c115bcbbcbdce7202063ca0cfc
company,2023-07-03 09:46:00,AstraZeneca Stock Sinks as Cancer Drug Results Disappoint Investors,121182709,https://s.yimg.com/ny/api/res/1.2/ZlvvfmQvg0MNx1yuWHmrow--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02MDA-/https://media.zenfs.com/en/Barrons.com/69a2cbebd282a008cfd1593ded9cde25,AZN,Yahoo,"'For the dual primary endpoint of overall survival (OS), the data were not mature,' AstraZeneca said in its news release.",https://finnhub.io/api/news?id=2013ce791535e693ca1a1a3e914ad28bf36150f72615656c30369229028ba53c
company,2023-07-03 09:15:00,"Tesla, Rivian rise; Apple, AstraZeneca fall, Monday, 7/3/2023",121185393,,AZN,"Associated Press, The",Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=625143abad9fd59f9d07260cf3b9c4b3bb582fb5e170731b6f3728d28d879d09
company,2023-07-03 08:45:41,"Midday movers: Tesla, AstraZeneca, Carnival Corp. and more",121191378,https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png,AZN,Yahoo,Investing.com -- Stocks are rising in light trading on a shortened market day in the U.S. session. Here are the market movers for July 3.,https://finnhub.io/api/news?id=26bcbd429fada197939ad164a5c90486983516d66fbe44934714125f40d76602
company,2023-07-03 08:28:00,What You Missed On Wall Street On Monday,121185632,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=73e6007a88023cbc04717adf9207ff1cd391b77614a3cba41c6066195d120ebe
company,2023-07-03 08:16:00,"AstraZeneca drug hits PFS, but no 'clinically meaningful,' says Credit Suisse",121200165,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=b980ff866f375b5b12aaf582d91f7828b0b1600103846f31e33a9e25dbe5377e
company,2023-07-03 08:12:20,"European Stocks Rise, AstraZeneca Drops After Lung-Cancer Trial Update",121182712,https://media.zenfs.com/en/Barrons.com/12ea0f43d8f8307249a68d1cb2e0587e,AZN,Yahoo,"European stock markets were mostly in the green on Monday, despite eurozone data suggesting a decline in manufacturing activity in June.  London-listed pharmaceutical company AstraZeneca was among the biggest decliners as the results of a study on a lung-cancer treatment disappointed investors.  AstraZeneca (ticker: AZN) was down nearly 6% in London after it reported results for its datopotamab deruxtecan treatment in patients with advanced non-small cell lung cancer in a clinical Phase 3 trial.",https://finnhub.io/api/news?id=c6571982266f6dd7343cb2f0bcd760f8c06e995f062340cc6a9b368ff3448c82
company,2023-07-03 08:10:00,European stocks decrease for first time in four days,121219428,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,"European stocks fell Monday, as the Stoxx Europe 600 index closed down 0.21% to 460.98. The German DAX weakened 0.41% to 16,081.04, the French CAC 40 index...",https://finnhub.io/api/news?id=d391aa447b3a3a4581e941408f9fb518bfea9f2f37c9431dff3188b4b000f585
company,2023-07-03 08:05:00,LONDON MARKET CLOSE: Blue chips lose early shine as US treads water,121184246,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=3de046effc9b0607150cceafea5db1529d6e632b6dc056bdc8a359bceb241179
company,2023-07-03 08:01:00,U.K. stocks drop Monday,121219412,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,"U.K. stocks finished down Monday, with the FTSE 100 Index decreasing 0.06% at 7,527.26. Among FTSE 100 constituents, biotechnology company AstraZeneca PLC...",https://finnhub.io/api/news?id=e85ad70d5902de55d77b59b306d1bc896d7e835b2820a8e59a4a2fc936aea35c
company,2023-07-03 08:01:00,"AstraZeneca falls Monday, underperforms market",121219429,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"Shares of AstraZeneca PLC slipped 8.00% to £103.74 Monday, on what proved to be an all-around dismal trading session for the stock market, with the FTSE 100...",https://finnhub.io/api/news?id=e73c33f3689945c2313ea05a144c2050fbe4b6c3dcae1ab5fb3c1a4bf2c6517e
company,2023-07-03 07:01:00,AstraZeneca Losses Leave The FTSE In The Red To Start July,121189714,,AZN,TalkMarkets,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=d79d1307c37ff86e29656e797ce77cbc9406de7fac84b90794f2c3235bd06771
company,2023-07-03 07:00:00,Datopotamab Deruxtecan Met Dual Primary Endpoint of Progression-Free Survival in Patients With Advanced Non-Small Cell Lung Cancer in TROPION-Lung01 Phase III Trial,121182714,https://media.zenfs.com/en/business-wire.com/0b44cf6bcf61c3902f8e8e62b03e2b79,AZN,Yahoo,"WILMINGTON, Del., July 03, 2023--Positive high-level results from the TROPION-Lung01 Phase III trial showed datopotamab deruxtecan (Dato-DXd) demonstrated a statistically significant improvement for the dual primary endpoint of progression-free survival (PFS) compared to docetaxel, the current standard of care chemotherapy, in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) treated with at least one prior therapy.",https://finnhub.io/api/news?id=396676075c87a4e65ca6e568fad490d495c41d4cb17088217714f8c776642b61
company,2023-07-03 06:57:12,"Stocks making the biggest moves midday: Tesla, Rivian, XPeng and more",121183995,https://image.cnbcfm.com/api/v1/image/107261899-1687547267957-gettyimages-1500922372-dscf1308_axhqjbyg.jpeg?v=1688396232&w=1920&h=1080,AZN,CNBC,These are the stocks posting the largest moves in midday trading. ,https://finnhub.io/api/news?id=eecaa559113820cc52e3159fffb98c197cfec295374b3dec0440687974374ac3
company,2023-07-03 06:44:00,AstraZeneca Stock (NASDAQ:AZN) Dives as Phase Three Data Disappoints,121200168,,AZN,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=39682202a8a93c61f42d465568630ad357e54c877c4916c6294a9700ee369356
company,2023-07-03 06:33:00,AZN Crosses Below Key Moving Average Level,121200169,,AZN,Market News Video,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=1f1cae1a37d19d21d08ceb47465515b9b250567512c4ed1e4d58561d63b9cb3e
company,2023-07-03 05:44:00,"AstraZeneca, ECARX Holdings And Other Big Stocks Moving Lower On Monday",121184667,,AZN,Benzinga,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=a30c3430cc95edaa319c5f5be8760679ee8090a91349b82bc7ac86df5c42a0f4
company,2023-07-03 05:40:00,AstraZeneca reports mixed Phase 3 data for lung cancer drug,121200171,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=35b86ea93136dac833bf9ea19fff3650e241f7d80a4ae0b9d9fd481c3ca5d2a4
company,2023-07-03 05:33:00,AstraZeneca Unusual Options Activity,121200172,,AZN,Benzinga,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=aff719cfadbe177f8bdc530d7939802a472e66520a33872a04555f29bf4c4e91
company,2023-07-03 05:25:00,"Video: Nasdaq 100 Movers: AZN, TSLA",121200173,,AZN,Market News Video,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=2761cc8c69e0fdfa94a7233e97b7e2f6bf84b1860cb812aae1a66d7757815035
company,2023-07-03 05:17:00,"AstraZeneca 'glossing over' patient deaths in trial 'shameful,' Feuerstein says",121200174,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=f09ba79ce7290232aa5e97cd29a95c328a0df5bf4afce29fafaf0b3b1bf7a33a
company,2023-07-03 05:09:26,AstraZeneca shares fall after cancer drug trial disappoints investors,121182717,https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png,AZN,Yahoo,"AstraZeneca failed to meet investor expectations for a new lung cancer drug, despite announcing positive results showing a statistically significant improvement over chemotherapy.  Shares in the Anglo-Swedish drugmaker fell 5 per cent on Monday morning after it published the first results from its phase 3 trial for datopotamab deruxtecan, which it is developing with Daiichi Sankyo.  Investors were hoping that the drug would become as successful as Enhertu, another cancer treatment AstraZeneca developed with the Japanese group, and the companies have been investing heavily in trials for different types of cancer.",https://finnhub.io/api/news?id=0f376cdbcf7dae638dcf501ecfb82e029c68225b28a1b9c13983e3fb647dee5c
company,2023-07-03 04:40:00,Unusually active option classes on open July 3rd,121185979,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=1ea1bd91f894936dbc7a49314d0848686e77fe36eeeef131b80a0ef064e938c0
company,2023-07-03 04:11:45,AstraZeneca shares drop as lung cancer trial update lags expectations,121182719,https://media.zenfs.com/en/reuters-finance.com/f69a5e9fde3b94dff9e0a531a2baf04e,AZN,Yahoo,"AstraZeneca said on Monday an experimental precision drug slowed progression of lung cancer in a late-stage trial, but the company's shares fell as much as 6% as analysts said the benefits may not be as pronounced as hoped.  The drug, datopotamab deruxtecan, which is being jointly developed with Japan's Daiichi Sankyo, was shown to prolong progression-free survival compared with standard chemotherapy in patients whose non-small cell lung cancer had returned after one or two prior treatment attempts, AstraZeneca said.  The British drugmaker also said some trial participants had died of interstitial lung disease, or scarring of lung tissue, but added that the drug's safety profile was in line with observations during previous clinical trials.",https://finnhub.io/api/news?id=2425096a99bcbb7dd8b7089b37445e628d20923e9132376d02ddf1d7a2af8a51
company,2023-07-03 04:03:35,"Tesla, XPeng, Nio rise premarket; AstraZeneca, AMC Entertainment fall",121183242,https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png,AZN,Yahoo,"Investing.com -- U.S. futures inched lower at the start of a holiday-shortened week that includes the release of some key economic data, including the monthly employment report.",https://finnhub.io/api/news?id=5480585ba9e5f51a61a3eb0f29d49101f68400133b38370e5169e5d12076557d
company,2023-07-03 04:02:00,Fly Intel: Pre-market Movers,121184120,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=387c94f7d2d421fa6082bda227a5137475fbd45126b47ebbf91c75911ed771bb
company,2023-07-03 03:56:24,"Stocks making the biggest moves in the premarket: Tesla, Apple, AstraZeneca and more",121182377,https://image.cnbcfm.com/api/v1/image/107249250-1685628646520-gettyimages-1258298763-RAFAPRESS_30052023-06611.jpeg?v=1688385384&w=1920&h=1080,AZN,CNBC,These are the stocks posting the largest moves in premarket trading. ,https://finnhub.io/api/news?id=4f780ff69da650e2d50fb4f060c7fac73f0dd52f6da8adb9dfd2cf20cfbc8287
company,2023-07-03 03:42:30,AstraZeneca Drops on Concern Over Lung Cancer Trial,121182721,https://s.yimg.com/ny/api/res/1.2/rat5.K0G5mOXJ41TOh1PZg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD05MDA-/https://media.zenfs.com/en/bloomberg_markets_842/56f1a5afcf24af10c111138777794f10,AZN,Yahoo,(Bloomberg) -- AstraZeneca Plc shares fell as results from a high-level study of a new cancer medicine raised concern the drug might not work as well as anticipated.Most Read from BloombergTesla and BYD Post Record Sales on Surge in Electric-Car DemandIt’s Getting a Lot Harder to Chase the Stock Rally From Here OnFrench Riots Begin to Abate Even as Economic Costs MountSingapore’s Star Banker Creates a Succession Dilemma for DBSThe drug helped patients with the most common form of lung cancer liv,https://finnhub.io/api/news?id=a621677f46917827a2ea17de1a6eb7c7fdd24d5288a4430278cf7848ac90331f
company,2023-07-03 03:34:00,AstraZeneca Lung Cancer Treatment Meets Dual Primary Endpoint in First Phase 3 Trial Results,121219433,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,By Ben Glickman AstraZeneca said its treatment for lung cancer met one of its dual primary endpoints in the first batch of results for a Phase 3 trial. The...,https://finnhub.io/api/news?id=8b0aee56cf008a94afd92311d4a1fd257462fbc76dd6849ce4df1fedde1f4d15
company,2023-07-03 03:26:28,AstraZeneca shares dip after lung cancer drug trial update 'disappoints' hopes,121182722,https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png,AZN,Yahoo,"Investing.com -- AstraZeneca (LON:AZN) has announced that its experimental precision drug has shown improvement in slowing the progression of lung cancer in a late-stage trial, however, shares slipped on Monday after analysts noted that the findings disappointed expectations.",https://finnhub.io/api/news?id=30414fca289bc05f7fce283d0cb0c2db5d27412ce26593fda3a4913c2fa5f4ce
company,2023-07-03 03:25:00,AZN and VBIV among pre-market losers,121185995,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=d12257054680ec323c6a20a4ed5600b4b9f55592ff70aa65986fa20da5549fda
company,2023-07-03 03:05:00,LONDON MARKET MIDDAY: Miners and oil majors lead FTSE 100 march,121184140,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=b776f7198fcdbdae0453d25fd401a7c872708c9a3a113af158ef09e407e10ee6
company,2023-07-03 02:28:59,Russia and Saudi Arabia cut oil supplies in effort to bolster prices,121182724,https://www.telegraph.co.uk/content/dam/business/2023/07/03/TELEMMGLPICT000227555544_16883890931910_trans_NvBQzQNjv4BqqVzuuqpFlyLIwiB6NTmJwSX5rhseiWKOo9p9OQ-ymek.jpeg?impolicy=logo-overlay,AZN,Yahoo,Oil prices have pushed higher as Saudi Arabia and Russia announced twin moves to cut supplies.,https://finnhub.io/api/news?id=d895666a28ff06bc10d5384cf75e4a66c650b4a47ca936864d5e46a2232b6933
company,2023-07-03 01:54:00,AstraZeneca (NASDAQ: AZN) Slumps Over Concerns about Lung Cancer Drug Trial,121200180,,AZN,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=eae8d0a0ed11554538d8c36342c39bfd74f0c0a98e6a7e74bb7be8ed00ad03e3
company,2023-07-03 01:40:00,AstraZeneca says TROPION-Lung01 Phase 3 trial met dual primary endpoint,121200181,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=e703d40dfa6c964685c96ce91efc32141e58ca79f0abecb84f42858c922167da
company,2023-07-03 01:36:00,AstraZeneca shares slump after Phase 3 lung cancer drug study,121219432,https://images.mktw.net/im-699609/social,AZN,MarketWatch,AstraZeneca shares fell Monday after a late-stage study on a lung cancer drug disappointed investors.,https://finnhub.io/api/news?id=dfdc75e5c49ba81bdddeba4947bdcc69dde2925e8fb758abd9f2999ef34a75dd
company,2023-07-03 01:31:00,"Tesla shares rally on delivery numbers, AstraZeneca stock slumps on drug trial, and other stocks on the move",121216679,https://images.mktw.net/im-801344/social,AZN,MarketWatch,Tesla and AstraZeneca stock head in opposite directions.,https://finnhub.io/api/news?id=7e4e7dd980490d83517c5362a68274eb673b12c9799887490cbc7c8ffbbf38c3
company,2023-07-03 00:53:00,"These Stocks Are Moving the Most Today: Tesla, AstraZeneca, and More",121214539,https://images.barrons.com/im-803052/social,AZN,MarketWatch,Stocks closed in the green Monday to start off the shortened holiday week.,https://finnhub.io/api/news?id=c41f7c6e3c3f0b095012f4673a8e9ecd5792d0bd31d08dc8e723f5bf6a36e818
company,2023-07-03 00:07:00,LONDON MARKET OPEN: Stocks start second half in green amid PMIs,121184249,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=d476c3811f7aa1d62430a18b59b329a2afd0154134bea4b0ee5322fca7ac0a0e
company,2023-07-03 00:00:10,How a Swedish start-up reignited the search for an Alzheimer’s drug,121182726,https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png,AZN,Yahoo,A decade ago a large part of Big Pharma gave up on one of humanity’s cruellest diseases. But then a new treatment showed promise,https://finnhub.io/api/news?id=ab883bdcd41ee3514c9a212fc3cb11af0df887a7c0fe224b0c8d2b78e0e3584d
company,2023-07-02 23:42:00,"TOP NEWS: AstraZeneca, Daiichi hail datopotamab lung cancer trial",121200185,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=d845973e7ba4d868fc85083cfe5e28be72edc975e906a25c192c00e461e4f01c
company,2023-07-02 22:20:00,AstraZeneca Says Datopotamab Deruxtecan Phase 3 Trial Shows Positive Results in Lung Cancer Patients,121219435,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,By Anthony O. Goriainoff AstraZeneca said Monday that its datopotamab deruxtecan treatment showed positive results in patients with advanced non-small cell...,https://finnhub.io/api/news?id=3532f86320b5c08cca34779f1a95591834a328d9086a1b59eee52cb7f370a8a4
company,2023-07-02 22:00:00,Datopotamab Deruxtecan Met Dual Primary Endpoint of Progression-Free Survival in Patients with Advanced Non Small Cell Lung Cancer in TROPION-Lung01 Phase 3 Trial,121200187,,AZN,Business Wire,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=8827617770d0a5ecc8681007480a9743e182f7a023aac327de1154397eb58903
company,2023-07-02 21:15:11,Europe stocks close slightly lower after strong first half; mining stocks up 2%,121189583,https://image.cnbcfm.com/api/v1/image/107265878-1688353525644-gettyimages-1229453089-GERMANY_DAX.jpeg?v=1688361311&w=1920&h=1080,AZN,CNBC,"European stock markets closed slightly lower on Monday, shortly after ending the first half of the year 8.8% higher.",https://finnhub.io/api/news?id=e49f5e0eb2004c697b44887994b9a0ebcb738de8fd33aea5673e7fdd83d5de8a
company,2023-07-09 07:00:00,Goldman Sachs sees rays of hope in underperforming health sector,121283860,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=06213154d705d1d21de35238e56a94d433ff70c58826c039c5a22b1ac80ef9b3
company,2023-07-07 18:15:20,Astrazeneca (AZN) Dips More Than Broader Markets: What You Should Know,121267362,https://media.zenfs.com/en/zacks.com/3cb5117fc22f5e37890d1860dcd61f9f,AZN,Yahoo,"Astrazeneca (AZN) closed at $64.85 in the latest trading session, marking a -0.86% move from the prior day.",https://finnhub.io/api/news?id=61e48f55a612b5cd60407d70123598ac2b8dc50d9f175da7579c460ac625e99d
company,2023-07-07 13:25:00,AstraZeneca PLC ADR outperforms competitors despite losses on the day,121278980,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR shed 0.86% to $64.85 Friday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite...",https://finnhub.io/api/news?id=bc0073c400367522d0f3ae8cd9d1c75ae0d1c3c00db00ca0ce6529e129a20c33
company,2023-07-07 12:19:00,"Top Analyst Reports for BHP Group, AstraZeneca & Boeing",121259507,https://media.zenfs.com/en/zacks.com/644b3b1202fd5dc567afa200fe8deed9,AZN,Yahoo,"Today's Research Daily features new research reports on 16 major stocks, including BHP Group Limited (BHP), AstraZeneca PLC (AZN) and The Boeing Company (BA).",https://finnhub.io/api/news?id=4f1dcf67cae5ae179b64b2aa7b091ab7525f0f1c398e71473afae677904b1d51
company,2023-07-07 09:40:07,Here's Why Astrazeneca (AZN) is a Strong Value Stock,121262489,https://media.zenfs.com/en/zacks.com/105b2acef7bf0873f24b78932b1fdc3c,AZN,Yahoo,"Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.",https://finnhub.io/api/news?id=edd19b788103e78733b458cb4c7f0278715ddc410cea6ea2a920be582c85a0f9
company,2023-07-07 08:01:00,U.K. stocks extend negative streak for fifth day,121275274,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,"U.K. stocks finished down Friday, with the FTSE 100 Index falling 0.32% at 7,256.94. Of the FTSE 100 constituents, publishing company RELX PLC saw the...",https://finnhub.io/api/news?id=ecd11d72e7f81eb3f236a9d410cba0115642d1cd7bc7d4981fe3201bb34a95f1
company,2023-07-07 08:01:00,"AstraZeneca falls Friday, underperforms market",121278981,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"AstraZeneca PLC shares slipped 2.11% to £101.10 Friday, on what proved to be an all-around grim trading session for the stock market, with the FTSE 100 Index...",https://finnhub.io/api/news?id=7af9cd88e73f6af9f2c3a05d3993fb0146a337e27b3d9f75e7039714516184b2
company,2023-07-07 07:55:00,LONDON MARKET CLOSE: FTSE 100 ends rough week in tepid fashion,121255939,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=ac3839e77700d6aac2cbce9e66fbf59a3656e3ebc518abd1e8e22c80653652c5
company,2023-07-06 23:49:00,A Look Into AstraZeneca's Debt,121274821,,AZN,Benzinga,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=5998a33d3463cd7d38eb95dbf506c6670fe5aee2fc0b047381cee91650d9ad1b
company,2023-07-06 13:25:00,"AstraZeneca PLC ADR falls Thursday, underperforms market",121278983,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR slipped 2.46% to $65.41 Thursday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=bbca3209404bb4b16920f4dc4759e29209ea6e654142744914666ce39ed38d17
company,2023-07-06 10:38:00,Moderna (MRNA) Initiates Rolling BLA Filing for RSV Vaccine,121236762,https://media.zenfs.com/en/zacks.com/e57c38ef2cab6e9081bde6f59c7a4095,AZN,Yahoo,"Alongside the FDA filing, Moderna (MRNA) submits similar filings in Europe and Australia, seeking approval for using its RSV vaccine in older adults aged 60 years and above.",https://finnhub.io/api/news?id=edc33994fa875362149eb2e4a7079e5ff0770c0175e35452f4d71c7a74676a77
company,2023-07-06 08:01:00,"AstraZeneca falls Thursday, underperforms market",121243288,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"AstraZeneca PLC shares slipped 2.75% to £103.28 Thursday, on what proved to be an all-around poor trading session for the stock market, with the FTSE 100...",https://finnhub.io/api/news?id=eb19978afc0869e93d73d56fd870cbb822509f06cab00bbc0a8f7b360f127ae5
company,2023-07-06 06:33:00,Interesting AZN Put And Call Options For November 17th,121242685,,AZN,Stock Options Channel,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=9a49455189bdc08c7910f506997c48066e443df76acb70607efa52e627959226
company,2023-07-05 22:41:00,"Analysts Offer Insights on Healthcare Companies: Lineage Therap (LCTX), Liquidia Technologies (LQDA) and AstraZeneca (AZN)",121237244,,AZN,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=1fb922704a2397992db141e822359dbc205fefbe05ec1fce184356ace0152cd2
company,2023-07-13 13:24:00,AstraZeneca PLC ADR outperforms market on strong trading day,121398121,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR rose 1.87% to $67.71 Thursday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=c00f409feb9411fe8f648474708eeafffc7febe381f0bdb13279a9b075071315
company,2023-07-13 12:38:38,10 Buyable Inflation-Busting July Dividend Stocks,121370500,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/471803403/image_471803403.jpg?io=getty-c-w1536,AZN,SeekingAlpha,Top 10 Inflation-Busting Dividend stocks boasted net gains from 21.29% to 52.44% per YCharts forward-looking data 7/11/23. Read more to see my exclusive lists.,https://finnhub.io/api/news?id=6a1db8dce796b515d3c78586dcd704ee8639c74520b119368c362ce1e98eeea8
company,2023-07-13 08:27:00,Nvidia Just Confirmed an Emerging AI Boom in Biotech,121368180,,AZN,InvestorPlace,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=d78975dd74ccfee707d58c6c53c6bfdad56cc18bb217d0335c0838c4dab7d25e
company,2023-07-13 08:01:00,"AstraZeneca rises Thursday, outperforms market",121398123,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"Shares of AstraZeneca PLC inched up 0.80% to £103.30 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the...",https://finnhub.io/api/news?id=d2ab86472e4d3e14100134d49aa3c5d0f4af003f878b9baf0a4c7292dc17b0f9
company,2023-07-13 07:30:00,"AstraZeneca price target lowered to 12,600 GBp from 13,200 GBp at Morgan Stanley",121368968,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=a763fd487d5d8d521066d6e9ceb2e691ffeaaba58e594d082fdc1c68b80c7d37
company,2023-07-13 06:35:00,AZN September 1st Options Begin Trading,121368969,,AZN,Stock Options Channel,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=7a95c8efa7c1018136534c00241abcaaa17e401703e15148b6c179c1b114d83d
company,2023-07-13 03:57:41,"PepsiCo, Walt Disney, Delta rise premarket; Carvana, Coinbase SoFi fall",121361191,https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png,AZN,Yahoo,"Investing.com -- U.S. futures traded higher Thursday, continuing the recent positive sentiment ahead of the latest data on producer prices, with investors looking for more clues guiding future Federal Reserve monetary policy.",https://finnhub.io/api/news?id=fe23a60d32b3ba5dd5ad8071e6a13ec4ef033f260b93f453bfed0abfbec85b80
company,2023-07-12 21:26:00,This Is What Whales Are Betting On AstraZeneca,121368970,,AZN,Benzinga,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=9fcd4e258947918af35cfe406b64748c773ac12d4eef2a3ab28a543474f12b56
company,2023-07-12 13:24:00,"AstraZeneca PLC ADR rises Wednesday, outperforms market",121349288,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR rose 2.48% to $66.47 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=61b924269d52251f707f1dbaaabc409ed87da767076da94c8bb8edf41cc8946f
company,2023-07-12 08:01:00,"AstraZeneca rises Wednesday, still underperforms market",121349289,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"Shares of AstraZeneca PLC rose 1.65% to £102.48 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the FTSE...",https://finnhub.io/api/news?id=bfc1d29c2ad795ce9d5f07f009b54bb65c32223f05fb2177ce307f8958d3a024
company,2023-07-12 04:13:00,IN THE KNOW: UBS backs AstraZeneca despite underwhelming Dato-DXd data,121335899,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=7daf07c720923dc1ceda96e8c0776e687ce57ea6ec472952d10c01587e561b89
company,2023-07-12 03:08:00,"Astra, Daiichi get China approval for Enhertu breast cancer treatment",121335901,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=d4314bb05ce7571a3bed12546f473b2ab032252fb781e50e5c7fad5bc89b2a1e
company,2023-07-12 03:03:00,LianBio announces clinical supply agreement with AstraZeneca,121335902,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=ad236dfc5e6d14e69826545c9a6c411807e2c41b0c22b13cde99f972a9912fd4
company,2023-07-12 02:27:00,GLOBAL BROKER RATINGS: Raymond James cuts Activision to market perform,121335575,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=19e26eb94d2b1f206e7cddbd4e0eed82be4643324d36ef241445f04becc2269e
company,2023-07-12 01:35:00,AstraZeneca's Enhertu approved in China for HER2-low metastatic breast cancer,121335905,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=42a1c23c5087a53e71f394ff51988572abf9fd32de504ff570a53a16f6ac3feb
company,2023-07-12 00:28:00,AstraZeneca upgraded to Buy from Neutral at UBS,121335908,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=24c3c7b3080b65f7fdc07deadfde892f269088d9df33c7ac58a2f16780828ae0
company,2023-07-12 00:27:00,LONDON BROKER RATINGS: UBS raises AstraZeneca; RBC cuts Bunzl,121335910,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=e08728ddb31b9b487854e3d9e49370f88bb93e12367cde43dbcaebc84b6d6f3a
company,2023-07-11 23:45:00,LONDON MARKET OPEN: FTSE 100 higher as UK banks pass BoE stress tests,121335912,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=27c4940d1b4db2285a6a26255ed6dfc59fede33087803dab4420769b8c7e3e73
company,2023-07-11 22:40:00,LONDON BRIEFING: UK banks pass stress test; Wetherspoon trades well,121335913,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=8061c9ffddf327783240c845b20143569c72a098ef67d99c34892cd65815f1b3
company,2023-07-11 18:00:19,Astrazeneca (AZN) Stock Sinks As Market Gains: What You Should Know,121327876,https://media.zenfs.com/en/zacks.com/090f58c1efbe3555b861102525e50b39,AZN,Yahoo,"Astrazeneca (AZN) closed at $64.86 in the latest trading session, marking a -0.51% move from the prior day.",https://finnhub.io/api/news?id=36b7422dfcd18b970e82c51c8cfcb74aa6e34e687f56fabb14e23477eb4ae3d4
company,2023-07-11 13:24:00,AstraZeneca PLC ADR outperforms competitors despite losses on the day,121349291,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR slipped 0.51% to $64.86 Tuesday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=4d2e8c8ea2585e19efe245975ae6e77f4626551fa5f38acdfa112a944152d886
company,2023-07-11 09:40:00,Ionis (IONS) Posts Encouraging Data From Amyloidosis Drug Study,121310162,https://media.zenfs.com/en/zacks.com/c8704ffaba0234da981fa842a48f77b5,AZN,Yahoo,"Ionis (IONS) reports positive 85-week phase III study data, supporting the benefits of eplontersen as a treatment for hereditary transthyretin-mediated amyloid polyneuropathy (ATTRv-PN).",https://finnhub.io/api/news?id=96128d5a605f03256795873e7870d84452c28c274a07d89050d4186c7bc31988
company,2023-07-11 09:00:06,AstraZeneca PLC (AZN) Is a Trending Stock: Facts to Know Before Betting on It,121311117,https://media.zenfs.com/en/zacks.com/71afbbc0512eb3c471136d93f39079c9,AZN,Yahoo,"Astrazeneca (AZN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",https://finnhub.io/api/news?id=aeb5a64aeb9d2b20951ea977387d4944b3cba2b55dec33f3cf174132746cf33e
company,2023-07-11 08:01:00,"AstraZeneca falls Tuesday, underperforms market",121349292,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"Shares of AstraZeneca PLC inched down 0.96% to £100.82 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the...",https://finnhub.io/api/news?id=f6c14e243d50f34aedc24392f5424ebe0a854b5cbc8368ece2e7d162fd1256a3
company,2023-07-11 03:22:00,"50% Of Women Have Elevated Breast Density, Which Significantly Decreases The Effectiveness Of Mammography – Atossa Therapeutics Is Looking To Ensure Earlier, Accurate Diagnosis",121315057,,AZN,Benzinga,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=d812f30ccb1d131462930ace00c1e6b082a01cae3940bd174701b5bdcb5519c0
company,2023-07-10 08:48:00,"The Zacks Analyst Blog Highlights BHP Group, AstraZeneca, The Boeing, Diageo and General Mills",121291887,https://media.zenfs.com/en/zacks.com/0f71f7d46b723bf612b871cd753b1222,AZN,Yahoo,"BHP Group, AstraZeneca, The Boeing, Diageo and General Mills are part of the Zacks top Analyst Blog.",https://finnhub.io/api/news?id=b60c241e7a27cc3ba51c22c71106831cdabea3b07822557236a2056cefa988a0
company,2023-07-10 08:01:00,"AstraZeneca rises Monday, outperforms market",121349296,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"Shares of AstraZeneca PLC inched up 0.69% to £101.80 Monday, on what proved to be an all-around positive trading session for the stock market, with the FTSE...",https://finnhub.io/api/news?id=172502cc7a18feddb4e2cabbf546e1780145fee28b4d1d83a4c967628055b3ed
company,2023-07-10 02:09:00,Ionis Pharmaceuticals announces 'positive' results from Phase 3 NEURO-TTRansform,121298681,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=ca9a886b9ea155e555c1e773ded5e36c218c1c8aaa54e59cdfaa06c0ff7db96e
company,2023-07-09 21:45:00,B. Riley biotechnology analysts to hold an analyst/industry conference call,121296440,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=b01d656c76cdd4d56b886e2765386e4efcf91e0d67b561e7b45ddfe18bed4ebe
company,2023-07-17 17:50:20,Astrazeneca (AZN) Stock Sinks As Market Gains: What You Should Know,121438382,https://media.zenfs.com/en/zacks.com/71afbbc0512eb3c471136d93f39079c9,AZN,Yahoo,"In the latest trading session, Astrazeneca (AZN) closed at $67.05, marking a -0.49% move from the previous day.",https://finnhub.io/api/news?id=6f0d524f213c962ff2e0ec60744eea406ba54516dd05a384b85e5c6f9a2fc7ee
company,2023-07-17 13:13:00,FDA Approves First RSV Drug to Protect All Infants From Virus,121428435,,AZN,Yahoo,"While the virus often leads to mild, coldlike symptoms, it is the leading cause of hospitalization of infants in the U.S.",https://finnhub.io/api/news?id=0566d8c4409b30af3791e590703043a8e38900fd4f9538fe6d0235817d56c634
company,2023-07-17 10:33:00,US FDA approves AstraZeneca and Sanofi's Beyfortus for RSV in infants,121453953,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=6e7983aa091d915528963564a0740b0d8943ae61f9e1e8d108a6589d869d01c8
company,2023-07-17 10:13:00,Newly approved RSV drug for infants provides all-season protection with 1 shot,121453954,,AZN,United Press International,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=d207f782be26c90545c1e61b78d91cbd3b84b79dcb1914edd49da0200ec1d9bd
company,2023-07-17 09:31:00,FDA approves Sanofi and AstraZeneca infant RSV vaccine,121579586,https://s.wsj.net/public/resources/MWimages/MW-GP644_MicroS_ZG_20180906154215.jpg,AZN,MarketWatch,The U.S. Food and Drug Administration on Monday approved a Sanofi and AstraZeneca PLC respiratory syncytial virus vaccine for newborns and infants. The RSV...,https://finnhub.io/api/news?id=fa17679d4da46922cdce9db5cfbc36f56c120b96ee8a7ac9b110e2b7fc4c8c6f
company,2023-07-17 09:12:15,"FDA approves AstraZeneca, Sanofi shot that protects infants and toddlers against RSV",121435303,https://image.cnbcfm.com/api/v1/image/107201060-1677609193625-gettyimages-499391736-000080197245_Unapproved.jpeg?v=1689613935&w=1920&h=1080,AZN,CNBC,"RSV is the leading cause of hospitalization among children less than a year old, according to scientists.",https://finnhub.io/api/news?id=43f4e31c528ab7f56414bac90971d33b0e7254338479255c821a096ed6f2ea44
company,2023-07-17 09:08:00,New drug to protect babies and toddlers from RSV gets FDA approval ahead of cold season,121429176,,AZN,"Associated Press, The",Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=f77517dbaba654b0911da308c898931a6cf8f4e8e6e5126a93c4aa3359940a53
company,2023-07-17 08:07:00,"Sanofi, AstraZeneca confirm FDA approves Beyfortus for RSV disease in infants",121453957,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=cc9e14e52cf45b6361f4fa550f4fdb8d1b479b15eb892c226ef7c2ad3d20a549
company,2023-07-17 07:56:00,"FDA approves AstraZeneca's Beyfortus for prevention of RSV in neonates, infants",121453958,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=4b22d6f2275837a1d9ec65133b61c3a105232b279fa99b6ef27900368967bd39
company,2023-07-17 03:17:00,"The Acute Hospital Care Market Is Worth Over $3 Trillion, And Windtree Therapeutics Brings A First-In-Class Drug To An Active Segment Of This Market",121426627,,AZN,Benzinga,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=52a0126f688071d79887bd7aec496d361e649cbcd9cfb3ba520d412551c30c60
company,2023-07-17 02:30:00,3 Doomed Biotech Stocks Destined for Disaster,121426628,,AZN,InvestorPlace,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=317b015588276cc35f59503fcf6063fee5553b283a2f2915934e4b50ae920d14
company,2023-07-17 00:27:00,"AstraZeneca PLC ADR falls Monday, underperforms market",121453959,,AZN,MarketWatch,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=c5f80a61b00c055b9e04cb21340fb73d80af3242928e32e78fc053bf8a8c670e
company,2023-07-16 21:09:00,"AstraZeneca's nirsevimab approved as RSV treatment for babies, infants",121453961,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=0377347756ac4c4422f7bc57cbe0a0e2a6b2504f10d963576838246982a871d6
company,2023-07-16 03:43:00,Buy/Sell: Wall Street's top 10 stock calls this week,121414423,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=06f08f9f615a7dd2eec1a5c65cb60378829a994c14f239a6095f3841332beddd
company,2023-07-16 03:21:00,"HSBC bullish on Roche, Lonza; bearish on Bristol-Myers, GSK, Moderna",121426515,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=273ffc67c8cb88da0498fe3cb4eeb264c7d90eef59e18b24d83004eb31033ed2
company,2023-07-15 22:49:02,Renalytix: Commercializing First AI Kidney Disease Diagnostic Tool,121412312,https://media.gettyimages.com/id/1480574699/photo/digital-brain-ai-concept.jpg?b=1&s=170667a&w=0&k=20&c=B1lvBIs1XFiijz7XJ1nCSQrFqy6ZPPegmTaIIIWoV30=,AZN,SeekingAlpha,"Renalytix's lead product, KidneyIntelX, an AI diagnostic tool for kidney disease, has received FDA approval. Find out why RNLX stock is a Strong Buy.",https://finnhub.io/api/news?id=03a0dfd9827ff0df74a7647b95b43a96312d2a1f9bc32a1011b1314c6075775d
company,2023-07-14 13:25:00,AstraZeneca PLC ADR underperforms Friday when compared to competitors,121398119,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR shed 0.49% to $67.38 Friday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...",https://finnhub.io/api/news?id=fffbc3b527751ef91ae24a1c8e776051f0f96c98ef45dd9155ca18a842cd4d63
company,2023-07-14 12:54:37,More Challenges Await AbbVie Following A Disappointing Quarter,121394328,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1374841003/image_1374841003.jpg?io=getty-c-w1536,AZN,SeekingAlpha,"AbbVie Inc., one of the leaders in the global immunology market, will release its financial report for the second quarter of 2023. Click here to read more.",https://finnhub.io/api/news?id=5dcefae653c6ddb97d78b5ea409041ed34cc77beab6f76dc5c9437d3a76dc4c0
company,2023-07-14 08:01:00,AstraZeneca outperforms market despite losses on the day,121398120,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"AstraZeneca PLC shares inched down 0.06% to £103.24 Friday, on what proved to be an all-around dismal trading session for the stock market, with the FTSE 100...",https://finnhub.io/api/news?id=07dce62e4d9555df808d1ce81dd2e50896329bbb63805313d0aa50534bd0c9f4
company,2023-07-14 00:13:00,LONDON BROKER RATINGS: HSBC says 'buy' AstraZeneca but 'reduce' GSK,121385054,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=fd85eb09d15a9160923e3025777817ea86cce73a06b0a154831588a17db83191
company,2023-07-13 23:56:00,LONDON MARKET OPEN: Stocks mixed ahead of US bank earnings,121394653,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=d26abd071ac0e022bd136caf956f25d45ec0f1e067d5c29c3038f978689bd73a
company,2023-07-13 23:39:00,AstraZeneca initiated with a Buy at HSBC,121394655,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=99bd2ab0035acb43768b37874c84424aa0af3a6a8332f49d4b1e36463bc4974a
company,2023-07-13 22:56:00,LONDON BRIEFING: Burberry shines in China; ITV-All3Media deal unlikely,121388270,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=a47b69a6c1db47646be5487ac5c4d787294ca96bf0c35c7ad147c2d112f79074
company,2023-07-21 13:24:00,AstraZeneca PLC ADR outperforms competitors on strong trading day,121579570,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR rallied 1.14% to $69.34 Friday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...",https://finnhub.io/api/news?id=453920503e2ca5741c8b9b438191a281055ec8e5891274417b0412ea029f26bd
company,2023-07-21 13:08:52,Sanofi expects infant RSV shot to roll out before respiratory virus season this fall,121543194,https://image.cnbcfm.com/api/v1/image/107275093-1689969223046-gettyimages-927424104-_dsc5372.jpeg?v=1689973732&w=1920&h=1080,AZN,CNBC,Sanofi said it is working with a CDC panel to include Beyfortus on the childhood immunization schedule and the Vaccines for Children Program.,https://finnhub.io/api/news?id=b214b26ccda4c9eb13d12c90df1dbc8bde07b53c42d99c80416293b8114fa3f7
company,2023-07-21 13:05:00,AbbVie (ABBV) to Report Q2 Earnings: What's in the Cards?,121534662,https://media.zenfs.com/en/zacks.com/6d12ae6d407957348a46f55b412dfc98,AZN,Yahoo,AbbVie's (ABBV) Q2 performance will likely reflect Skyrizi and Rinvoq sales trying to make up for the declining Humira sales following the loss of U.S. exclusivity.,https://finnhub.io/api/news?id=b479fdb01624d31bf2453d8421daf0068b06bf6c6c1ac32e995f45ac7c78bbb6
company,2023-07-21 11:21:00,"Pharma Stock Roundup: JNJ, NVS Upbeat Q2 Results, FDA Nod to SNY & AZN RSV Antibody",121531300,https://media.zenfs.com/en/zacks.com/00ec4a55c0f0d99f7e816f5da7894e0c,AZN,Yahoo,"FDA approves AstraZeneca (AZN) and Sanofi's (SNY) RSV antibody, Beyfortus. J&J (JNJ) and Novartis (NVS) announce strong second-quarter results.",https://finnhub.io/api/news?id=60adfd0f68eac7c7cb18d71f7c544980fcd248ffa49ca011556d01bfed075a1f
company,2023-07-21 08:01:00,"AstraZeneca rises Friday, outperforms market",121579571,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"AstraZeneca PLC shares inched up 0.69% to £107.70 Friday, on what proved to be an all-around positive trading session for the stock market, with the FTSE 100...",https://finnhub.io/api/news?id=69b7ebf232500995bdd05c2146139e4e00e07cce04bbc883aea9de2dccb5430e
company,2023-07-21 07:08:50,The Bristol-Myers Squibb Phenomenon: A Game Changer In The Pharmaceutical Industry,121526751,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1400621080/image_1400621080.jpg?io=getty-c-w1536,AZN,SeekingAlpha,"On July 27, 2023, Bristol-Myers Squibb will release its financial report for the second quarter of 2023. Read more to see a detailed analysis on BMY stock.",https://finnhub.io/api/news?id=239dd48b2f0ee8fb9868942c57aae17607ea6ff0a6ee13e950a5b0d4141cc313
company,2023-07-21 01:47:00,Pfizer price target lowered to $42 from $43 at Morgan Stanley,121528659,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=ee3fecf0b3dedeeba3db1f455a16f51232c57f81558b8a80b94e4a2c28f968ba
company,2023-07-20 23:30:00,"Earnings week ahead: Microsoft, Google, Meta, Boeing, Coca-Cola and more",121537391,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=7e8fcb1fce5d0c30b373e9d0ca9b2eada7522ac2c7e32987e9e10b92f3fcd943
company,2023-07-20 23:18:00,"Dow Jones Leads Weekly Gains As Tesla, Netflix Sell-Offs Dent Nasdaq; Big Banks Show Resilience To Volatility",121536827,,AZN,Benzinga,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=1d680f742ea905e419e91e9232a968493a906e77d1eedf524b034b8efd35f4a0
company,2023-07-20 19:54:00,SK Chemicals' Shares Climb After AstraZeneca Deal,121579572,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,By Kwanwoo Jun SK Chemicals' shares climbed Friday after it won a contract with biopharmaceuticals giant AstraZeneca. Shares of the South Korean...,https://finnhub.io/api/news?id=a1810b3b158e4b8f318babf7819dfc7bae0a5cd0c9351c7ea30f70ff5bbbe2e8
company,2023-07-20 13:24:00,"AstraZeneca PLC ADR rises Thursday, outperforms market",121579573,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR advanced 1.50% to $68.56 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...",https://finnhub.io/api/news?id=57e6419aca853b326c5bbc89f347839be2d674c41d102476a00cd31c84deebf3
company,2023-07-20 08:01:00,"AstraZeneca rises Thursday, outperforms market",121579574,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"Shares of AstraZeneca PLC rallied 1.85% to £106.96 Thursday, on what proved to be an all-around great trading session for the stock market, with the FTSE 100...",https://finnhub.io/api/news?id=7cfaa11f6cf81b6adc79c37a63da13175bec3036cf4a3cf172df0616aaff6385
company,2023-07-19 14:02:39,Pieris lays off most staff after AstraZeneca pulls out of partnership,121584305,https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png,AZN,Yahoo,Pieris has also begun the process of exploring strategic alternatives. That could include a merger or acquisition or an asset sale.,https://finnhub.io/api/news?id=3438054101dd82ba6fd4b09cf8421c3ebb6d32527a655e5d48868d3142f6c1d1
company,2023-07-19 13:25:00,"AstraZeneca PLC ADR rises Wednesday, outperforms market",121579576,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR rallied 1.17% to $67.55 Wednesday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=f98399b739fa390a0a7840ce4cbbea0f77395674b498a0d0e510a5699b3b2e94
company,2023-07-19 08:01:00,"AstraZeneca rises Wednesday, outperforms market",121579578,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"AstraZeneca PLC shares advanced 2.16% to £105.02 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the FTSE...",https://finnhub.io/api/news?id=0212a633e097a37aa948a67fc3da40ed5cafaf3d79b3c3b567cc92f58d80fafd
company,2023-07-18 13:59:10,Why Pieris Pharmaceuticals Shares Shooting Higher Today?,121453478,https://media.zenfs.com/en/Benzinga/1728edde24a45c3ff04ede018d84fcfa,AZN,Yahoo,"Pieris Pharmaceuticals Inc (NASDAQ: PIRS) shares are trading higher after the company provided a strategic update. The company says the update follows recent events that have impacted its inhaled respiratory franchise, including AstraZeneca Plc's (NASDAQ: AZN) discontinuation of enrollment of the Phase 2a study for elarekibep. AstraZeneca has now informed the company of its decision to terminate the parties' R&D collaboration agreement, hand back elarekibep, and discontinue the remaining discove",https://finnhub.io/api/news?id=7daad5467c4bd9a6ef5fd28a1bf05c8e180ff0455042ff3099126c38160efd21
company,2023-07-18 13:25:00,AstraZeneca PLC ADR underperforms Tuesday when compared to competitors,121579579,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR slipped 0.42% to $66.77 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=ec3fec3af541b568b7592f67b970e94f9d9469f4cb003542d8524e1914c7c3d9
company,2023-07-18 11:24:00,"Sanofi (SNY), AstraZeneca's RSV Antibody Gets FDA Nod in Infants",121453479,https://media.zenfs.com/en/zacks.com/c0c563b233f28a1874a33c46aadaa70e,AZN,Yahoo,"Following FDA approval, Sanofi (SNY)/AstraZeneca's (AZN) Beyfortus is the first RSV antibody approved to protect all infants. The companies plan to make it available ahead of the upcoming RSV season.",https://finnhub.io/api/news?id=861184ac9c6435f090d58ddc18f8c4d2d9929e8d724958dfe638d65838cce9b2
company,2023-07-18 11:07:02,AstraZeneca-Sanofi's Respiratory Syncytial Virus Treatment Scores FDA Approval To Prevent Infection In Infants,121447390,https://media.zenfs.com/en/Benzinga/564733f2d2db42195fda6b473e7386c1,AZN,Yahoo,The FDA approved AstraZeneca Plc (NASDAQ: AZN) and Sanofi SA’s (NASDAQ: SNY) Beyfortus (nirsevimab) for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease (LRTD) in newborns and infants. The approval covers newborns and infants during or entering their first RSV season and children up to 24 months of age who remain vulnerable to severe RSV disease through their second RSV season. Beyfortus was approved in the European Union in November 2022 to prevent RSV LRTD in,https://finnhub.io/api/news?id=b0cce19cd91ad40ed35b14ab55e31ba0921f3abe6a1a5c97a4fafe31a88eb7a9
company,2023-07-18 08:01:00,"AstraZeneca rises Tuesday, outperforms market",121579581,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"AstraZeneca PLC shares inched up 0.78% to £102.80 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the FTSE...",https://finnhub.io/api/news?id=6b8018d7c989f9e2f9bea80ae3012625d17a6caf225232e16e1ddc9d9f55d799
company,2023-07-18 05:30:00,"Pieris Pharma to Cut 70% of Workforce, Explore Strategic Options",121579583,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,By Ben Glickman Pieris Pharmaceuticals said Tuesday it would cut about 70% of its workforce and explore strategic options after AstraZeneca terminated a...,https://finnhub.io/api/news?id=63d3cacc7895b3cfb4a7ab24adedb4f975e64035e0a30cdf42b3da6aa54454ad
company,2023-07-18 04:51:00,"NBCUniversal's Peacock Raises Prices First Time Since Launch, Warren Buffett Sells Majority of Activision Blizzard Stake Before Microsoft Deal Approval, Novartis Launches $15B Share Buyback: Today's Top Stories",121449294,,AZN,Benzinga,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=c99edeff41ed6065164d60d5aad65369dfa834b50b14dc4cf284c89fe380e8ad
company,2023-07-18 04:20:00,"Pieris Pharmaceuticals announces restructuring, to reduce workforce by 70%",121453441,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=7cc38524e807bff3c2dc934d6d856be4aa37f58a652a50110e531fd3a14f3543
company,2023-07-18 02:28:00,"The Tech Stock Rally Has Reached a Critical Moment. Watch Tesla, Netflix Earnings.",121511054,https://images.barrons.com/im-818976/social,AZN,MarketWatch,"AT&T hit by report about lead on cables, Eli Lilly’s Alzheimer’s drug shows promise in latest trial, and other news to start your day.",https://finnhub.io/api/news?id=b04f2eeb8e66010386f1bbb6cb3f2c288d81f58c2e5cc688179cb31a246f39b0
company,2023-07-17 22:21:00,AstraZeneca (NASDAQ:AZN) and Sanofi Secure FDA Green Light,121453951,,AZN,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=2c97e7a084c09733247d6b95aeb66c905136f3ac37a850d50897c260b508bbb8
company,2023-07-17 21:04:00,Rishi Sunak to meet bosses at inaugural Business Council gathering,121450757,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=07cba9796ea48ae69bcc565a4f409e2dae921c9e7b2801716bec72340494fea9
company,2023-07-25 03:07:00,IN BRIEF: OTAQ names interim finance chief with incumbent to move on,121587591,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=c415ef2e16711aca408b85981a89f9e8119368a99d82d36f21b88bce01223ef4
company,2023-07-25 00:26:00,"AstraZeneca PLC ADR rises Tuesday, still underperforms market",121594056,,AZN,MarketWatch,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=9a551e99a69d4fa62381dc053e1041c183f5ec89f929e6e14872f68b8ce5bf4a
company,2023-07-24 18:00:19,Astrazeneca (AZN) Stock Sinks As Market Gains: What You Should Know,121584302,https://media.zenfs.com/en/zacks.com/17a4db66bb13bdabcbf848550a6ea15a,AZN,Yahoo,"Astrazeneca (AZN) closed the most recent trading day at $68.92, moving -0.61% from the previous trading session.",https://finnhub.io/api/news?id=c7986783e034f2755e508d04c81d2ed8ccc54cbab4c8ad65c0d68bff5fa01ae5
company,2023-07-24 13:25:00,"AstraZeneca PLC ADR falls Monday, underperforms market",121579568,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR dropped 0.61% to $68.92 Monday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=1ddf081fb8f1e7a0ff532a2602f5bb51325f3de1ec71cb322c0854dcd16675be
company,2023-07-24 11:16:00,AstraZeneca (AZN) to Report Q2 Earnings: What's in the Cards?,121569206,https://media.zenfs.com/en/zacks.com/ef77d5a5eb4e72e4dd31ccfaf4ca4ccd,AZN,Yahoo,"Higher sales of AstraZeneca's (AZN) key medicines, Lynparza, Tagrisso, Imfinzi and Farxiga, are likely to have driven sales, partially offset by lower sales of legacy drugs.",https://finnhub.io/api/news?id=9ea445e0eeeaa39206a0e7b996155f77375188b88eceb3114d9bca52519e5a9a
company,2023-07-24 09:00:06,AstraZeneca PLC (AZN) is Attracting Investor Attention: Here is What You Should Know,121584304,https://media.zenfs.com/en/zacks.com/39dfb058875b6e691de9136bc97a47b4,AZN,Yahoo,"Recently, Zacks.com users have been paying close attention to Astrazeneca (AZN). This makes it worthwhile to examine what the stock has in store.",https://finnhub.io/api/news?id=c227343f356ff59e587f05f22eee3e22a099a6964c7d320a737806daaf6b39ac
company,2023-07-24 08:01:00,"AstraZeneca rises Monday, still underperforms market",121579569,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"Shares of AstraZeneca PLC inched up 0.09% to £107.80 Monday, on what proved to be an all-around favorable trading session for the stock market, with the FTSE...",https://finnhub.io/api/news?id=69042d071e5b3736af8113f8d690a7d16415bf9d848e021bf852da9ef8f7271e
company,2023-07-23 07:00:00,Big Pharma Bets Big on China,121556276,,AZN,Yahoo,China remains attractive to global pharmaceutical companies even as many multinationals shift their focus elsewhere.,https://finnhub.io/api/news?id=f84dd8429cdc9f81d8a204def97b09ad1e7de72485b7b1f017e862a852442034
company,2023-07-23 03:54:18,4 Ideal Barron's Mid-Year 2023 Dividend Dog Buys,121556188,https://media.gettyimages.com/id/1423260813/photo/back-to-school-lovable-adorable-puppy-and-vintage-books.jpg?b=1&s=170667a&w=0&k=20&c=e0cBemk4n3YwqhSm5Q93yv01rxL-jJs6q7ebn3fl4do=,AZN,SeekingAlpha,"Barronâs Mid-Year Roundtable, Published July 17, listed 40 stocks of note for 2023; 38 of those were unduplicated US publicly-listed companies. Read more here.",https://finnhub.io/api/news?id=5ab330942fdbf4a3cbf52412ba5a106d0e56ab9c6512d6e98f43280252e771f1
company,2023-07-29 08:47:55,AstraZeneca PLC (NASDAQ:AZN) Q2 2023 Earnings Call Transcript,121695688,https://media.zenfs.com/en/insidermonkey.com/91d6221e3df11e4933938a3082c41da1,AZN,Yahoo,"AstraZeneca PLC (NASDAQ:AZN) Q2 2023 Earnings Call Transcript July 28, 2023 AstraZeneca PLC misses on earnings expectations. Reported EPS is $0.86 EPS, expectations were $0.98. Operator: Good morning to those joining from the UK and the US. Good afternoon to those in Central Europe, and good evening to those listening in Asia. Welcome, ladies and […]",https://finnhub.io/api/news?id=1fe3aa6f8595d1c4afec7396b447be87e077d79f84ba35544195e827d032897c
company,2023-07-29 06:03:55,AstraZeneca: Solid Earnings Report Reinforces Medium To Long-Term Upside,121690465,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1437627078/image_1437627078.jpg?io=getty-c-w1536,AZN,SeekingAlpha,"AstraZeneca's H1 2023 results show robust growth, with revenues ex-COVID-19 medicines increasing by 16% YoY. Read more about AZN stock here.",https://finnhub.io/api/news?id=0e18a3d3a3f5f5dcd36a1d2335c1c4399915b0e411a480634f53edef7d262e2a
company,2023-07-29 00:06:00,"Analysts Are Bullish on Top Healthcare Stocks: Amplifon S.p.A. (GB:0N61), AstraZeneca (GB:AZN)",121691179,,AZN,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=cd37c229c75f62195bd74d4777db5e2ab519e597428113c697ed822095162181
company,2023-07-28 15:00:27,AstraZeneca Plc (AZN) Q2 2023 Earnings Call Transcript,121675230,https://media.zenfs.com/en/motleyfool.com/ce68ea0b0cd2631701fe87e542e7a165,AZN,Yahoo,"Before I hand over to AstraZeneca, I'd like to read the safe harbor statement.  Participants on this call may make forward-looking statements with respect to the operations and financial performance of AstraZeneca.  Although we believe our expectations are based on reasonable assumptions, by their very nature, forward-looking statements involve risks and uncertainties and may be influenced by factors that could cause actual results to differ materially from those expressed or implied by these forward-looking statements.",https://finnhub.io/api/news?id=32b70495bb36a467f395a7046e58a12b67296bceaba2f0e53124858b8af28c36
company,2023-07-28 14:50:28,"AstraZeneca plays up China, downplays patent loss in latest earnings: CFO",121675232,https://s.yimg.com/ny/api/res/1.2/e9Yt0OV0HzIk1qJxd28B3g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD03MDg-/https://s.yimg.com/os/creatr-uploaded-images/2021-01/dc694830-4c3f-11eb-9def-3b85c8a344be,AZN,Yahoo,"AstraZeneca (AZN) reported strong earnings Friday, including $22 billion, or 4% revenue growth, in the first half of the year, and kept its 2023 forecast stable.",https://finnhub.io/api/news?id=6984ced22bffe9fd767737985cf44c3a0d2478a6dd1d0c3c1daba57dca5ad24b
company,2023-07-28 12:24:31,"iPhone US Shipments Take A Hit, Does Social Media Algorithm Impact Political Beliefs? Research Reveals Answer, Disney Joins Netflix To Crack Down Password Sharing In India: Today's Top Stories",121668850,https://media.zenfs.com/en/Benzinga/0fb7363b549bc8f9d4a1af83c1cf0c92,AZN,Yahoo,"Bloomberg DoorDash Embraces AI Chatbot to Revolutionize Food Ordering and Gain Competitive Edge DoorDash Inc (NYSE: DASH) has leveraged an artificial intelligence-based chatbot to speed up ordering and help customers find food options. The Uber Technologies Inc (NYSE: UBER) rival is working on a system called DashAI that it's testing in a limited capacity. The technology will help customers to get personalized restaurant recommendations with simple text prompts, adding an edge over its peers. Be",https://finnhub.io/api/news?id=4f138708623b67d8cbe3369c366fec40b41b30c3dec65e53f0a095c0920e7ec7
company,2023-07-28 11:57:00,"AstraZeneca (AZN) Q2 Earnings & Sales Beat, Nil COVID Sales",121675241,https://media.zenfs.com/en/zacks.com/ef77d5a5eb4e72e4dd31ccfaf4ca4ccd,AZN,Yahoo,AstraZeneca (AZN) beats second-quarter estimates for earnings and sales. The company did not generate any revenues from COVID-19 medications. Management reaffirms its 2023 guidance.,https://finnhub.io/api/news?id=8502c820824d9d3e583564fc222495c52947a48598cccda6882c1034065b6bbe
company,2023-07-28 11:43:01,AstraZeneca Shares Surge After Revenue Beat,121675243,https://s.yimg.com/ny/api/res/1.2/Tu5Hh2AejOiW57mn_3eNIQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/investopedia.com/6a0f9e714310eff75389bddfe7db7d79,AZN,Yahoo,AstraZeneca's shares rose on Friday after it announced the purchase of Pfizer's rare disease portfolio for up to $1 billion and reported better-than-expected financial results on strong sales of its cancer drugs.,https://finnhub.io/api/news?id=0492323e53082974b8959e5e52c7cf4b67018d71710a9078a2d6272e8d7249bc
company,2023-07-28 11:32:00,"Pharma Stock Roundup: AZN, SNY, ABBV Q2 Results, MRK, MRNA Cancer Jab in Phase III",121672331,https://media.zenfs.com/en/zacks.com/59a827b8514d5d6d47690daa5eb16f24,AZN,Yahoo,"AstraZeneca (AZN), Sanofi (SNY) and AbbVie (ABBV) announce second-quarter results.",https://finnhub.io/api/news?id=eab0d730a3d5c4d533a8b9b04710d1b98de641e81e48c155d09500ee6848e8de
company,2023-07-28 10:34:21,UK economy left behind as US heads for 'immaculate soft landing',121672470,https://s.yimg.com/ny/api/res/1.2/FH8CbPYP0_TBz0.D3xqt5Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD03NTA-/https://media.zenfs.com/en/the_telegraph_818/eb36c5838caf2efdd8bfbcdce8919f63,AZN,Yahoo,The US economy is poised to make an “immaculate soft landing” from the inflation crisis leaving the British economy behind.,https://finnhub.io/api/news?id=b8819d11364c39b1ed7522dc0fd4d03818b00566758b6ed1e2dbad9f54c95786
company,2023-07-28 10:15:20,"AstraZeneca beats Q2 earnings estimates, sees strong sales of cancer treatment drugs",121666749,https://s.yimg.com/ny/api/res/1.2/lvryJy43jbefmI9C5nbiPw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzQ-/https://s.yimg.com/os/creatr-uploaded-images/2023-07/38a85900-2d4e-11ee-8c81-e2c8d428336c,AZN,Yahoo,"Pharma manufacturer AstraZeneca reports a second-quarter earnings beat, offsetting its losses tied to slowing COVID-19 vaccine sales. AstraZeneca CFO Aradhana Sarin joins Yahoo Finance Live to discuss the value of gene therapy treatment for rare diseases, the company's guidance regarding China, and expectations for its cancer treatment drug Dato-DXd. ""What you see this quarter is really a reflection of all the investments we've made in innovation and new products over the decade,"" Sarin said.",https://finnhub.io/api/news?id=8a6f24264205dab3838f674bfd878967ccf1d364fde93dd1ef70d831893d7705
company,2023-07-28 09:30:28,"Compared to Estimates, Astrazeneca (AZN) Q2 Earnings: A Look at Key Metrics",121675257,https://media.zenfs.com/en/zacks.com/2a50596f066181e48e4ae0ad6be00462,AZN,Yahoo,"The headline numbers for Astrazeneca (AZN) give insight into how the company performed in the quarter ended June 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.",https://finnhub.io/api/news?id=8e28d9ae979de3eb8c74367227bc692c87612ed9c0d40301f7c857d6c13252a9
company,2023-07-28 09:09:46,AstraZeneca's Covid vaccine sales drop to zero as health officials back safer mRNA jabs,121665716,https://www.telegraph.co.uk/content/dam/business/2023/07/28/TELEMMGLPICT000257327930_16905435303270_trans_NvBQzQNjv4BqRJxb5Tk3GcrERkI30rx3BU2RwvYCvFb3qFA7OQLnTBo.jpeg?impolicy=logo-overlay,AZN,Yahoo,Sales of the Oxford AstraZeneca Covid vaccine have fallen to zero as health officials switch their backing to safer jabs.,https://finnhub.io/api/news?id=db81b47ae9e7d51c2098c0f7d923afdbb873176298eac3fa6c65b6ad6d2acfcc
company,2023-07-28 08:52:00,"Stocks Surge, Tech Rallies On Strong Earnings, Inflation Softens: What's Driving Markets Friday?",121671355,,AZN,Benzinga,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=19dac16b648c2d17661994e1a8a3c01d8436f6a82e544d4fb65f50b3f324701b
company,2023-07-28 07:00:00,AstraZeneca strikes $1 billion deal for Pfizer rare-disease gene therapies,121701055,https://images.mktw.net/im-279157/social,AZN,MarketWatch,Stock gains 5% after AstraZeneca's second-quarter results top analyst expectations.,https://finnhub.io/api/news?id=4cc9298529a7665a0c49691568fecdefbdac1c979d6c223aee6b52a5273d9289
company,2023-07-28 06:48:00,European Stock Futures Surge After ECB Meeting,121670082,,AZN,TalkMarkets,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=1459c2c0385758178fe6e0923d82bfe25483f459f0801f9dfded92a7dd94bf16
company,2023-07-28 05:44:09,Trending tickers: IAG | NatWest | AstraZeneca | Intel,121662063,https://s.yimg.com/ny/api/res/1.2/q6OfSxoKbzKzIdnZrJ8q9g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://s.yimg.com/os/creatr-uploaded-images/2023-06/eb7be080-0bbe-11ee-a7df-0aa362a8c8c6,AZN,Yahoo,A look at the stocks making headlines on Friday.,https://finnhub.io/api/news?id=84a598c15c2404dfaaaa8427e0ec81a27f18952378285b5def6f089b407bd4c8
company,2023-07-28 05:13:52,UPDATE 2-AstraZeneca CEO says lung cancer drug trial data 'very encouraging',121665366,https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png,AZN,Yahoo,"AstraZeneca Chief Executive Pascal Soriot said on Friday the company is ""very encouraged"" by interim data from a key lung cancer drug trial, but he did not explain why the company had not declared results as ""clinically meaningful"".  The drugmaker's shares fell by as much as 8% earlier this month after the company released interim data from the late-stage clinical trial called TROPION-Lung01 testing an experimental precision drug called datopotamab deruxtecan.  Speaking to media on Friday after the company released better-than-expected quarterly results, Soriot said people would understand when full results are released why the company did not use that description, but he did not comment further.",https://finnhub.io/api/news?id=66ba517a93717c806d51671a222d93d6bcc6d429193dea51ecd2712cf19c8d50
company,2023-07-28 03:08:14,AstraZeneca beats estimates with strong cancer and diabetes drug sales,121658602,,AZN,Yahoo,"Strong sales of drugs for cancer and diabetes helped AstraZeneca beat expectations in the second quarter, as the drugmaker expands its genomic medicine business with a $1bn deal to buy assets from Pfizer.  Pascal Soriot, AstraZeneca’s chief executive, said eight medicines delivered more than $1bn of revenue in the first half, with each area of the business, except Covid-19 therapies, growing by double digits year-on-year.  “We look forward to sharing the data with the medical community at an upcoming medical congress and are proceeding to file the data with the US Food and Drug Administration,” he said.",https://finnhub.io/api/news?id=f9b7fd093fcb9d1f93831cee0f8d2227922dddfe0c10aa85aeb23fe3ca06ca9e
company,2023-07-28 04:40:00,Unusually active option classes on open July 28th,121669621,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=98512a55edbac2d17bd8fc483fd8548f5118bea2687a49c8dd9d272517a5dea7
company,2023-07-28 04:35:10,AstraZeneca CEO says lung cancer drug trial data 'very encouraging',121665368,https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png,AZN,Yahoo,"AstraZeneca Chief Executive Pascal Soriot said on Friday the company is ""very encouraged"" by interim data from a key lung cancer drug trial, but he did not explain why the company had not declared results as ""clinically meaningful"".  The drugmaker's shares fell by as much as 8% earlier this month, after the company released interim data from the late-stage clinical trial called TROPION-Lung01 testing an experimental precision drug called datopotamab deruxtecan.",https://finnhub.io/api/news?id=355c6d340ce2fd9231d1e8566a9669b8c26de22eff79f7d7828c063c082592ea
company,2023-07-28 04:34:36,AstraZeneca PLC 2023 Q2 - Results - Earnings Call Presentation,121665084,https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png,AZN,SeekingAlpha,The following slide deck was published by AstraZeneca PLC in conjunction with their 2023 Q2 earnings call.,https://finnhub.io/api/news?id=84965bd538e850cbcc144b1856320473469054285a3257c398d2ecdd9f782bd5
company,2023-07-28 04:28:00,"6 stocks to watch on Friday: Palantir, Chevron, Ford, AstraZeneca and more",121668041,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=22e1eb5287604bf0ef452f212feb99721e4a4916305ccaec175de8559f7fac72
company,2023-07-28 04:15:00,AstraZeneca (NASDAQ:AZN) Soars on Q2 Beat; Enters Into $1B Gene Therapy Deal with Pfizer (NYSE:PFE),121670087,,AZN,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=02fe59c733a3917621b99381286315ab65c8b4267730866e419ab9c198c25c3f
company,2023-07-28 03:56:16,"Stocks making the biggest moves premarket: Intel, Roku, Procter & Gamble and more ",121665760,https://image.cnbcfm.com/api/v1/image/107186186-1675118079202-gettyimages-1246677801-INTEL_EARNS.jpeg?v=1690545376&w=1920&h=1080,AZN,CNBC,These are the stocks posting the largest moves in premarket trading. ,https://finnhub.io/api/news?id=19e9d20b49201befab9d9359bdb2d34b826835743cd2afc06ddbece8b2860acd
company,2023-07-28 03:11:00,AstraZeneca-Ionis deal for eplontersen expands to Latin America,121670089,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=a2b38cf9d1651b888cf06b85a9278c98d5b0562c39ef299d8cee28e6a5fd6ddf
company,2023-07-28 02:22:32,UPDATE 1-AstraZeneca to buy Pfizer's rare disease gene therapy portfolio for up to $1 bln,121658603,https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png,AZN,Yahoo,"AstraZeneca said on Friday its unit Alexion has agreed to buy U.S. drugmaker Pfizer's early-stage rare disease gene therapy portfolio for up to $1 billion, plus royalties on sales.  AstraZeneca bought Alexion in 2021.  It focuses on rare diseases and plans to close the deal in the third quarter, the British drugmaker said.",https://finnhub.io/api/news?id=5883d983061053c3057305d16f69f0bb55db57c39a9b8a80488c6103ae11265d
company,2023-07-28 02:15:52,AstraZeneca to buy Pfizer's rare disease gene therapy portfolio for up to $1 billion,121658604,https://media.zenfs.com/en/reuters-finance.com/4d513b879a24ea1eab146f42ad736bb6,AZN,Yahoo,"AstraZeneca bought Alexion in 2021.  It focuses on rare diseases and plans to close the deal in the third quarter, the British drugmaker said.  The deal will bring a number of novel adeno-associated virus (AAV) capsids to Alexion and help build on Alexion and AstraZeneca's capabilities in genomic medicine, it said.",https://finnhub.io/api/news?id=64ac639fa559d56162415eba453d90877faf43c6280f447041c6b743b851cf25
company,2023-07-28 02:12:58,AstraZeneca Q2 results beat estimates; COVID vaccine sales dry up,121665371,https://media.zenfs.com/en/reuters-finance.com/e93864558cf4dc50a9fc2b483be42523,AZN,Yahoo,"LONDON (Reuters) -AstraZeneca on Friday delivered forecast-beating profits and sales in the second quarter as a strong performance by its blockbuster cancer drugs offset the loss of COVID-19 vaccine sales.  Shares in the Anglo-Swedish drugmaker, which has a strong line-up of cancer, metabolic and rare disease drugs, rose as much as 4.8%, before settling back to 3.9% by 1052 GMT, making the stock the largest weighted gainer on the FTSE 100.  Sentiment was boosted by Chief Executive Pascal Soriot's positive remarks on the company's data from a key lung cancer trial, an AstraZeneca shareholder and an analyst told Reuters.",https://finnhub.io/api/news?id=2707ab0dc7560e3fd014b2efe36635c2b3fa6facb6a15e6953f819e4f784190b
company,2023-07-28 02:12:00,Ionis expands collaboration with AstraZeneca for eplontersen,121670090,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=635342bea45c8c70fc526ba95e76d9df010556e99e7d518f05d36adba51576e2
company,2023-07-28 02:08:30,UPDATE 3-AstraZeneca Q2 results beat estimates; COVID vaccine sales evaporate,121658607,https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png,AZN,Yahoo,"AstraZeneca on Friday delivered better-than-expected profits and sales in the second quarter as a strong performance of its blockbuster cancer drugs helped offset the loss of COVID-19 vaccine sales.  The Anglo-Swedish drugmaker posted an adjusted profit of $2.15 per share, up 25% and exceeding the $1.98 per share expected in company-compiled consensus estimates.  Total revenue in the quarter was $11.4 billion, up 6% and beating company-compiled analyst estimates of $10.97 billion.",https://finnhub.io/api/news?id=83a1971c415704f44f598e11a14142f2619fd1eeb9a6f51df96d79f7265355f5
company,2023-07-28 02:01:00,US Stock Futures Signal Rebound On Tech Earnings Support: Analyst Tells Why Fed May Not Start Cutting Rates Anytime Soon,121668047,,AZN,Benzinga,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=ab4056182b0bcf6466390fd4583d696c18282549b148fe77932e430c97e4ea4a
company,2023-07-28 01:56:00,AstraZeneca unit in $1B deal with Pfizer for gene therapies,121670092,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=30263ca8ff7092c7d6edfcb774faf0810b53d41d4ad3fa1907f8da3a9c042b18
company,2023-07-28 01:42:00,AstraZeneca backs FY23 view of core EPS up high single-to low double-digit,121670093,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=e02036a364ed80583926ab02b706bca3e10cf1be021a37e623ec00cd83502d01
company,2023-07-28 01:41:00,"AstraZeneca reports Q2 core EPS $2.15, consensus $1.97",121670094,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=881e5b0fe92947e5530682bac1752b5cd2b2cce51cfc6eeefc9b71084953bd79
company,2023-07-28 01:21:00,Alexion to acquire portfolio of rare disease gene therapies from Pfizer,121670095,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=d02d2f47b0863bf30b0fcd522a29886d0f2c1bf94623ae6e32abf48b29d778a6
company,2023-07-28 01:12:00,"Earnings Scheduled For July 28, 2023",121668053,,AZN,Benzinga,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=363e8baef9b561503908a69fec2186270e713e05a493a4407b69264d635983fd
company,2023-07-28 01:01:00,Astrazeneca: Q2 Earnings Snapshot,121670097,,AZN,"Associated Press, The",Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=f5fb66beb94f023577e36c00814ff2fbeacd24caa8f2d693f38eb42c7b6fec35
company,2023-07-28 00:26:00,AstraZeneca PLC ADR outperforms market on strong trading day,121691182,,AZN,MarketWatch,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=33b7732cba0d5af0bee8d9650c9ba2516ef7989260e6c0390303d0bce153a2b7
company,2023-07-28 00:20:46,European stocks mixed; strong AstraZeneca numbers help U.K. outperform,121663423,https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png,AZN,Yahoo,"European stock markets traded in a mixed fashion Friday, as investors digested a week of corporate earnings, important central bank decisions and economic data.  AstraZeneca stock rose 3.5% after the drugmaker delivered better-than-expected profits and sales in the second quarter as a strong performance of its blockbuster cancer drugs helped offset the loss of COVID-19 vaccine sales.",https://finnhub.io/api/news?id=91278d8089feb308f2976b9205f74530690e12b0019f3e3f4a8bbe27fae50f17
company,2023-07-28 00:04:00,"AstraZeneca Shares Rise After 2Q Revenue, Earnings Beat Market Views -- Update",121964460,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,"By Joe Hoppe AstraZeneca shares rose Friday after the company reported a significant rise in second-quarter revenue and earnings per share, ahead of market...",https://finnhub.io/api/news?id=e02c6995f88f0f68e8e7bd521e08b14c87ac5150bcab2ea8494f50dc62150c93
company,2023-07-27 23:52:00,"LONDON MARKET OPEN: StanChart, AstraZeneca lift FTSE 100 into green",121670098,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=f088d6c1f41aad221523507905c066d53dc54eacba3d6cd1804ad31676ed9c95
company,2023-07-27 23:51:00,TOP NEWS: AstraZeneca profit surges as Alexion agrees Pfizer deal,121670099,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=775d707c05dca2594efb12049ca9e6e5e56425658fed6ed5e4ba37ce900c6dff
company,2023-07-27 22:54:00,LONDON BRIEFING: NatWest posts interim growth; IAG swings to profit,121670100,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=6470935918a1f1efc2c4429b5b9165c64be1c49e2e7ba840bfbd65fe7df026a2
company,2023-07-27 22:40:00,AstraZeneca's Alexion to Buy Gene Therapies Portfolio for Up to $1 Bln From Pfizer,121701056,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,By Anthony O. Goriainoff AstraZeneca said Friday that its Alexion division will buy a portfolio of preclinical rare-disease gene therapies from Pfizer for up...,https://finnhub.io/api/news?id=743690aeffb1225db773946e311420c994d4cbfbba9c2867d9e4df76b035ae5b
company,2023-07-27 22:36:31,Europe stocks set for lower open; Bank of Japan jolts markets by easing YCC stance,121658534,https://image.cnbcfm.com/api/v1/image/107240734-1683956473849-gettyimages-1254370845-AFP_33EY4NF.jpeg?v=1690526191&w=1920&h=1080,AZN,CNBC,European stock markets are heading for a lower open Friday after the Bank of Japan rattled markets. ,https://finnhub.io/api/news?id=a1153d41df26b375ff78a628b7543f8be5969daa32ceb3d0c3e69fd9c014d1f6
company,2023-07-27 22:33:00,AstraZeneca PLC 2Q EPS $1.17,121964462,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,"By Joe Hoppe AstraZeneca on Friday reported a significant rise in second-quarter net profit, but missed market forecasts, and backed its full-year guidance....",https://finnhub.io/api/news?id=b1f0d2e66da50184408369dcc9106cdaa97c5e90a621dbb69fc8ac6197d47237
company,2023-07-27 21:59:00,LONDON MARKET EARLY CALL: Stocks to fall; yen firms after BoJ move,121670101,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=d11572753093dead4717919758b0741c8975aeed3fd8b0446e69a6fdc086fce9
company,2023-07-27 21:38:00,"Earnings week ahead: Amazon, Apple, Pfizer, Starbucks, Uber and more",121672775,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=b0a2a0be8b2d7a46fc56480c580ed87cd56a0b43d1ffccdb0ab7eac0511782b8
company,2023-07-27 21:34:00,"GET READY: AstraZeneca, AIB, IAG, Intertek and NatWest at 0700 BST",121670102,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=418c4e0e3cbbebf456f093798f136897ba193e2772fda669a67cf65ae06dea6e
company,2023-07-27 21:23:00,AstraZeneca beats Q2 top and bottom line estimates; reaffirms FY23 outlook,121670103,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=471b3a2d484c7c34ae3938529491e256b0add11888db1c8f92c026e6c9034581
company,2023-07-27 20:36:00,GLOBAL BRIEFING: Yen rises as BoJ adjusts yield curve control,121654088,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=6a3418cc8f153c80dd2df492a8712ee592338782b27f7c02aad7afbcc1609086
company,2023-07-27 16:54:11,50 Most Valuable Companies in the World by Market Cap,121636895,https://s.yimg.com/ny/api/res/1.2/YQ61rfVZRHXthQM8zrNCYA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDE-/https://media.zenfs.com/en/insidermonkey.com/7d2f0700c4eb282c59bd0a98eddb3443,AZN,Yahoo,"In this article, we will be taking a look at the 50 most valuable companies in the world by market cap. If you want to skip our detailed analysis of the most valuable industries, you can go directly to 10 Most Valuable Companies in the World by Market Cap. The most valuable companies in the […]",https://finnhub.io/api/news?id=f87d8613f32068b2249875cc3ce65226132b56b0c9724ea4d76f91be8029d016
company,2023-07-27 12:08:00,IN BRIEF: Astra drug approved while another shows promise,121654090,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=67817de4d37393cde0eca97eddf269f575204ed75c8fba0fc143962a75c850f7
company,2023-07-27 08:44:00,Why AstraZeneca (AZN) Might Surprise This Earnings Season,121628679,https://media.zenfs.com/en/zacks.com/ef77d5a5eb4e72e4dd31ccfaf4ca4ccd,AZN,Yahoo,AstraZeneca (AZN) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.,https://finnhub.io/api/news?id=575dd0cb131c6333a1db4ef317bd4b9ee2e03de2f7a013299b6ddbf0a20a4926
company,2023-07-27 07:00:00,ENHERTU® (fam-trastuzumab deruxtecan-nxki) Demonstrated Clinically Meaningful Progression-Free Survival and Overall Survival Across Multiple HER2-Expressing Advanced Solid Tumors in DESTINY-PanTumor02 Phase II Trial,121619062,https://media.zenfs.com/en/business-wire.com/aabcdda636103a0d67e3b831da597f9a,AZN,Yahoo,"WILMINGTON, Del., July 27, 2023--High-level results from the primary analysis of the ongoing DESTINY-PanTumor02 Phase II trial showed ENHERTU® (fam-trastuzumab deruxtecan-nxki) demonstrated clinically meaningful progression-free survival (PFS) and overall survival (OS) in previously treated patients across multiple HER2-expressing advanced solid tumors, two secondary endpoints of the trial.",https://finnhub.io/api/news?id=bd7a997c2b495f51c519c5424613c072e15098bc9a3eef082472ed6e1752cec0
company,2023-07-27 06:40:00,"UK earnings, trading statements calendar - next 7 days",121623670,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=4c5737775b4452d419567f196c9592a67f7a146e500e3decb8fc75d4390c35fa
company,2023-07-27 06:03:00,Notable earnings before Friday's open,121624463,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=a093b3ecb0f7d36a6d7a188d9d66cef1ec8cfb503eb683facef930462f6bb7c9
company,2023-07-27 05:40:36,"Starpharma: Patience Needed, But A Lot To Like",121620603,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1403049813/image_1403049813.jpg?io=getty-c-w1536,AZN,SeekingAlpha,The news on Starpharma share price is challenging as a significant shareholder exits. Read more about SPHRF here.,https://finnhub.io/api/news?id=eded2fbdf48034e5131d67bb69291c3c1a3c176c1b463cacbed127ef40e9f999
company,2023-07-27 01:31:00,AstraZeneca says Soliris approved in EU for children with refractory gMG,121654095,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=0524ca3606f8851c68b9201db6762a1a6643125019df2df0d285e55343aafd08
company,2023-07-27 01:29:00,"AstraZeneca: Enhertu showed clinically meaningful PFS, OS in DESTINY-PanTumor02",121654096,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=9aa8b5df411fec3145c2520f8d4e5511dd272cfa641440539da7fc60143084ad
company,2023-07-27 00:28:00,"AstraZeneca PLC ADR falls Thursday, underperforms market",121654097,,AZN,MarketWatch,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=a784a58480957b32c3c0a5620c18b2b355335e331ed2ab2635d6c336e5461a34
company,2023-07-26 22:00:00,ENHERTU® Demonstrated Clinically Meaningful Progression-Free Survival and Overall Survival Across Multiple HER2 Expressing Advanced Solid Tumors in DESTINY-PanTumor02 Phase 2 Trial,121654098,,AZN,Business Wire,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=1898d459e6f0c408a1b665435e10d09bbbbaff01218034c4212540024cc58fd9
company,2023-07-26 11:19:00,Merck (MRK) to Report Q2 Earnings: What's in the Cards?,121607147,https://media.zenfs.com/en/zacks.com/9883d206905e7516b2353476e213e60c,AZN,Yahoo,"Investor focus is likely to be on the sales of Merck's (MRK) blockbuster oncology medicine, Keytruda when the company reports Q2 earnings.",https://finnhub.io/api/news?id=d182197fb3d0aec8b4675c35cfd41182a68f785909e3967b09d7e1f83a9c1272
company,2023-07-26 10:22:47,"UK investigates weight loss, diabetes drugs like Wegovy and Ozempic for suicide risks ",121610945,https://image.cnbcfm.com/api/v1/image/107265316-1688128139756-gettyimages-1259158436-20090101230628-99-216239.jpeg?v=1690395767&w=1920&h=1080,AZN,CNBC,The probe into potentially life-threatening side effects comes as the drugs skyrocket in popularity in the U.S. and draw heightened investor interest.,https://finnhub.io/api/news?id=95d394644969ed15a11c4d4e21c2ecd6d6421a87f55ab53aa71037fa68ffe597
company,2023-07-26 07:54:00,Probe over suicide risk linked to weight loss drugs expands to U.K. – Reuters,121630831,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=4062a1ecda113ed49dc306742a1c8c94986aaf1406290efbca95c3f52cb8ecd7
company,2023-07-26 03:28:06,LIVE: FTSE 100 and European stocks mixed ahead of Fed interest rates decision,121601909,https://s.yimg.com/ny/api/res/1.2/J6E6We7AfUx_FHgbNAz2fw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://s.yimg.com/os/creatr-uploaded-images/2023-06/a2918880-10d1-11ee-af6a-6ba4a06334e7,AZN,Yahoo,A look at how the major markets are performing on Wednesday.,https://finnhub.io/api/news?id=3dc02c3e88484af6f324c84995c678cf79f3e674076274515759c46c36e3fe86
company,2023-08-02 01:48:00,"Stick to U.S. stocks that offer experience over hope, Goldman says",121768599,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=7a1f4877f60d3bd9880b7d2b82f9379ebdde06acee191d346b032db59b4598d7
company,2023-08-02 00:27:00,AstraZeneca PLC ADR outperforms market despite losses on the day,121795834,,AZN,MarketWatch,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=f02680114349ec17986bd54126a7bff123b29c1bfc06fa801478300a408a9828
company,2023-08-01 09:09:06,Astrazeneca plc - ADR (AZN) Declares $0.46 Dividend,121733277,,AZN,Fintel,,https://finnhub.io/api/news?id=39c709bcab6ecd463d171ac9d197111e6397815dd785e516169b53cd4043726f
company,2023-08-01 03:12:00,GLOBAL BROKER RATINGS: LBBW says 'buy' Vodafone; DZ raises Intel,121736087,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=7e626617cea1346d3e395aa78aca1cb4fb484e612712473f8d90b1c0fa39bd31
company,2023-08-01 02:30:00,Zentalis appoints Freeman as Chief Strategy Officer,121744076,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=91d6a51190e31e173f321653cda9732057506a5b470f56fe7cc8a94bdd0d8320
company,2023-08-01 02:22:00,Analysts Offer Insights on Healthcare Companies: BioMarin Pharmaceutical (BMRN) and AstraZeneca (AZN),121744077,,AZN,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=aa244a543b1a01373014b0bc1af8d41fcf47821fa16c88fb51e911f335eef767
company,2023-08-01 00:26:00,"AstraZeneca PLC ADR falls Tuesday, still outperforms market",121770591,,AZN,MarketWatch,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=e3f18d6cce30d51d90ba9a9dd571d1d422db6f20eee3a2592abf92c4eb235b84
company,2023-07-31 08:59:00,Analyst Upgrades Ionis Pharmaceuticals To Buy Amid Key Pipeline Developments: Eplontersen And Donidalorsen Show Promising Outlook,121721045,,AZN,Benzinga,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=1767d683e1115d459a3cd4eaa08f16bd6c0d7d039e919aa23d947c9e873d2838
company,2023-07-31 05:34:27,3 Pharma Stocks to Buy for Their Promising Progress,121857925,https://media.zenfs.com/en/investorplace_417/44f955a82e96f5a3269fad084f079fe2,AZN,Yahoo,"Identifying promising pharma stocks is no small feat in the dynamic and competitive realm of pharmaceuticals. The industry is replete with businesses boasting robust pipelines, each vying for a breakthrough that could potentially revolutionize healthcare. Today’s article sheds light on three high-potential pharma stocks that hold strong promise for the future. These companies are among the cream of the crop regarding R&D pipeline size as of 2023, demonstrating a powerful blend of innovation and",https://finnhub.io/api/news?id=df4a27eb03682845c7c0799082c29cb04e05c6610a588c5f65facf8684d241c0
company,2023-07-31 03:32:00,Viatris launches first generic of AstraZeneca asthma drug Symbicort,121716142,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=2f70c80e5ad3acda0bef31c7d4417547e901cacfeed032c9f98c94f0cf0ce0c9
company,2023-07-31 02:09:00,Ionis Pharmacompletes enrollment for Phase 3 CARDIO-TTRansform study,121717604,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=996224c5bdafcf587c15d692b24d6718726c86b8b589194e84e9a817e682684b
company,2023-07-31 00:27:00,AstraZeneca PLC ADR outperforms market on strong trading day,121744079,,AZN,MarketWatch,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=f8635250bb3b6589770954e5483054719f2c785359cfb26960ebaff4d5fe7947
company,2023-07-30 08:27:00,"AstraZeneca's Q2 Earnings Exceed Expectations, Astonishing Investors (Rating Upgrade)",121703126,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=018c6b3d00532a5846472d130981cbdf478c8251f6311b08b731a28022f0d466
company,2023-07-30 08:08:40,AstraZeneca: Robust Performance And Promising Growth Initiatives,121703304,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1287552192/image_1287552192.jpg?io=getty-c-w1536,AZN,SeekingAlpha,AstraZeneca's Q2 2023 financial performance showed a 6% increase in total revenue. Read more to see what makes me bullish on AZN stock.,https://finnhub.io/api/news?id=e149107cbc56b08a356150a34eaefc98c2a67ce7186c4f19442065cdf81a0a23
company,2023-07-30 01:55:00,Baron International Growth Fund Q2 2023 Shareholder Letter,121699197,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/169975453/image_169975453.jpg?io=getty-c-w1536,AZN,SeekingAlpha,Baron International Growth Fund gained 3.45% (Institutional Shares) during the second quarter of 2023. Click here to read the full fund letter.,https://finnhub.io/api/news?id=570150029bc12fb125d7699048033af0021bd4d119995d72f256b19a005a822b
company,2023-07-29 21:05:00,RSV treatment market to surge past $9B by 2029,121705798,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=fdc2cb3696dc7ef0e2d3f3dbbfe368a0ac0af543e254af16fa03a92802b81aa6
company,2023-08-04 21:19:00,Week In Review: Mundipharma Considers $1 Billion Sale Of China Operations,121852041,,AZN,TalkMarkets,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=c68366533c145a5db32c4034111d452f2dc310f4d658003244e4e28e61b96ba8
company,2023-08-04 13:25:00,"AstraZeneca PLC ADR falls Friday, underperforms market",121964452,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR sank 0.39% to $69.40 Friday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite...",https://finnhub.io/api/news?id=f3e02de4507978ef3672fa0e206ae3cabd9d8d5479bfea58fd9427bf2c3594f7
company,2023-08-04 09:59:00,"CDC Recommends New Sanofi, AstraZeneca Shot to Prevent RSV in Babies",121820797,,AZN,Yahoo,"The Centers for Disease Control and Prevention recommended a new  Sanofi  and  AstraZeneca  injection for all newborns in the U.S. to prevent cases of respiratory syncytial virus, making the drug the latest in a series of tools against the virus to roll out this fall.  Following a meeting of an expert outside advisory committee, which voted unanimously to support use of the medicine, the CDC said late Thursday it recommends routine use of the medicine in babies younger than eight months old.  Sanofi  (ticker: SNY) American depositary receipt was 1.1% higher in early trading, while  AstraZeneca  (AZN) ADR was down 0.2%.",https://finnhub.io/api/news?id=c7da01541384e32811abeb838278d54c6a1762d7771928d957e94933069cf4a1
company,2023-08-04 08:09:00,"5 Healthcare Stocks to Buy Now, According to Analysts – August 2023",121828758,,AZN,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=8daef503e1e7128fa57d06f5e6fbfb34b4be3a1e19322c5a327537027c2b7279
company,2023-08-04 08:01:00,"AstraZeneca rises Friday, still underperforms market",121964453,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"AstraZeneca PLC shares inched up 0.09% to £109.10 Friday, on what proved to be an all-around great trading session for the stock market, with the FTSE 100...",https://finnhub.io/api/news?id=b744fcdf57b81e41a2ab70e6018617ae8acc1ced8974c83f5838bd961c8ca991
company,2023-08-04 06:47:00,UK dividends calendar - next 7 days,121823084,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=d4f6570a5dbdcaedf7813422a206434d18b05e3f84a87a144e88c85dea9a2862
company,2023-08-04 04:13:00,IN BRIEF: Sanofi wins US CDC recommendation for Beyfortus in RSV,121833061,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=b3c9b6963c568c6b3c1745ce609dd0868e2bb7db6bcd9024290a3cded65d7534
company,2023-08-03 22:47:00,"Sanofi, AstraZeneca RSV Treatment for Infants Gets U.S. CDC Panel Recommendation",121964455,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,By Cecilia Butini Sanofi and AstraZeneca's preventative treatment for respiratory syncytial virus was recommended for use by an independent health expert...,https://finnhub.io/api/news?id=ef2a27fe6dfe90bc3958058fe2e31b074b9010caf4e1613dad575c0bc9d4ec24
company,2023-08-03 14:35:00,CDC panel says babies should get new drug that prevents RSV,121964456,https://images.mktw.net/im-829628/social,AZN,MarketWatch,"Infants should get a new drug to protect them against a respiratory virus that sends tens of thousands of American children to the hospital each year, heath...",https://finnhub.io/api/news?id=002c01b685b1424bf2567f1bb1849905f32418bb83022eb5d79e6486cf651589
company,2023-08-03 13:25:00,"AstraZeneca PLC ADR falls Thursday, underperforms market",121964457,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR slipped 1.14% to $69.67 Thursday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=f161a25e57d24b8c4109e2f84769916fde4147a660479ceb6bef8c2bc65f871b
company,2023-08-03 08:01:00,"AstraZeneca falls Thursday, underperforms market",121964458,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"Shares of AstraZeneca PLC slipped 1.77% to £109.00 Thursday, on what proved to be an all-around grim trading session for the stock market, with the FTSE 100...",https://finnhub.io/api/news?id=dbc4b3044d7b8e9c4b14f13770cf900aef1578acd0b232c886e3fdeac0cc2e2f
company,2023-08-03 06:10:33,"Infant RSV shot wins backing of CDC advisors, paving way for fall availability",121802847,https://image.cnbcfm.com/api/v1/image/107160369-16699949192022-12-02t135820z_1175064686_rc2mxx9bklwy_rtrmadp_0_health-rsv.jpeg?v=1691071833&w=1920&h=1080,AZN,CNBC,Sanofi has said the companies are prepared to roll the shot out before RSV season this fall and do not foresee any challenges meeting demand. ,https://finnhub.io/api/news?id=777ebc1302d05e6c4d79f321a407b2661d28932e9355acc82e4cab860cd8c30a
company,2023-08-02 22:33:00,Sanofi says CDC panel unanimously recommends use of Beyfortus for infants,121797380,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=0e48538df1c6c05e9cf464864ae12ff78fa362ea60994a7038f422a98531faa2
company,2023-08-02 22:01:00,"AstraZeneca, Sanofi RSV treatment Beyfortus endorsed by CDC panel (updated)",121797381,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=034cfa8d43a01e446804040aa836ee911881d20f8bb297a430ea26e285423fe9
company,2023-08-02 21:38:00,"AstraZeneca, Sanofi RSV treatment Beyfortus priced at $495",121795832,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=56eb7d52f3821875842d7c9be347e4c88f634c7e9f60e4ed29d215c8b74c42e5
company,2023-08-02 21:31:00,"AstraZeneca and Sanofi RSV drug wins support of CDC panel, Bloomberg says",121795833,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=c58720806323064eab9cb5fd971989dc5073e9bd34a56d709526325321a1fc34
company,2023-08-02 20:39:44,The Petri Dish: Alexion buys Pfizer gene therapies in $1B deal; Peter Hecht's plan to save Cyclerion assets,121785785,https://s.yimg.com/ny/api/res/1.2/o9HN4iBu6Xxshjpwl5TYpA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDI-/https://media.zenfs.com/en/bizjournals.com/01e667f4bbc7bbf59f5ba702818b6c69,AZN,Yahoo,"Peter Hecht, the co-founder and CEO of embattled biotech Cyclerion Therapeutics Inc. (Nasdaq: CYCN), is heading up a new startup that's effectively a life raft for Cyclerion's research. Elsewhere in the Petri Dish: a $1 billion deal for Pfizer gene therapies, a succession plan for a founder-led biotech organization, and a new Longwood Fund spinout with assets from GSK.",https://finnhub.io/api/news?id=39c1703a5082dd35cd67d1a816eb2eb7a57cf1a507e900be2ab654261c58596c
company,2023-08-10 11:31:00,"Ionis (IONS) Q2 Loss Narrows Y/Y, Sales Surpass Estimates",121956079,,AZN,Yahoo,Ionis (IONS) Q2 loss narrows from the year-ago levels. Sales beat estimates. The company re-affirms its previously issued financial guidance for 2023.,https://finnhub.io/api/news?id=dac1226718404ceefd2efdea8e59b794895e38a0cbc0d25183504e71560ec444
company,2023-08-10 09:21:52,These 10 medications are likely targets for Medicare price negotiations this fall,121962765,https://image.cnbcfm.com/api/v1/image/104579256-GettyImages-471365098.jpg?v=1691688112&w=1920&h=1080,AZN,CNBC,"It's still unclear which drugs Medicare will select, but several companies have revealed in court filings that four of their medications are targets.",https://finnhub.io/api/news?id=d3b7c588f02a49fb114aca4fd8c78700954702c5540aeb23aabb48e8155f27d1
company,2023-08-10 08:01:00,"AstraZeneca rises Thursday, outperforms market",121964439,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"Shares of AstraZeneca PLC inched up 0.47% to £111.62 Thursday, on what proved to be an all-around positive trading session for the stock market, with the...",https://finnhub.io/api/news?id=48ab8f9b82961e45fac1c110e25da7fbba26e1d31e468de4e7c825aea284951f
company,2023-08-10 07:01:31,Organon Q2 2023 Earnings Review: Incremental Growth With A Slather Of Risk,121953224,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1409674827/image_1409674827.jpg?io=getty-c-w1536,AZN,SeekingAlpha,"Organon & Co. formed via Merck & Co.'s spinout of its Established Brands, reported its Q2 2023 earnings on 8th August. Read more about OGN stock here.",https://finnhub.io/api/news?id=b5944e30ae59aac8c27bf7e873d89998546c954785a19defb339ed3ab2641868
company,2023-08-10 04:56:27,Q2 2023 Ionis Pharmaceuticals Inc Earnings Call,121948320,https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png,AZN,Yahoo,Q2 2023 Ionis Pharmaceuticals Inc Earnings Call,https://finnhub.io/api/news?id=7d6626eaa9b96e926c2b8cbbbb6a86b4aaa590e076678f806e58f5e7b1e0e26c
company,2023-08-10 02:59:00,"LONDON MARKET MIDDAY: FTSE 100 flat, peers and pound up before US data",121956600,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=3420e80cee6d3c6358307a007556f81d3603a14bf88574a725dd923537c4da7b
company,2023-08-10 00:26:00,"AstraZeneca PLC ADR falls Thursday, underperforms market",121990104,,AZN,MarketWatch,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=648ff1d85e41cde1055a8199cde64ce9a3fcf402cb4880a04d1503ab895d38c2
company,2023-08-09 23:08:00,Dr. Reddy's launches generic version of Kombiglyze XR in US,121966203,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=6983c3d56b81e38cf8faacc2c80ea5a5fcf70794e316151b81485f1bceda3d21
company,2023-08-09 13:25:00,AstraZeneca PLC ADR outperforms market on strong trading day,121964440,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR rose 1.14% to $71.28 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=15e9e26f0fd83b8b41bc9d0b4fdc5744e3e7c18b8b59073799953b23446205dd
company,2023-08-09 08:15:00,AstraZeneca declares goes ex-dividend tomorrow,121930077,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=e2bf7aa2c8e341b6a8ccc8a5846590282e00dc77c615b3640b655414cd19c90b
company,2023-08-09 08:01:00,"AstraZeneca rises Wednesday, outperforms market",121964441,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"AstraZeneca PLC shares advanced 1.38% to £111.82 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the FTSE...",https://finnhub.io/api/news?id=a73ea90e97abb16402cdaced47f01ead6c445615103632f98346dab35156b222
company,2023-08-09 07:05:00,What You Missed On Wall Street This Morning,121922859,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=b31e95fb774e20607450cbcd05213b68380b163f6050e549885832b19587cb7e
company,2023-08-09 06:49:00,UK dividends calendar - next 7 days,121922157,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=c941a58e478bc901817f9886262a7a42f210d0eaa84f5704211199ed494afedb
company,2023-08-09 04:44:49,AstraZeneca signs vaccine deal with China’s CanSino,121919307,https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png,AZN,Yahoo,Drugmaker says it is working on new technologies to develop vaccines for infectious diseases where there is ‘high unmet need’,https://finnhub.io/api/news?id=362255c992137f457b1f0879c15a6797dbbda3a95ed8ac37ff74acb34a47b410
company,2023-08-09 03:19:49,UPDATE 1-China's CanSino in mRNA vaccine deal with AstraZeneca,121916401,https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png,AZN,Yahoo,"CanSino Biologics has agreed with AstraZeneca to provide ""contract development and manufacturing services"" to support the Anglo-Swedish drugmaker's messenger RNA (mRNA) vaccine programme, the Chinese company said on Tuesday.  In a filing to Shanghai's stock exchange, CanSino said it would manufacture and supply unspecified mRNA products to AstraZeneca.",https://finnhub.io/api/news?id=3ac03fc3156fbd4c1065f17af990196a8f89b3536730d11178cf415fe04fff62
company,2023-08-09 02:00:00,Statkraft Strikes Swedish Wind Power Purchase Deal with AstraZeneca,121964442,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,By Dominic Chopping Renewable energy producer Statkraft said it has entered a wind power agreement with AstraZeneca that sees the Anglo-Swedish pharma giant...,https://finnhub.io/api/news?id=789de8cfa1744986a8b8ad8a61287ac7dd4cc2a61b0bd6524c0f51b8f17d5338
company,2023-08-09 00:58:00,"AstraZeneca signs vaccine deal with China's CanSino Biologics, FT reports",121930085,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=c2e61f9afa970c8ec021ea3d34ad5b03ed6c4a8720988049a559182541447588
company,2023-08-08 23:31:00,What You Missed On Wall Street On Wednesday,121934108,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=5e3c6f5e53c33c772acd953834a82a3adc1898e8d6f0f73c1e3fc37efcf97aea
company,2023-08-08 13:26:00,"AstraZeneca PLC ADR rises Tuesday, outperforms market",121964443,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR inched 0.79% higher to $70.48 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=9f4a644d70763ad529eccf0bb9433d68a41fcf8e4671ffa6a3f99a1210594c5e
company,2023-08-08 08:46:53,3 Stocks That Are Still A Buy On China's Recovery Story,121896722,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1084890230/image_1084890230.jpg?io=getty-c-w1536,AZN,SeekingAlpha,China's economic recovery has turned out to be slower than expected. Read why strong domestic consumption indicates that there are still pockets of recovery.,https://finnhub.io/api/news?id=6b8b371e576bbab839e5792f9c20ba8cf5c03f6549d5b45fe5f5b3c46a45c6ee
company,2023-08-08 08:25:00,AstraZeneca inks mRNA vaccine deal with China's CanSino,121930091,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=d40288a99988e98a9c8a08814ca0f49e50517f900a8826ca625eb0437a031760
company,2023-08-08 08:01:00,"AstraZeneca rises Tuesday, outperforms market",121964444,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"Shares of AstraZeneca PLC advanced 1.32% to £110.30 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the FTSE 100...",https://finnhub.io/api/news?id=c78b9728ede0dd045eb3126eb86c36c9ca984f29ea007bb95e328e68bea0ebdb
company,2023-08-08 08:00:00,U.K. stocks drop for second session,121964445,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,"U.K. stocks dropped Tuesday, as the FTSE 100 Index finished down 0.36% at 7,527.42. Of the FTSE 100 constituents, investment advisors company abrdn PLC saw...",https://finnhub.io/api/news?id=75cf76961a4e66a5a7e465647464023f49710999890ced2a67583eebb83e65cf
company,2023-08-08 07:20:41,China's CanSino in mRNA vaccine deal with AstraZeneca,121892200,https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png,AZN,Yahoo,"CanSino Biologics has agreed with AstraZeneca to provide ""contract development and manufacturing services"" to support the Anglo-Swedish drugmaker's messenger RNA (mRNA) vaccine programme, the Chinese company said on Tuesday.  In a filing to Shanghai's stock exchange, CanSino said it would manufacture and supply unspecified mRNA products to AstraZeneca.  AstraZeneca did not have an immediate comment on the announcement.",https://finnhub.io/api/news?id=65be673885559621cc9051c19962e54521012fac3e529759ee2dbffa54f8cba5
company,2023-08-08 05:20:00,Is This Blue Chip Dividend Stock a Buy for Growth Investors?,121892201,,AZN,Yahoo,"An investor who put $3,000 into AstraZeneca (NASDAQ: AZN) five years ago and reinvested dividends would have $6,200 today.  The same amount put into the S&P 500 would be worth only $5,200 with dividends reinvested.  Let's examine AstraZeneca's fundamentals and valuation to decide.",https://finnhub.io/api/news?id=ddabe44cf77099fb17d250b20d24eb6cd7a68c14b09b276f5d3664be001543a4
company,2023-08-07 13:44:22,Future Prospects For Johnson & Johnson Following Strong Q2 Performance,121880242,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1042651550/image_1042651550.jpg?io=getty-c-w1536,AZN,SeekingAlpha,"Johnson & Johnson, the mastodon of the healthcare sector, released its financial results for the 2nd quarter of 2023. Read why JNJ stock is a hold.",https://finnhub.io/api/news?id=ea74e3a360ba579aa30b3787eeef5a35f93c31e286f47c542cbf4986da153865
company,2023-08-07 13:25:00,AstraZeneca PLC ADR underperforms Monday when compared to competitors despite daily gains,121964448,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR inched 0.76% higher to $69.93 Monday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=db57976503f24a94219e3f0608e0834231886b788aba13a0e7a30853a9de9f56
company,2023-08-07 08:01:00,"AstraZeneca falls Monday, underperforms market",121964451,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"AstraZeneca PLC shares inched down 0.22% to £108.86 Monday, on what proved to be an all-around rough trading session for the stock market, with the FTSE 100...",https://finnhub.io/api/news?id=e80daa302df22f6731828c3f354d2ccdf42134c077ed916d9ba21305c229e727
company,2023-08-07 05:38:00,Nvidia Just Confirmed an Emerging AI Boom in Biotech,121873820,,AZN,InvestorPlace,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=f616eacce8706ca2737a0e0e436128c0db6aace58e5ac88607869e5a240af468
company,2023-08-07 04:29:00,IN THE KNOW: Wegovy study key share price driver for Novo - Barclays,121873624,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=a9b129ca9876862019057ad7186fd84e55a7b8b8c1e0f1a0da4201ac49c88dbb
company,2023-08-06 21:59:00,"AstraZeneca price target raised to 12,700 GBp from 12,600 GBp at Morgan Stanley",121876940,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=778817d824ea4a73e94cc9c10462f3b2aea15f256b1f431fe96dd9de821124b6
company,2023-08-14 06:21:38,China Looks to Attract Foreign Investment as Its Economy Struggles,122021877,https://s.yimg.com/ny/api/res/1.2/zvznii_4HUYLKuIb1Dln6Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD03MjA-/https://media.zenfs.com/en/bloomberg_markets_842/c8ccaef3ab5f34d29751ce28a223b436,AZN,Yahoo,"(Bloomberg) -- China’s latest attempt to reverse the nation’s foreign investment slump includes pledges to offer overseas firms better tax treatment and make it easier for them to obtain visas, as officials try to allay fears about doing business in the world’s second-largest economy. Most Read from BloombergOutsider Milei Upends Argentina’s Election With Primary WinAmerica’s Fastest Growing City Is Embracing ‘Yellowstone’ ManiaZuckerberg Says ‘Time to Move On’ From Musk Cage FightRuble Sinks to",https://finnhub.io/api/news?id=4fd68cf91ccf84b7f84938d3ccd9e099e52e0fa3bb4c8311800db698d7f8f294
company,2023-08-14 01:45:30,Capitalizing On Inflammation's Role In Neurological Disease Part 1: Coya Therapeutics,122020443,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1434534146/image_1434534146.jpg?io=getty-c-w1536,AZN,SeekingAlpha,"Coya Therapeutics aims to target inflammation-related diseases, like ALS, with Treg-enhancing therapeutics. Click here to read my analysis of COYA stock.",https://finnhub.io/api/news?id=b8efac08f8dee4ab8ee73c620504ff77ac2ec83ecc2ac08b48476f8b9f42b646
company,2023-08-14 00:26:00,"AstraZeneca PLC ADR rises Monday, still underperforms market",122032253,,AZN,MarketWatch,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=31b1274f76c579260fa1010f2945a6bbb9007b0bd20db000a5da5510856ce9f8
company,2023-08-13 03:51:07,AstraZeneca (LON:AZN) shareholders have earned a 16% CAGR over the last five years,122011542,https://media.zenfs.com/en/simply_wall_st__316/bba95900ab96866c17a285be850152bf,AZN,Yahoo,"When we invest, we're generally looking for stocks that outperform the market average. And the truth is, you can make...",https://finnhub.io/api/news?id=3618c300b9c46ea44c6662b6fccc371d0275ed5f79cb133989ce87d72262aa2f
company,2023-08-13 03:00:00,Week In Review: BeiGene And BMS Close BeiGene-Celgene PD-1 Partnership,122011609,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1395657542/image_1395657542.jpg?io=getty-c-w1536,AZN,SeekingAlpha,What are the pivotal collaborations and transformative partnerships reshaping China's biopharma sector this week? Click here to find out. ,https://finnhub.io/api/news?id=b2b7a9fa09a5e33420084f98f5d3a51f679b05e94edbcc4522a58bd0c13fd901
company,2023-08-11 21:41:00,Week In Review: BeiGene And Bristol-Myers Squibb Close BeiGene-Celgene PD-1 Partnership,122006384,,AZN,TalkMarkets,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=edb9cdb60a83f3133166243a8df6eea651308c2eb8854010d1bdf51d13d14b2f
company,2023-08-11 13:59:00,Hutchmed: Attractive Chinese R&D Giant,121992982,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/469868251/image_469868251.jpg?io=getty-c-w1536,AZN,SeekingAlpha,Hutchmed (China) Limited shows promise for growth with a range of products in clinical trials and collaborations. Click here to read an analysis on HCM stock.,https://finnhub.io/api/news?id=05734eda0ab0a4609215cacc91ca50d3da958ded15a1d00dc017f85a4808a46d
company,2023-08-11 09:00:06,Is Most-Watched Stock AstraZeneca PLC (AZN) Worth Betting on Now?,121983207,https://media.zenfs.com/en/zacks.com/7ea641b46fe75c0a913349e5e610d6a2,AZN,Yahoo,"Zacks.com users have recently been watching Astrazeneca (AZN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",https://finnhub.io/api/news?id=c571ae1b6054f54e98250d7d7f05bcdc47c6f752ebefd569833dff856d3b1513
company,2023-08-11 00:26:00,AstraZeneca PLC ADR outperforms market on strong trading day,122005148,,AZN,MarketWatch,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=60e0ac1ec1dc354399e1a1f800154cef0d50c32bcbfcea75022ddfaaf3100f3b
company,2023-08-18 13:25:00,AstraZeneca PLC ADR underperforms Friday when compared to competitors,122208285,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR slid 0.95% to $68.46 Friday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...",https://finnhub.io/api/news?id=540719f69f0ee0536f7444b31d44b087ec27420f390878900351bb309e4d0632
company,2023-08-18 08:01:00,"AstraZeneca falls Friday, underperforms market",122208286,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"Shares of AstraZeneca PLC slid 1.24% to £106.58 Friday, on what proved to be an all-around grim trading session for the stock market, with the FTSE 100 Index...",https://finnhub.io/api/news?id=b182adfc2cc20047b6b2677da1668ba6cb6d8c298812466c635702ffce3c5586
company,2023-08-18 07:25:00,AstraZeneca call volume above normal and directionally bullish,122126291,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=0da466195467b561fbd0c180fa018e6f96010c792c13f55c29d207af65d8bf1a
company,2023-08-17 22:48:00,TOP NEWS: AstraZeneca hails heart-focused Forxiga approval in China,122126293,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=63a57bed1c6bb438ad3b037aea34aec484b5dbdaaf43c4cbef71bf2436b76e82
company,2023-08-17 13:25:00,AstraZeneca PLC ADR outperforms competitors despite losses on the day,122208287,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR sank 0.85% to $69.12 Thursday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=5a46dccb653b1c649fccf85d2150e0ab2733deafeb1e4ca38a4ab02558712b6a
company,2023-08-17 08:01:00,"AstraZeneca falls Thursday, underperforms market",122208288,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"Shares of AstraZeneca PLC inched down 0.79% to £107.92 Thursday, on what proved to be an all-around grim trading session for the stock market, with the FTSE...",https://finnhub.io/api/news?id=bb761861f6edf677f58df43ca8b97507eee52e11ab1997dfd2c014b5c8696d92
company,2023-08-17 06:36:00,TAKING AIM: Shore impressed by C4X Discovery's promising portfolio,122088245,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=5e06cec0b6fd5b4b19db1ceb64296fd11dfe338cc24da0407bbacd98d5153cc9
company,2023-08-16 10:00:00,AstraZeneca Data at WCLC Advance Ambition to Have an AstraZeneca Medicine for More Than Half of All Patients Treated for Lung Cancer by 2030,122074847,https://media.zenfs.com/en/business-wire.com/3ed4860300b9567a4f5a3fd0aaea1f7b,AZN,Yahoo,"WILMINGTON, Del., August 16, 2023--AstraZeneca advances its robust lung cancer portfolio and pipeline at the International Association for the Study of Lung Cancer (IASLC) 2023 World Conference on Lung Cancer (WCLC), September 9-12, 2023.",https://finnhub.io/api/news?id=b684f7a8c2512dd773c926bd01739acc775fee62fce2d3038510e9a98791e4c5
company,2023-08-16 04:18:00,Cheaper Alternatives of Weight-Loss Drugs? Chinese Pharma Companies Are Working On a Local Version,122085572,,AZN,Benzinga,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=a9ae069b92d07e98774c57b39fd4b04a1da973d18fb35a4d1a628d5f08c38d92
company,2023-08-16 00:27:00,AstraZeneca PLC ADR outperforms competitors on strong trading day,122088248,,AZN,MarketWatch,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=9b0bd20bd874918f6c76b0b46fab36bb264b8d2092077480ff5304c2d5e0ed59
company,2023-08-15 01:48:00,Murphy Canyon to hold meeting on planned buy of interest in AZD1656,122046052,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=c8a93ef3c7d101f6add7b58fc1a3049b123df540f3a51454132cbe2bdc4c17fa
company,2023-08-15 00:27:00,AstraZeneca PLC ADR underperforms Tuesday when compared to competitors,122088249,,AZN,MarketWatch,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=d2c2b4f215a27e735b1c48ceaafbfd1ca01cfbbf1f9622ffbef0780c167ee7b0
company,2023-08-22 17:55:33,Is Trending Stock AstraZeneca PLC (AZN) a Buy Now?,122178430,https://media.zenfs.com/en/zacks.com/3cb5117fc22f5e37890d1860dcd61f9f,AZN,Yahoo,"Recently, Zacks.com users have been paying close attention to Astrazeneca (AZN). This makes it worthwhile to examine what the stock has in store.",https://finnhub.io/api/news?id=45d2ef418cc13b343de114c8d8aa8409954497f310f00c6988d5291d1bc0bf52
company,2023-08-22 16:38:01,3 Sorry Pharma Stocks to Sell in August Before It’s Too Late,122290268,https://media.zenfs.com/en/investorplace_417/f14cb8eae8211d74a9da418e15fc0108,AZN,Yahoo,"Pharmaceutical stocks can bring you from rags to riches — and back to rags again. The truth is the innovative sector can function similarly to a lottery. Not every company can deliver consistent growth and profits, but those who beat the trend will have their shares pop somewhere in the double digits in share appreciation. A few years ago, the advent of the Covid-19 pandemic saw stocks in various industries plummet. Still, pharmaceutical shares began to rise to astronomic levels due to increased",https://finnhub.io/api/news?id=51471784b3b073bdb94b81a8bf28e93b05e1ed20e880f74a7764dbfbc92cd68e
company,2023-08-22 13:25:00,"AstraZeneca PLC ADR falls Tuesday, underperforms market",122208281,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR dropped 0.16% to $68.77 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=627bf06b6c76288516dacd741d925fa9f2ddb82741a8acb56efd2ab5c4045714
company,2023-08-22 08:01:00,"AstraZeneca rises Tuesday, outperforms market",122208282,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"Shares of AstraZeneca PLC inched up 0.22% to £106.98 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the...",https://finnhub.io/api/news?id=76c3a2dc7d536590dc36f5a0639de5b26cf660cbfb0dacdc803e0023efed9de1
company,2023-08-22 07:38:00,"Zacks Industry Outlook Highlights Eli Lilly, J&J, Novo Nordisk, Novartis and AstraZeneca",122163841,https://media.zenfs.com/en/zacks.com/60c096e1e24bb285c41a58d325d8d707,AZN,Yahoo,"Eli Lilly, J&J, Novo Nordisk, Novartis and AstraZeneca are part of the Zacks Industry Outlook article",https://finnhub.io/api/news?id=ac2d92891af61ed92e1c4e9227b7f92cf2f5eb6ba963116e08bf9f23fde18ce4
company,2023-08-22 04:32:00,FDA Greenlights Pfizer's RSV Vaccine: Moms Can Now Protect Babies Before Birth,122170344,,AZN,Benzinga,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=4be06393a685ff989e3ae321ec98f4f8ee90765bb1111ed202fed8d40b61d045
company,2023-08-22 03:30:00,3 Big Reasons Why Fed's Powell Can Be Hawkish At Jackson Hole On Aug 25,122162006,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/476954484/image_476954484.jpg?io=getty-c-w1536,AZN,SeekingAlpha,The annual economic symposium at Jackson Hole is awaited for insights into Fed's next policy actions. Read why I think Powell will likely continue to be hawkish.,https://finnhub.io/api/news?id=43b5df0101760bdd201297fba3520a5453f3a3b3867d65b898210d325ec23d45
company,2023-08-21 21:06:00,Pay for FTSE 100 bosses jumps 16% as wider wages behind inflation,122165781,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=4c9459182237919c1e8ffbd314a94048d87bb130d40d178543efcf6ee956bfde
company,2023-08-21 20:45:00,US approves Pfizer's maternal vaccine to prevent RSV in infants,122170345,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=87aebdb5f85f378ba3b9bc1bd0b78ce98c4f63e7d92237045222a7595f7454ce
company,2023-08-21 13:56:00,FDA approves RSV vaccine for moms-to-be to guard their newborns,122171524,,AZN,"Associated Press, The",Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=c2cc09ca2e30785c18fbf95efc1af576c8829eac269cf31ddd7645c471d85c51
company,2023-08-21 13:43:22,FDA approves Pfizer maternal RSV vaccine for infants,122158828,https://image.cnbcfm.com/api/v1/image/107261573-1687527105095-gettyimages-1246630631-Illustration_Pfizer_Inc.jpeg?v=1692654202&w=1920&h=1080,AZN,CNBC,Pfizer hopes that its respiratory syncytial virus vaccine will be available to the public by the end of October or the beginning of November. ,https://finnhub.io/api/news?id=c7fc7cec3ec8020943be02ead1ca312ed68b62f4c7a069c6592553f3c13f704e
company,2023-08-21 13:25:00,"AstraZeneca PLC ADR rises Monday, still underperforms market",122208283,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR inched 0.61% higher to $68.88 Monday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=9c93b69193914c199fedab0fc27ff110d90f049858eb383ffc0655eb137bb970
company,2023-08-21 12:58:32,Medicare drug price negotiations unlikely to be derailed by lawsuits: UBS,122152966,https://s.yimg.com/ny/api/res/1.2/Qg9jETT9r6r7f3pLdU8S9w--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://s.yimg.com/os/creatr-uploaded-images/2023-08/508edaf0-4043-11ee-9ffe-942b52240a34,AZN,Yahoo,UBS believes there is little chance the lawsuits brought on by pharma companies will delay Medicare pricing negotiations.,https://finnhub.io/api/news?id=a882c9aa88351d199d3f4f924984cd1f5da785c768aabedb75ba25e1ac5fb15c
company,2023-08-21 09:51:00,5 Large Drug Stocks to Watch as New Drug Approvals & M&A Gain Pace,122153012,https://media.zenfs.com/en/zacks.com/65d4d9838ddb692fbe578219ce60c69d,AZN,Yahoo,"Drug, biotech companies are likely to see significant innovation. In the Large-Cap Pharmaceuticals industry, Eli Lilly (LLY), J&J (JNJ), Novo Nordisk (NVO), Novartis (NVS) and AstraZeneca (AZN) are worth retaining in your portfolio.",https://finnhub.io/api/news?id=e54d728e4e724cc6ce097a2c114a044dc9f2c978acd1e2d4c0656481e192ea29
company,2023-08-21 08:01:00,"AstraZeneca rises Monday, outperforms market",122208284,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"AstraZeneca PLC shares inched up 0.15% to £106.74 Monday, on what proved to be an all-around rough trading session for the stock market, with the FTSE 100...",https://finnhub.io/api/news?id=4034116ffeb555256e2cbc1702c73ab8718092dccbf6f879295409f9e0557163
company,2023-08-21 05:30:10,The 3 Most Undervalued Pharma Stocks to Buy Now: August 2023,122265530,https://media.zenfs.com/en/investorplace_417/82c6c2cedce4e93bbf33a1bd53260198,AZN,Yahoo,"There are sectors in the economy that go through an extended period of trending sideways to lower. A good example is the pharmaceutical sector. In the last 10 years, the S&P Pharmaceuticals Select Industry Index has delivered annualized total returns of 2.65%. Furthermore, the index has annualized total returns in the last five years of -2.63%, clearly indicating an extended bear market among pharma stocks. Covid-19 did translate into buying action in selected pharma stocks. However, the interes",https://finnhub.io/api/news?id=31fc868e0c3070c341fc5c10fd8a610e8f3a2922671fdabe6b658fe6cf419c3e
company,2023-08-21 02:13:00,AstraZeneca to present 19 abstracts at upcoming ESC Congress,122171525,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=d346b55ba3efb763de70e3c3815fb5d3bfe08cf21945ea32d7bc860ec3382b22
company,2023-08-20 22:45:00,AstraZeneca hails new data on Forxiga's impact on heart failure,122171528,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=45a5a16e908965001f4a9493d718b803ff9b1fcd28b6ed68187de8d87f8ddb0e
company,2023-08-26 10:20:01,Ken Fisher’s Top 15 Healthcare Stock Picks,122256498,https://media.zenfs.com/en/insidermonkey.com/f6912e9062ff18c96d4aa8c374f90a3f,AZN,Yahoo,"In this article, we discuss the top 15 healthcare stock picks of Ken Fisher. If you want to skip our detailed discussion about the healthcare industry, head directly to Ken Fisher’s Top 5 Healthcare Stock Picks. The healthcare sector was forever changed by the COVID-19 pandemic. While it highlighted the weaknesses in the global medical […]",https://finnhub.io/api/news?id=6f9fc4c3005d0ead0df77678bf18dcf783e8279b40c5777984929a0eb5b08502
company,2023-08-25 17:07:44,AstraZeneca sues US over drug pricing laws,122245066,https://s.yimg.com/ny/api/res/1.2/e6QxAJgKlgR512U81zyGVA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD03NTA-/https://media.zenfs.com/en/the_telegraph_818/da8c38b9590a50c890653e2cc34c4b08,AZN,Yahoo,Covid vaccine maker AstraZeneca has sued the US government over legislation designed to lower prescription drug prices.,https://finnhub.io/api/news?id=dc1b8191e65f7bb74b8f48f9e98aa567ec4431cdbf68163784040a7d4b5d62fd
company,2023-08-25 13:38:37,Untapped Potential: 3 Stocks Tackling the Toughest Rare Diseases,122352359,https://media.zenfs.com/en/investorplace_417/d7550376d156248d3f0f64b4264097db,AZN,Yahoo,"Rare disease stocks have a difficult task. The rarer a disease is, the less public research goes into studying it. And that in turn makes it more difficult for a company to develop and test effective treatments. With so much less known about rare diseases than common ones, scientists may find themselves groping blindly trying to develop drugs and treatments. Rare diseases have less financial incentive as well. Fewer people having a disease means fewer patients that a treatment can be sold to. Th",https://finnhub.io/api/news?id=f16e4938ea6c0167c3c45e108daa447d85a1359de5ab13b7a6c75a3168425ea7
company,2023-08-25 13:31:00,"AstraZeneca PLC ADR rises Friday, still underperforms market",122284206,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR inched 0.53% higher to $68.25 Friday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=5d79ad00fc363706426870be831d8893c23a165cda4741ae73bb6d5e177b1582
company,2023-08-25 12:30:49,AstraZeneca becomes first international company to file Medicare drug pricing suit,122239616,https://s.yimg.com/ny/api/res/1.2/X8fuP_ivhNrwQ_SNpkt6hw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD03OTk-/https://s.yimg.com/os/creatr-uploaded-images/2023-07/bbd9f1c0-2d45-11ee-bafb-204c6815f483,AZN,Yahoo,"AstraZeneca joins as the sixth pharma company, and the first non-US company, to file suit against the Biden Administration over Medicare drug pricing.",https://finnhub.io/api/news?id=d301909219273c5c8c93b4076f5182aa8f05106d7347433251e2b0648754f015
company,2023-08-25 12:07:00,AstraZeneca's (AZN) Lynparza Gets Expanded Use Nod in Japan,122239617,https://media.zenfs.com/en/zacks.com/ef77d5a5eb4e72e4dd31ccfaf4ca4ccd,AZN,Yahoo,AstraZeneca (AZN) gets approval for Lynparza with abiraterone and prednisolone combo in Japan to treat adult patients with BRCA-mutated castration-resistant prostate cancer with distant metastasis.,https://finnhub.io/api/news?id=b45f7adac871df404b8bc04a96c02e9b2261b5c8849ba9fac95c73afc5df437c
company,2023-08-25 11:07:33,AstraZeneca files lawsuit against U.S. over drug pricing,122237462,https://s.yimg.com/ny/api/res/1.2/Ma060Smd0vrKB_huxng5vw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzY-/https://s.yimg.com/os/creatr-uploaded-images/2023-08/0ad64930-4359-11ee-bf1f-b670f4599beb,AZN,Yahoo,"AstraZeneca (AZN) joins Johnson & Johnson (JNJ), Merck (MRK), and Bristol-Myers (BMY) in a lawsuit against the U.S. Department of Health and Human Services (HHS) over certain provisions on prices found in President Biden's Inflation Reduction Act (IRA). Yahoo Finance Health Care Reporter Anjalee Khemlani joins the Live show to break down the lawsuit and what to expect moving forward.",https://finnhub.io/api/news?id=4d6a9453976d75813b68b92462e65f53d3198a2f64a427e40a33486ac64d9e0d
company,2023-08-25 09:57:37,AstraZeneca sues US government over drug price reforms,122239619,https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png,AZN,Yahoo,Anglo-Swedish group is latest to challenge Medicare’s new power to negotiate prices for a limited number of medicines,https://finnhub.io/api/news?id=e5ff183d9a26d3772a24dcff498852c174bfb199cbdb894c6bd9805e01bb69b2
company,2023-08-25 09:24:00,"Pharma Stock Roundup: PFE Gets Nod for RSV Vaccine, J&J Finalizes Kenvue Separation",122236346,https://media.zenfs.com/en/zacks.com/65d4d9838ddb692fbe578219ce60c69d,AZN,Yahoo,"FDA and EU approve Pfizer's (PFE) RSV vaccine, Abrysvo for maternal immunization. J&J (JNJ) finalizes separation of its Consumer Health company, Kenvue.",https://finnhub.io/api/news?id=69a40350d63329f377f5dd1d83425ae0e98394a586709033ed95f0dd55be3876
company,2023-08-25 08:53:00,Pharma Giants Unite Against Drug Price Negotiation: AstraZeneca Latest To Challenge The Government,122239631,,AZN,Benzinga,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=e60d7c21fce8ea6a9945479824811581c8db3fbdbc25a67bccd4465872ada17c
company,2023-08-25 08:01:00,"AstraZeneca falls Friday, underperforms market",122284207,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"Shares of AstraZeneca PLC inched down 0.84% to £106.60 Friday, on what proved to be an all-around favorable trading session for the stock market, with the...",https://finnhub.io/api/news?id=15076c9e3b19ae067fcfd39bcb8ece92601d3450591d9fb37d556acecf17bc92
company,2023-08-25 07:32:09,AstraZeneca sues US over Medicare drug price negotiation plans,122235796,https://media.zenfs.com/en/reuters-finance.com/e91b41b4d6b4c5d730246ddbd6c23a73,AZN,Yahoo,"The program faces at least seven other court challenges, including from leading industry group PhRMA and drugmakers Johnson & Johnson, Merck & Co, Bristol Myers Squibb and privately-held Boehringer Ingelheim.  The drug price negotiation program is part of President Joe Biden's signature Inflation Reduction Act (IRA).  AstraZeneca said it was filing the legal challenge to ""protect timely access to medicines for orphan indications"" in the United States.",https://finnhub.io/api/news?id=64340fad968f49b4378c65558b72e08c656bbb56e3e25cdd8e8253c871a367d7
company,2023-08-25 07:28:41,UPDATE 2-AstraZeneca sues US over Medicare drug price negotiation plans,122235797,https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png,AZN,Yahoo,"AstraZeneca said on Friday it has sued the U.S. government to block parts of a program that gives the Medicare health insurance plan the power to negotiate lower drug prices.  The British drugmaker, which filed its complaint in a Delaware district court, joins other drugmakers and business groups claiming that the program would restrict the development of new medicines.  The program faces at least seven other court challenges, including from leading industry group PhRMA and drugmakers Johnson & Johnson, Merck & Co, Bristol Myers Squibb and privately-held Boehringer Ingelheim.",https://finnhub.io/api/news?id=e87a7038eadb393a0007c671515ac451e8c3456fc9a9b86d8ad45f3cf2ac836a
company,2023-08-25 07:10:00,AstraZeneca urges re-examination of unintended consequences of Inflation Reduction Act on American cancer and rare disease patients,122235799,https://media.zenfs.com/en/business-wire.com/1e08556528146b1e860ed2b1a58b66cf,AZN,Yahoo,"WILMINGTON, Del., August 25, 2023--To help protect access to medicines for cancer and rare disease patients, AstraZeneca today has filed a legal challenge to critical aspects of the drug price negotiation provisions of the Inflation Reduction Act (IRA). The drug price negotiation provisions of the IRA run headlong into the goals of the Orphan Drug Act (ODA), a federal statute designed to encourage manufacturers to invest in new therapies for rare diseases.",https://finnhub.io/api/news?id=a57d78abcbfc4e55da56942f28d263be301960d6853ca6e266c35021c4d3e5d1
company,2023-08-25 06:56:00,AstraZeneca latest drugmaker to challenge Medicare drug price negotiation,122242107,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=2b4db88faeffc54fa9bbb546565a5f988e0c487891cdd3960e20fcc5a2c5dcdb
company,2023-08-25 06:02:00,"As Medicare picks 10 drugs for price negotiations, 50 million people stand to benefit — even if their drugs aren’t on the list",122237505,,AZN,MarketWatch,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=bac685e89ceb707b46ba15ca4daba6232ebf960b0566bcde3cda5ce4f00aaece
company,2023-08-25 03:50:04,"Affirm, Netflix, AstraZeneca rise premarket; Nordstrom, Hawaiian Electric fall",122235727,https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png,AZN,Yahoo,"Investing.com -- U.S. futures traded higher Friday, bouncing after the previous session’s substantial losses ahead of Fed chief Jerome Powell’s key speech at the Jackson Hole gathering.",https://finnhub.io/api/news?id=6effb1c1b85c0fa8c96d54e2f0be2c2e3655100671c1b8c60a48d6649c4ebf88
company,2023-08-25 03:27:00,AstraZeneca Files Legal Challenge to Some Drug-Price Provisions of IRA,122284208,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,"By Will Feuer AstraZeneca said it has filed a legal challenge to certain aspects of the drug price negotiation provisions of the Inflation Reduction Act,...",https://finnhub.io/api/news?id=0246ab59378c70785fd9b96c214363be1ae518950c2a6ebaae16911f2062aab1
company,2023-08-25 02:47:00,AstraZeneca files challenge to aspects of Inflation Reduction Act,122244582,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=7aedf701463f4eb56dd523730a192416cc2be1e1ba7ac635a21f56a61c34a7fb
company,2023-08-24 13:26:00,AstraZeneca PLC ADR underperforms Thursday when compared to competitors,122284209,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR shed 1.75% to $67.89 Thursday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=7f306afb714f04593973b2cf60011ee7b7d8b10bb3221bbea04c729775aa8e4f
company,2023-08-24 08:01:00,"AstraZeneca falls Thursday, underperforms market",122208277,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"Shares of AstraZeneca PLC inched down 0.19% to £107.50 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the...",https://finnhub.io/api/news?id=ec492584acc55b9cb3b36130302f45225cd56e2355da75e7bef9044377433770
company,2023-08-24 07:24:00,"UPDATE: AstraZeneca, Merck & Co say Lynparza approved in Japan",122205511,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=372ed9bc46cbc78f82448efe9e9128b8276f5dde5b221c07ad1c7b9e6b1311ee
company,2023-08-24 07:15:00,AZN October 6th Options Begin Trading,122205512,,AZN,Stock Options Channel,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=225b7980f5bc511269b286d1050ab39584fd62c95fc9db375a0a96c21bb298af
company,2023-08-24 06:21:02,The Petri Dish: Selecta gets selective with drug programs; Moderna enters 2nd cancer vaccine collab,122199110,https://s.yimg.com/ny/api/res/1.2/o9HN4iBu6Xxshjpwl5TYpA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDI-/https://media.zenfs.com/en/bizjournals.com/01e667f4bbc7bbf59f5ba702818b6c69,AZN,Yahoo,"A Watertown biotech trimmed its pipeline again, setting aside all of its experimental drugs except one. It's the second time the company has cut programs this year. Plus other life sciences news you may have missed.",https://finnhub.io/api/news?id=396884545285d996b4dacde7382ef723a45812cb29351ecab22a524cdafc8bc2
company,2023-08-24 05:25:00,"Boeing's 737 Deliveries Delay Due To Supplier Spirit Aerosystems, Petco Health and Wellness Stock Tumbles, AstraZeneca Under Legal Lens: Today's Top Stories",122205514,,AZN,Benzinga,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=28a0747e92abb9f3382b10b6faac34c64b0635494fab0b34f7c53cec9455709b
company,2023-08-24 04:46:00,Drugs picked for Medicare price negotiations to be announced on Tuesday – Politico,122205516,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=323e62aa4a2526bd984da085607284014db2dbfc15837237f94a2ae0977a2d3c
company,2023-08-24 03:45:00,"AstraZeneca Under Legal Lens, Faces Two COVID-19 Vaccine Lawsuits In London",122205517,,AZN,Benzinga,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=14d06e691900d8bda88ed3b5707e3cfe166e8cea3694b6cd1eb8777018ae381e
company,2023-08-24 03:28:00,GRI Bio Is Bringing Hope To Patients With Idiopathic Pulmonary Fibrosis And Lupus,122205519,,AZN,Benzinga,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=f5d3c6a0843ad029658dad87d619387ea1c635292d6020ed41f2f9933b49b0e9
company,2023-08-24 01:48:00,"Merck, AstraZeneca: LYNPARZA/(abi/pred) combination approved in Japan",122205520,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=f138609fc5a99ee88f4db410cc25b96c9b02b302304966007b7e035fa2efce43
company,2023-08-24 01:24:00,AstraZeneca says Soliris approved in Japan for pediatric gMG,122205522,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=17a2d1633e4c9fd2f8c17d84b9d8ef946742e49095562e37bc1171bf76b3a5fc
company,2023-08-24 01:22:00,AstraZeneca says Lynparza combo approved in Japan for certain mCRPC,122205524,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=e49c95ff824e84065e111eada8689fee849749b2ba9169981e8fa85457541083
company,2023-08-23 23:25:00,AstraZeneca says Soliris and Lynparza approved in Japan,122205525,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=29e07a7c040c1f727a1439297818f971863f1e306545405cc21c1c3f8ed3567f
company,2023-08-23 22:28:00,"AstraZeneca Prostate Cancer, Generalized Myasthenia Gravis Treatments Get Approval in Japan",122208278,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,AZN,MarketWatch,"By Michael Susin AstraZeneca's prostate-cancer treatment Lynparza has been approved in Japan, while Soliris has been approved for expanded use to treat...",https://finnhub.io/api/news?id=1ea795fa0e9f6a4908a5d742a087d25530f464cd12545207ee098d98961dba8d
company,2023-08-23 22:20:26,Bristol-Myers Squibb: Top Defensive Pick During Recessions With A Value Proposition,122195778,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1072593728/image_1072593728.jpg?io=getty-c-w1536,AZN,SeekingAlpha,"Discover why Bristol-Myers is a strong investment, undervalued with a promising dividend yield. After a slow start, expect a bullish turnaround.",https://finnhub.io/api/news?id=8aadcfcce666098da02f8040842f7d3e8f37654e9d67d2dbd3c0d80938b0f419
company,2023-08-23 15:49:00,U.K. Dividend Stocks Portfolio Review: Summer 2023,122191947,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1252406331/image_1252406331.jpg?io=getty-c-w1536,AZN,SeekingAlpha,"The UK Dividend Stocks Portfolio invests exclusively in dividend-paying FTSE All-Share stocks, producing over ten years to July-end a total return of 76.8%.",https://finnhub.io/api/news?id=2361f0cd5ae505d7aa31c2a894fee82438c9ea9a6808ab0179d9b2439a6c0b9f
company,2023-08-23 13:25:00,"AstraZeneca PLC ADR rises Wednesday, still underperforms market",122208279,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR inched 0.48% higher to $69.10 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the...",https://finnhub.io/api/news?id=22c771f1a779b0eea1b5c107ce154e8dba74e2f2110115c184fbd0d454b9eade
company,2023-08-23 11:15:15,AstraZeneca facing two London lawsuits over COVID-19 vaccines,122191111,https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png,AZN,Yahoo,"AstraZeneca is facing two London lawsuits, including one from the husband of a woman who died after receiving the Anglo-Swedish drugmaker's COVID-19 vaccine, in the first of potentially dozens of cases brought in England.  Britain was the first country to roll out the at-cost AstraZeneca COVID-19 vaccine in early 2021, although it later restricted the use of it among under 40s due to the small risk of blood clots.  Anish Tailor, whose wife Alpa died in March 2021 after receiving her first dose of the vaccine, filed a product liability claim against AstraZeneca at London's High Court on Aug. 4, according to court records.",https://finnhub.io/api/news?id=3b998a59018cba203920a5caac9e9bbddfbf4b1f7e0d9c3307a87e4786c17699
company,2023-08-23 08:37:00,AstraZeneca sued in London over adverse events linked to COVID shot,122205528,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=7d5f95e0e4b1d59e9de352d2d95ac493b412591386f73e58d7789f7904d1d0cb
company,2023-08-23 08:01:00,"AstraZeneca rises Wednesday, still underperforms market",122208280,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"AstraZeneca PLC shares inched up 0.67% to £107.70 Wednesday, on what proved to be an all-around great trading session for the stock market, with the FTSE 100...",https://finnhub.io/api/news?id=0fff29ba093b5017406f355acd14f7a4b1afad2878c45253cc1a3b01e9315fe4
company,2023-08-23 03:10:00,LONDON MARKET MIDDAY: Stocks rise but pound slumps on sub-par UK data,122203750,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=b319045f859e85134657d68683fd5d0aa83bbd2e04dfbaf95781e454fad91d7a
company,2023-08-23 01:44:00,Five metrics for AI trendspotting,122203490,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=f81f6e2d6a3ca7cb40e24bf6814cddb7871b02e36b7302617bd6b5556bab3dc6
company,2023-08-22 22:42:00,Daiichi Sankyo and AstraZeneca's Enhertu wins new approval in Japan,122205533,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=36fa26361cc6b4d5bfbf80f09f0bda7552b21f3dffbc3f48613702873814d340
company,2023-08-30 13:26:00,"AstraZeneca PLC ADR falls Wednesday, underperforms market",122399502,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR slid 0.40% to $68.86 Wednesday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=812be97d634b1abbca7b5cf4ab948d80bd78858fa87d762a0935245af340631a
company,2023-08-30 11:33:30,Medicare price negotiation list: What it means for pharma companies,122317084,https://s.yimg.com/ny/api/res/1.2/17Tdc.jZYOhDWq.DjeH51Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzY-/https://s.yimg.com/os/creatr-uploaded-images/2023-08/76956bc0-474a-11ee-b3bb-6467d0e87a11,AZN,Yahoo,"On Tuesday, the Biden administration listed ten drugs subject to Medicare price negotiations. Yahoo Finance Health Care Reporter Anjalee Khemlani breaks down the list and how this may impact the pharmaceutical companies who profit from these drugs.   The ten drugs and pharma companies impacted are:  Eliquis - Bristol-Myers Squibb (BMY), Pfizer (PFE) Jardiance - Boehringer Ingelheim, Eli Lilly (LLY) Xarelto- Bayer (BAYRY), Johnson & Johnson (JNJ) Januvia - Merck (MRK) Farxiga - AstraZeneca (AZN) Entresto - Novartis (NVS) Enbrel - Amgen (AMGN) Imbruvica - Johnson & Johnson (JNJ), AbbVie (ABBV) Stelara - Johnson & Johnson (JNJ) Fiasp, NovoLog - Novo Nordisk (NVO)",https://finnhub.io/api/news?id=e15b9656e478250e738526ac2b61b94737e5abf5a87d6c1dadcd3015789888ed
company,2023-08-30 09:48:18,Medicare drug price negotiations may have a muted impact on drugmakers in the near term,122479255,https://image.cnbcfm.com/api/v1/image/107293902-1693410787832-gettyimages-1647281024-030a1110_tfuqqjak.jpeg?v=1693417698&w=1920&h=1080,AZN,CNBC,Many of the drugs are already facing strong competition from other branded medications or patent expirations that will open the market to generic alternatives. ,https://finnhub.io/api/news?id=f0a87a85fa455088df0515f708aee19e6f0c789e112ea86b5c95286cf846d4cf
company,2023-08-30 08:01:00,"AstraZeneca falls Wednesday, underperforms market",122399503,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"Shares of AstraZeneca PLC inched down 0.65% to £107.34 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the...",https://finnhub.io/api/news?id=2fe38887c38e5136282635707da3a32c973f7fe59b517ee4a3da7f5160abc643
company,2023-08-29 11:37:00,Expensive Drugs Targeted for First U.S. Price Negotiations,122307073,,AZN,Yahoo,Lower prices would take effect in 2026 depending on the talks between the U.S. and drugmakers and the outcome of industry lawsuits.,https://finnhub.io/api/news?id=cf223460d1afa0084a97f2633a5999f462656214a7c429f99fd892316ab5522f
company,2023-08-29 13:26:00,"AstraZeneca PLC ADR rises Tuesday, still underperforms market",122399504,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR inched 0.73% higher to $69.14 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the...",https://finnhub.io/api/news?id=0fcf90e9bb2e9a9fadd502124ec7b6970344fd3807069ae9b19be5e3434032d4
company,2023-08-29 09:45:00,"The Zacks Analyst Blog Highlights Regeneron Pharmaceuticals, Merck, Novartis and AstraZeneca",122305579,https://media.zenfs.com/en/zacks.com/cb27584804ea583a87d27499a6976ec2,AZN,Yahoo,"Regeneron Pharmaceuticals, Merck, Novartis and AstraZeneca are part of the Zacks top Analyst Blog.",https://finnhub.io/api/news?id=03b8244a0a0e302c221c6253bf8f2bccb36886b3338ba656218ab3f40f81ff8f
company,2023-08-29 08:01:00,"AstraZeneca rises Tuesday, still underperforms market",122399506,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"AstraZeneca PLC shares rallied 1.35% to £108.04 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the FTSE 100...",https://finnhub.io/api/news?id=05b371807e7691b63c698ac26c2317664943d99b25eb302a5304f89bc6965ca2
company,2023-08-29 07:46:18,"Biden Administration targets drugs from J&J, Merck for controversial Medicare price negotiations",122298982,https://s.yimg.com/ny/api/res/1.2/hBNsRHKacFslYjfHkLg0UA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://s.yimg.com/os/creatr-uploaded-images/2023-07/e087fc20-3096-11ee-95f5-2aba02544846,AZN,Yahoo,The Biden administration revealed the first 10 drugs that will face the Medicare negotiation process under the Inflation Reduction Act.,https://finnhub.io/api/news?id=2e235583614dc8ae4b843287ee9c6e50fc7db7ac1135e1b118581ed85a951e92
company,2023-08-29 07:02:00,What You Missed On Wall Street This Morning,122302915,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=ad3b9c5e4cf7272bc43b31a8a92caf9843c8750fe9813f7090c16b91f4a00dd3
company,2023-08-29 06:29:00,White House names first 10 drugs eligible for Medicare price negotiations,122324256,,AZN,United Press International,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=d8ec0c9a0c2cfd318aae331b0c4edb8e0d15b3918312051268b145e7822cd7de
company,2023-08-29 06:29:00,Biden administration announces first 10 drugs eligible for Medicare price negotiations,122303399,,AZN,United Press International,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=65a78b8975099d473d415d6e9b2a0a787c6e0d2771f4ed89eb0196e1c9912849
company,2023-08-29 04:59:00,"IN THE KNOW: US drug pricing an ""important catalyst"" for AstraZeneca",122308683,,AZN,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=5dee4c2d8c17eefa1dad0ae4af267599073fba72de137ba5054de1a0fe5e5f50
company,2023-08-29 04:35:00,"Biden Targets Cancer, Diabetes Drugs In Controversial Medicare Price Battle",122303400,,AZN,Benzinga,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=71c1023f4c6ee5fce732f0502875a4d5d5b7186e7edc2e53500512354ea66471
company,2023-08-29 03:50:00,"Merck, Amgen, AbbVie products among first 10 drugs selected for Medicare price negotiations",122299002,https://s.wsj.net/public/resources/MWimages/MW-GP644_MicroS_ZG_20180906154215.jpg,AZN,MarketWatch,"Medicare on Tuesday announced the first 10 drugs selected for price negotiations, launching a historic and highly contentious process with big implications...",https://finnhub.io/api/news?id=2ad425bfeb46acae25f5cd95f102e887ae759ab851815a5cb2a357f4d4b45b4d
company,2023-08-29 03:37:25,Biden administration unveils first 10 drugs subject to Medicare price negotiations,122479256,https://image.cnbcfm.com/api/v1/image/106330644-1578667127386rts2xt0x.jpg?v=1693393644&w=1920&h=1080,AZN,CNBC,The announcement of the 10 drugs kicks off a Medicare negotiation process that aims to make costly medications more affordable for older Americans. ,https://finnhub.io/api/news?id=c5992e934f84e12be1597886ef6b97bf9a050aaaf11b9db7b9ec25fc31d45cfb
company,2023-08-29 03:23:00,"Beaten Down COVID-19 Vaccine Partner Stock Catalent Finalizes Deal With Activist Investor, Reports Mixed Q4 Earnings",122302467,,AZN,Benzinga,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=ab8951c06beccb0e32f11a8ca03f5615dc74ff18bb6e2eaae4058ce474cef6e9
company,2023-08-29 02:51:00,Biden unveils first 10 drugs subject to Medicare price negotiation,122303404,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=c1513e20d37b94e326ecad61ef07a56c79cbbfb6e00fe6593bed653163760bdc
company,2023-08-28 23:35:00,What You Missed On Wall Street On Tuesday,122311375,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=54a718202ecf01b09841ac8515201d686144d08569dde07a19bede44be2e3397
company,2023-08-28 22:33:00,Republicans say Medicare drug negotiations will mean fewer new meds,122317882,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=3a46f98ceb3ab18c8cda7ad6b508e7765632d8a3926bd493b730369033b541b0
company,2023-08-28 20:04:00,10 drugs targeted for Medicare price negotiations as Biden pitches cost reductions,122324090,,AZN,"Associated Press, The",Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=8d1baf4e0a095105e47302a7e49868c4012960ff648d6b61769678c97fbd736e
company,2023-08-28 20:04:00,See which drugs President Biden is targeting first for Medicare price-lowering talks,122305669,,AZN,"Associated Press, The",Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=24b78401674f8216d7f47a560d747ca5a7a3933399bd24872b171287fa398e29
company,2023-08-28 13:26:00,"AstraZeneca PLC ADR rises Monday, still underperforms market",122295429,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR inched 0.57% higher to $68.64 Monday, on what proved to be an all-around favorable trading session for the stock market, with the...",https://finnhub.io/api/news?id=db82750c18eb3f927acb8631ebf9d84e6a41f5ba29923c8e201e433d9a50dcbb
company,2023-08-28 08:38:00,Oncology Market's Huge Potential Puts These Stocks in Focus,122276980,https://media.zenfs.com/en/zacks.com/bbb2ede8f8cb3117fe54f0e6dc1c346c,AZN,Yahoo,"The oncology treatment market has been experiencing significant growth lately. Companies like Regeneron Pharmaceuticals (REGN), Merck & Co. (MRK), Novartis (NVS) and AstraZeneca (AZN) have made meaningful contributions in cancer treatment.",https://finnhub.io/api/news?id=6f2b83dde20bfe188e7fa9a0dcb34b4545364f6f4b7e059bca5c58ae245093a8
company,2023-08-28 04:15:00,"Lexicon Pharmaceuticals Underway With Inpefa, But A Lot Of Hard Work",122274247,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1435498034/image_1435498034.jpg?io=getty-c-w1536,AZN,SeekingAlpha,I expect Lexicon Pharmaceuticals to continue to increase its SG&A spending to support Inpefa. Read more to see why LXRX stock is a Buy.,https://finnhub.io/api/news?id=463b36ea85c98dd2f85e63a1254377844bd5db656fb78fb9c5176145f57db6d3
company,2023-08-27 01:01:00,Week In Review: A Consortium Of China Drug Distributors Want To Acquire Poland's Neuca,122264800,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1460462096/image_1460462096.jpg?io=getty-c-w1536,AZN,SeekingAlpha,"WIR China and Poland partner to create a new drug distribution network. Click here to read more about the past week's new deals, financings, and approvals. ",https://finnhub.io/api/news?id=26f248e6f2c7799a908d148ef5f65d76791b512a56eae49a36bb98b973a801a1
company,2023-09-01 13:26:00,AstraZeneca PLC ADR underperforms Friday when compared to competitors despite daily gains,122399498,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR inched 0.47% higher to $68.14 Friday, on what proved to be an all-around mixed trading session for the stock market, with the Dow...",https://finnhub.io/api/news?id=70b68940f02d3a7767ec0eb52c1f2ff40f2b647571e4be81fc3380892d294ed5
company,2023-09-01 13:23:06,Judge withdraws from Medicare drug price case after stock ownership is revealed,122479254,https://image.cnbcfm.com/api/v1/image/107295200-1693595060922-AP19014576261064.jpg?v=1693603386&w=1920&h=1080,AZN,CNBC,Judge Thomas Rose of the U.S. District Court for the Southern District of Ohio withdrew from a case that could block Medicare's drug price negotiation program.,https://finnhub.io/api/news?id=6a6c43b3e9a153d1a7be6f9392400a8b166d5382e0818e03d1e1ef6e8859918f
company,2023-09-01 08:01:00,"AstraZeneca rises Friday, outperforms market",122399499,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"AstraZeneca PLC shares inched up 0.36% to £107.00 Friday, on what proved to be an all-around great trading session for the stock market, with the FTSE 100...",https://finnhub.io/api/news?id=ac8758f8a5c10d71a3aa58cb826ac154a701de929f8d7a64af239d2cc3e854dc
company,2023-08-31 18:05:22,Why this S.F. company says Big Pharma deal is big win for patients,122356230,,AZN,Yahoo,"It's no picnic for chronic disease patients — or, really, anyone — to gather their medical records from multiple doctor offices.  Now the 100-employee, San Francisco-based company, which has raised more than $100 million over nine years, has a new partnership with AstraZeneca plc (NASDAQ: AZN) to expand its platform into cancer.  The company isn't disclosing the value of the deal or how it came together, but it says the information it gathers on behalf of patients ultimately could provide insights that allow paying customers such as AstraZeneca and dozens of other biopharma partners like Genentech Inc. to make better medicines.",https://finnhub.io/api/news?id=9d6b47e54b0759b6e669018d66f24d83b20b39f12651c16ea081c296945d546f
company,2023-08-31 13:26:00,"AstraZeneca PLC ADR falls Thursday, underperforms market",122399500,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"The AstraZeneca PLC ADR shed 1.51% to $67.82 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ...",https://finnhub.io/api/news?id=026d79d161bdabe3a8dc4d12b14936da6e717fc05d1bbbb3b792dc6db7374628
company,2023-08-31 11:22:12,Big Pharma's biggest ally gets trolled on X for attacking Medicare drug pricing list,122351998,https://s.yimg.com/ny/api/res/1.2/IdZwSXWv8Z2H0t7RtGzePQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://s.yimg.com/os/creatr-uploaded-images/2023-08/29771160-4757-11ee-bbba-d4ee97a674c4,AZN,Yahoo,Drug lobbying firm PhRMA faced backlash on social media for its attempt to call Medicare pricing negotiations unfair.,https://finnhub.io/api/news?id=1db5ac297696303216d2f52f1ebde1d7eb2f6c77d4b9b3b8ff230ea5de974404
company,2023-08-31 08:39:00,Biden Administration Vs. Big Pharma: What the Legal Showdown Means for Your Wallet,122346400,,AZN,Benzinga,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=d0ae76f6f343e40c1c73db690e6fa289f4ad78b548ddcf972083801f58cb7267
company,2023-08-31 08:01:00,"AstraZeneca falls Thursday, underperforms market",122399501,https://images.mktw.net/im-220105/social,AZN,MarketWatch,"Shares of AstraZeneca PLC inched down 0.67% to £106.62 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the...",https://finnhub.io/api/news?id=7fb45990a72ac5d4962fc36a9bdc36b03b9512058b6e8b706baa46da6d45212f
company,2023-08-31 07:56:00,Amazon continues hot streak as analysts eye AWS event in the fall as a potential catalyst,122343934,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=cc92e9cfaea5c786018072d0b132d08b04ed9300e2ecb3364f54ea5f07a076b2
company,2023-08-31 07:17:22,Novo Nordisk: Super Focused Pharma Company For The Long Run,122342424,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1445935636/image_1445935636.jpg?io=getty-c-w1536,AZN,SeekingAlpha,Novo Nordisk is one of the most qualitative big pharma companies globally. Read why I am bullish on NVO stock with the long-term investment horizon here.,https://finnhub.io/api/news?id=0c6b5a7c24e70d55f13012bf313cfa55f160536f617b5a35309101e39a9761af
company,2023-08-31 05:03:00,AstraZeneca Enhertu granted Breakthrough Therapy status for two indications,122343936,,AZN,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=5a2bfb4c036ddebd2105e0c5d3691ddb7dc5295d09413ed1eb9758b3432c15c1
company,2023-08-31 04:02:26,China's CanSino seeks more vaccine contracts after AstraZenca deal,122338983,https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png,AZN,Yahoo,"China's CanSino Biologics , which recently announced a contract manufacturing deal to support AstraZenca's  messenger RNA (mRNA) technology vaccine programme, is in talks with more firms on similar deals, its CEO said, as it seeks new revenue streams to make up for plummeting COVID vaccine demand.  CanSino begun researching mRNA technology in 2018 and has built a facility in Shanghai that can produce up to 200 million doses a year, giving it the capacity to provide similar services to other companies, CanSino's CEO and co-founder Xuefeng Yu told Reuters in an interview.  ""This is the first step,"" he said, describing the AstraZenca deal announced earlier this month as ""a business model"".",https://finnhub.io/api/news?id=2fdd2aabb6dee396a5bcc369ee1d99ff56532c780a71f32eba41af4686a1f6fa
company,2023-08-31 04:00:00,ENHERTU® Granted Two Breakthrough Therapy Designations in U.S. for Patients Across Multiple HER2 Expressing Cancers,122343937,,AZN,Business Wire,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=558dc52be7e98739f8e5313f93a0b4240f3d7205d7b9fa16d79fc1a76c2275bd
company,2023-08-31 00:51:18,"CanSino Biologics on AstraZeneca Deal, Earnings",122336350,https://s.yimg.com/ny/api/res/1.2/9WY0.fHsxYu0padSgDkrWA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzU-/https://media.zenfs.com/en/bloomberg_markets_video_2/9e536d29612fca96086e4342a72d0429,AZN,Yahoo,"Xuefeng Yu, Chairman, Co-Founder & CEO at CanSino Biologics, discusses collaboration plans with pharmaceutical companies including AstraZeneca as well as the company's first half results. He speaks with Rishaad Salamat, David Ingles and Yvonne Man on ""Bloomberg Markets Asia"".",https://finnhub.io/api/news?id=3fee467ec3c43a0789aa718f2e3a8e18685a51ac0fc7f0b337a6bc32f26880e2
company,2023-08-30 23:39:00,Roche downgraded to Neutral from Buy at BofA,122343938,,AZN,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=dd27bcd22cbe732d5109235f3d31914a015ecb0be47aa966eaed534c63c70df6
